date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume,label
2009-09-18,Sanofi-aventis (SNY) Completes Acquisition of Merial ,MRK,-0.0040611843525213,0.3361922481064197,-0.0049737481253072,-0.0162080306076066,-0.0057766315639486,0.0107555636934457,0.0181479316871056,-0.0018819977159921,-0.3320394117049259,2
2009-11-04,Merck Says It Won't Seek Another Larger Merger,MRK,0.0642320791869826,-0.4668800422671491,-0.0188738830596296,0.0106694801737896,-0.0121370864026634,-0.0230890392858191,-0.0117171400280389,0.0021441334591578,-0.3720195033821023,2
2009-11-13,Merck (MRK) Drugs Under Scanner Of Cholesterol Study,MRK,0.0036386454143706,0.0295344834050756,-0.0072246194649645,-0.0116037431356234,0.0053843073888477,0.025774928768814,-0.0036680986034048,0.0214499605459119,0.7290495025943453,0
2009-12-02,"Google's Most Popular Stock Searches Today, SNTS, MRK, ITVI, DYAX, SNDA",MRK,-0.0021693576592661,-0.2766428763760342,0.0185034503873953,-0.0022048019756483,-0.0076563334348207,0.0096631384501513,-0.0054914582311769,-0.0008150617607562,0.0823216015883205,2
2009-12-10,SEC On Trail Of Insider Trading Transactions,MRK,0.0104980304104489,-0.1759604808565783,0.0220083975878691,-0.0095366697830951,0.0,-0.0019040826884287,-0.0008150617607562,-0.0024221386470476,-0.0608916215166266,2
2009-12-21,"Health Brings Wealth To The Street (PFE, MRK, AET, UNH, SNY, CHTT)",MRK,0.0077539673603792,-0.4183563958918792,0.0032193771469726,-0.0124504785407009,-0.0065792960882009,0.006089830520479,0.0188831822772139,0.0015916345538258,-0.046830727575306,2
2009-12-23,Merck & Co. Inc (MRK) Gets A Hold Rating,MRK,-0.0132446560176076,-0.095645150917147,0.0015916345538258,0.0077539673603792,0.0032193771469726,-0.0124504785407009,-0.0065792960882009,-0.0069797623896654,-0.5069155002095289,1
2009-12-24,Merck Decides To Discontinue Its Collaboration With ARNA For Dyslipidemia,MRK,-0.0069797623896654,-0.5069155002095289,-0.0132446560176076,0.0015916345538258,0.0077539673603792,0.0032193771469726,-0.0124504785407009,0.0081097078859668,0.5855182035831781,0
2009-12-28,"The World's Largest M&A Deals in 2009 (PFE, WLA, GM, SGP, MRK)",MRK,0.0081097078859668,0.5855182035831781,-0.0069797623896654,-0.0132446560176076,0.0015916345538258,0.0077539673603792,0.0032193771469726,-0.0050951008120174,-0.2465253952790762,1
2010-01-04,"Biotech Listings To Form A Major Chunk Of IPO Market (JNJ, PFE, MRK, CDXS,TNGN, MBGI)",MRK,0.0128627696198126,0.9672281993204984,-0.0140316881717992,-0.0010778513924056,-0.0050951008120174,0.0081097078859668,-0.0069797623896654,0.004052919507697,0.0610441203411369,2
2010-01-14,Merck & Co (MRK) Submits New Data To FDA To Widen Gardasil Use,MRK,0.0272283050780866,-0.1320609809517159,0.0367510467468124,-0.0079263604388246,0.0039789914195067,-0.0005302341958086,0.0015934043572551,-0.0130032986937046,-0.0531685465732548,1
2010-01-25,"Merck (MRK) Doing Well, But Becoming More Transparent",MRK,-0.0028300477504266,-0.1194312947437616,-0.0301896837452576,-0.0231537163457851,0.0100934969875396,0.0291363316040627,-0.0130032986937046,-0.0046435767225014,0.2917043697896238,2
2010-02-05,"Market Round-up (UBS, GOOG¸ AAPL, MOT¸ PG, PFE, MRK, LLY, CVS, WAG)",MRK,-0.0099729671884765,-0.0931294839058439,-0.0418387857930701,-0.0207387824616313,0.0323763634124067,0.0031428281744196,0.0055309286156366,-0.0038115098979041,-0.5553078986183575,2
2010-02-10,Merck & Co. To Change Safety Procedures (MRK),MRK,-0.0074032057747576,-0.018812343230473,-0.0032798278374226,-0.0038115098979041,-0.0099729671884765,-0.0418387857930701,-0.0207387824616313,0.0187846794801631,-0.1420707102452001,0
2010-02-10,Merck & Co. (MRK) Agrees To Changes In Vioxx Settlement,MRK,-0.0074032057747576,-0.018812343230473,-0.0032798278374226,-0.0038115098979041,-0.0099729671884765,-0.0418387857930701,-0.0207387824616313,0.0187846794801631,-0.1420707102452001,0
2010-02-10,"Market Roundup (AAPL, MRK, FITB, PNC, TTWO, GOOG)",MRK,-0.0074032057747576,-0.018812343230473,-0.0032798278374226,-0.0038115098979041,-0.0099729671884765,-0.0418387857930701,-0.0207387824616313,0.0187846794801631,-0.1420707102452001,0
2010-02-11,"Credit Suisse Lowers Estimates, Price Targets On Merck, Pfizer",MRK,0.0187846794801631,-0.1420707102452001,-0.0074032057747576,-0.0032798278374226,-0.0038115098979041,-0.0099729671884765,-0.0418387857930701,0.0010844515353078,0.2409152841694219,2
2010-02-16,"Merck & Co. (MRK) Reports Bigger Profit, Helped By Schering-Ploug Deal ",MRK,0.0200432628760163,0.1599618052049467,0.0010844515353078,0.0187846794801631,-0.0074032057747576,-0.0032798278374226,-0.0038115098979041,-0.0084970144664936,-0.4241836457806349,1
2010-02-16,Merck & Co. (MRK) Reports Schering Fueled Profit Jump,MRK,0.0200432628760163,0.1599618052049467,0.0010844515353078,0.0187846794801631,-0.0074032057747576,-0.0032798278374226,-0.0038115098979041,-0.0084970144664936,-0.4241836457806349,1
2010-02-16,"Merck Reports Inline, Stock Off To Good Start In Premarket (MRK)",MRK,0.0200432628760163,0.1599618052049467,0.0010844515353078,0.0187846794801631,-0.0074032057747576,-0.0032798278374226,-0.0038115098979041,-0.0084970144664936,-0.4241836457806349,1
2010-02-16,MRK Shares Up As 4Q Earnings Match Expectations,MRK,0.0200432628760163,0.1599618052049467,0.0010844515353078,0.0187846794801631,-0.0074032057747576,-0.0032798278374226,-0.0038115098979041,-0.0084970144664936,-0.4241836457806349,1
2010-02-16,Merck Posts Bigger Profit (MRK),MRK,0.0200432628760163,0.1599618052049467,0.0010844515353078,0.0187846794801631,-0.0074032057747576,-0.0032798278374226,-0.0038115098979041,-0.0084970144664936,-0.4241836457806349,1
2010-02-25,Eli Lilly Banks On Its Restructured Development Process To Offset Sales Loss (LLY),MRK,-0.0097482140318786,-0.0033346008716763,0.0115038637859223,-0.0164334191577451,-0.0098689703022577,0.0053633173165825,-0.0013392022572161,0.008477035531569,-0.2270478203175355,0
2010-03-08,"ThinkEquity Reiterates Buy on OraSure Technologies (OSUR, MRK, PFE)",MRK,-0.0037340756544663,0.2207461985504089,0.0094234554607715,-0.0018813820901457,-0.0048139732492509,0.0032198177969877,0.0105747678473262,-0.0082999205238013,0.2198417972416295,1
2010-03-09,Sonofi-Merck (MRK) Deal Positive,MRK,-0.0082999205238013,0.2198417972416295,-0.0037340756544663,0.0094234554607715,-0.0018813820901457,-0.0048139732492509,0.0032198177969877,-0.0099891216083196,0.3218130823329457,1
2010-03-12,Overhang On Merck & Company (MRK) Lifted By IMPROVE-IT Update,MRK,0.0075921348324095,0.0700073904101126,0.0162578844057905,-0.0099891216083196,-0.0082999205238013,-0.0037340756544663,0.0094234554607715,0.0158774195121955,0.0628394260717191,0
2010-03-12,"Merck To Continue Its M&A Spree (MRK, MIL)",MRK,0.0075921348324095,0.0700073904101126,0.0162578844057905,-0.0099891216083196,-0.0082999205238013,-0.0037340756544663,0.0094234554607715,0.0158774195121955,0.0628394260717191,0
2010-03-15,"Benzinga’s News Roundup (PEP, ALKS, MRK)",MRK,0.0158774195121955,0.0628394260717191,0.0075921348324095,0.0162578844057905,-0.0099891216083196,-0.0082999205238013,-0.0037340756544663,0.0050330013806472,0.0512864905900289,0
2010-03-22,FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine,MRK,0.0063056805380454,-0.4972267019180333,-0.0101428504427123,0.0097162236823649,0.0036901329272061,0.0050330013806472,0.0158774195121955,0.0052223353212725,-0.2028087346787853,0
2010-04-23,"Market Roundup (MS, C, HLS, UBS, HBC, USB, MRK)",MRK,0.0500444452970529,0.0813658216818675,-0.0279215182242604,-0.0366057707721817,0.0044566297801147,0.005320695214017,-0.0091563056059913,-0.0129724234663203,-0.3565904113847017,1
2010-04-23,Merck & Co. (MRK) Says U.S. Health-Care Legislation To Reduce 2010 Revenue By $170 Million,MRK,0.0500444452970529,0.0813658216818675,-0.0279215182242604,-0.0366057707721817,0.0044566297801147,0.005320695214017,-0.0091563056059913,-0.0129724234663203,-0.3565904113847017,1
2010-04-23,Merck To Lose $170 Million In Revenue (MRK),MRK,0.0500444452970529,0.0813658216818675,-0.0279215182242604,-0.0366057707721817,0.0044566297801147,0.005320695214017,-0.0091563056059913,-0.0129724234663203,-0.3565904113847017,1
2010-04-23,US Stock Ended In Positive Territory After Losing 100 Points,MRK,0.0500444452970529,0.0813658216818675,-0.0279215182242604,-0.0366057707721817,0.0044566297801147,0.005320695214017,-0.0091563056059913,-0.0129724234663203,-0.3565904113847017,1
2010-04-28,"Afternoon Market Update - Goldman Sachs (NYSE: GS), Merck (NYSE: MRK), AstraZeneca (NYSE: AZN)",MRK,0.0023204008562935,-0.1353025419189474,-0.0148571856731299,-0.0129724234663203,0.0500444452970529,-0.0279215182242604,-0.0366057707721817,0.0199652331084123,0.0807665877733707,0
2010-04-28,Investors Allowed To Sue Merck Over Vioxx (MRK),MRK,0.0023204008562935,-0.1353025419189474,-0.0148571856731299,-0.0129724234663203,0.0500444452970529,-0.0279215182242604,-0.0366057707721817,0.0199652331084123,0.0807665877733707,0
2010-04-30,"DOW Gains The Highest Since March 5, Led By Q1 Gains",MRK,-0.0059576450289002,-0.1381969483515769,0.0199652331084123,0.0023204008562935,-0.0148571856731299,-0.0129724234663203,0.0500444452970529,0.0065638249646675,-0.2097038286775062,0
2010-05-04,Merck & Co.’s (MRK) First-Quarter Profit Down By 77%,MRK,0.015310736483858,1.6108187500527986,0.0065638249646675,-0.0059576450289002,0.0199652331084123,0.0023204008562935,-0.0148571856731299,-0.0061438434668467,-0.3384609121429021,1
2010-05-04,"MRK Shares Rise As Q1 Profits, Sales Exceeds Expectations",MRK,0.015310736483858,1.6108187500527986,0.0065638249646675,-0.0059576450289002,0.0199652331084123,0.0023204008562935,-0.0148571856731299,-0.0061438434668467,-0.3384609121429021,1
2010-05-05,"Merck And Ariad Re-Write Ridaforolimus Contract (MRK, ARIA)",MRK,-0.0061438434668467,-0.3384609121429021,0.015310736483858,0.0065638249646675,-0.0059576450289002,0.0199652331084123,0.0023204008562935,-0.0370885788929216,0.4338477578652697,1
2010-05-05,"US Stocks Dive, Hit By Europe Crisis, Investors Take Refuge In Dollar & Bonds",MRK,-0.0061438434668467,-0.3384609121429021,0.015310736483858,0.0065638249646675,-0.0059576450289002,0.0199652331084123,0.0023204008562935,-0.0370885788929216,0.4338477578652697,1
2010-05-05,"Benzinga’s Top Pre-Market Gainers (AMMD, HNSN, ACAS, ARIA, ERTS)",MRK,-0.0061438434668467,-0.3384609121429021,0.015310736483858,0.0065638249646675,-0.0059576450289002,0.0199652331084123,0.0023204008562935,-0.0370885788929216,0.4338477578652697,1
2010-05-11,Five New Drugs On Cards for Merck (MRK),MRK,-0.021605842867672,0.0512096420906851,0.0226934015559525,-0.0227608087917201,-0.0370885788929216,-0.0061438434668467,0.015310736483858,0.0038795199916572,-0.2253056628742004,2
2010-05-12,"US Stocks End Lower Yesterday After Soaring On Monday, Dow And S&P Down, Nasdaq Bucks Trend",MRK,0.0038795199916572,-0.2253056628742004,-0.021605842867672,0.0226934015559525,-0.0227608087917201,-0.0370885788929216,-0.0061438434668467,-0.0098097335911042,-0.2323760768810128,1
2010-05-27,"Citigroup Outlook For U.S. Major Pharmaceuticals (MRK, PFE, BMY)",MRK,0.0370143503308355,0.1646254381049932,0.0112288184579143,0.0062778513790195,-0.0056181096889401,0.0069138463390676,-0.0245249998734879,0.0020817306480851,-0.1827397451248081,2
2010-06-22,Late Market Roundup,MRK,0.000284623631515,0.0532606070515184,-0.0154188866334789,-0.0052986587005104,-0.0041655464017232,-0.0002778539854643,0.0285555150051144,0.008255331820566,-0.2072756332585582,0
2010-07-08,Late Market Roundup,MRK,0.012136951097377,-0.0782748721149666,0.0225107619348527,0.0125658371478596,-0.0063882166730827,-0.0151554030228708,-0.0129835250637452,0.0122699043951302,-0.2295724654977134,0
2010-07-08,Merck Details Global Restructuring Program,MRK,0.012136951097377,-0.0782748721149666,0.0225107619348527,0.0125658371478596,-0.0063882166730827,-0.0151554030228708,-0.0129835250637452,0.0122699043951302,-0.2295724654977134,0
2010-07-08,"News Summary (HRB, BP, MRK)",MRK,0.012136951097377,-0.0782748721149666,0.0225107619348527,0.0125658371478596,-0.0063882166730827,-0.0151554030228708,-0.0129835250637452,0.0122699043951302,-0.2295724654977134,0
2010-07-13,GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth ,MRK,0.0099750672397562,0.022706378048656,-0.0057852603744796,0.0122699043951302,0.012136951097377,0.0225107619348527,0.0125658371478596,-0.0068588289241968,-0.1321285463367943,1
2010-07-14,10 Firms Expecting Clinical Trial Results,MRK,-0.0068588289241968,-0.1321285463367943,0.0099750672397562,-0.0057852603744796,0.0122699043951302,0.012136951097377,0.0225107619348527,0.0080110663900863,-0.0185729207218035,0
2010-07-26,Corporate Catalysts For The Week Starting July 26 ,MRK,0.0114709878972023,-0.3855235110549653,-0.0088118749287465,-0.0002839699986221,-0.0131804373461245,-0.0039104201778575,-0.0030630984731945,-0.0025515052256336,0.3158233035778308,2
2010-07-27,Merk and Sinopharm Sign Statement of Mutual Intent,MRK,-0.0025515052256336,0.3158233035778308,0.0114709878972023,-0.0088118749287465,-0.0002839699986221,-0.0131804373461245,-0.0039104201778575,-0.0125075106181884,-0.2340798189948524,1
2010-07-27,A Peek Into The Market At The Start Of The Trading Day,MRK,-0.0025515052256336,0.3158233035778308,0.0114709878972023,-0.0088118749287465,-0.0002839699986221,-0.0131804373461245,-0.0039104201778575,-0.0125075106181884,-0.2340798189948524,1
2010-07-27,Sanofi-aventis and Merck Appoint CEO for Joint Venture,MRK,-0.0025515052256336,0.3158233035778308,0.0114709878972023,-0.0088118749287465,-0.0002839699986221,-0.0131804373461245,-0.0039104201778575,-0.0125075106181884,-0.2340798189948524,1
2010-07-30,US Stock Futures Point To Weak Day Today,MRK,-0.0171133271168336,0.4907386828206288,0.0092113999575798,-0.0125075106181884,-0.0025515052256336,0.0114709878972023,-0.0088118749287465,0.0177013672319688,-0.4426434117871142,0
2010-07-30,"Merck’s Q2 Earnings Beat Targets, Revenue Misses",MRK,-0.0171133271168336,0.4907386828206288,0.0092113999575798,-0.0125075106181884,-0.0025515052256336,0.0114709878972023,-0.0088118749287465,0.0177013672319688,-0.4426434117871142,0
2010-07-30,"Earnings Scheduled For July 30 (MRK, AON, CVX, CVH, WY, PPC)",MRK,-0.0171133271168336,0.4907386828206288,0.0092113999575798,-0.0125075106181884,-0.0025515052256336,0.0114709878972023,-0.0088118749287465,0.0177013672319688,-0.4426434117871142,0
2010-07-30,"Stocks To Watch For July 30 (FSLR, MRK, CVX, AON, CSTR)",MRK,-0.0171133271168336,0.4907386828206288,0.0092113999575798,-0.0125075106181884,-0.0025515052256336,0.0114709878972023,-0.0088118749287465,0.0177013672319688,-0.4426434117871142,0
2010-07-30,"ETFs To Watch July 30, 2010 (HAO, PPH, YCS, PALL)",MRK,-0.0171133271168336,0.4907386828206288,0.0092113999575798,-0.0125075106181884,-0.0025515052256336,0.0114709878972023,-0.0088118749287465,0.0177013672319688,-0.4426434117871142,0
2010-07-30,Merck Posts Mixed Results (MRK),MRK,-0.0171133271168336,0.4907386828206288,0.0092113999575798,-0.0125075106181884,-0.0025515052256336,0.0114709878972023,-0.0088118749287465,0.0177013672319688,-0.4426434117871142,0
2010-08-06,Oncothyreon Phase 3 Breast Cancer Trial Shut Down,MRK,-0.0025657930796052,0.1586153990580054,-0.0034102660931942,0.0106260564638134,-0.0071283741527287,0.0177013672319688,-0.0171133271168336,0.0108632122747129,-0.1163755843430518,0
2010-08-09,Finally There Is A Cure For Tobacco Addiction (CIGX),MRK,0.0108632122747129,-0.1163755843430518,-0.0025657930796052,-0.0034102660931942,0.0106260564638134,-0.0071283741527287,0.0177013672319688,0.0115949821459855,0.151689029477712,0
2010-08-12,Merck Announces Mandatory Conversion of its 6.00% Mandatory Convertible Preferred Stock,MRK,0.0042991773256582,-0.263958683124681,-0.0246017298096654,0.0115949821459855,0.0108632122747129,-0.0025657930796052,-0.0034102660931942,-0.0011414458331469,-0.0443004876593113,2
2010-08-13,All Is Not Well In The Pharmaceutical Industry,MRK,-0.0011414458331469,-0.0443004876593113,0.0042991773256582,-0.0246017298096654,0.0115949821459855,0.0108632122747129,-0.0025657930796052,-0.0008574147142116,-0.2131692946135901,2
2010-08-13,"U.S. Probing Pharmaceutical Corruption (GSK, PFE, BMY, LLY)",MRK,-0.0011414458331469,-0.0443004876593113,0.0042991773256582,-0.0246017298096654,0.0115949821459855,0.0108632122747129,-0.0025657930796052,-0.0008574147142116,-0.2131692946135901,2
2010-08-26,A New Round Of Corporate Layoffs?,MRK,-0.001737132240641,-0.1989948967501037,0.0029034177343807,-0.0151554030228708,0.0153886238188123,-0.0077787190930146,-0.0186597035265789,0.0150812252557455,0.1236919967193352,0
2010-09-09,Top 10 'Buy'-Rated Stocks Under $5,MRK,0.0075393451105223,-0.4777780698258125,0.0098704830831928,-0.0036526299654142,0.0067892261218114,-0.0075799092839251,0.0130825222027637,0.0157986315661855,-0.0296164987677807,0
2010-09-16,Unconfirmed Chatter that Merck & Co. Inc. (MRK) will buy Medicines Co. (MDCO) at $23.00 a share,MRK,-0.0021913039034751,-0.2089928307858534,-0.0002737962543504,0.008282762973516,-0.0013786693634334,0.0157986315661855,0.0075393451105223,-0.0027447269235201,0.8041738583830411,2
2010-09-23,Travelers Mad As Hell ,MRK,-0.0081170084447043,-0.144792996731264,0.0065362331269487,0.0049262197497637,0.0057800422189864,-0.0027447269235201,-0.0021913039034751,0.0185487055696094,0.0975137976110389,0
2010-10-01,Merck Announces Pivotal Phase III Data for Boceprevir will be Presented at Liver Diseases Meeting  ,MRK,-0.0057051673466893,-0.1426767078592067,-0.0083509026546811,-0.0034903332687626,0.0032322345941548,-0.0056241084255737,0.0185487055696094,-0.0021858321296249,-0.2135088904475401,2
2010-10-04,Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX Case ,MRK,-0.0021858321296249,-0.2135088904475401,-0.0057051673466893,-0.0083509026546811,-0.0034903332687626,0.0032322345941548,-0.0056241084255737,0.0136912317834712,0.1553130626383589,0
2010-10-27,"Merck In Talks To Acquire InterMune (MRK, ITMN)",MRK,-0.0164550899464216,0.7061407403158604,-0.0093532040650633,0.0086249993015596,0.0,0.0029739854157193,0.0128696760714845,0.0131651821667366,-0.1855785126537156,0
2010-10-29,News Summary,MRK,-0.0170552675604052,0.5430737444453704,0.0131651821667366,-0.0164550899464216,-0.0093532040650633,0.0086249993015596,0.0,-0.0016518592631019,-0.3652581067806881,2
2010-10-29,"Stocks To Watch For October 29 (MSFT, MRK, EXPE, CVX, MXIM)",MRK,-0.0170552675604052,0.5430737444453704,0.0131651821667366,-0.0164550899464216,-0.0093532040650633,0.0086249993015596,0.0,-0.0016518592631019,-0.3652581067806881,2
2010-10-29,"Earnings Scheduled For October 29 (CVX, POM, CEG, MRK, PGN, NEE, SNE, D, EL, ITT, CI, WY, EIX, LNT)",MRK,-0.0170552675604052,0.5430737444453704,0.0131651821667366,-0.0164550899464216,-0.0093532040650633,0.0086249993015596,0.0,-0.0016518592631019,-0.3652581067806881,2
2010-10-29,US Stock Futures Down As Investors Await Q3 GDP Data,MRK,-0.0170552675604052,0.5430737444453704,0.0131651821667366,-0.0164550899464216,-0.0093532040650633,0.0086249993015596,0.0,-0.0016518592631019,-0.3652581067806881,2
2010-11-09,Merck Wins TEMODAR Patent Infringement Lawsuit ,MRK,-0.0160022470825412,0.5560961772246957,-0.0022409368777873,-0.0259207928961677,0.0038346148364232,-0.002731315374705,0.0099305819640933,-0.0025681221649286,-0.1047768478136643,2
2010-11-30,Merck Board Elects Kenneth C. Frazier as Next CEO,MRK,-0.0063421537926158,1.9027574563871688,-0.0028742881422602,-0.0102419622716127,0.0097675968072235,-0.0219163056063137,0.0073595160521957,0.0171162825250537,-0.1438667334000074,0
2010-11-30,Merck Down Slightly On New CEO (MRK),MRK,-0.0063421537926158,1.9027574563871688,-0.0028742881422602,-0.0102419622716127,0.0097675968072235,-0.0219163056063137,0.0073595160521957,0.0171162825250537,-0.1438667334000074,0
2010-11-30,News Summary,MRK,-0.0063421537926158,1.9027574563871688,-0.0028742881422602,-0.0102419622716127,0.0097675968072235,-0.0219163056063137,0.0073595160521957,0.0171162825250537,-0.1438667334000074,0
2010-12-02,A Peek Into The Market Before The Trading Starts,MRK,0.0045636023216855,0.1381035555768874,0.0171162825250537,-0.0063421537926158,-0.0028742881422602,-0.0102419622716127,0.0097675968072235,0.0022717381783232,-0.7126189571224669,2
2010-12-02,"Merck to Acquire SmartCells, Inc; Transaction May Exceed $500M",MRK,0.0045636023216855,0.1381035555768874,0.0171162825250537,-0.0063421537926158,-0.0028742881422602,-0.0102419622716127,0.0097675968072235,0.0022717381783232,-0.7126189571224669,2
2010-12-06,ETFs For Biotech M&A Mania,MRK,-0.0014166397657103,-0.0155637732240595,0.0022717381783232,0.0045636023216855,0.0171162825250537,-0.0063421537926158,-0.0028742881422602,0.0034042744555746,0.7076104130230969,2
2010-12-10,"Mad Money Lightning Round: Cramer Advises Investors To Buy BlackRock (LLY, DECK, CMI, OXPS, AXP, V, MRK, ABT, BLK)",MRK,0.008971117820766,0.3622446097598824,0.0076269016769003,0.0008483535494239,0.0034042744555746,-0.0014166397657103,0.0022717381783232,0.0137603780091113,0.5663669981418074,0
2010-12-22,FDA's Approves Gardasil to Prevent Anal Cancer ,MRK,0.001105392998933,-0.1331197022393209,-0.0087673484714635,0.0005486061311428,-0.009772188326151,0.0049100853022108,0.0030096982098772,0.0019326973619779,-0.1603875223826,2
2011-01-11,Merck Announces FDA Acceptance of New Drug Application for JANUMET®   ,MRK,-0.0067204308704078,-0.045609274171375,-0.0040162416644936,0.0078250429045418,0.0136763973427846,0.0057769398706684,0.0086016436993228,0.0054128511214515,0.2593457066057447,0
2011-01-19,Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar (MRK),MRK,0.0011811394919238,-0.4956066097356558,-0.0105173082127159,-0.0132603288488516,-0.0662179754594153,0.0054128511214515,-0.0067204308704078,0.0041288887900554,-0.2735976595182777,2
2011-02-03,"US Stock Futures Mixed As Investors Await Earnings Reports, Economic Data; Merck Earnings In Focus",MRK,-0.0272027131363629,1.917659414071008,-0.0052942276532972,0.0250222789653831,0.0030244183542491,-0.005413827262633,0.0015062423337588,-0.0003041970668912,-0.3719311477654439,2
2011-02-03,Merck Reports Q4 EPS of $0.88,MRK,-0.0272027131363629,1.917659414071008,-0.0052942276532972,0.0250222789653831,0.0030244183542491,-0.005413827262633,0.0015062423337588,-0.0003041970668912,-0.3719311477654439,2
2011-02-03,A Peek Into The Market Before The Trading Starts,MRK,-0.0272027131363629,1.917659414071008,-0.0052942276532972,0.0250222789653831,0.0030244183542491,-0.005413827262633,0.0015062423337588,-0.0003041970668912,-0.3719311477654439,2
2011-02-14,Merck Wins First FOSAMAX State Court Trial ,MRK,-0.0075597233467602,0.1627387103780784,0.0009079027801817,-0.0015111581224885,-0.00541021094247,0.0081817596838771,0.0033447098037111,-0.0009138968381043,0.3645342687873636,2
2011-03-07,Merck Announces New Data Analyses for VICTRELIS Will Be Presented at The International Liver Congress,MRK,-0.0069571054981415,-0.006669955796437,-0.0012084336108754,0.0159605566544442,0.003696871755515,-0.0033772924038981,0.0118047964311904,0.0045686424610509,-0.7003424884759404,2
2011-03-17,ARIAD Announces Election to Co-Promote Ridaforolimus in Sarcoma Indication in U.S. upon Approval ,MRK,0.011583092696398,-0.4078588606126012,-0.0244821395400632,-0.0160592852264078,-0.0106934544573762,0.0064574491288165,-0.0117151866046916,0.0149492208040367,0.4209911549785603,0
2011-03-18,Committee for Medicinal Products for Human Use (CHMP) Issues Positive Opinion for New Contraception Offering,MRK,0.0149492208040367,0.4209911549785603,0.011583092696398,-0.0244821395400632,-0.0160592852264078,-0.0106934544573762,0.0064574491288165,0.0150423155346068,-0.2164600929814257,0
2011-03-22,"Zings Of The Day (SNY, MRK, AAPL, AMZN)",MRK,0.0043222437227776,0.0798587307170104,0.0150423155346068,0.0149492208040367,0.011583092696398,-0.0244821395400632,-0.0160592852264078,0.0030736636263035,-0.2528622161874543,2
2011-03-24,Merck Announces FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age ,MRK,0.0027586978200695,-0.0674169622837287,0.0030736636263035,0.0043222437227776,0.0150423155346068,0.0149492208040367,0.011583092696398,-0.0045842693680596,-0.0805454423692956,2
2011-03-24,Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck   ,MRK,0.0027586978200695,-0.0674169622837287,0.0030736636263035,0.0043222437227776,0.0150423155346068,0.0149492208040367,0.011583092696398,-0.0045842693680596,-0.0805454423692956,2
2011-03-31,"VICTRELIS, Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control   ",MRK,-0.0087082865036377,-0.268773451342218,0.0158633242519103,0.0101693102597923,-0.0036846715029124,-0.0045842693680596,0.0027586978200695,0.0018171465876137,-0.0926821533338618,2
2011-04-05,"Merck to Acquire Inspire Pharmaceuticals, Inc. for $5.00 per Share Totaling $430M",MRK,-0.0033061336562308,-0.1975777376002248,0.0060479415875027,0.0018171465876137,-0.0087082865036377,0.0158633242519103,0.0101693102597923,0.0057296924140781,0.4111098263150776,0
2011-04-06,Experts Think Merck's Gardasil Could Be Widely Distributed (MRK),MRK,0.0057296924140781,0.4111098263150776,-0.0033061336562308,0.0060479415875027,0.0018171465876137,-0.0087082865036377,0.0158633242519103,-0.0005995106827064,-0.0357923021301499,2
2011-04-08,Merck Loses U.K. Appeal Against Teva to Reinstate Cosopt Patent (MRK),MRK,0.0102010155931393,0.4620241518419299,-0.0005995106827064,0.0057296924140781,-0.0033061336562308,0.0060479415875027,0.0018171465876137,-0.0023759596660657,-0.3917574516993177,2
2011-04-11,Merck & Co and Sun Pharma Establish Joint Venture (MRK),MRK,-0.0023759596660657,-0.3917574516993177,0.0102010155931393,-0.0005995106827064,0.0057296924140781,-0.0033061336562308,0.0060479415875027,-0.0008931956210248,0.3038291750448936,2
2011-04-11,"FDA Approves Merck's SYLATRON for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement   ",MRK,-0.0023759596660657,-0.3917574516993177,0.0102010155931393,-0.0005995106827064,0.0057296924140781,-0.0033061336562308,0.0060479415875027,-0.0008931956210248,0.3038291750448936,2
2011-04-12,"Inspire Pharmaceuticals Shareholder Sues Over Merck Deal (MRK, ISPH)",MRK,-0.0008931956210248,0.3038291750448936,-0.0023759596660657,0.0102010155931393,-0.0005995106827064,0.0057296924140781,-0.0033061336562308,-0.0026818935582849,-0.4633887323667134,2
2011-04-15,A Peek Into The Market Before The Trading Starts,MRK,0.0191970586194545,1.4570439160000408,0.011652018281071,-0.0026818935582849,-0.0008931956210248,-0.0023759596660657,0.0102010155931393,-0.0168067662491354,-0.5179840951406071,1
2011-04-15,Merck Reaffirms 2011 Non-GAAP EPS Target of $3.64 to $3.76,MRK,0.0191970586194545,1.4570439160000408,0.011652018281071,-0.0026818935582849,-0.0008931956210248,-0.0023759596660657,0.0102010155931393,-0.0168067662491354,-0.5179840951406071,1
2011-04-15,"Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck (JNJ, MRK)",MRK,0.0191970586194545,1.4570439160000408,0.011652018281071,-0.0026818935582849,-0.0008931956210248,-0.0023759596660657,0.0102010155931393,-0.0168067662491354,-0.5179840951406071,1
2011-04-15,"  Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI® (MRK, JNJ)",MRK,0.0191970586194545,1.4570439160000408,0.011652018281071,-0.0026818935582849,-0.0008931956210248,-0.0023759596660657,0.0102010155931393,-0.0168067662491354,-0.5179840951406071,1
2011-04-15,Merck Commences Tender Offer for Inspire Pharmaceuticals at $5.00 per Share    ,MRK,0.0191970586194545,1.4570439160000408,0.011652018281071,-0.0026818935582849,-0.0008931956210248,-0.0023759596660657,0.0102010155931393,-0.0168067662491354,-0.5179840951406071,1
2011-04-18,Don't Fall For The 'Defensive Portfolio' Hype,MRK,-0.0168067662491354,-0.5179840951406071,0.0191970586194545,0.011652018281071,-0.0026818935582849,-0.0008931956210248,-0.0023759596660657,-0.005305296175171,-0.145907230112949,1
2011-04-21,Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases   ,MRK,0.0,0.1116892681577643,0.0085928824773962,-0.005305296175171,-0.0168067662491354,0.0191970586194545,0.011652018281071,0.0085191483987214,-0.3910936566715548,0
2011-04-25,"Merck's Hepatitis C Drug Increases Anemia Risk, FDA Staff Says -Bloomberg (MRK)",MRK,0.0085191483987214,-0.3910936566715548,0.0,0.0085928824773962,-0.005305296175171,-0.0168067662491354,0.0191970586194545,0.0212640842153093,1.2334876843950662,0
2011-04-25,"Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing   ",MRK,0.0085191483987214,-0.3910936566715548,0.0,0.0085928824773962,-0.005305296175171,-0.0168067662491354,0.0191970586194545,0.0212640842153093,1.2334876843950662,0
2011-04-27,Hepatitis Treatment Wins Over the U.S. FDA Panel -Bloomberg (MRK),MRK,0.0162579827032678,-0.0519767441860464,0.0212640842153093,0.0085191483987214,0.0,0.0085928824773962,-0.005305296175171,0.0039294544150987,-0.3400564396751816,2
2011-04-27,VICTRELIS Unanimously Recommended for Approval by FDA Advisory Committee for Treatment of Chronic HCV Genotype 1 Infection   ,MRK,0.0162579827032678,-0.0519767441860464,0.0212640842153093,0.0085191483987214,0.0,0.0085928824773962,-0.005305296175171,0.0039294544150987,-0.3400564396751816,2
2011-04-27,VICTRELIS™ Unanimously Recommended for Approval by FDA Advisory Committee (MRK),MRK,0.0162579827032678,-0.0519767441860464,0.0212640842153093,0.0085191483987214,0.0,0.0085928824773962,-0.005305296175171,0.0039294544150987,-0.3400564396751816,2
2011-04-27,Merck Announces New $5 Billion Share Repurchase Program (MRK),MRK,0.0162579827032678,-0.0519767441860464,0.0212640842153093,0.0085191483987214,0.0,0.0085928824773962,-0.005305296175171,0.0039294544150987,-0.3400564396751816,2
2011-04-28,"  Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire (ISPH, MRK)",MRK,0.0039294544150987,-0.3400564396751816,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0085928824773962,0.0050318096152415,0.4076706740076337,0
2011-04-29,Merck Up On Strong Earnings Today (MRK),MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,"Stocks To Watch For April 29 (CVX, RIMM, CAT, MSFT, MRK)",MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,UPDATE: Merck Reports Upbeat Q1 Earnings; Shares Rise In Pre-Market trading,MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,Merck Announces First Quarter 2011 Financial Results   ,MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,Merck Guides FY 2011 EPS $3.66-3.76 vs. $3.69 Est. (MRK),MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,Merck Reports EPS of $0.92 vs. $0.84 Estimate; Revenues $11.58B vs. $11.37B Estimate ,MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,"US Stock Futures Mixed As Investors Await Economic Data, Earnings Reports; Research In Motion Shares Decline In Pre-Market trading",MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,A Peek Into The Market Before The Trading Starts,MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-04-29,Friday Morning Market Summary 4/29/2011,MRK,0.0050318096152415,0.4076706740076337,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0085191483987214,0.0,0.0100140638764383,-0.028925290820142,0
2011-05-03,"Morning News Summary for May 3, 2011",MRK,0.0027542597295746,-0.0362314989862422,0.0100140638764383,0.0050318096152415,0.0039294544150987,0.0162579827032678,0.0212640842153093,0.0041195915570195,-0.0181704294051927,2
2011-05-06,"UPDATE: FDA Approves New Treatment for Rare Type of Pancreatic Cancer (PFE, MRK, GSK)",MRK,0.00386183490701,-0.225269563766037,-0.00847897996174,0.0041195915570195,0.0027542597295746,0.0100140638764383,0.0050318096152415,0.0024734087462596,-0.1597670619112221,2
2011-05-17,Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C ,MRK,-0.0008041950831315,0.0878052305139418,0.0059332524179143,-0.00322542924441,0.0155606555210101,-0.0038077069090582,0.0079497453825767,0.0083172907507929,-0.363161393397697,0
2011-05-19,Exclusive – Merck Talks To Benzinga About Collaboration With Roche (MRK),MRK,-0.0053218851977014,-0.1217560215047282,0.0083172907507929,-0.0008041950831315,0.0059332524179143,-0.00322542924441,0.0155606555210101,-0.0085606544730374,-0.0064993894974478,1
2011-05-20,"CHMP Issues Positive Opinion for Merck's VICTRELISTM, Oral Hepatitis C Virus Protease Inhibitor   ",MRK,-0.0085606544730374,-0.0064993894974478,-0.0053218851977014,0.0083172907507929,-0.0008041950831315,0.0059332524179143,-0.00322542924441,-0.0043173262552728,0.1121303249615692,2
2011-05-23,Vertex Hepatitis C Drug Approved by the FDA -Bloomberg,MRK,-0.0043173262552728,0.1121303249615692,-0.0085606544730374,-0.0053218851977014,0.0083172907507929,-0.0008041950831315,0.0059332524179143,-0.0008132359421684,-0.0853688382936185,2
2011-05-24,FTC Files Amicus Brief In K-dur Antitrust Litigation -Bloomberg,MRK,-0.0008132359421684,-0.0853688382936185,-0.0043173262552728,-0.0085606544730374,-0.0053218851977014,0.0083172907507929,-0.0008041950831315,-0.0048817697155125,-0.0225922011418546,2
2011-05-26,InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Sandoz   ,MRK,-0.0084490982360135,0.5104960223935933,-0.0048817697155125,-0.0008132359421684,-0.0043173262552728,-0.0085606544730374,-0.0053218851977014,-0.0046729768518002,-0.3831443275779145,2
2011-05-31,Health Canada Approves Gardasil to Prevent Anal Cancer,MRK,0.014913069124776,0.4101440277817816,-0.0046729768518002,-0.0084490982360135,-0.0048817697155125,-0.0008132359421684,-0.0043173262552728,-0.0136054405211933,-0.2360085284249446,1
2011-06-02,FDA Says that High Blood Pressure Drugs Do Not Increase Cancer Risk -Bloomberg,MRK,-0.0027586532482009,-0.0641961926092581,-0.0136054405211933,0.014913069124776,-0.0046729768518002,-0.0084490982360135,-0.0048817697155125,-0.0091286315267191,-0.0655562569104453,1
2011-06-02,FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer ,MRK,-0.0027586532482009,-0.0641961926092581,-0.0136054405211933,0.014913069124776,-0.0046729768518002,-0.0084490982360135,-0.0048817697155125,-0.0091286315267191,-0.0655562569104453,1
2011-06-03,"Pimco's Gross Likes P&G and Merck, Offer Better Yields and Conservative -Bloomberg",MRK,-0.0091286315267191,-0.0655562569104453,-0.0027586532482009,-0.0136054405211933,0.014913069124776,-0.0046729768518002,-0.0084490982360135,-0.0072588837050421,-0.0250374287261491,1
2011-06-06,Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting ,MRK,-0.0072588837050421,-0.0250374287261491,-0.0091286315267191,-0.0027586532482009,-0.0136054405211933,0.014913069124776,-0.0046729768518002,0.0002816291124851,0.0426865116021191,2
2011-06-07,Roche and Merck Collaborate to Develop Diagnostic Tests for Merck's Investigational Cancer Therapies   ,MRK,0.0002816291124851,0.0426865116021191,-0.0072588837050421,-0.0091286315267191,-0.0027586532482009,-0.0136054405211933,0.014913069124776,0.0061848758879945,0.2008438148681612,0
2011-06-08,Merck Announces U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose and Updated Drug Interaction Information  ,MRK,0.0061848758879945,0.2008438148681612,0.0002816291124851,-0.0072588837050421,-0.0091286315267191,-0.0027586532482009,-0.0136054405211933,0.0058677888978848,0.1266221409884922,0
2011-06-08,"UPDATE: Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 ",MRK,0.0061848758879945,0.2008438148681612,0.0002816291124851,-0.0072588837050421,-0.0091286315267191,-0.0027586532482009,-0.0136054405211933,0.0058677888978848,0.1266221409884922,0
2011-06-09,FDA Urges Limits On Dosages Of Zocor -WSJ,,,,,,,,,,,2
MRK,0.0058677888978848625,0.12662214098849223,0.0061848758879945,0.0002816291124851,-0.0072588837050421,-0.0091286315267191,-0.0027586532482009,-0.0152779147731286,-0.1246303774029986,,,2
2011-06-09,5-Alpha Reductase Inhibitors May Increase Risk of Prostate Cancer -FDA,MRK,0.0058677888978848,0.1266221409884922,0.0061848758879945,0.0002816291124851,-0.0072588837050421,-0.0091286315267191,-0.0027586532482009,-0.0152779147731286,-0.1246303774029986,1
2011-06-20,Ligand Enters into Captisol Commercial Supply Agreement with Merck   ,MRK,0.0113028690346861,-0.2834767457992694,0.0059690936168275,0.0002847188420305,-0.0131876016632742,0.0087746247586257,0.0074133669028735,-0.0002796216396986,-0.2023166918359157,2
2011-06-27,"Stocks Shrug Off Greece, Deficit Uncertainty",MRK,-0.0005785465020089,-0.3461072761478777,-0.0120102217955549,-0.0140968233273259,-0.008664018159964,-0.0002796216396986,0.0113028690346861,0.011004896959194,-0.0796763959061747,0
2011-06-28,A Peek Into The Market Before The Trading Starts,MRK,0.011004896959194,-0.0796763959061747,-0.0005785465020089,-0.0120102217955549,-0.0140968233273259,-0.008664018159964,-0.0002796216396986,0.0054424270034141,0.2820073826652849,0
2011-06-28,UPS and Merck Expand Their Distribution and Logistics Agreement,MRK,0.011004896959194,-0.0796763959061747,-0.0005785465020089,-0.0120102217955549,-0.0140968233273259,-0.008664018159964,-0.0002796216396986,0.0054424270034141,0.2820073826652849,0
2011-07-01,"Merck Receives Approval to Market GARDASIL, ZOLINZA and CUBICIN in Japan",MRK,0.0087841499500365,-0.2250219968812994,0.0054133034495229,0.0054424270034141,0.011004896959194,-0.0005785465020089,-0.0120102217955549,-0.0030893553447968,-0.0906202266056058,2
2011-07-08,Hottest and Coldest Sectors for Friday 7/8/11,MRK,0.010915471855238,0.2306085817705927,0.0056288757357152,0.0011266112968295,-0.0030893553447968,0.0087841499500365,0.0054133034495229,-0.0121816393498846,-0.3180780965013356,1
2011-07-11,Merck to Participate in New Research Efforts to Eradicate HIV   ,MRK,-0.0121816393498846,-0.3180780965013356,0.010915471855238,0.0056288757357152,0.0011266112968295,-0.0030893553447968,0.0087841499500365,-0.0014015094870553,0.1553673723304873,2
2011-07-18,"Merck Announces VICTRELIS First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the EU for Treatment of Chronic Hepatitis C   ",MRK,-0.0122455654031008,-0.2723282384640827,-0.0104654933426218,0.0077712790860162,0.0112266528410629,-0.0014015094870553,-0.0121816393498846,0.0084529090440059,0.0667280727951755,0
2011-07-18,Merck's ISENTRESS in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1 ,MRK,-0.0122455654031008,-0.2723282384640827,-0.0104654933426218,0.0077712790860162,0.0112266528410629,-0.0014015094870553,-0.0121816393498846,0.0084529090440059,0.0667280727951755,0
2011-07-19,Dow Jones Industrial Average Companies Increase Expected Dividend Distribution by 12.66% From a Year Ago,MRK,0.0084529090440059,0.0667280727951755,-0.0122455654031008,-0.0104654933426218,0.0077712790860162,0.0112266528410629,-0.0014015094870553,-0.0055883946388463,-0.2653099120717836,1
2011-07-20,Merck and Roche Expand Agreement in Fight Against Chronic Hepatitis C,MRK,-0.0055883946388463,-0.2653099120717836,0.0084529090440059,-0.0122455654031008,-0.0104654933426218,0.0077712790860162,0.0112266528410629,0.0165775448489666,0.3672658912211628,0
2011-07-21,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",MRK,0.0165775448489666,0.3672658912211628,-0.0055883946388463,0.0084529090440059,-0.0122455654031008,-0.0104654933426218,0.0077712790860162,-0.0024874301704442,-0.3341266691560015,2
2011-07-22,"Earnings Preview: Mylan Laboratories EPS, Revenue Expected to Rise from Previous Quarter",MRK,-0.0024874301704442,-0.3341266691560015,0.0165775448489666,-0.0055883946388463,0.0084529090440059,-0.0122455654031008,-0.0104654933426218,-0.0055418604976167,0.594186565990247,1
2011-07-25,Ratchet Back The Risk With These ETFs,MRK,-0.0055418604976167,0.594186565990247,-0.0024874301704442,0.0165775448489666,-0.0055883946388463,0.0084529090440059,-0.0122455654031008,-0.0027858788429107,-0.2098266432108798,2
2011-07-26,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",MRK,-0.0027858788429107,-0.2098266432108798,-0.0055418604976167,-0.0024874301704442,0.0165775448489666,-0.0055883946388463,0.0084529090440059,-0.0167646894485643,0.4964769392119412,1
2011-07-26,"Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas ",MRK,-0.0027858788429107,-0.2098266432108798,-0.0055418604976167,-0.0024874301704442,0.0165775448489666,-0.0055883946388463,0.0084529090440059,-0.0167646894485643,0.4964769392119412,1
2011-07-28,How to Profit from Exploding Government Healthcare Costs ,MRK,-0.0073885071001364,-0.0317491153504504,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0024874301704442,0.0165775448489666,-0.0229027628552871,0.393728097113335,1
2011-07-29,US Stock Futures Down On Debt Worries,MRK,-0.0229027628552871,0.393728097113335,-0.0073885071001364,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0024874301704442,-0.0202169201671078,0.3220831065142442,1
2011-07-29,"News Summary for July 29, 2011",MRK,-0.0229027628552871,0.393728097113335,-0.0073885071001364,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0024874301704442,-0.0202169201671078,0.3220831065142442,1
2011-07-29,Merck Doubles Profits In Second Quarter,MRK,-0.0229027628552871,0.393728097113335,-0.0073885071001364,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0024874301704442,-0.0202169201671078,0.3220831065142442,1
2011-07-29,Stocks To Watch For July 29,MRK,-0.0229027628552871,0.393728097113335,-0.0073885071001364,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0024874301704442,-0.0202169201671078,0.3220831065142442,1
2011-07-29,Earnings Scheduled For July 29,MRK,-0.0229027628552871,0.393728097113335,-0.0073885071001364,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0024874301704442,-0.0202169201671078,0.3220831065142442,1
2011-08-01,"ARIAD Announces That Merck Has Submitted for Approval of Ridaforolimus, an Investigational mTOR Inhibitor, in the EU",MRK,-0.0202169201671078,0.3220831065142442,-0.0229027628552871,-0.0073885071001364,-0.0167646894485643,-0.0027858788429107,-0.0055418604976167,-0.0161486118597324,0.0310732837598646,1
2011-08-03,Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine ,MRK,-0.0060787551340625,-0.1611469122134422,-0.0161486118597324,-0.0202169201671078,-0.0229027628552871,-0.0073885071001364,-0.0167646894485643,-0.0363916242438969,0.1872027525673587,1
2011-08-09,"News Summary for August 9, 2011",MRK,0.0427524198925333,-0.0263093094672069,-0.055818338167783,0.0063471874465572,-0.0363916242438969,-0.0060787551340625,-0.0161486118597324,-0.0451633742528699,-0.0958145244068501,1
2011-08-18,Merck and ARIAD Announce European Medicines Agency Accepts Marketing Authorization Application for Ridaforolimus,MRK,-0.0354037374041594,0.6480387073112857,0.0031151703364995,-0.0009334125620182,0.025206848602775,0.0044874975137207,0.0466285490617151,0.0064389554621346,-0.102347342991777,0
2011-08-29,Zymeworks Announces Collaboration with Merck to Develop Bi-specific Antibody Therapeutics,MRK,0.0169174082156935,-0.3742046816096774,0.0018832932181911,-0.0114801775740875,0.0090799250600981,0.0201211434270991,0.001599770380348,0.0073935628353343,0.1085063225112936,0
2011-08-30,Merck Millipore Strengthens Bioscience Business by acquiring Amnis Corporation,MRK,0.0073935628353343,0.1085063225112936,0.0169174082156935,0.0018832932181911,-0.0114801775740875,0.0090799250600981,0.0201211434270991,0.0122323157731525,0.1248231895933871,0
2011-09-13,Merck Issues Statement on HPV Vaccine,MRK,0.0037951799233277,-0.0306096630678186,0.005025084663867,-0.0286761226485303,-0.0054609644622536,0.0220153577142374,-0.0037071513532811,0.0119719427906783,0.0673951913207107,0
2011-09-13,A Peek Into The Market Before The Trading Starts,MRK,0.0037951799233277,-0.0306096630678186,0.005025084663867,-0.0286761226485303,-0.0054609644622536,0.0220153577142374,-0.0037071513532811,0.0119719427906783,0.0673951913207107,0
2011-09-13,Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies  ,MRK,0.0037951799233277,-0.0306096630678186,0.005025084663867,-0.0286761226485303,-0.0054609644622536,0.0220153577142374,-0.0037071513532811,0.0119719427906783,0.0673951913207107,0
2011-09-14,S&P Likes Three Health Care ETFs,MRK,0.0119719427906783,0.0673951913207107,0.0037951799233277,0.005025084663867,-0.0286761226485303,-0.0054609644622536,0.0220153577142374,0.0115193547353864,-0.1843006607640734,0
2011-09-19,"Merck's Iss=entress Combo Showed Efficacy, Tolerability",MRK,-0.0131576846891253,-0.3186915165031683,0.0058482412128819,0.0115193547353864,0.0119719427906783,0.0037951799233277,0.005025084663867,0.0077518735336119,0.0325850274013646,0
2011-09-27,Merck Names Cuong Viet Do as Chief Strategy Officer,MRK,0.0167663052999025,-0.0161941596185596,0.0180354927835031,-0.0025694774724842,-0.0226060933708778,-0.0200003013119984,0.0077518735336119,-0.0062223282178839,-0.0306898163172746,1
2011-09-28,Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals for $175M   ,MRK,-0.0062223282178839,-0.0306898163172746,0.0167663052999025,0.0180354927835031,-0.0025694774724842,-0.0226060933708778,-0.0200003013119984,0.0225419325533231,0.3072781706825569,0
2011-09-30,Merck Announces New Data Analyses for VICTRELIS will be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting   ,MRK,0.0012248657564621,0.2550086425865665,0.0225419325533231,-0.0062223282178839,0.0167663052999025,0.0180354927835031,-0.0025694774724842,-0.0345567838149736,-0.0169458025262618,1
2011-10-03,Merck Wins Another Federal Bellwether Trial Regarding FOSAMAX,MRK,-0.0345567838149736,-0.0169458025262618,0.0012248657564621,0.0225419325533231,-0.0062223282178839,0.0167663052999025,0.0180354927835031,-0.00696852788879,0.204890080860264,1
2011-10-05,"FDA Accepts New Drug Application Filing for Ridaforolimus, Investigational mTOR Inhibitor   ",MRK,0.0035088074851585,-0.1193728222996515,-0.00696852788879,-0.0345567838149736,0.0012248657564621,0.0225419325533231,-0.0062223282178839,-0.0012717718436865,-0.2640183436860256,2
2011-10-06,Merck Announces Retirement of Chairman and Former CEO Richard T. Clark   ,MRK,-0.0012717718436865,-0.2640183436860256,0.0035088074851585,-0.00696852788879,-0.0345567838149736,0.0012248657564621,0.0225419325533231,0.0060477738795423,0.1758757463428086,0
2011-10-13,Under The Hood: Emerging Markets Health Care,MRK,0.003991230978388,-0.1680528787279049,0.0200438951390857,-0.0129828020621345,0.023409946283651,0.0060477738795423,-0.0012717718436865,0.0085625906651887,-0.207071695457809,0
2011-10-21,"Mylan Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",MRK,0.0167681016967404,0.3235761965400179,0.0079901792716423,-0.0076238608516958,0.0148558948522361,-0.0203152672565906,0.0085625906651887,0.0053969818953747,-0.2033974872305743,0
2011-10-24,Merck Announces Presentation of Phase III Investigational Studies Evaluating DULERA Inhalation Aerosol in Chronic Obstructive Pulmonary Disease ,MRK,0.0053969818953747,-0.2033974872305743,0.0167681016967404,0.0079901792716423,-0.0076238608516958,0.0148558948522361,-0.0203152672565906,-0.018490809877133,0.0966150573060646,1
2011-10-25,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",MRK,-0.018490809877133,0.0966150573060646,0.0053969818953747,0.0167681016967404,0.0079901792716423,-0.0076238608516958,0.0148558948522361,0.0191430957967762,-0.0251440441567355,0
2011-10-25,What Does Novartis' Earnings Release Really Mean for the Company?,MRK,-0.018490809877133,0.0966150573060646,0.0053969818953747,0.0167681016967404,0.0079901792716423,-0.0076238608516958,0.0148558948522361,0.0191430957967762,-0.0251440441567355,0
2011-10-25,Merck Announces CDC Advisory Committee on Immunization Practices Votes for Expanded Use of GARDASIL® in Boys and Young Men   ,MRK,-0.018490809877133,0.0966150573060646,0.0053969818953747,0.0167681016967404,0.0079901792716423,-0.0076238608516958,0.0148558948522361,0.0191430957967762,-0.0251440441567355,0
2011-10-28,US Stock Futures Signal Lower Start On Wall Street,MRK,0.0233166644963116,0.2402503682482892,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0053969818953747,0.0167681016967404,-0.0173735553892221,-0.3225038265299481,1
2011-10-28,Earnings Scheduled For October 28,MRK,0.0233166644963116,0.2402503682482892,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0053969818953747,0.0167681016967404,-0.0173735553892221,-0.3225038265299481,1
2011-10-28,"Financial Breakfast: Morning News Summary for October 28, 2011",MRK,0.0233166644963116,0.2402503682482892,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0053969818953747,0.0167681016967404,-0.0173735553892221,-0.3225038265299481,1
2011-10-28,Merck Announces Increased Earnings,MRK,0.0233166644963116,0.2402503682482892,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0053969818953747,0.0167681016967404,-0.0173735553892221,-0.3225038265299481,1
2011-10-31,A Look at The New DRGS ETN,MRK,-0.0173735553892221,-0.3225038265299481,0.0233166644963116,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0053969818953747,-0.0127537473826737,0.540463907750018,1
2011-11-01,Which Pharma Stock Should You Short?,MRK,-0.0127537473826737,0.540463907750018,-0.0173735553892221,0.0233166644963116,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0038169715628901,-0.5302724129118623,2
2011-11-01,"One Pill Makes You Stronger: Pfizer Earnings Are the ""White Knight""",MRK,-0.0127537473826737,0.540463907750018,-0.0173735553892221,0.0233166644963116,0.0229578975303061,0.0191430957967762,-0.018490809877133,0.0038169715628901,-0.5302724129118623,2
2011-11-02,"FDA Advisers Vote 16-0 Efficacy, Safety data Support Approval of Merck's Vytorin ",MRK,0.0038169715628901,-0.5302724129118623,-0.0127537473826737,-0.0173735553892221,0.0233166644963116,0.0229578975303061,0.0191430957967762,0.009944082808283,0.1785572294153716,0
2011-11-02,FDA Advisory Committee Unanimously Recommends Approval of Merck's VYTORIN for Use in Patients with Pre-Dialysis Chronic Kidney Disease,MRK,0.0038169715628901,-0.5302724129118623,-0.0127537473826737,-0.0173735553892221,0.0233166644963116,0.0229578975303061,0.0191430957967762,0.009944082808283,0.1785572294153716,0
2011-11-07,JP Morgan Maintains Overweight Rating and $44 PT on Merck & Co ,MRK,0.0088179606429221,-0.1063577709667479,-0.014769468503392,0.009944082808283,0.0038169715628901,-0.0127537473826737,-0.0173735553892221,0.0043706966984629,0.4953734399749638,2
2011-11-09,Merck Launches NEXPLANON 68 mg in the United States,MRK,-0.0197271281832966,0.4969794053999004,0.0043706966984629,0.0088179606429221,-0.014769468503392,0.009944082808283,0.0038169715628901,0.0349211034230305,0.2322579463217609,0
2011-11-10,Merck Increase Quarterly Dividend by 11%,MRK,0.0349211034230305,0.2322579463217609,-0.0197271281832966,0.0043706966984629,0.0088179606429221,-0.014769468503392,0.009944082808283,0.0285962193130784,0.1490759345022523,0
2011-11-15,"Merck Settles Vioxx Suits From NY, Florida, S Carolina -Reuters ",MRK,0.0016819317875138,-0.3693223948319857,-0.0083402495106684,0.0285962193130784,0.0349211034230305,-0.0197271281832966,0.0043706966984629,-0.0179120857249502,0.4393960425580607,1
2011-11-22,"End-of-Day Market Summary for November 22, 2011",MRK,-0.0096665178126674,0.0291337102752231,-0.0231758857111502,0.0031573220207463,-0.0071243976795478,-0.0179120857249502,0.0016819317875138,-0.0183375046311836,-0.1910367662412947,1
2011-11-22,UPDATE: Merck Resolves Previously Disclosed Seven-Year Investigation Led by U.S. Attorney's Office for the District of Massachusetts Related to Vioxx,MRK,-0.0096665178126674,0.0291337102752231,-0.0231758857111502,0.0031573220207463,-0.0071243976795478,-0.0179120857249502,0.0016819317875138,-0.0183375046311836,-0.1910367662412947,1
2011-11-28,Is Arena Pharma Going to Cure Obesity?,MRK,0.0331723896381381,2.171714696512403,-0.000903847899952,-0.0183375046311836,-0.0096665178126674,-0.0231758857111502,0.0031573220207463,0.0064216328047972,-0.219725382744458,0
2011-12-01,Are the Samsung M&A Rumors True?,MRK,-0.0019585280223831,-0.3187526367970572,0.0368331369921568,0.0064216328047972,0.0331723896381381,-0.000903847899952,-0.0183375046311836,-0.0056053050681279,0.1529406099815915,1
2011-12-01,These Stocks May Be Better Than Their Dow Equivalents,MRK,-0.0019585280223831,-0.3187526367970572,0.0368331369921568,0.0064216328047972,0.0331723896381381,-0.000903847899952,-0.0183375046311836,-0.0056053050681279,0.1529406099815915,1
2011-12-09,Are You Guaranteed Profits if These Rumors are True?,MRK,0.013924311047865,-0.0489786866379408,-0.0117946686110697,0.0059321949475323,0.0039704991483462,-0.0062004110661755,-0.0056053050681279,-0.0075669412957385,-0.687296051707273,1
2011-12-13,Benzinga's Top Pre-Market Losers,MRK,0.0,0.4525932980555343,-0.0075669412957385,0.013924311047865,-0.0117946686110697,0.0059321949475323,0.0039704991483462,0.0162903691236997,0.2305554997051271,0
2011-12-21,Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV   ,MRK,0.007013863882936,-0.3563164974929681,0.0164518843187895,0.006068541485249,-0.0030252497266621,0.0224972154546094,0.0162903691236997,0.006161445993382,-0.1232663297488315,0
2011-12-21,Exelixis Licenses PI3K-Delta Program to Merck   ,MRK,0.007013863882936,-0.3563164974929681,0.0164518843187895,0.006068541485249,-0.0030252497266621,0.0224972154546094,0.0162903691236997,0.006161445993382,-0.1232663297488315,0
2011-12-27,Inside: 2012's Best Value Investment,MRK,-0.0039577840421478,-0.2079350512389213,0.0090521583093743,0.006161445993382,0.007013863882936,0.0164518843187895,0.006068541485249,-0.008476923772913,-0.0382189034317238,1
2011-12-30,ETF Showdown: Fun With Pharma,MRK,-0.0007949706864577,0.1456577545000916,0.0080150398466838,-0.008476923772913,-0.0039577840421478,0.0090521583093743,0.006161445993382,0.0159146606173834,1.197407120766525,0
2012-01-03,Can Germany's Employers Turn Europe Around? ,MRK,0.0159146606173834,1.197407120766525,-0.0007949706864577,0.0080150398466838,-0.008476923772913,-0.0039577840421478,0.0090521583093743,0.0010446625772959,-0.2058374092500691,2
2012-01-04,Bark At The Dow's Dogs With These ETFs,MRK,0.0010446625772959,-0.2058374092500691,0.0159146606173834,-0.0007949706864577,0.0080150398466838,-0.008476923772913,-0.0039577840421478,0.0104329447084652,0.530121153288817,0
2012-01-04,Will Alnylam's Prospective Obesity Drug Change the World Forever?,MRK,0.0010446625772959,-0.2058374092500691,0.0159146606173834,-0.0007949706864577,0.0080150398466838,-0.008476923772913,-0.0039577840421478,0.0104329447084652,0.530121153288817,0
2012-01-10,Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target?,MRK,0.003386123898617,-0.1826934444301805,-0.0020797917782721,-0.0069692443779156,0.0104329447084652,0.0010446625772959,0.0159146606173834,-0.0028556104090606,0.0509932270396578,2
2012-01-10,"Feuerstein: Merck for Idenix Pharma was Just a Prediction, Not a Rumor",MRK,0.003386123898617,-0.1826934444301805,-0.0020797917782721,-0.0069692443779156,0.0104329447084652,0.0010446625772959,0.0159146606173834,-0.0028556104090606,0.0509932270396578,2
2012-01-11,How to Trade Biotechs Based on the JP Morgan Health Care Conference,MRK,-0.0028556104090606,0.0509932270396578,0.003386123898617,-0.0020797917782721,-0.0069692443779156,0.0104329447084652,0.0010446625772959,0.0052070036437104,-0.1686449882811982,0
2012-01-18,"Benzinga's M&A Chatter for Wednesday January 18, 2012",MRK,0.0012881692662132,-0.1113943561842114,0.0130480450215684,-0.0075110340549737,0.0052070036437104,-0.0028556104090606,0.003386123898617,0.0100328525855342,0.1248215167063218,0
2012-01-20,Merck Announces Remicade Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients  ,MRK,-0.0015279072490099,-0.073301172259159,0.0100328525855342,0.0012881692662132,0.0130480450215684,-0.0075110340549737,0.0052070036437104,-0.0109696600892345,-0.1196042769827143,1
2012-01-20,What's the Future Like For Health Care?,MRK,-0.0015279072490099,-0.073301172259159,0.0100328525855342,0.0012881692662132,0.0130480450215684,-0.0075110340549737,0.0052070036437104,-0.0109696600892345,-0.1196042769827143,1
2012-01-25,"Benzinga's M&A Chatter for Wednesday January 25, 2012",MRK,-0.002578921212312,0.1012194999784401,0.0002584267434464,-0.0109696600892345,-0.0015279072490099,0.0100328525855342,0.0012881692662132,0.0025855892432578,-0.1441362266735486,2
2012-01-25,Merck Announces New FDA Approved Labeling For VYTORIN Includes Results From the Study of Heart and Renal Protection in Patients With Moderate to Severe Chronic Kidney Disease   ,MRK,-0.002578921212312,0.1012194999784401,0.0002584267434464,-0.0109696600892345,-0.0015279072490099,0.0100328525855342,0.0012881692662132,0.0025855892432578,-0.1441362266735486,2
2012-01-26,"Benzinga's M&A Chatter for Thursday January 26, 2012",MRK,0.0025855892432578,-0.1441362266735486,-0.002578921212312,0.0002584267434464,-0.0109696600892345,-0.0015279072490099,0.0100328525855342,-0.0067047347231946,-0.0216485402737729,1
2012-02-02,UPDATE: Merck Swings To Q4 Profit,MRK,-0.0049186554715821,0.425571623273747,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0025855892432578,-0.0018214444971877,-0.2776855396600284,2
2012-02-02,"Merck's Earnings Are Up, But a Huge Drop may be Coming",MRK,-0.0049186554715821,0.425571623273747,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0025855892432578,-0.0018214444971877,-0.2776855396600284,2
2012-02-02,FDA Approves JANUMET XR for Type 2 Diabetes,MRK,-0.0049186554715821,0.425571623273747,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0025855892432578,-0.0018214444971877,-0.2776855396600284,2
2012-02-02,Earnings Scheduled For February 2,MRK,-0.0049186554715821,0.425571623273747,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0025855892432578,-0.0018214444971877,-0.2776855396600284,2
2012-02-02,"Financial Breakfast: Morning News Summary for February 2, 2012",MRK,-0.0049186554715821,0.425571623273747,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0025855892432578,-0.0018214444971877,-0.2776855396600284,2
2012-02-03,Candlesticks – Bears Appeared on Merck ,MRK,-0.0018214444971877,-0.2776855396600284,-0.0049186554715821,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0007820113521117,-0.2650131685259833,2
2012-02-03,From Earlier: Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302  ,MRK,-0.0018214444971877,-0.2776855396600284,-0.0049186554715821,0.009407148990749,-0.0159424290845712,0.0096055272715092,-0.0067047347231946,0.0007820113521117,-0.2650131685259833,2
2012-02-06,"Benzinga's M&A Chatter for Monday February 6, 2012",MRK,0.0007820113521117,-0.2650131685259833,-0.0018214444971877,-0.0049186554715821,0.009407148990749,-0.0159424290845712,0.0096055272715092,0.0059900605643345,0.1282688324100382,0
2012-02-06,Merck Confirms Plans to File NDA for Suvorexant in 2012   ,MRK,0.0007820113521117,-0.2650131685259833,-0.0018214444971877,-0.0049186554715821,0.009407148990749,-0.0159424290845712,0.0096055272715092,0.0059900605643345,0.1282688324100382,0
2012-02-07,Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar,MRK,0.0059900605643345,0.1282688324100382,0.0007820113521117,-0.0018214444971877,-0.0049186554715821,0.009407148990749,-0.0159424290845712,-0.0054366362560456,-0.0895126246897728,1
2012-02-10,Grandpa's 2012 ETF Portfolio,MRK,-0.0062909565913729,0.0962105267343977,-0.007027217462352,-0.0054366362560456,0.0059900605643345,0.0007820113521117,-0.0018214444971877,0.0052756020838042,0.1045993270702014,0
2012-02-13,"FDA Approves ZIOPTAN, Merck's Once-Daily, Preservative-Free Ophthalmic Medication",MRK,0.0052756020838042,0.1045993270702014,-0.0062909565913729,-0.007027217462352,-0.0054366362560456,0.0059900605643345,0.0007820113521117,0.0026239580831708,-0.0390050049111465,2
2012-02-15,Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil  ,MRK,-0.0049724954089925,0.0910165409900465,0.0026239580831708,0.0052756020838042,-0.0062909565913729,-0.007027217462352,-0.0054366362560456,0.0031560821466085,-0.1437857047206387,2
2012-02-23,"Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)",MRK,0.0075876761334665,0.050361068003599,0.0023603463623806,-0.011151280790039,0.011011987259841,0.0031560821466085,-0.0049724954089925,-0.0080498326534901,-0.1780271793468449,1
2012-02-28,"The Rick Santorum ETF Portfolio (KOL, PBS, IYZ)",MRK,0.0060284811177695,-0.4269509245580168,-0.0013088502962799,-0.0080498326534901,0.0075876761334665,0.0023603463623806,-0.011151280790039,-0.0054716766074044,0.6106701938701327,1
2012-03-05,Merck's Investigational Allergy Immunotherapy Tablet Significantly Reduced the Combination of Ragweed Allergy Symptoms,MRK,0.0137095969000546,0.4300788070676375,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0060284811177695,-0.0013088502962799,-0.0262676129444739,-0.0036328676278747,1
2012-03-06,Merck Down 2% After Reaffirming 2012 Guidance,MRK,-0.0262676129444739,-0.0036328676278747,0.0137095969000546,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0060284811177695,-0.003472350423248,-0.0927814906849253,2
2012-03-06,Merck Issues Q1 Profit Forecast,MRK,-0.0262676129444739,-0.0036328676278747,0.0137095969000546,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0060284811177695,-0.003472350423248,-0.0927814906849253,2
2012-03-06,UPDATE: Merck Confirms 2012 Full-Year Guidance,MRK,-0.0262676129444739,-0.0036328676278747,0.0137095969000546,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0060284811177695,-0.003472350423248,-0.0927814906849253,2
2012-03-06,Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy,MRK,-0.0262676129444739,-0.0036328676278747,0.0137095969000546,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0060284811177695,-0.003472350423248,-0.0927814906849253,2
2012-03-07,Merck Gives Weak Q1 Outlook,MRK,-0.003472350423248,-0.0927814906849253,-0.0262676129444739,0.0137095969000546,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0024124538006684,1.425726141078838,2
2012-03-07,From Earlier: Merck Announces Results from Investigational Studies with VICTRELIS Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1  ,MRK,-0.003472350423248,-0.0927814906849253,-0.0262676129444739,0.0137095969000546,0.0037044048192242,-0.0099551897627647,-0.0054716766074044,0.0024124538006684,1.425726141078838,2
2012-03-12,"Benzinga's M&A Chatter for  Monday March 12, 2012",MRK,0.0132978205992138,-0.7557691918609127,0.0053475416985973,0.0024124538006684,-0.003472350423248,-0.0262676129444739,0.0137095969000546,0.0159234715512726,0.3797524651122219,0
2012-03-15,"A Look At The New Russell High Yield ETF (HDIV, ABT, KFT)",MRK,-0.0041866172667539,0.0415036570845381,-0.0015672326357595,0.0159234715512726,0.0132978205992138,0.0053475416985973,0.0024124538006684,-0.0007881460204388,0.515229462681692,2
2012-03-16,"ETF Showdown: Dividend Dilemma (HDV, HDIV, JNJ)",MRK,-0.0007881460204388,0.515229462681692,-0.0041866172667539,-0.0015672326357595,0.0159234715512726,0.0132978205992138,0.0053475416985973,-0.0036814151444892,-0.4746894554627843,2
2012-03-21,UPDATE: Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote; Voted 13 To 1 Against The Use of Ridaforolimus,MRK,-0.0015888908433121,-0.1699516280412967,-0.0034308734106784,-0.0036814151444892,-0.0007881460204388,-0.0041866172667539,-0.0015672326357595,-0.0026523405424545,0.1299904322866834,2
2012-03-26,Merck Reports C$35M Investment and Start of Merck Lumira Fund,MRK,0.0171004311356084,0.1146333889081308,0.0109040614542146,-0.0026523405424545,-0.0015888908433121,-0.0034308734106784,-0.0036814151444892,0.0036214240132326,0.0573966182317284,2
2012-03-27,"Benzinga's M&A Chatter for Tuesday March 27, 2012",MRK,0.0036214240132326,0.0573966182317284,0.0171004311356084,0.0109040614542146,-0.0026523405424545,-0.0015888908433121,-0.0034308734106784,-0.0126285141213766,0.2833287062784673,1
2012-04-03,Codexis and Merck Develop Prototype Enzyme-Based Method for Production of Boceprevir  ,MRK,0.0054527739351977,-0.0430735017822675,0.0028649240171358,0.0102603485996315,-0.0078309921814234,-0.0126285141213766,0.0036214240132326,0.004649005662854,0.3893551715070646,2
2012-04-16,Morning Market Movers,MRK,0.0044996874787734,-0.3317655940227516,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0072294617997056,-0.0038582031943062,0.0147565523844777,-0.1964184748419761,0
2012-04-16,Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide,MRK,0.0044996874787734,-0.3317655940227516,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0072294617997056,-0.0038582031943062,0.0147565523844777,-0.1964184748419761,0
2012-04-16,Benzinga's Top Pre-Market Gainers,MRK,0.0044996874787734,-0.3317655940227516,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0072294617997056,-0.0038582031943062,0.0147565523844777,-0.1964184748419761,0
2012-04-16,"Financial Breakfast: Morning News Summary for April 16, 2012",MRK,0.0044996874787734,-0.3317655940227516,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0072294617997056,-0.0038582031943062,0.0147565523844777,-0.1964184748419761,0
2012-04-17,"Benzinga's Microcap Movers for Monday April 16, 2012",MRK,0.0147565523844777,-0.1964184748419761,0.0044996874787734,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0072294617997056,-0.0028567396750301,-0.3156137334587718,2
2012-04-17,Benzinga's Top Pre-Market Gainers,MRK,0.0147565523844777,-0.1964184748419761,0.0044996874787734,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0072294617997056,-0.0028567396750301,-0.3156137334587718,2
2012-04-18,Merck Wins Another FOSAMAX State Court Trial   ,MRK,-0.0028567396750301,-0.3156137334587718,0.0147565523844777,0.0044996874787734,-0.0128038487904172,-0.0054574695158733,0.0007804480287243,-0.0010414331829494,0.4012054016393431,2
2012-04-19,S&P: Bullish On Pharma ETFs Long-Term,MRK,-0.0010414331829494,0.4012054016393431,-0.0028567396750301,0.0147565523844777,0.0044996874787734,-0.0128038487904172,-0.0054574695158733,0.0096452116856857,0.3851110634540942,0
2012-04-19,Merck Reports Phase III Study Results Evaluating Anaemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy   ,MRK,-0.0010414331829494,0.4012054016393431,-0.0028567396750301,0.0147565523844777,0.0044996874787734,-0.0128038487904172,-0.0054574695158733,0.0096452116856857,0.3851110634540942,0
2012-04-27,Earnings Scheduled For April 27,MRK,-0.000260014038685,0.5218649739496437,0.0010411389977629,0.0041806268350339,0.0,-0.0118768994177631,0.0096452116856857,0.020280667512327,0.2767797989519285,0
2012-04-27,US Stock Futures Flat; GDP Data In Focus,MRK,-0.000260014038685,0.5218649739496437,0.0010411389977629,0.0041806268350339,0.0,-0.0118768994177631,0.0096452116856857,0.020280667512327,0.2767797989519285,0
2012-04-30,FDA Considering Letting Patients Purchase Drugs Without Prescriptions,MRK,0.020280667512327,0.2767797989519285,-0.000260014038685,0.0010411389977629,0.0041806268350339,0.0,-0.0118768994177631,0.0033129834488736,-0.2634512353504408,2
2012-04-30,New Kids: Do These New ETFs Have The Right Stuff?,MRK,0.020280667512327,0.2767797989519285,-0.000260014038685,0.0010411389977629,0.0041806268350339,0.0,-0.0118768994177631,0.0033129834488736,-0.2634512353504408,2
2012-05-11,The Shorts Report: 10 Mega-Caps With Increased Short Selling,MRK,-0.0093776379243547,0.2812634824048623,0.0078762236568459,-0.0139792809100898,0.0023355063551151,-0.0077239853831582,-0.0084243637445075,0.0049963025578629,0.3435854350520024,2
2012-05-15,"S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",MRK,-0.0125591811187965,-0.3453636992129022,0.0049963025578629,-0.0093776379243547,0.0078762236568459,-0.0139792809100898,0.0023355063551151,0.0129837374807113,0.4426013724434634,0
2012-05-21,"Merck: FDA Approves New Labeling for ISENTRESS to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability",MRK,-0.005816665902287,-0.5024236832930624,-0.0055220478242459,-0.0052315868585566,0.0129837374807113,-0.0125591811187965,0.0049963025578629,-0.0037236669188349,0.3255484076171715,2
2012-05-22,Health Care SPDR In Focus Ahead Of Obamacare Decision,MRK,-0.0037236669188349,0.3255484076171715,-0.005816665902287,-0.0055220478242459,-0.0052315868585566,0.0129837374807113,-0.0125591811187965,-0.0032035351870711,-0.0884844215932334,2
2012-05-25,"Amylin Shares Jump as Sanofi, Merck Sumbit Bids",MRK,-0.0013300000765064,-0.238115064086374,0.006963427209524,-0.0032035351870711,-0.0037236669188349,-0.005816665902287,-0.0055220478242459,0.0010651591765591,0.3338794154079685,2
2012-05-25,Government of Rwanda Introduces Merck's ROTATEQ,MRK,-0.0013300000765064,-0.238115064086374,0.006963427209524,-0.0032035351870711,-0.0037236669188349,-0.005816665902287,-0.0055220478242459,0.0010651591765591,0.3338794154079685,2
2012-06-04,The US Economy and the United Nations: Bold Strategies Needed - Tax Reform and Benefits Reform,MRK,0.0075308504181503,-0.1836579420166516,-0.0106440723696575,0.0048127821792267,-0.0050542552395107,0.0010651591765591,-0.0013300000765064,0.0010676423101736,-0.0325491151124001,2
2012-06-07,Pfizer Plans to IPO Part of its Animal Health Segment,MRK,0.0113456005155847,3.231118101191986,0.0106669354318691,0.0010676423101736,0.0075308504181503,-0.0106440723696575,0.0048127821792267,0.003391711843669,-0.0458414641609579,2
2012-06-13,Merck Announces New Phase III Data Showed Merck's Investigational Insomnia Medicine Suvorexant Improved Patients' Ability to Fall Asleep and Stay Asleep ,,,,,,,,,,,2
MRK,-0.0007807699227191378,0.1050444253367726,0.0098777941421768,0.0002600816635687,0.003391711843669,0.0113456005155847,0.0106669354318691,0.0101562525220597,0.116119845315324,,,2
2012-06-14,"Believe In The Rally? Try These ETFs (HDV, IYZ, HYD)",MRK,0.0101562525220597,0.116119845315324,-0.0007807699227191,0.0098777941421768,0.0002600816635687,0.003391711843669,0.0113456005155847,0.0038671836953654,0.2434931959698316,2
2012-06-14,Johnson & Johnson to Complete Synthes Acquisition ,MRK,0.0101562525220597,0.116119845315324,-0.0007807699227191,0.0098777941421768,0.0002600816635687,0.003391711843669,0.0113456005155847,0.0038671836953654,0.2434931959698316,2
2012-06-15,US District Court Rules Against Merck in NASONEX Patent Lawsuit,MRK,0.0038671836953654,0.2434931959698316,0.0101562525220597,-0.0007807699227191,0.0098777941421768,0.0002600816635687,0.003391711843669,-0.0023114874806848,-0.4857721417080729,2
2012-06-18,From Earlier: U.S. District Court Rules Against Merck in NASONEX Patent Lawsuit  ,MRK,-0.0023114874806848,-0.4857721417080729,0.0038671836953654,0.0101562525220597,-0.0007807699227191,0.0098777941421768,0.0002600816635687,0.0097813147800256,0.441701349013742,0
2012-06-18,"Geisinger and Merck to Collaborate on Multi-year Effort to Improve Patient Adherence, Engagement and Care Delivery   ",MRK,-0.0023114874806848,-0.4857721417080729,0.0038671836953654,0.0101562525220597,-0.0007807699227191,0.0098777941421768,0.0002600816635687,0.0097813147800256,0.441701349013742,0
2012-06-20,Merck Statement on CDC Advisory Committee on Immunization Practices' Recommendation for Pneumococcal Vaccination in Immunocompromised Adults   ,MRK,-0.0005097550805661,-0.0427607364865314,0.0097813147800256,-0.0023114874806848,0.0038671836953654,0.0101562525220597,-0.0007807699227191,0.0061208274401611,0.5216288162870237,0
2012-06-25,"Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",MRK,-0.0097067418638293,-0.3644167765605079,0.0185046571589297,0.0061208274401611,-0.0005097550805661,0.0097813147800256,-0.0023114874806848,0.006785692487583,-0.254684637031555,0
2012-06-27,A Peek Into The Market Before The Trading Starts,MRK,0.011732314935305,0.1475990052532592,0.006785692487583,-0.0097067418638293,0.0185046571589297,0.0061208274401611,-0.0005097550805661,0.0037008835268557,-0.0430394210626546,2
2012-06-27,Merck and AstraZeneca Agree to Amend Partnership   ,MRK,0.011732314935305,0.1475990052532592,0.006785692487583,-0.0097067418638293,0.0185046571589297,0.0061208274401611,-0.0005097550805661,0.0037008835268557,-0.0430394210626546,2
2012-06-28,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,MRK,0.0037008835268557,-0.0430394210626546,0.011732314935305,0.006785692487583,-0.0097067418638293,0.0185046571589297,0.0061208274401611,0.0263032175233259,0.8846169154228856,0
2012-06-29,ALPS Unveils Dogs of the Dow ETF,MRK,0.0263032175233259,0.8846169154228856,0.0037008835268557,0.011732314935305,0.006785692487583,-0.0097067418638293,0.0185046571589297,0.0023949330262276,-0.394559768924006,2
2012-07-11,Merck Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning   ,MRK,-0.0038670241647638,-0.2602091797407098,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0043049641858327,-0.0009558863723819,0.0412520771350857,2.7173883913857697,0
2012-07-12,"From Earlier: Update on Phase III Trial for Odanacatib, Merck's Investigational Cat-K Inhibitor for Osteoporosis ",MRK,0.0412520771350857,2.7173883913857697,-0.0038670241647638,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0043049641858327,0.0130503120806733,-0.6307591555772005,0
2012-07-12,Benzinga's Top Pre-Market Gainers,MRK,0.0412520771350857,2.7173883913857697,-0.0038670241647638,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0043049641858327,0.0130503120806733,-0.6307591555772005,0
2012-07-12,Thursday Market Movers,MRK,0.0412520771350857,2.7173883913857697,-0.0038670241647638,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0043049641858327,0.0130503120806733,-0.6307591555772005,0
2012-07-13,"5 Market-Based ETFs Your Broker Forgot to Mention (HDIV, OFF, PDP)",MRK,0.0130503120806733,-0.6307591555772005,0.0412520771350857,-0.0038670241647638,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0027601417564526,-0.1022541881038214,2
2012-07-13,"Low Volume, High Returns for These ETFs (BIB, FHC, DRW)",MRK,0.0130503120806733,-0.6307591555772005,0.0412520771350857,-0.0038670241647638,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0027601417564526,-0.1022541881038214,2
2012-07-13,"Low Volume, High Returns for These ETFs (BIB, FHC)",MRK,0.0130503120806733,-0.6307591555772005,0.0412520771350857,-0.0038670241647638,-0.0180398608688721,0.0149361323776944,-0.0028824072455478,-0.0027601417564526,-0.1022541881038214,2
2012-07-17,Popular Drug Manufacturing Stocks Among Hedge Funds,MRK,0.0193770032325983,0.3223443138548449,-0.0027601417564526,0.0130503120806733,0.0412520771350857,-0.0038670241647638,-0.0180398608688721,-0.0056576282794323,-0.1952312623237256,1
2012-07-23,"From Earlier: Merck ISENTRESS in Combination Therapy Demonstrated Long-Term Efficacy, Safety and Tolerability in Previously Untreated Adult Patients with HIV-1 for up to 240 Weeks  ",MRK,-0.0032250154919643,0.1046571056223144,-0.0120616035981298,0.0,-0.0056576282794323,0.0193770032325983,-0.0027601417564526,-0.0134047414241305,0.4171122913033036,1
2012-07-23,"Earnings Expectations for the Week of July 23 (MCD, AAPL, F, XOM)",MRK,-0.0032250154919643,0.1046571056223144,-0.0120616035981298,0.0,-0.0056576282794323,0.0193770032325983,-0.0027601417564526,-0.0134047414241305,0.4171122913033036,1
2012-07-23,Earnings Expectations for the Week of July 23,MRK,-0.0032250154919643,0.1046571056223144,-0.0120616035981298,0.0,-0.0056576282794323,0.0193770032325983,-0.0027601417564526,-0.0134047414241305,0.4171122913033036,1
2012-07-27,US Stock Futures Up; GDP Data In Focus,MRK,0.0408490600695272,0.8389467476552832,0.0166590382178675,-0.0016392757778739,-0.0134047414241305,-0.0032250154919643,-0.0120616035981298,-0.0137470790088629,-0.5680483340808937,1
2012-07-27,Earnings Scheduled For July 27,MRK,0.0408490600695272,0.8389467476552832,0.0166590382178675,-0.0016392757778739,-0.0134047414241305,-0.0032250154919643,-0.0120616035981298,-0.0137470790088629,-0.5680483340808937,1
2012-07-27,Stocks To Watch For July 27,MRK,0.0408490600695272,0.8389467476552832,0.0166590382178675,-0.0016392757778739,-0.0134047414241305,-0.0032250154919643,-0.0120616035981298,-0.0137470790088629,-0.5680483340808937,1
2012-07-27,"Benzinga Market Primer, Friday July 27",MRK,0.0408490600695272,0.8389467476552832,0.0166590382178675,-0.0016392757778739,-0.0134047414241305,-0.0032250154919643,-0.0120616035981298,-0.0137470790088629,-0.5680483340808937,1
2012-07-30,"Benzinga Market Primer, Monday July 30",MRK,-0.0137470790088629,-0.5680483340808937,0.0408490600695272,0.0166590382178675,-0.0016392757778739,-0.0134047414241305,-0.0032250154919643,-0.0069695060279547,-0.0242774158456943,1
2012-08-06,Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge,MRK,0.0077010251207976,-0.0917986128041939,0.005466059690288,-0.0083564158728126,0.0024903457085627,-0.0069695060279547,-0.0137470790088629,-0.0110141513810022,0.1967238136719773,1
2012-08-09,Under The Hood: Tempting Technicals And a Dividend,MRK,0.0049934473432726,-0.0744879638884821,0.0013639920568049,-0.0110141513810022,0.0077010251207976,0.005466059690288,-0.0083564158728126,0.0065488580171544,-0.0697993596001599,0
2012-08-16,S&P Still Bullish on Health Care ETFs,MRK,-0.0027235648498803,0.1268756333862646,-0.0078813403195142,-0.0002252246681075,-0.0033650420838861,0.0065488580171544,0.0049934473432726,-0.0136550145671014,0.7671601789450344,1
2012-09-10,"Merck Announces New Phase III Data for Suvorexant, Says Patients Normal Sleep Patterns Return After Stopping Use",MRK,0.0047668871250428,0.0788170744351057,-0.0042943887451899,0.0184162924981012,0.0043928176275527,0.004645551337318,-0.0016228632540061,0.0015815087791082,-0.0479128453115447,2
2012-09-13,Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer ,MRK,0.0124686849831412,0.325350596095469,0.0045116704175474,0.0015815087791082,0.0047668871250428,-0.0042943887451899,0.0184162924981012,-0.0232867304605066,0.3943962491476707,1
2012-09-25,S&P Highlights Election ETFs,MRK,-0.0006644992746336,0.2818917112261154,0.0051210600729199,0.0004455079605172,0.0085376088362512,0.0097550669633219,0.0018184590528942,-0.0022169241127586,-0.0119014743085802,2
2012-09-26,Merck Returns Rights for Vernakalant to Cardiome,MRK,-0.0022169241127586,-0.0119014743085802,-0.0006644992746336,0.0051210600729199,0.0004455079605172,0.0085376088362512,0.0097550669633219,0.0048878959161899,-0.222757024929009,2
2012-10-08,Delphi Genetics Grants Merck License for the Use of the StabyExpress System,MRK,0.0012966235264868,-0.4085848497705046,0.0034687690668384,0.0074270689300126,0.0068179065995344,0.0055282719428904,0.0026606629671381,-0.003668567689154,0.4261198607901599,2
2012-10-09,Part I: Must Know ETFs For Q3 Earnings ,MRK,-0.003668567689154,0.4261198607901599,0.0012966235264868,0.0034687690668384,0.0074270689300126,0.0068179065995344,0.0055282719428904,-0.01234527454569,-0.0553888685372289,1
2012-10-09,Merck to Move Global Headquarters Within New Jersey  ,MRK,-0.003668567689154,0.4261198607901599,0.0012966235264868,0.0034687690668384,0.0074270689300126,0.0068179065995344,0.0055282719428904,-0.01234527454569,-0.0553888685372289,1
2012-10-15,"AiCuris, Merck Enter Exclusive Worldwide License Agreement ",MRK,0.021262676506361,0.5021697166500345,0.0037401599823942,-0.0032898960562987,-0.01234527454569,-0.003668567689154,0.0012966235264868,0.0124493909543164,0.1627129667904803,0
2012-10-15,A Peek Into The Market Before The Trading Starts,MRK,0.021262676506361,0.5021697166500345,0.0037401599823942,-0.0032898960562987,-0.01234527454569,-0.003668567689154,0.0012966235264868,0.0124493909543164,0.1627129667904803,0
2012-10-22,Earnings Expectations for the Week of October 22,MRK,-0.0116945273666086,0.0805224682433864,-0.019391382838671,0.0120279289353182,0.0046639500621878,0.0124493909543164,0.021262676506361,-0.0126936835999841,-0.1082059885696802,1
2012-10-24,S&P Likes a Trio of Biotech ETFs ,MRK,-0.0002178999022703,-0.2290830211100056,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,0.0120279289353182,0.0046639500621878,0.0091540338181603,0.1381577814235539,0
2012-10-26,S&P Bullish on Select Dividend ETFs,MRK,-0.0032396764434408,0.088319737501709,0.0091540338181603,-0.0002178999022703,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,-0.0112673245652493,0.1335371215610736,1
2012-10-26,"Earnings Scheduled For October 26, 2012",MRK,-0.0032396764434408,0.088319737501709,0.0091540338181603,-0.0002178999022703,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,-0.0112673245652493,0.1335371215610736,1
2012-10-26,US Stock Futures Down After Apple Earnings,MRK,-0.0032396764434408,0.088319737501709,0.0091540338181603,-0.0002178999022703,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,-0.0112673245652493,0.1335371215610736,1
2012-10-26,"Stocks To Watch For October 26, 2012",MRK,-0.0032396764434408,0.088319737501709,0.0091540338181603,-0.0002178999022703,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,-0.0112673245652493,0.1335371215610736,1
2012-10-26,"Benzinga Market Primer, Friday October 26",MRK,-0.0032396764434408,0.088319737501709,0.0091540338181603,-0.0002178999022703,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,-0.0112673245652493,0.1335371215610736,1
2012-10-26,"Benzinga Market Primer, Friday, October 26",MRK,-0.0032396764434408,0.088319737501709,0.0091540338181603,-0.0002178999022703,-0.0126936835999841,-0.0116945273666086,-0.019391382838671,-0.0112673245652493,0.1335371215610736,1
2012-11-08,"Futures Flat, Euro Falls Ahead of Central Banks",MRK,-0.0139451988085316,-0.3215070721316073,-0.0317943673294851,0.0054737993249045,-0.0071735637189491,0.0013060374602331,0.0067935081767966,0.0047904447776341,-0.1429708359981032,2
2012-11-12,Merck Presents Early-Stage Interim Data for MK-3475  Study for Treatment of Advanced Melanoma ,MRK,-0.0006814485761963,-0.4762633318265463,0.0047904447776341,-0.0139451988085316,-0.0317943673294851,0.0054737993249045,-0.0071735637189491,-0.0077233841283482,0.3095992647393848,1
2012-11-16,S&P Reiterates Bullish View on Health Care ETFs,MRK,0.0063084404660369,0.3544108606103695,-0.0058073852452623,-0.0144230142598983,-0.0077233841283482,-0.0006814485761963,0.0047904447776341,0.0062686343373528,-0.4476181659796598,0
2012-12-03,"Merck Begins Phase II/III Study of Investigational BACE Inhibitor, MK-8931",MRK,0.0031600257156456,-0.2262139483058421,-0.0091700553427935,0.0024667901292352,0.0164080812022764,-0.0072396574112788,-0.0018069590423457,-0.0009001011444151,-0.1396890177383309,2
2012-12-11,"Benzinga's M&A Chatter for Tuesday December 11, 2012",MRK,0.0159619382533755,0.4531692966033698,-0.0033605257380278,0.0026959946002358,0.0027034087154753,-0.0002255265791055,-0.0009001011444151,0.0015489882510457,-0.1717893031987337,2
2012-12-11,"Benzinga's Small Cap Movers for Tuesday December 11, 2012",MRK,0.0159619382533755,0.4531692966033698,-0.0033605257380278,0.0026959946002358,0.0027034087154753,-0.0002255265791055,-0.0009001011444151,0.0015489882510457,-0.1717893031987337,2
2012-12-11,Cardiome Reaches Deal with Merck to Retire Debt/Close Line of Credit; Will Pay Merck $20M,MRK,0.0159619382533755,0.4531692966033698,-0.0033605257380278,0.0026959946002358,0.0027034087154753,-0.0002255265791055,-0.0009001011444151,0.0015489882510457,-0.1717893031987337,2
2012-12-18,"Merck, GE Healthcare Announce Collaboration on Use of Imaging Biomarkers for Investigational BACE Inhibitor Program",MRK,0.013980942738565,0.0603002662087348,0.0020674346598525,-0.0093286225837601,-0.0196298006602338,0.0015489882510457,0.0159619382533755,-0.0131099721428556,-0.1695831126454303,1
2012-12-20,Merck Says HPS2-THRIVE Study of TREDAPTIVE Did Not Achieve Primary Endpoint,MRK,-0.0343566767814721,1.8775944318308024,-0.0131099721428556,0.013980942738565,0.0020674346598525,-0.0093286225837601,-0.0196298006602338,-0.0151805392422535,-0.1467784004493761,1
2012-12-20,"Mid-Morning Market Update: Rite Aid Rallies, New York Stock Exchange Acquired by ICE",MRK,-0.0343566767814721,1.8775944318308024,-0.0131099721428556,0.013980942738565,0.0020674346598525,-0.0093286225837601,-0.0196298006602338,-0.0151805392422535,-0.1467784004493761,1
2012-12-20,"Mid-Morning Market Update: Rite Aid Rallys, New York Stock Exchange Acquired by ICE",MRK,-0.0343566767814721,1.8775944318308024,-0.0131099721428556,0.013980942738565,0.0020674346598525,-0.0093286225837601,-0.0196298006602338,-0.0151805392422535,-0.1467784004493761,1
2013-01-02,"Merck Says FDA Acknowledged Resubmission of NDA for Ezetimibe, Atorvastatin Tablets",MRK,0.00977039375491,0.1145110160960263,0.0073822822776659,-0.0135924208735818,-0.0033867471460157,-0.001931193917243,-0.0024083617168355,0.0239475500529653,0.4754369639925202,0
2013-01-07,4 Health Care ETFs Your Broker Forgot to Mention,MRK,0.0035743352598567,-0.25439283204202,-0.0085045609358465,0.0239475500529653,0.00977039375491,0.0073822822776659,-0.0135924208735818,0.0014238806628394,0.2822855075323665,2
2013-01-07,Merck Receives FDA Acceptance of Resubmission of NDA for Sugammadex Sodium Injection,MRK,0.0035743352598567,-0.25439283204202,-0.0085045609358465,0.0239475500529653,0.00977039375491,0.0073822822776659,-0.0135924208735818,0.0014238806628394,0.2822855075323665,2
2013-01-09,"Microbiotix, Merck Announce Licensing Pact for HCV NS5B",MRK,0.0097201454781095,-0.3171196116060457,0.0014238806628394,0.0035743352598567,-0.0085045609358465,0.0239475500529653,0.00977039375491,0.0044616017384546,0.2876373464244057,2
2013-01-11,Three Stocks to Buy for Flu Season,MRK,0.0105190053132633,-0.0640221895193173,0.0044616017384546,0.0097201454781095,0.0014238806628394,0.0035743352598567,-0.0085045609358465,0.0025441882295165,-0.0842661908813491,2
2013-01-11,Merck to Suspend Availability of TREDAPTIVE Worldwide,MRK,0.0105190053132633,-0.0640221895193173,0.0044616017384546,0.0097201454781095,0.0014238806628394,0.0035743352598567,-0.0085045609358465,0.0025441882295165,-0.0842661908813491,2
2013-01-25,FDA Approves OXYTROL for Women,MRK,0.0106977108072727,0.0536958956246742,0.0042036208749194,-0.0087961796069995,0.0051185541655389,0.0053801028015796,0.0049367869940131,-0.0121949652651892,-0.1000432629700137,1
2013-01-30,Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Disease,MRK,-0.0036650473311988,-0.1938703142737237,0.0170047477017596,-0.0121949652651892,0.0106977108072727,0.0042036208749194,-0.0087961796069995,-0.0057473565197542,0.1473099119524037,1
2013-02-01,US Stock Futures Up; All Eyes On Payroll Data ,MRK,-0.0328318870326611,1.592129007708785,-0.0057473565197542,-0.0036650473311988,0.0170047477017596,-0.0121949652651892,0.0106977108072727,-0.0234283293355989,-0.2196534604733764,1
2013-02-01,"Earnings Scheduled For February 1, 2013",MRK,-0.0328318870326611,1.592129007708785,-0.0057473565197542,-0.0036650473311988,0.0170047477017596,-0.0121949652651892,0.0106977108072727,-0.0234283293355989,-0.2196534604733764,1
2013-02-01,"Stocks To Watch For February 1, 2013",MRK,-0.0328318870326611,1.592129007708785,-0.0057473565197542,-0.0036650473311988,0.0170047477017596,-0.0121949652651892,0.0106977108072727,-0.0234283293355989,-0.2196534604733764,1
2013-02-05,"Merck Serono, Opexa Therapeutics Enter Option, License Agreement for Development of Tcelna",MRK,0.0141976516660535,-0.2755009625465658,-0.0234283293355989,-0.0328318870326611,-0.0057473565197542,-0.0036650473311988,0.0170047477017596,-0.0082061804934023,-0.1841387726404553,1
2013-02-14,"Merck Resolves Securities Class-Action Suit Related to ENHANCE, to Record $493M Charge",MRK,0.0009725037447136,0.0335056610194339,-0.0072377530761067,0.0016912354629703,0.0048571634938496,0.004390288466433,-0.0021904368192515,0.0055835947008195,-0.0461463708056202,0
2013-02-27,Still No Herbalife in 13F ETFs,MRK,0.0129656051461788,-0.0709194342603992,-0.0023516557872329,-0.0104726221543235,0.0110589518074311,-0.0037504439473573,0.0104216487764119,-0.0055855614529484,0.1001927219236644,1
2013-02-27,Still no Herbalife in 13F ETFs,MRK,0.0129656051461788,-0.0709194342603992,-0.0023516557872329,-0.0104726221543235,0.0110589518074311,-0.0037504439473573,0.0104216487764119,-0.0055855614529484,0.1001927219236644,1
2013-02-28,"If The Market Falls, Try These Low Beta ETFs",MRK,-0.0055855614529484,0.1001927219236644,0.0129656051461788,-0.0023516557872329,-0.0104726221543235,0.0110589518074311,-0.0037504439473573,-0.0023404220082733,0.0425717574218236,2
2013-03-04,The News of an HIV Cure Is Great News For These Publicly-Traded Companies,MRK,0.0166550834349323,-0.0442822603175453,-0.0023404220082733,-0.0055855614529484,0.0129656051461788,-0.0023516557872329,-0.0104726221543235,-0.0020766564905672,0.0676473343131249,2
2013-03-04,An HIV Cure Is Great News For These Publicly-Traded Companies,MRK,0.0166550834349323,-0.0442822603175453,-0.0023404220082733,-0.0055855614529484,0.0129656051461788,-0.0023516557872329,-0.0104726221543235,-0.0020766564905672,0.0676473343131249,2
2013-03-04,An HIV Cure Is Great News For These Drug Manufacturers,MRK,0.0166550834349323,-0.0442822603175453,-0.0023404220082733,-0.0055855614529484,0.0129656051461788,-0.0023516557872329,-0.0104726221543235,-0.0020766564905672,0.0676473343131249,2
2013-03-06,3 Sector ETFs Outpacing Larger Rivals,MRK,0.0099422159350668,0.2182152491619891,-0.0020766564905672,0.0166550834349323,-0.0023404220082733,-0.0055855614529484,0.0129656051461788,-0.009386158902615,-0.2543017061029771,1
2013-03-07,"Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire ",MRK,-0.009386158902615,-0.2543017061029771,0.0099422159350668,-0.0020766564905672,0.0166550834349323,-0.0023404220082733,-0.0055855614529484,-0.0069331932303638,1.131509524927476,1
2013-03-12,"Merck Issues Update on IMPROVE-IT Trial, Says DSMB Recommend Study to Continue",MRK,0.0316070840318167,0.4495407311273092,0.0160579906157214,-0.0069331932303638,-0.009386158902615,0.0099422159350668,-0.0020766564905672,-0.0004482754895924,-0.6800214188871243,2
2013-03-14,Embrace These New ETFs,MRK,-0.0071762999065223,0.4448474018308948,-0.0004482754895924,0.0316070840318167,0.0160579906157214,-0.0069331932303638,-0.009386158902615,-0.0040657111441488,-0.0603049430166983,2
2013-03-14,Generic Drugs Will Hit Pharmaceuticals Hard in 2013,MRK,-0.0071762999065223,0.4448474018308948,-0.0004482754895924,0.0316070840318167,0.0160579906157214,-0.0069331932303638,-0.009386158902615,-0.0040657111441488,-0.0603049430166983,2
2013-03-14,Generics Will Hit Drug Companies Hard in 2013,MRK,-0.0071762999065223,0.4448474018308948,-0.0004482754895924,0.0316070840318167,0.0160579906157214,-0.0069331932303638,-0.009386158902615,-0.0040657111441488,-0.0603049430166983,2
2013-03-26,Risk On Rally? These ETFs Say No,MRK,0.016022339795402,-0.0765717875557377,-0.0047833915317417,0.002511682776191,-0.0074793734992244,0.0096105622206466,0.0016046443884385,-0.0065329448352883,-0.0942647416794087,1
2013-03-26,The Supreme Court is About to Stick it to Big Pharma,MRK,0.016022339795402,-0.0765717875557377,-0.0047833915317417,0.002511682776191,-0.0074793734992244,0.0096105622206466,0.0016046443884385,-0.0065329448352883,-0.0942647416794087,1
2013-03-27,Merck Announces FDA Acceptance of Biologics License App for Investigational Grass Pollen Allergy Immunotherapy Tablet,MRK,-0.0065329448352883,-0.0942647416794087,0.016022339795402,-0.0047833915317417,0.002511682776191,-0.0074793734992244,0.0096105622206466,0.0022671723342146,0.5168947553220904,2
2013-04-04,2 New Dividend ETFs to Consider,MRK,-0.0008820887988303,-0.4601386970143098,0.0100200370258536,0.0126273351726706,0.0033933136093611,0.0022671723342146,-0.0065329448352883,-0.0041922012478916,-0.0977919890475607,2
2013-04-10,Merck Announces FDA Acceptance of NDA for NOXAFIL Investigational Tablet Formulation,MRK,0.0292248238252372,0.7675790727206697,0.0006594901139089,0.0077551556752011,-0.0041922012478916,-0.0008820887988303,0.0100200370258536,0.0078988518625378,-0.0639014667380719,0
2013-04-11,ETF Showdown: A Pharma Fight,MRK,0.0078988518625378,-0.0639014667380719,0.0292248238252372,0.0006594901139089,0.0077551556752011,-0.0041922012478916,-0.0008820887988303,-0.0021182855376528,-0.4261342624443823,2
2013-04-12,"Benzinga Market Primer, Friday April 12",MRK,-0.0021182855376528,-0.4261342624443823,0.0078988518625378,0.0292248238252372,0.0006594901139089,0.0077551556752011,-0.0041922012478916,-0.0137972125218461,0.5249095732814562,1
2013-04-12,"Benzinga Market Primer: Friday, April 12",MRK,-0.0021182855376528,-0.4261342624443823,0.0078988518625378,0.0292248238252372,0.0006594901139089,0.0077551556752011,-0.0041922012478916,-0.0137972125218461,0.5249095732814562,1
2013-04-26,Weekly Preview: Focus Shifts from Earnings to Economy,MRK,0.0109819820694969,-0.3347848690232073,-0.0125129942808605,-0.0139834564492902,0.0148166109584917,0.0090548199995641,0.0199737877480301,-0.0010444826527914,0.0730361081706933,2
2013-04-29,Merck Wins FOSAMAX Federal Bellwether Trial Involving Atypical Femur Fracture Claims ,MRK,-0.0010444826527914,0.0730361081706933,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0148166109584917,0.0090548199995641,-0.0171477234158815,0.7356605378837997,1
2013-04-29,"Market Wrap for Monday, April 29: Stocks Start Week With a Rally",MRK,-0.0010444826527914,0.0730361081706933,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0148166109584917,0.0090548199995641,-0.0171477234158815,0.7356605378837997,1
2013-04-29,"Merck, Pfizer Announce Worldwide Collaboration Deal for Development, Commercialization of Ertugliflozin",MRK,-0.0010444826527914,0.0730361081706933,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0148166109584917,0.0090548199995641,-0.0171477234158815,0.7356605378837997,1
2013-04-30,"Pfizer Tanks on Earnings, Unhealthy Guidance",MRK,-0.0171477234158815,0.7356605378837997,-0.0010444826527914,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0148166109584917,-0.0278722674233345,1.0127324725167823,1
2013-04-30,"Pfizer Tanks on Ill Earnings, Unhealthy Guidance",MRK,-0.0171477234158815,0.7356605378837997,-0.0010444826527914,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0148166109584917,-0.0278722674233345,1.0127324725167823,1
2013-05-01,Earnings Trigger Volume Spike in Pharma ETF,MRK,-0.0278722674233345,1.0127324725167823,-0.0171477234158815,-0.0010444826527914,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0008755981311385,-0.6415371525571308,2
2013-05-01,Merck Announces New $15B Share Repurchase Program ,MRK,-0.0278722674233345,1.0127324725167823,-0.0171477234158815,-0.0010444826527914,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0008755981311385,-0.6415371525571308,2
2013-05-01,"UPDATE: Merck Posts 8.3% Drop In Q1 Profit, Lowers Forecast",MRK,-0.0278722674233345,1.0127324725167823,-0.0171477234158815,-0.0010444826527914,0.0109819820694969,-0.0125129942808605,-0.0139834564492902,0.0008755981311385,-0.6415371525571308,2
2013-05-03,UPDATE: Fitch Affirms Ratings on Merck; Outlook Lowered from Positive to Negative,MRK,-0.0013118889698409,-0.0962402413119518,0.0008755981311385,-0.0278722674233345,-0.0171477234158815,-0.0010444826527914,0.0109819820694969,-0.0151089991853469,0.0948922226221951,1
2013-05-08,Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet,MRK,-0.0061855054088623,0.2601470976307884,0.0064479265908692,-0.0151089991853469,-0.0013118889698409,0.0008755981311385,-0.0278722674233345,0.0111139929607138,-0.2257227226337198,0
2013-05-22,Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant ,MRK,-0.013098846776234,-0.0934864971562995,0.0468920172008169,-0.0169604011240178,-0.0081946644343131,-0.0077039462906808,0.0017151591569568,0.013272703890806,-0.4702720641706417,0
2013-05-22,"PreMarket Info Recap for May 22, 2013",MRK,-0.013098846776234,-0.0934864971562995,0.0468920172008169,-0.0169604011240178,-0.0081946644343131,-0.0077039462906808,0.0017151591569568,0.013272703890806,-0.4702720641706417,0
2013-05-23,Merck Issues Update on Phase III Trial for Preladenant,MRK,0.013272703890806,-0.4702720641706417,-0.013098846776234,0.0468920172008169,-0.0169604011240178,-0.0081946644343131,-0.0077039462906808,-0.0035912498037544,-0.3004304829804617,2
2013-05-28,"PreMarket Info Recap for May 28, 2013",MRK,0.009753650173214,0.1182514439833062,-0.0035912498037544,0.013272703890806,-0.013098846776234,0.0468920172008169,-0.0169604011240178,-0.0157496069382626,-0.091270865714764,1
2013-06-03,"ISM Manufacturing Index Drops in May, Shows Contraction",MRK,0.0374731238081815,0.7482336583504741,-0.0078607217517854,0.0042671860113405,-0.0157496069382626,0.009753650173214,-0.0035912498037544,0.0204334357627169,-0.0256356101991058,0
2013-06-03,Benzinga's Top Pre-Market Gainers,MRK,0.0374731238081815,0.7482336583504741,-0.0078607217517854,0.0042671860113405,-0.0157496069382626,0.009753650173214,-0.0035912498037544,0.0204334357627169,-0.0256356101991058,0
2013-06-18,Interesting Similarities Among 2013's Top-Performing ETFs,MRK,-0.0010460279543166,-0.0535354454013874,-0.0031281542939134,0.0010440710820176,0.0230671375340005,-0.0065180958819698,-0.0185724636141794,-0.0035603327658906,0.5227642816064526,2
2013-07-01,FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients ,MRK,-0.0027984831630183,-0.1975299154233417,-0.0175549311731431,0.0126365785234991,0.0099498061422746,-0.0038782519760122,-0.0125531137231106,0.004965237364281,-0.1369945943648717,2
2013-07-01,"Merck Receives Complete Response Letter for Suvorexant, Merck's Investigational Medicine for Insomnia; FDA Says Data Does Not Support Approval of Suvorexant 30mg and 40mg",MRK,-0.0027984831630183,-0.1975299154233417,-0.0175549311731431,0.0126365785234991,0.0099498061422746,-0.0038782519760122,-0.0125531137231106,0.004965237364281,-0.1369945943648717,2
2013-07-02,Pfizer and Novartis Said to be Zeroing in on Onyx,MRK,0.004965237364281,-0.1369945943648717,-0.0027984831630183,-0.0175549311731431,0.0126365785234991,0.0099498061422746,-0.0038782519760122,0.0,-0.3925361556811023,2
2013-07-02,"Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)",MRK,0.004965237364281,-0.1369945943648717,-0.0027984831630183,-0.0175549311731431,0.0126365785234991,0.0099498061422746,-0.0038782519760122,0.0,-0.3925361556811023,2
2013-07-15,Health Care ETFs Looking Healthy Ahead of Earnings,MRK,-0.0004116971625871,0.0902150989961385,0.0047605944172579,0.0072981089946579,0.0071396488423081,0.0044298022943505,0.0053010034329847,-0.00597726759584,0.5820351852787129,1
2013-07-16,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues,MRK,-0.00597726759584,0.5820351852787129,-0.0004116971625871,0.0047605944172579,0.0072981089946579,0.0071396488423081,0.0044298022943505,-0.0020730668598093,-0.3775010803266351,2
2013-07-16,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY),MRK,-0.00597726759584,0.5820351852787129,-0.0004116971625871,0.0047605944172579,0.0072981089946579,0.0071396488423081,0.0044298022943505,-0.0020730668598093,-0.3775010803266351,2
2013-07-16,Merck in Talks with FDA to Identify Steps Needed for Review of Sugammadex Sodium Injection,MRK,-0.00597726759584,0.5820351852787129,-0.0004116971625871,0.0047605944172579,0.0072981089946579,0.0071396488423081,0.0044298022943505,-0.0020730668598093,-0.3775010803266351,2
2013-07-16,Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization ,MRK,-0.00597726759584,0.5820351852787129,-0.0004116971625871,0.0047605944172579,0.0072981089946579,0.0071396488423081,0.0044298022943505,-0.0020730668598093,-0.3775010803266351,2
2013-07-24,"UPDATE: Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine ",MRK,-0.0033382113694127,-0.0325470264359024,0.0044006835880869,-0.0014648592726885,0.0082279870610502,-0.015167632883354,-0.0020730668598093,0.0083732537027265,0.1229364493086617,0
2013-07-26,"Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected",MRK,0.0066437230441251,-0.0193418022361757,0.0083732537027265,-0.0033382113694127,0.0044006835880869,-0.0014648592726885,0.0082279870610502,-0.0030938768787169,0.0452357043219484,2
2013-07-26,"Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin ",MRK,0.0066437230441251,-0.0193418022361757,0.0083732537027265,-0.0033382113694127,0.0044006835880869,-0.0014648592726885,0.0082279870610502,-0.0030938768787169,0.0452357043219484,2
2013-07-30,"Earnings Scheduled For July 30, 2013",MRK,-0.0059993029548093,0.630281012724655,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0044006835880869,0.002497406439573,0.285978193031966,2
2013-07-30,SLIDESHOW: 8 Stocks to Benefit From a Repatriation Deal In Congress,MRK,-0.0059993029548093,0.630281012724655,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0044006835880869,0.002497406439573,0.285978193031966,2
2013-07-30,"Benzinga Market Primer: Wednesday, July 30: Futures Higher After Asia Turnaround",MRK,-0.0059993029548093,0.630281012724655,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0044006835880869,0.002497406439573,0.285978193031966,2
2013-07-30,UPDATE: Merck Posts Drop In Q2 Profit,MRK,-0.0059993029548093,0.630281012724655,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0044006835880869,0.002497406439573,0.285978193031966,2
2013-07-30,"Benzinga Market Primer, Wednesday July 30",MRK,-0.0059993029548093,0.630281012724655,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0044006835880869,0.002497406439573,0.285978193031966,2
2013-07-30,US Stock Futures Up Ahead Of Fed Meeting,MRK,-0.0059993029548093,0.630281012724655,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0044006835880869,0.002497406439573,0.285978193031966,2
2013-07-31,"Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision",MRK,0.002497406439573,0.285978193031966,-0.0059993029548093,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0085117738225755,-0.3721010113759171,0
2013-07-31,"Benzinga Market Primer, Wednesday July 31",MRK,0.002497406439573,0.285978193031966,-0.0059993029548093,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0085117738225755,-0.3721010113759171,0
2013-07-31,Bionomics Signs Option and License Agreement With Merck ,MRK,0.002497406439573,0.285978193031966,-0.0059993029548093,-0.0030938768787169,0.0066437230441251,0.0083732537027265,-0.0033382113694127,0.0085117738225755,-0.3721010113759171,0
2013-08-02,"Three Soaring, But Overlooked Health Care ETFs",MRK,-0.0008233864997674,-0.341428081825631,0.0085117738225755,0.002497406439573,-0.0059993029548093,-0.0030938768787169,0.0066437230441251,-0.0002062398221486,-0.2390778170841966,2
2013-08-02,S&P: Heaping Praise For Some Health Care ETFs,MRK,-0.0008233864997674,-0.341428081825631,0.0085117738225755,0.002497406439573,-0.0059993029548093,-0.0030938768787169,0.0066437230441251,-0.0002062398221486,-0.2390778170841966,2
2013-08-12,Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck ,MRK,0.0016536878483657,0.2594888200246914,-0.0016509576797126,-0.0016475670557668,0.002270857150282,-0.001854305168877,-0.0002062398221486,-0.0008257027288826,-0.2496200292259353,2
2013-08-13,Mid-Day Market Update: US Stocks Edge Higher; Valspar Shares Decline On Downbeat Results,MRK,-0.0008257027288826,-0.2496200292259353,0.0016536878483657,-0.0016509576797126,-0.0016475670557668,0.002270857150282,-0.001854305168877,0.0028911153632895,0.14430384445302,2
2013-08-13,"Mid-Afternoon Market Update: Apple Rises Sharply On Icahn Stake, NASDAQ Pulled Upward",MRK,-0.0008257027288826,-0.2496200292259353,0.0016536878483657,-0.0016509576797126,-0.0016475670557668,0.002270857150282,-0.001854305168877,0.0028911153632895,0.14430384445302,2
2013-08-13,"Mid-Afternoon Market Update: Apple Rises Sharply on Icahn Stake, NASDAQ Pulled Upward",MRK,-0.0008257027288826,-0.2496200292259353,0.0016536878483657,-0.0016509576797126,-0.0016475670557668,0.002270857150282,-0.001854305168877,0.0028911153632895,0.14430384445302,2
2013-08-13,"Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down 13%",MRK,-0.0008257027288826,-0.2496200292259353,0.0016536878483657,-0.0016509576797126,-0.0016475670557668,0.002270857150282,-0.001854305168877,0.0028911153632895,0.14430384445302,2
2013-08-13,Benzinga's Top Pre-Market Gainers,MRK,-0.0008257027288826,-0.2496200292259353,0.0016536878483657,-0.0016509576797126,-0.0016475670557668,0.002270857150282,-0.001854305168877,0.0028911153632895,0.14430384445302,2
2013-08-30,Plenty Of ETFs With Favorable Risk Traits,MRK,0.0040337505631871,-0.1412113185416197,0.000212590373954,-0.000424424409667,-0.0107100429769031,-0.0023045230812673,-0.0016727283539769,-0.0016913502140204,0.7069287031045974,2
2013-09-09,USA TD Ameritrade's Investor Movement Index for Aug 5.16 vs 4.87 Prior,MRK,0.0052643960540565,0.0943300215084623,-0.0004208510991122,-0.0035657873773812,0.0099553132069407,-0.0016913502140204,0.0040337505631871,0.0050272451180928,0.0558049563697542,0
2013-09-09,Merck Reports FDA Acceptance of NDA for Investigational Fertility Treatment,MRK,0.0052643960540565,0.0943300215084623,-0.0004208510991122,-0.0035657873773812,0.0099553132069407,-0.0016913502140204,0.0040337505631871,0.0050272451180928,0.0558049563697542,0
2013-09-11,US Stock Futures Flat; Apple Shares Drop In Pre-Market Trading,MRK,0.0033343929657596,-0.5657348887010551,0.0050272451180928,0.0052643960540565,-0.0004208510991122,-0.0035657873773812,0.0099553132069407,0.0029345682354742,-0.2897579303826172,2
2013-09-11,"Merck, AstraZeneca Announce License Agreement for MK-1775",MRK,0.0033343929657596,-0.5657348887010551,0.0050272451180928,0.0052643960540565,-0.0004208510991122,-0.0035657873773812,0.0099553132069407,0.0029345682354742,-0.2897579303826172,2
2013-09-19,Write A Prescription For Health Care ETFs,MRK,-0.0028921768344313,-0.3341280956940745,0.0081232415501721,-0.0037352272559888,0.0083698161809093,-0.0012538476839724,0.0029345682354742,-0.0051805925618221,1.997534305317324,1
2013-10-01,Merck Shares Soar After Announcing More Job Cuts,MRK,0.0237345796841503,0.6830337590297579,-0.0037664904215154,0.0023068597102451,0.0002100457125799,0.0029450008920988,-0.0031457382926644,-0.0075910366123563,-0.4888182747405527,1
2013-10-01,Merck Says Interim Data for MK-3475 to be Presented at 15th World Conference on Lung Cancer,MRK,0.0237345796841503,0.6830337590297579,-0.0037664904215154,0.0023068597102451,0.0002100457125799,0.0029450008920988,-0.0031457382926644,-0.0075910366123563,-0.4888182747405527,1
2013-10-01,UPDATE: Merck Announces Global Initiative to Sharpen Commercial and R&D Focus; Cutting 8500 Jobs; Affirms FY Target,MRK,0.0237345796841503,0.6830337590297579,-0.0037664904215154,0.0023068597102451,0.0002100457125799,0.0029450008920988,-0.0031457382926644,-0.0075910366123563,-0.4888182747405527,1
2013-10-07,Merck Says Data Shows Cognigram as Sensitive Assessment,MRK,-0.0070501556493118,-0.2052580701717059,-0.0026875201058061,-0.000207228241118,-0.0075910366123563,0.0237345796841503,-0.0037664904215154,-0.0029230888083606,0.5246852871550425,2
2013-10-14,"Merck, Endocyte Report Vintafolide-PLD Generaly Well Tolerated, Showed Median PFS of Five Months",MRK,-0.0114187134903246,1.016335885307456,-0.0042115139550773,0.0046541925387759,-0.0100524617280747,-0.0029230888083606,-0.0070501556493118,-0.0038503938964228,-0.3150499407482647,2
2013-10-16,"Merck Confirms Development of Investigational Dosing ISENTRESS, Will Begin Phase III Trial Early 2014",MRK,0.0128837938971722,-0.2159663596017661,-0.0038503938964228,-0.0114187134903246,-0.0042115139550773,0.0046541925387759,-0.0100524617280747,-0.0012722649211253,0.2500112155508553,2
2013-10-22,Merck's MK-5172/MK-8742 Receives Breakthrough Therapy Designation from FDA,MRK,-0.0008596347656416,-0.0501558939920854,-0.0021453416781106,-0.0106135448744481,-0.0012722649211253,0.0128837938971722,-0.0038503938964228,0.0019365655868535,-0.390796302011843,2
2013-10-25,Benzinga Weekly Preview: FOMC Meeting Closely Watched,MRK,0.0069236008355464,0.5975216447607339,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,-0.0106135448744481,-0.0255695148581627,0.5255169437151948,1
2013-10-28,Mid-Afternoon Market Update: Markets Mixed as JC Penney Rises,MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-28,Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates,MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-28,Mid-Day Market Update: Burger King Surges On Upbeat Earnings; Sohu Shares Dip,MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-28,"#PreMarket Primer: Monday, October 28: All Eyes On Apple",MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-28,"Earnings Scheduled For October 28, 2013",MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-28,"Stocks To Watch For October 28, 2013",MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-28,UPDATE: Merck Posts Upbeat Q3 Profit,MRK,-0.0255695148581627,0.5255169437151948,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0021453416781106,0.0050717932901545,-0.4178975481759661,0
2013-10-29,"#PreMarket Primer: Tuesday, October 29: Fed Meeting Likely Uneventful",MRK,0.0050717932901545,-0.4178975481759661,-0.0255695148581627,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0074598154500883,-0.3732850849590937,1
2013-10-29,US Stock Futures Flat Ahead Of Fed,MRK,0.0050717932901545,-0.4178975481759661,-0.0255695148581627,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0074598154500883,-0.3732850849590937,1
2013-10-29,Merck Presents Interim Data from Phase 1B Study of MK-3475 at 15th World Conference on Lung Cancer ,MRK,0.0050717932901545,-0.4178975481759661,-0.0255695148581627,0.0069236008355464,-0.0073025697126994,0.0019365655868535,-0.0008596347656416,-0.0074598154500883,-0.3732850849590937,1
2013-10-31,Market Wrap for October 31: Fed Worries Pull Stocks Lower,MRK,-0.0033152257183682,0.505668562703157,-0.0074598154500883,0.0050717932901545,-0.0255695148581627,0.0069236008355464,-0.0073025697126994,0.0031045465270826,0.3934387608644105,2
2013-11-06,Job Cuts Higher in October; Pharmaceutical & Financial Sectors Took Biggest Hits,MRK,0.0132275950843427,0.1862482240123419,-0.0078736906782691,0.0108334427140104,0.0031045465270826,-0.0033152257183682,-0.0074598154500883,-0.0030463055764147,-0.0554876776988511,2
2013-12-10,Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931,MRK,-0.002622989952475,0.0969725991705841,0.0034414157972395,0.0118829085439762,-0.0101396859574215,-0.0090433845138334,-0.0083700378685139,-0.0097104816718316,0.4169044068619441,1
2013-12-12,"#PreMarket Primer: Thursday, December, 12th: US Budget Deal Gaining Momentum",MRK,-0.0039168310031444,-0.1994139284556405,-0.0097104816718316,-0.002622989952475,0.0034414157972395,0.0118829085439762,-0.0101396859574215,0.0012417403422677,-0.2769104142948734,2
2013-12-12,"#PreMarket Primer: Thursday, December 12: US Budget Deal Gaining Momentum",MRK,-0.0039168310031444,-0.1994139284556405,-0.0097104816718316,-0.002622989952475,0.0034414157972395,0.0118829085439762,-0.0101396859574215,0.0012417403422677,-0.2769104142948734,2
2013-12-18,"Is Amarin's Vascepa Not as Effective as Hoped, or the Target of an Effort to Keep it Off the Market? -- HOLD FOR JOE",MRK,0.020876801869808,-0.025201411389972,-0.0039508180117052,-0.005994246545526,0.0012417403422677,-0.0039168310031444,-0.0097104816718316,-0.0022495765833049,-0.3533141278158456,2
2013-12-18,Merck Collaborates with GlaxoSmithKline on MK-3475,MRK,0.020876801869808,-0.025201411389972,-0.0039508180117052,-0.005994246545526,0.0012417403422677,-0.0039168310031444,-0.0097104816718316,-0.0022495765833049,-0.3533141278158456,2
2013-12-26,Merck Sues to Stop Generic NuvaRing,MRK,0.0062740733901891,0.192080661623109,0.0010128189999274,0.0008110420139428,0.0108629890838176,-0.0022495765833049,0.020876801869808,0.0014078515349547,-0.1628269482322163,2
2014-01-13,Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Market Wrap For January 13: Markets Showing Weakness Ahead of Major Earning Releases,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,"Benzinga's M&A Chatter for Monday January 13, 2014",MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Mid-Afternoon Market Update: Markets Dip Despite Large Amount of M&A,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Morning Market Movers ,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Merck Initiates Rolling Submission to FDA of US Biologics License Application for MK-3475,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Benzinga's Top #PreMarket Gainers,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares Spike Higher,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-13,id-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook,MRK,0.0649558972303274,3.579496597655792,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,0.0074384145410519,0.0002013567522989,-0.0022589693634114,-0.4317521620708348,2
2014-01-15,Market Wrap For January 15: Bulls Take Over as Economic Growth Remains Healthy,MRK,-0.0090567376378577,-0.5050659104657298,-0.0022589693634114,0.0649558972303274,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,-0.0003807115226421,-0.2591914387071229,2
2014-01-15,Merck Pleased with FDA Advisory Committee Recommendation for Approval of Vorapaxar,MRK,-0.0090567376378577,-0.5050659104657298,-0.0022589693634114,0.0649558972303274,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,-0.0003807115226421,-0.2591914387071229,2
2014-01-15,Market Wrap For January 15: Bulls Take Over As Economic Growth Remains Healthy,MRK,-0.0090567376378577,-0.5050659104657298,-0.0022589693634114,0.0649558972303274,0.0072698987300114,-0.0054228031091665,-0.0063860456479749,-0.0003807115226421,-0.2591914387071229,2
2014-01-24,Merck Shares Higher Following Bristol-Myers' Phase 3 Disappointment,MRK,0.0073645531255714,0.150115258870618,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,-0.0003807115226421,0.0105808904228614,0.6976885899674581,0
2014-01-27,"Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower",MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-27,US Stock Futures Gain Ahead Of Home-Sales Data,MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-27,Winter's Stock Knockdown May Give Way to a Spring Thaw,MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-27,Winter's Stock Knockdown May Give Way To A Spring Thaw,MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-27,Winter's Stock Knockdown May Give Way To a Spring Thaw,MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-27,Stocks Hitting 52-Week Highs,MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-27,UPDATE: Merck Upgraded by Morgan Stanley on Oncology Optimism,MRK,0.0105808904228614,0.6976885899674581,0.0073645531255714,0.0048683607095165,-0.0092608739104702,-0.0023099473814544,-0.0104760919654804,0.0064723838934535,-0.513637817505987,0
2014-01-31,Market Wrap For January 31: Markets End January On Sour Note,MRK,-0.0100919190949431,-0.06227331894732,0.0248997148124028,-0.0124836343121381,0.0064723838934535,0.0105808904228614,0.0073645531255714,-0.0168014615373084,-0.0491958139447701,1
2014-01-31,Market Wrap For January 31: Markets End January on Sour Note,MRK,-0.0100919190949431,-0.06227331894732,0.0248997148124028,-0.0124836343121381,0.0064723838934535,0.0105808904228614,0.0073645531255714,-0.0168014615373084,-0.0491958139447701,1
2014-02-03,"Earnings Expectations For The Week Of February 3: GM, Twitter, Disney And More",MRK,-0.0168014615373084,-0.0491958139447701,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0064723838934535,0.0105808904228614,0.0274575934724081,0.1738891562268802,0
2014-02-05,Market Wrap For February 5: Markets Unsure of Which Direction to Take,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,"Earnings Scheduled For February 5, 2014",MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,US Stock Futures Flat; All Eyes On ADP Report,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,UPDATE: Merck Posts Drop In Q4 Profit,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,"Stocks To Watch For February 5, 2014",MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,Market Wrap For February 5: Markets Unsure Of Which Direction To Take,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,Stocks Hitting 52-Week Highs,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,Top Trending Tickers On StockTwits For February 5,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-05,Benzinga's Top #PreMarket Gainers,MRK,0.0003734686292327,0.3478404278728881,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,-0.0124836343121381,0.0044840321624601,-0.5003407365032562,2
2014-02-06,#PreMarket Primer: Thursday February 6: Taking a Breather,MRK,0.0044840321624601,-0.5003407365032562,0.0003734686292327,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,0.0185972063852635,0.1839393573373959,0
2014-02-06,"#PreMarket Primer: Thursday, February 6: Markets Taking A Breather After Twitter Earnings",MRK,0.0044840321624601,-0.5003407365032562,0.0003734686292327,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0248997148124028,0.0185972063852635,0.1839393573373959,0
2014-02-07,"Market Wrap For February 7: Jobs Report Not Great, But Not Too Bad",MRK,0.0185972063852635,0.1839393573373959,0.0044840321624601,0.0003734686292327,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0021910131874318,-0.2681570761617831,2
2014-02-07,Market Wrap For February 7: Jobs Report Not That Great But Not So Bad,MRK,0.0185972063852635,0.1839393573373959,0.0044840321624601,0.0003734686292327,0.0274575934724081,-0.0168014615373084,-0.0100919190949431,0.0021910131874318,-0.2681570761617831,2
2014-02-20,"FDA Accepts for Review Merck's Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine",MRK,0.0139899844143691,-0.0159268140506095,-0.011671972529195,0.0045095904495191,0.0061704961901425,0.001818402735656,-0.0125674156497113,0.0039417172041347,0.1513357186960691,2
2014-03-14,UPDATE: FDA Approves Merck Noxafi Injection for IV Use,MRK,-0.0016133748414183,0.1974110294783211,-0.0102889822910144,0.0021168069849555,-0.0109912280106407,-0.0026101416633338,0.0036676751966857,0.0100541765046922,-0.2152535849179028,0
2014-03-21,Benzinga's Volume Movers,MRK,-0.016729526963976,1.7686390017365672,-0.0071443432737614,-0.0065648078449688,0.0017771613710084,0.0100541765046922,-0.0016133748414183,-0.0160994778199988,-0.3382768018389123,1
2014-03-21,Mid-Morning Market Update: Markets Open Higher; Tiffany Posts Downbeat Earnings,MRK,-0.016729526963976,1.7686390017365672,-0.0071443432737614,-0.0065648078449688,0.0017771613710084,0.0100541765046922,-0.0016133748414183,-0.0160994778199988,-0.3382768018389123,1
2014-03-21,Benzinga's Top #PreMarket Gainers,MRK,-0.016729526963976,1.7686390017365672,-0.0071443432737614,-0.0065648078449688,0.0017771613710084,0.0100541765046922,-0.0016133748414183,-0.0160994778199988,-0.3382768018389123,1
2014-03-21,Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares Spike Higher,MRK,-0.016729526963976,1.7686390017365672,-0.0071443432737614,-0.0065648078449688,0.0017771613710084,0.0100541765046922,-0.0016133748414183,-0.0160994778199988,-0.3382768018389123,1
2014-03-24,Google Honors Activist Dorothy Height and Her Contributions,MRK,-0.0160994778199988,-0.3382768018389123,-0.016729526963976,-0.0071443432737614,-0.0065648078449688,0.0017771613710084,0.0100541765046922,0.0262180423086948,-0.0893566313188226,0
2014-03-24,Google Honors Activist Dorothy Height & Her Contributions,MRK,-0.0160994778199988,-0.3382768018389123,-0.016729526963976,-0.0071443432737614,-0.0065648078449688,0.0017771613710084,0.0100541765046922,0.0262180423086948,-0.0893566313188226,0
2014-03-27,"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007",MRK,-0.0051766798511125,-0.1491402937260736,0.0150387732670262,0.0262180423086948,-0.0160994778199988,-0.016729526963976,-0.0071443432737614,0.0044861060229672,-0.1944928957940568,2
2014-04-08,Biotechs Struggling To Find A Bottom,MRK,-0.0027180953154749,-0.0577177233251066,-0.0165715298492098,-0.0016011317423803,-0.0044279154415941,0.0015965870934038,-0.0070462738663326,0.037427468260023,0.4961270359847729,0
2014-04-10,US Stock Futures Edge Lower Ahead Of Jobless Claims Data,MRK,-0.0218914270785997,0.118570940807648,0.037427468260023,-0.0027180953154749,-0.0165715298492098,-0.0016011317423803,-0.0044279154415941,0.0012534675339221,-0.243460866238622,2
2014-04-11,Top 40 Upcoming Earnings Releases  ,MRK,0.0012534675339221,-0.243460866238622,-0.0218914270785997,0.037427468260023,-0.0027180953154749,-0.0165715298492098,-0.0016011317423803,-0.0062593024773194,-0.208682724974104,1
2014-04-11,US Stock Futures Slip Ahead Of Consumer Sentiment Report,MRK,0.0012534675339221,-0.243460866238622,-0.0218914270785997,0.037427468260023,-0.0027180953154749,-0.0165715298492098,-0.0016011317423803,-0.0062593024773194,-0.208682724974104,1
2014-04-11,Google Honors Chemist Percy Julian & His Contributions ,MRK,0.0012534675339221,-0.243460866238622,-0.0218914270785997,0.037427468260023,-0.0027180953154749,-0.0165715298492098,-0.0016011317423803,-0.0062593024773194,-0.208682724974104,1
2014-04-14,Markets Falling? Get Your Defense Ready,MRK,-0.0062593024773194,-0.208682724974104,0.0012534675339221,-0.0218914270785997,0.037427468260023,-0.0027180953154749,-0.0165715298492098,0.0086379729577092,0.0329934003115144,0
2014-04-14,"Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings",MRK,-0.0062593024773194,-0.208682724974104,0.0012534675339221,-0.0218914270785997,0.037427468260023,-0.0027180953154749,-0.0165715298492098,0.0086379729577092,0.0329934003115144,0
2014-04-23,Bill Ackman Talks Partnership With Valeant For Allergan Deal ,MRK,-0.0046736854939182,-0.446321983688166,0.0090831361887606,0.0138126161726355,0.0037324336367734,0.003746890366852,0.0086379729577092,0.0005217981307046,-0.1320174955500711,2
2014-04-23,Ackman Talks Partnership With Valeant For Allergan Deal ,MRK,-0.0046736854939182,-0.446321983688166,0.0090831361887606,0.0138126161726355,0.0037324336367734,0.003746890366852,0.0086379729577092,0.0005217981307046,-0.1320174955500711,2
2014-04-24,Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns,MRK,0.0005217981307046,-0.1320174955500711,-0.0046736854939182,0.0090831361887606,0.0138126161726355,0.0037324336367734,0.003746890366852,-0.0050409890574212,-0.0725411425997319,1
2014-04-25,3 Ways To Profit From Merger Activity In The Pharmaceutical Sector,MRK,-0.0050409890574212,-0.0725411425997319,0.0005217981307046,-0.0046736854939182,0.0090831361887606,0.0138126161726355,0.0037324336367734,-0.0097833052665244,1.7284871365467325,1
2014-04-25,3 Ways to Profit from Merger Activity in the Pharmaceutical Sector,MRK,-0.0050409890574212,-0.0725411425997319,0.0005217981307046,-0.0046736854939182,0.0090831361887606,0.0138126161726355,0.0037324336367734,-0.0097833052665244,1.7284871365467325,1
2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report,MRK,-0.0050409890574212,-0.0725411425997319,0.0005217981307046,-0.0046736854939182,0.0090831361887606,0.0138126161726355,0.0037324336367734,-0.0097833052665244,1.7284871365467325,1
2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech and Pharmaceutical Companies Report,MRK,-0.0050409890574212,-0.0725411425997319,0.0005217981307046,-0.0046736854939182,0.0090831361887606,0.0138126161726355,0.0037324336367734,-0.0097833052665244,1.7284871365467325,1
2014-04-28,Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week,MRK,-0.0097833052665244,1.7284871365467325,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,0.0138126161726355,0.0359915905275418,-0.1960134830607621,0
2014-04-29,Mid-Day Market Update: Coach Slips After Q3 Results; Orbital Shares Spike Higher,MRK,0.0359915905275418,-0.1960134830607621,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,-0.0027247134399684,-0.007400372641342,2
2014-04-29,Mid-Morning Market Update: Markets Rise; Merck Earnings Beat Street View,MRK,0.0359915905275418,-0.1960134830607621,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,-0.0027247134399684,-0.007400372641342,2
2014-04-29,Mid-Afternoon Market Update: Markets Show Strength as Prothena Shares Plummet,MRK,0.0359915905275418,-0.1960134830607621,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,-0.0027247134399684,-0.007400372641342,2
2014-04-29,"#PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against Russia",MRK,0.0359915905275418,-0.1960134830607621,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,-0.0027247134399684,-0.007400372641342,2
2014-04-29,UPDATE: Merck Posts Upbeat Q1 Profit,MRK,0.0359915905275418,-0.1960134830607621,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,-0.0027247134399684,-0.007400372641342,2
2014-04-29,Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting ,MRK,0.0359915905275418,-0.1960134830607621,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0090831361887606,-0.0027247134399684,-0.007400372641342,2
2014-04-30,"#PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon ",MRK,-0.0027247134399684,-0.007400372641342,0.0359915905275418,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0046736854939182,0.0181008500959465,-0.1353868495765235,0
2014-05-01,"Benzinga's M&A Chatter for Thursday May 1, 2014",MRK,0.0181008500959465,-0.1353868495765235,-0.0027247134399684,0.0359915905275418,-0.0097833052665244,-0.0050409890574212,0.0005217981307046,-0.0234821686810462,0.0302613858433715,1
2014-05-02,Market Wrap For May 2: Markets Slip On Ukraine Tensions Despite Positive Jobs Data ,MRK,-0.0234821686810462,0.0302613858433715,0.0181008500959465,-0.0027247134399684,0.0359915905275418,-0.0097833052665244,-0.0050409890574212,0.0070423552203682,-0.3265338010440863,0
2014-05-02,Market Wrap For May 2: Markets Slip on Ukraine Tensions Despite Positive Jobs Data ,MRK,-0.0234821686810462,0.0302613858433715,0.0181008500959465,-0.0027247134399684,0.0359915905275418,-0.0097833052665244,-0.0050409890574212,0.0070423552203682,-0.3265338010440863,0
2014-05-06,"Market Wrap For May 6: Dow Suffers Triple-Digit Point Loss, Nasdaq Underperforms Once Again",MRK,-0.025925373425092,0.7010816986257666,0.0070423552203682,-0.0234821686810462,0.0181008500959465,-0.0027247134399684,0.0359915905275418,-0.0222375902774222,0.6555429815112361,1
2014-05-06,US Stock Futures Flat Ahead Of International Trade Data ,MRK,-0.025925373425092,0.7010816986257666,0.0070423552203682,-0.0234821686810462,0.0181008500959465,-0.0027247134399684,0.0359915905275418,-0.0222375902774222,0.6555429815112361,1
2014-05-06,UPDATE: Merck Highlights Strategic Initiative,MRK,-0.025925373425092,0.7010816986257666,0.0070423552203682,-0.0234821686810462,0.0181008500959465,-0.0027247134399684,0.0359915905275418,-0.0222375902774222,0.6555429815112361,1
2014-05-07,Market Wrap For May 7: Dow Banks Triple-Digit Point Gain While Nasdaq Closes Lower,MRK,-0.0222375902774222,0.6555429815112361,-0.025925373425092,0.0070423552203682,-0.0234821686810462,0.0181008500959465,-0.0027247134399684,-0.0180871970682606,-0.3726991419048442,1
2014-05-12,UPDATE: Merck Reports FDA Okay of Zontivity,MRK,0.001449017318386,-0.3471941865159467,0.0069301698040604,-0.0180871970682606,-0.0222375902774222,-0.025925373425092,0.0070423552203682,0.0083195310481123,0.1081014223871366,0
2014-05-13,US Stock Futures Up Ahead Of Retail Sales Report,MRK,0.0083195310481123,0.1081014223871366,0.001449017318386,0.0069301698040604,-0.0180871970682606,-0.0222375902774222,-0.025925373425092,0.0111213264324427,-0.1296461658667261,0
2014-05-14,The 5 Most Overvalued Dow Stocks,MRK,0.0111213264324427,-0.1296461658667261,0.0083195310481123,0.001449017318386,0.0069301698040604,-0.0180871970682606,-0.0222375902774222,-0.0085149122829234,0.1437640269317088,1
2014-06-04,ASCO Meeting Day 4: Risks and Rewards of Immunotherapy,MRK,0.000345433078847,-0.0286376818940369,-0.0003453137960391,0.0012097405085131,0.0027730639529455,0.0230496954268604,-0.005115498883334,0.0029345739436597,0.1112954014194038,2
2014-06-04,ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy,MRK,0.000345433078847,-0.0286376818940369,-0.0003453137960391,0.0012097405085131,0.0027730639529455,0.0230496954268604,-0.005115498883334,0.0029345739436597,0.1112954014194038,2
2014-06-09,Morning Market Movers ,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,"Market Wrap For June 9: Markets Higher On St. Louis Fed Comments, Low Volume",MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Hepatitis C Stocks Move After Idenix Up 235%,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Hepatitis C Stocks Move After Idenix Rockets Up 235%,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Benzinga's Top #PreMarket Gainers,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Benzinga's Top #PreMarket Losers,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,UPDATE: Merck Announces Will Purchase Idenix for $3.85Bn,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Benzinga's Volume Movers,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Stocks Hitting 52-Week Highs,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Mid-Day Market Update: Idenix Pharma Surges On Merck Buyout; Pilgrim's Pride Shares Slide,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,"Mid-Afternoon Update; Icahn's 9% Stake In Family Dollar, Tyson Foods Wins Bid For Hillshire Brands",MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,"Mid-Afternoon Market Update; Icahn's 9% Stake In Family Dollar, Tyson Foods Wins Bid For Hillshire Brands",MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,"Benzinga's M&A Chatter for Monday June 9, 2014",MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Are Gilead Shares Overreacting to Merck's Idenix Acquisition?,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,Are Gilead Shares Overreacting To Merck's Idenix Acquisition?,MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-09,"Market Wrap For June 9: Markets Higher on St. Louis Fed Comments, Low Volume",MRK,0.0015562896322098,0.2058269705395936,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0003453137960391,0.0012097405085131,0.0094922502194685,-0.051862504469725,0
2014-06-11,Takeover Whispers Add To Achillion Pharmaceuticals' Momentum,MRK,0.005470856258527,0.5262600357240774,0.0094922502194685,0.0015562896322098,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0011991903015293,-0.1823490081696843,2
2014-06-11,What Happens When All The Good News Is Out?,MRK,0.005470856258527,0.5262600357240774,0.0094922502194685,0.0015562896322098,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0011991903015293,-0.1823490081696843,2
2014-06-11,When News And Rumors Add To A Stock's Momentum,MRK,0.005470856258527,0.5262600357240774,0.0094922502194685,0.0015562896322098,-0.0043030190394417,0.0029345739436597,0.000345433078847,-0.0011991903015293,-0.1823490081696843,2
2014-06-18,5-Star Biotech Stock Watch: Synta Pharmaceuticals,MRK,0.0060281456286159,0.2505783782022448,-0.0001719913644608,-0.0029192827116464,-0.0010289571775569,-0.0011991903015293,0.005470856258527,-0.0018832283416385,-0.2328825048921391,2
2014-06-20,"Market Wrap For June 20: Yet Again, Dow And S&P 500 Indices Hit New Highs",MRK,0.0106347180414272,1.3982435598862373,-0.0018832283416385,0.0060281456286159,-0.0001719913644608,-0.0029192827116464,-0.0010289571775569,-0.007128600019169,-0.5107227209626644,1
2014-06-27,Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly,MRK,-0.0170851283899837,1.3880885419454243,-0.0056066704746503,0.016229447693882,-0.0099145565682456,-0.007128600019169,0.0106347180414272,0.005562681935944,-0.4946690150167144,0
2014-06-30,Endocyte Spikes Sharply On Rumored Resumption Of Cancer Drug Trial,MRK,0.005562681935944,-0.4946690150167144,-0.0170851283899837,-0.0056066704746503,0.016229447693882,-0.0099145565682456,-0.007128600019169,0.0114085657687685,0.0117916428162563,0
2014-06-30,US Stock Futures Fall Ahead Of Home Sales Report,MRK,0.005562681935944,-0.4946690150167144,-0.0170851283899837,-0.0056066704746503,0.016229447693882,-0.0099145565682456,-0.007128600019169,0.0114085657687685,0.0117916428162563,0
2014-07-01,"Stock Market News for July 01, 2014 - Market News",MRK,0.0114085657687685,0.0117916428162563,0.005562681935944,-0.0170851283899837,-0.0056066704746503,0.016229447693882,-0.0099145565682456,0.0092290812261226,-0.2146413215659651,0
2014-07-02,Markets Little Changed Ahead of Vacation,MRK,0.0092290812261226,-0.2146413215659651,0.0114085657687685,0.005562681935944,-0.0170851283899837,-0.0056066704746503,0.016229447693882,0.002540165364943,-0.2479325470624269,2
2014-07-02,Markets Little Changed Ahead of 4th Of July Break,MRK,0.0092290812261226,-0.2146413215659651,0.0114085657687685,0.005562681935944,-0.0170851283899837,-0.0056066704746503,0.016229447693882,0.002540165364943,-0.2479325470624269,2
2014-07-02,Markets Little Changed Ahead Of 4th Of July Break,MRK,0.0092290812261226,-0.2146413215659651,0.0114085657687685,0.005562681935944,-0.0170851283899837,-0.0056066704746503,0.016229447693882,0.002540165364943,-0.2479325470624269,2
2014-07-07,Markets Marginally Lower Ahead of Earnings Season,MRK,-0.0114864462328109,0.777015774133492,0.002540165364943,0.0092290812261226,0.0114085657687685,0.005562681935944,-0.0170851283899837,-0.0059806725427077,-0.1084603770339799,1
2014-07-07,Markets Marginally Lower Ahead Of Earnings Season,MRK,-0.0114864462328109,0.777015774133492,0.002540165364943,0.0092290812261226,0.0114085657687685,0.005562681935944,-0.0170851283899837,-0.0059806725427077,-0.1084603770339799,1
2014-07-15,Companies Leading In Healthy Work Places,MRK,-0.0046409407343018,0.2123139668320066,-0.004449389008292,-0.0023896929540656,0.0005123714488628,0.0065325551841848,-0.0059806725427077,0.004144635940062,-0.3300912698088399,2
2014-07-28,Markets Little Changed Ahead Of The Federal Reserve's Policy Decision,MRK,-0.0030954661173403,0.556659623284093,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0058278393534338,0.0105227887377397,0.2008324370884937,0
2014-07-29,Mid-Afternoon Market Update: Indeces Remain Mixed; Merck Beats Expectations,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Tuesday Morning Earnings Releases,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Mid-Day Market Update: Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Indices Remain Mixed; Merck Beats Expectations,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,"Earnings Scheduled For July 29, 2014",MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,"UPDATE: Merck Q2 Profit Beats Street View, Shares Rise",MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,"US Stock Futures Rise Ahead Of Earnings, Consumer Confidence Data",MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,"Stocks To Watch For July 29, 2014",MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Mid-Morning Market Update: Markets Open Higher; Merck Posts Upbeat Profit,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Markets Open Higher; Merck Posts Upbeat Profit,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-07-29,Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher,MRK,0.0105227887377397,0.2008324370884937,-0.0030954661173403,-0.0010309986630827,0.0017208968027302,-0.0054764601139088,0.0074137831341523,-0.0085354496207338,-0.2203912065917301,1
2014-08-04,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",MRK,0.0045773959118058,-0.1470762252243368,0.001057524602501,-0.0230715186444752,-0.0085354496207338,0.0105227887377397,-0.0030954661173403,-0.0180511196214004,0.0441297626081726,1
2014-08-04,"Glaxo, Sanofi, Trend Up On Potential Deal For Established Brands",MRK,0.0045773959118058,-0.1470762252243368,0.001057524602501,-0.0230715186444752,-0.0085354496207338,0.0105227887377397,-0.0030954661173403,-0.0180511196214004,0.0441297626081726,1
2014-08-05,Ukraine Tension Prominent As Dow Suffers Triple Digit Loss; S&P 500 & NASDAQ Also Lower,MRK,-0.0180511196214004,0.0441297626081726,0.0045773959118058,0.001057524602501,-0.0230715186444752,-0.0085354496207338,0.0105227887377397,-0.0017847817707594,0.3592655571260699,2
2014-08-05,Ukraine Tension Prominent As Dow Suffers Triple Point Digit Loss; S&P 500 & Nasdaq Also Lower,MRK,-0.0180511196214004,0.0441297626081726,0.0045773959118058,0.001057524602501,-0.0230715186444752,-0.0085354496207338,0.0105227887377397,-0.0017847817707594,0.3592655571260699,2
2014-08-05,Ukraine Tension Takes Center Stage As Dow Suffers Triple Point Digit Loss; S&P 500 And Nasdaq Also Lower,MRK,-0.0180511196214004,0.0441297626081726,0.0045773959118058,0.001057524602501,-0.0230715186444752,-0.0085354496207338,0.0105227887377397,-0.0017847817707594,0.3592655571260699,2
2014-08-11,Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments,MRK,0.0019447988949867,-0.2234554556464457,0.0163552281218992,-0.0051852528174367,-0.0017847817707594,-0.0180511196214004,0.0045773959118058,0.0065306588236515,0.2893382800135413,0
2014-08-11,Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments.,MRK,0.0019447988949867,-0.2234554556464457,0.0163552281218992,-0.0051852528174367,-0.0017847817707594,-0.0180511196214004,0.0045773959118058,0.0065306588236515,0.2893382800135413,0
2014-08-13,Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP Recommendations,MRK,0.0143786065461526,0.503582382414175,0.0065306588236515,0.0019447988949867,0.0163552281218992,-0.0051852528174367,-0.0017847817707594,0.0160756155877994,-0.2559307236556039,0
2014-08-13,UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid,MRK,0.0143786065461526,0.503582382414175,0.0065306588236515,0.0019447988949867,0.0163552281218992,-0.0051852528174367,-0.0017847817707594,0.0160756155877994,-0.2559307236556039,0
2014-08-25,US Stock Futures Rise Ahead Of Economic Data,MRK,0.0094641684100427,-0.0032386020319666,0.0054378230086933,-0.0105920074598735,0.0096757450312983,0.0083875967348707,-0.0032416680016537,0.0078689533479274,0.7832058620431306,0
2014-08-25," Advaxis, Merck to Collaborate on Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer",MRK,0.0094641684100427,-0.0032386020319666,0.0054378230086933,-0.0105920074598735,0.0096757450312983,0.0083875967348707,-0.0032416680016537,0.0078689533479274,0.7832058620431306,0
2014-08-26,"S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally",MRK,0.0078689533479274,0.7832058620431306,0.0094641684100427,0.0054378230086933,-0.0105920074598735,0.0096757450312983,0.0083875967348707,0.0013288165311682,-0.2899919477928042,2
2014-08-26,"S&P 500 Closes Above 2,000, Dow Hits New All-Time High As Markets Continue To Rally",MRK,0.0078689533479274,0.7832058620431306,0.0094641684100427,0.0054378230086933,-0.0105920074598735,0.0096757450312983,0.0083875967348707,0.0013288165311682,-0.2899919477928042,2
2014-08-26,"Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen",MRK,0.0078689533479274,0.7832058620431306,0.0094641684100427,0.0054378230086933,-0.0105920074598735,0.0096757450312983,0.0083875967348707,0.0013288165311682,-0.2899919477928042,2
2014-08-27,Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend,MRK,0.0013288165311682,-0.2899919477928042,0.0078689533479274,0.0094641684100427,0.0054378230086933,-0.0105920074598735,0.0096757450312983,-0.0046451212514035,-0.1994440413575862,2
2014-08-27,"Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold",MRK,0.0013288165311682,-0.2899919477928042,0.0078689533479274,0.0094641684100427,0.0054378230086933,-0.0105920074598735,0.0096757450312983,-0.0046451212514035,-0.1994440413575862,2
2014-09-05,"Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug",MRK,0.0183093459726138,-0.0059949688519391,-0.0066143634831459,0.0115406678320804,-0.0053236612833714,0.0018334978241809,-0.0046451212514035,-0.0021250599313739,-0.2162841802989399,2
2014-09-05,Bristol-Myers In Patent Suit Vs. Merck Over Skin Cancer Drug,MRK,0.0183093459726138,-0.0059949688519391,-0.0066143634831459,0.0115406678320804,-0.0053236612833714,0.0018334978241809,-0.0046451212514035,-0.0021250599313739,-0.2162841802989399,2
2014-09-17,"Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes",MRK,-0.0018335514643789,0.1355164612268118,0.0078963422560669,-0.0005035316335109,-0.0091514120014924,-0.0036474721256927,0.0033027271374541,0.0071809623749523,-0.2207239764189094,0
2014-10-02,Markets Little Changed Ahead Of Friday's Jobs Report,MRK,0.0023843511590952,-0.107724830441293,-0.0096150719185758,-0.0021883983577847,0.0003366212907833,-0.0041915704695172,-0.0119284579109418,0.0178420886837464,0.0655996479614828,0
2014-10-13,Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level,MRK,-0.0429593466529786,0.3121344664573695,-0.0092889680392973,-0.0161180116264814,0.0294213745827345,-0.0187979409584356,-0.0053423462048752,0.003384192117869,-0.2614788700174695,2
2014-10-16,Will Actavis Plc Win Allergan Over In 4-Way Tug Of War?,MRK,-0.0237530111810684,0.1634426442175189,-0.0284038890542513,0.003384192117869,-0.0429593466529786,-0.0092889680392973,-0.0161180116264814,0.0110423750019259,-0.0978257955866804,0
2014-10-20,US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine,MRK,0.0005552708095379,-0.3881712703516826,0.0110423750019259,-0.0237530111810684,-0.0284038890542513,0.003384192117869,-0.0429593466529786,0.0199815475158215,0.4331694478373593,0
2014-10-27,Merck Conf Call Highlights,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,Merck Conference Call Highlights,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,"Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook",MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,US Stock Futures Down Ahead Of Economic Data,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,"Earnings Scheduled For October 27, 2014",MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,UPDATE: Merck Q3 Earnings Top Street View,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,"#PreMarket Primer: Monday, October 27: ECB Stress Tests In Line With Expectations",MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,"#PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations",MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,"Keep an Eye on These 7 Stocks for October 27, 2014",MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-27,Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings,MRK,-0.0201357790382235,0.6853566321613542,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0005552708095379,-0.0106290257003339,0.6617911698406334,1
2014-10-28,"#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola",MRK,-0.0106290257003339,0.6617911698406334,-0.0201357790382235,0.0173053330592778,0.0201768669529347,0.0068926683636152,0.0199815475158215,0.0062672955854561,-0.4786196179590271,0
2014-11-06,"US Stock Futures Edge Lower Ahead Of Earnings, Jobless Claims ",MRK,-0.0052041819231559,0.0538931596909006,0.0033691914554825,0.0076371830463803,0.0169139778080928,0.0109930092258145,0.0197506711512371,0.0013498788819348,-0.2057386302734298,2
2014-11-10,RBC Sees Weak Merck Data as Positive for Gilead,MRK,-0.0089315395269421,0.375530010364647,0.0013498788819348,-0.0052041819231559,0.0033691914554825,0.0076371830463803,0.0169139778080928,0.0095219869861955,-0.0887008808549032,0
2014-11-10,RBC Sees Weak Merck Data As Positive For Gilead,MRK,-0.0089315395269421,0.375530010364647,0.0013498788819348,-0.0052041819231559,0.0033691914554825,0.0076371830463803,0.0169139778080928,0.0095219869861955,-0.0887008808549032,0
2014-11-11,Merck Announces Results From Phase 2 Study Of Investigational Chronic Hepatitis C Treatment Grazoprevir/Elbasvir In Genotype 1 Infected Treatment-Naïve And Difficult-To-Cure Patients,MRK,0.0095219869861955,-0.0887008808549032,-0.0089315395269421,0.0013498788819348,-0.0052041819231559,0.0033691914554825,0.0076371830463803,-0.0010104678288772,-0.4987221862761278,2
2014-11-17,Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today,MRK,0.0066019231815823,0.2020446230222956,-0.0078934297289521,0.0038779929172865,-0.0010104678288772,0.0095219869861955,-0.0089315395269421,0.007232037720301,-0.105969883071078,0
2014-12-04,Markets Marginally Lower Ahead Of Friday's Jobs Report,MRK,0.0056122155414841,-0.2688350864971282,-0.0032904304656965,0.0042961778205408,0.0019865581036975,0.0108787687948139,0.0069094946810799,0.0093563989431597,0.5702638684749577,0
2014-12-08,Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,"Benzinga's M&A Chatter for Monday December 8, 2014",MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Pharmaceutical Stocks In Play Following Merck/Cubist Deal,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Benzinga's Top #PreMarket Gainers,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,"Pharmaceitical Stocks In Play Monday Following Merck, Cubist Deal",MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,"Must Watch Stocks for December 8, 2014",MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,US Stock Futures Point To Lower Open Monday,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Benzinga's Volume Movers,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Morning Market Movers,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-08,Stocks Hitting 52-Week Highs,MRK,0.0063426944580184,0.0199520910662633,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,0.0019865581036975,-0.0302199400612791,0.6479766692129376,1
2014-12-09,Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO,MRK,-0.0302199400612791,0.6479766692129376,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,-0.000499671935637,-0.294197520939753,2
2014-12-09,Cellceutix Corp Shares Rise On Two Catalysts,MRK,-0.0302199400612791,0.6479766692129376,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,-0.000499671935637,-0.294197520939753,2
2014-12-09,Merck & Co. Under Pressure Following Patent Ruling,MRK,-0.0302199400612791,0.6479766692129376,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,-0.000499671935637,-0.294197520939753,2
2014-12-09,Cellceutix Corp. Shares Rise On Two Catalysts,MRK,-0.0302199400612791,0.6479766692129376,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,-0.000499671935637,-0.294197520939753,2
2014-12-09,Hospira Inc. Ticks Up On Favorable Patent Ruling Vs Cubist Pharmaceuticals Inc,MRK,-0.0302199400612791,0.6479766692129376,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,-0.000499671935637,-0.294197520939753,2
2014-12-09,"Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc",MRK,-0.0302199400612791,0.6479766692129376,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,0.0042961778205408,-0.000499671935637,-0.294197520939753,2
2014-12-10,"Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium",MRK,-0.000499671935637,-0.294197520939753,-0.0302199400612791,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0032904304656965,-0.0031917678917687,-0.1463440499621379,2
2014-12-11,Market Shrugs Off Plan To Spend $300 Million On Ebola Vaccines,MRK,-0.0031917678917687,-0.1463440499621379,-0.000499671935637,-0.0302199400612791,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0273003389350765,0.0712650237067389,1
2014-12-11,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,MRK,-0.0031917678917687,-0.1463440499621379,-0.000499671935637,-0.0302199400612791,0.0063426944580184,0.0093563989431597,0.0056122155414841,-0.0273003389350765,0.0712650237067389,1
2014-12-22,NewLink Genetics Surges 4% Following Ebola Contract News,MRK,-0.0104061383144805,-0.4238295990556323,0.0101728622027219,0.0234251619470398,0.0146125945829165,-0.0026337328834603,-0.0133401590032276,-0.0296811624709744,0.4150541740332956,1
2014-12-22,NewLink Genetics Surges 3% Following Ebola Contract News,MRK,-0.0104061383144805,-0.4238295990556323,0.0101728622027219,0.0234251619470398,0.0146125945829165,-0.0026337328834603,-0.0133401590032276,-0.0296811624709744,0.4150541740332956,1
2014-12-23,"FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities",MRK,-0.0296811624709744,0.4150541740332956,-0.0104061383144805,0.0101728622027219,0.0234251619470398,0.0146125945829165,-0.0026337328834603,0.0043699075933347,-0.6434269368991843,2
2015-01-12,Biotechs Presenting at the J.P. Morgan Healthcare Conference: Day One,MRK,-0.0041557362468481,-0.0846368969415549,-0.0046141886630503,0.0201265264778629,0.0213860452109289,0.0392832396043112,0.0148627001212373,-0.001766015262469,-0.1325784093975807,2
2015-01-12,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1,MRK,-0.0041557362468481,-0.0846368969415549,-0.0046141886630503,0.0201265264778629,0.0213860452109289,0.0392832396043112,0.0148627001212373,-0.001766015262469,-0.1325784093975807,2
2015-01-27,White House Budget To Support Biotech Rally,MRK,-0.0041389474626968,0.1862359581298642,0.0052810285563817,-0.0015975498067299,0.0069174994742264,-0.0071875836006835,-0.006663588934176,-0.0177431545869408,0.1133695720536571,1
2015-01-30,What Investors Are Watching For In Regulus Therapeutics' Next Data Release,MRK,-0.0291511144306981,0.3295018662461657,0.0104151413892219,-0.0177431545869408,-0.0041389474626968,0.0052810285563817,-0.0015975498067299,0.0099534736487219,-0.2333269466950962,0
2015-01-30,What Investors Are Watching For In Regulus Therapeutics Next Data Release,MRK,-0.0291511144306981,0.3295018662461657,0.0104151413892219,-0.0177431545869408,-0.0041389474626968,0.0052810285563817,-0.0015975498067299,0.0099534736487219,-0.2333269466950962,0
2015-02-04,"Gilead Sciences' 'Long Term Story Remains Intact,' Deutsche Bank Says",MRK,-0.0322844178619982,0.6943324227122099,0.0022996109441877,0.0099534736487219,-0.0291511144306981,0.0104151413892219,-0.0177431545869408,0.0020321429759926,-0.3489692564458089,2
2015-02-04,"Earnings Scheduled For February 4, 2015",MRK,-0.0322844178619982,0.6943324227122099,0.0022996109441877,0.0099534736487219,-0.0291511144306981,0.0104151413892219,-0.0177431545869408,0.0020321429759926,-0.3489692564458089,2
2015-02-04,"Keep an Eye on These 10 Stocks for February 4, 2015",MRK,-0.0322844178619982,0.6943324227122099,0.0022996109441877,0.0099534736487219,-0.0291511144306981,0.0104151413892219,-0.0177431545869408,0.0020321429759926,-0.3489692564458089,2
2015-02-04,"UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline",MRK,-0.0322844178619982,0.6943324227122099,0.0022996109441877,0.0099534736487219,-0.0291511144306981,0.0104151413892219,-0.0177431545869408,0.0020321429759926,-0.3489692564458089,2
2015-02-25,Heavy News Day For Several Biotech Stocks,MRK,0.002227450343798,0.096070853697199,0.001029275910074,-0.0008571719511571,0.000857907325253,-0.0085034828749669,0.0001698522540476,0.0080355861673124,0.3588205686684986,0
2015-02-25,News-Heavy Day For Several Biotech Stocks,MRK,0.002227450343798,0.096070853697199,0.001029275910074,-0.0008571719511571,0.000857907325253,-0.0085034828749669,0.0001698522540476,0.0080355861673124,0.3588205686684986,0
2015-03-11,US Stock Futures Signal Higher Start On Wall Street,MRK,-0.0091901050813461,0.1935466375863321,-0.0118757343989084,0.0073891800401979,-0.0196621229006431,0.0017276395888472,-0.0078844654137443,0.0100701231765496,-0.1730576539263556,0
2015-04-08,"Advaxis, Merck Report Initiation of Enrollment in Phase 1/2 Study of ADXS-PSA in Combo with Anti-PD-1 Therapy",MRK,-0.0048754976854694,0.4614423913305054,0.0043721812076051,0.0014010114233413,0.0042207743291755,-0.0107862139079983,-0.0147412629273574,0.0048993846238634,-0.1145822059445064,2
2015-04-14,UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone,MRK,0.0181561560899001,0.3983723390686238,-0.0090830282017313,-0.0031342740323744,0.0048993846238634,-0.0048754976854694,0.0043721812076051,0.0119460155303263,-0.1738104486168934,0
2015-04-17,It's A Big Weekend For Biotech,MRK,-0.016597574405328,0.8197335408053326,-0.0104360767590019,0.0119460155303263,0.0181561560899001,-0.0090830282017313,-0.0031342740323744,0.0128340023684301,-0.1459265761140477,0
2015-04-20,CAR-T Therapy Stocks Hit Hard Following AACR Data,MRK,0.0128340023684301,-0.1459265761140477,-0.016597574405328,-0.0104360767590019,0.0119460155303263,0.0181561560899001,-0.0090830282017313,0.0008678916163913,-0.0708635154379783,2
2015-04-20,Morning Market Gainers,MRK,0.0128340023684301,-0.1459265761140477,-0.016597574405328,-0.0104360767590019,0.0119460155303263,0.0181561560899001,-0.0090830282017313,0.0008678916163913,-0.0708635154379783,2
2015-04-24,Analyst: Biogen Inc. To Miss On Tecfidera Sales; No Threat To Gilead Science Inc.'s Harvoni,MRK,0.0015649572314895,-0.0570007192519779,-0.0031203259465523,0.0005203545919847,0.0008678916163913,0.0128340023684301,-0.016597574405328,-0.0086804241340548,0.3474353512794375,1
2015-04-28,Morning Market Gainers,MRK,0.0504377587985673,2.276651926144773,-0.0086804241340548,0.0015649572314895,-0.0031203259465523,0.0005203545919847,0.0008678916163913,-0.0050015911665752,-0.5049983930567303,1
2015-04-28,Benzinga's Top #PreMarket Gainers,MRK,0.0504377587985673,2.276651926144773,-0.0086804241340548,0.0015649572314895,-0.0031203259465523,0.0005203545919847,0.0008678916163913,-0.0050015911665752,-0.5049983930567303,1
2015-04-28,"Merck Beats Q1 Estimates, Shares Rise",MRK,0.0504377587985673,2.276651926144773,-0.0086804241340548,0.0015649572314895,-0.0031203259465523,0.0005203545919847,0.0008678916163913,-0.0050015911665752,-0.5049983930567303,1
2015-04-28,"Earnings Scheduled For April 28, 2015",MRK,0.0504377587985673,2.276651926144773,-0.0086804241340548,0.0015649572314895,-0.0031203259465523,0.0005203545919847,0.0008678916163913,-0.0050015911665752,-0.5049983930567303,1
2015-05-01,Analysts: Gilead Sciences Inc. Soothes Price-War Worry With Q1 Results,MRK,0.0050368609302904,-0.2808782286713458,-0.0020107962758409,-0.0050015911665752,0.0504377587985673,-0.0086804241340548,0.0015649572314895,0.0130304470239608,-0.032818615104429,0
2015-06-01,Merck Announces New Data on Breadth of KEYTRUDA at ASCO: Anti-Tumor Activity Now Shown in 13 Different Tumor Types,MRK,-0.0022995632716881,-0.4100901448579064,0.0199330698137332,0.00403647249849,0.0083093049653755,-0.0069044570998705,-0.0119802940797654,-0.0083951543826181,-0.2383589828962058,1
2015-06-03,Merck Announces Results from Investigational IMPROVE-IT Study of VYTORIN Published in NEJoM,MRK,0.0024905133640604,-0.0367619471633152,-0.0083951543826181,-0.0022995632716881,0.0199330698137332,0.00403647249849,0.0083093049653755,-0.0152346858712456,0.2502654988133654,1
2015-06-08,"TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes",MRK,-0.0020343164152482,-0.2604348636625024,-0.0080711572252732,-0.0152346858712456,0.0024905133640604,-0.0083951543826181,-0.0022995632716881,-0.0005097465278854,-0.1991350819661246,2
2015-06-08,"Benzinga's M&A Chatter for  Monday June 8, 2015",MRK,-0.0020343164152482,-0.2604348636625024,-0.0080711572252732,-0.0152346858712456,0.0024905133640604,-0.0083951543826181,-0.0022995632716881,-0.0005097465278854,-0.1991350819661246,2
2015-06-08,Analyst: Eli Lilly And Co To Post Key Data Thursday On Autoimmune Drug,MRK,-0.0020343164152482,-0.2604348636625024,-0.0080711572252732,-0.0152346858712456,0.0024905133640604,-0.0083951543826181,-0.0022995632716881,-0.0005097465278854,-0.1991350819661246,2
2015-06-10,"TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes",MRK,0.0130865924783021,0.5861726209070304,-0.0005097465278854,-0.0020343164152482,-0.0080711572252732,-0.0152346858712456,0.0024905133640604,-0.004225789293468,0.1386160090514072,2
2015-06-10,US Stock Futures Signal Higher Start On Wall Street,MRK,0.0130865924783021,0.5861726209070304,-0.0005097465278854,-0.0020343164152482,-0.0080711572252732,-0.0152346858712456,0.0024905133640604,-0.004225789293468,0.1386160090514072,2
2015-06-16,"Benzinga's M&A Chatter for Tuesday June 16, 2015",MRK,0.0103293798904993,-0.3104536873140745,-0.0129601401792408,-0.0176541477749754,-0.004225789293468,0.0130865924783021,-0.0005097465278854,0.0034654126971034,0.1360903205859949,2
2015-06-29,Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint,MRK,-0.0205159847589125,-0.2661708766180868,0.0101898751206139,-0.0058379318100543,-0.0133829075152475,0.0033996124346633,0.0136112695585906,-0.0062841473968778,0.2339394187550896,1
2015-07-22,"European Commission Approves MSD's Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma",MRK,-0.0092038546022136,0.2430475554994002,-0.0055930902783739,0.0030596939353995,0.0,0.0103063972101207,0.0005152222857391,-0.0010322086585368,-0.2525237907428859,2
2015-07-23,RaNA Therapeutics Announces $55 Million in Oversubscribed Series B Financing Led by Merck,MRK,-0.0010322086585368,-0.2525237907428859,-0.0092038546022136,-0.0055930902783739,0.0030596939353995,0.0,0.0103063972101207,-0.0113659396860442,0.2181911261736948,1
2015-07-28,Merck Q2 Profit Beats Estimates,MRK,0.0092998155848489,0.1007657816107807,-0.007315459886991,-0.0113659396860442,-0.0010322086585368,-0.0092038546022136,-0.0055930902783739,0.0177329329349174,-0.2142600063434274,0
2015-07-28,"Earnings Scheduled For July 28, 2015",MRK,0.0092998155848489,0.1007657816107807,-0.007315459886991,-0.0113659396860442,-0.0010322086585368,-0.0092038546022136,-0.0055930902783739,0.0177329329349174,-0.2142600063434274,0
2015-07-28,10 Stocks You Should Be Watching Today,MRK,0.0092998155848489,0.1007657816107807,-0.007315459886991,-0.0113659396860442,-0.0010322086585368,-0.0092038546022136,-0.0055930902783739,0.0177329329349174,-0.2142600063434274,0
2015-08-04,Morning Market Gainers,MRK,-0.0059272632123007,0.0189216421801983,0.0015266900055124,0.007518503954818,-0.0003415148772037,0.0177329329349174,0.0092998155848489,0.0068143687075543,-0.1778020553280509,0
2015-08-07,"ALK's Partner, Torii Pharmaceutical, Reports Positive Phase II/III Trial Results for Japanese Cedar SLIT-tablet",MRK,-0.00787250573073,0.383591788975574,-0.0113368638837236,0.0068143687075543,-0.0059272632123007,0.0015266900055124,0.007518503954818,0.007590013177533,-0.4797990292373357,0
2015-08-13,"US Stock Futures Rise Ahead of Jobless Claims, Retail Sales Data",MRK,0.0123586064237943,0.4560483884261157,0.0086566083342618,-0.0111284258113516,0.007590013177533,-0.00787250573073,-0.0113368638837236,0.0033909657972956,-0.1360567043212722,2
2015-08-18,"FDA Accepts Supplemental Biologics License Application for KEYTRUDA, Merck's Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review",MRK,-0.0008373559129255,0.1118307055952108,0.00895566941489,0.0033909657972956,0.0123586064237943,0.0086566083342618,-0.0111284258113516,0.0,0.1749050876127842,2
2015-08-20,New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN and the TECOS Cardiovascular Safety Trial of JANUVIA  Will Be Presented at the European Society of Cardiology Congress,MRK,-0.0454240737333732,1.9668809012380697,0.0,-0.0008373559129255,0.00895566941489,0.0033909657972956,0.0123586064237943,-0.020719888794032,-0.2558368162090674,1
2015-09-01,New Analyses from the IMPROVE-IT Study with VYTORIN (ezetimibe and simvastatin),MRK,-0.0245123412093694,0.2191126163384371,-0.0274517595788268,0.0076433270907438,0.0097390025888037,0.0635137873840587,-0.0522320019620876,0.0085664728579433,-0.166160777179075,0
2015-09-01,Organovo's Keith Murphy: 'People Are Missing The Forest For The Trees',MRK,-0.0245123412093694,0.2191126163384371,-0.0274517595788268,0.0076433270907438,0.0097390025888037,0.0635137873840587,-0.0522320019620876,0.0085664728579433,-0.166160777179075,0
2015-09-02,FDA Approves Pediatric Indication for EMEND® (aprepitant) Capsules in Combination with Other Antiemetic Agents,MRK,0.0085664728579433,-0.166160777179075,-0.0245123412093694,-0.0274517595788268,0.0076433270907438,0.0097390025888037,0.0635137873840587,-0.0062290998823827,-0.0747631108551234,1
2015-09-08,Giant Health Care ETF Eyes a Comeback,MRK,0.0213218212780856,0.0324194920326634,-0.0201325376510276,-0.0062290998823827,0.0085664728579433,-0.0245123412093694,-0.0274517595788268,-0.0144239297925847,-0.2569596994955047,1
2015-09-16,Merck Offers Highlights for Commitment to Infectious Disease with 40 Presentations of Data at ICAAC/ICC '15,MRK,0.005976064448482,-0.2638015359162391,0.023117742735913,0.0047994613905473,-0.0034434618596934,0.0152125511242557,-0.0144239297925847,0.0016705462430417,1.6262930299676626,2
2015-09-17,Merck To Submit Applications To U.S. For Approval Of Ertugliflozin By End Of 2016,MRK,0.0016705462430417,1.6262930299676626,0.005976064448482,0.023117742735913,0.0047994613905473,-0.0034434618596934,0.0152125511242557,-0.0339140233102902,0.271843299833705,1
2015-09-18,Merck Offers Results from Phase 2 Study of Investigational Beta-Lactamase Inhibitor at ICAAC/ICC '15: Met Primary Endpoint,MRK,-0.0339140233102902,0.271843299833705,0.0016705462430417,0.005976064448482,0.023117742735913,0.0047994613905473,-0.0034434618596934,-0.0220602930024422,-0.4053603974149352,1
2015-09-21,ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75M,MRK,-0.0220602930024422,-0.4053603974149352,-0.0339140233102902,0.0016705462430417,0.005976064448482,0.023117742735913,0.0047994613905473,-0.0047079221904718,-0.2579378382287887,2
2015-09-21,Data in Nine Difficult-to-Treat Cancers from Merck's KEYTRUDA Development Program to be Presented at European Cancer Congress 2015,MRK,-0.0220602930024422,-0.4053603974149352,-0.0339140233102902,0.0016705462430417,0.005976064448482,0.023117742735913,0.0047994613905473,-0.0047079221904718,-0.2579378382287887,2
2015-09-24,"Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab",MRK,-0.0086225348925172,0.0450300450818568,0.0057157227488988,-0.0047079221904718,-0.0220602930024422,-0.0339140233102902,0.0016705462430417,-0.019569117439149,0.4581522166502705,1
2015-10-05,"Agilent Company Dako, Announces FDA Approval of New Companion Diagnostic for Lung Cancer",MRK,0.0217390932311505,-0.3461106017552877,0.0155964146925222,-0.00040480364264,0.0152105342118482,0.0047504299050455,-0.0237904380917296,-0.0279131261893412,0.0385288511111896,1
2015-10-09,KEYTRUDA® (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma,MRK,-0.0013719930395196,-0.1292138567086346,0.0013738779905598,0.0230923268392224,-0.0279131261893412,0.0217390932311505,0.0155964146925222,-0.0047105945033982,0.0670152015263121,2
2015-10-13,Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma,MRK,-0.0244529789759743,0.2791140962106693,-0.0047105945033982,-0.0013719930395196,0.0013738779905598,0.0230923268392224,-0.0279131261893412,0.0014152869973682,-0.0788076830329299,2
2015-10-14,Biotech ETFs Get More Refined With Debut Of Cancer Immunotherapy Fund,MRK,0.0014152869973682,-0.0788076830329299,-0.0244529789759743,-0.0047105945033982,-0.0013719930395196,0.0013738779905598,0.0230923268392224,0.0238192468244093,0.0223068347854922,0
2015-10-27,"Earnings Scheduled For October 27, 2015",MRK,0.0105839654902337,0.2716760809632403,0.0005676557991809,0.0167276847097881,0.0280686970447476,0.0039689038755361,-0.0196498981460458,0.0304841423045165,0.0539589881089075,0
2015-10-27,These Three Pharma Giants Just Crushed Earnings,MRK,0.0105839654902337,0.2716760809632403,0.0005676557991809,0.0167276847097881,0.0280686970447476,0.0039689038755361,-0.0196498981460458,0.0304841423045165,0.0539589881089075,0
2015-10-27,These 3 Pharma Companies Just Crushed Earnings,MRK,0.0105839654902337,0.2716760809632403,0.0005676557991809,0.0167276847097881,0.0280686970447476,0.0039689038755361,-0.0196498981460458,0.0304841423045165,0.0539589881089075,0
2015-11-02,Merck Receives Breakthrough Therapy Designation from U.S.FDA for KEYTRUDA(R) (pembrolizumab) in Advanced Colorectal Cancer,MRK,0.008232562907064,-0.0415978022273061,-0.0038269943201303,-0.0041742398641143,0.0304841423045165,0.0105839654902337,0.0005676557991809,0.0,-0.127179379387394,2
2015-11-12,"Merck Issues Statement Regarding CUBICIN Patent Litigation; Says Reviewing Decision, Considering Next Steps",MRK,-0.0128445051174784,0.0038503626179695,-0.0130440951453609,0.0035028376977588,-0.0067755690942877,-0.0079925115075331,-0.0086438770817863,0.0,0.3284173710288545,2
2015-11-13,Merck Issues Update on REVEAL Outcomes Sutdy,MRK,0.0,0.3284173710288545,-0.0128445051174784,-0.0130440951453609,0.0035028376977588,-0.0067755690942877,-0.0079925115075331,0.0126344250032148,-0.3937601809363631,0
2015-11-19,US Stock Futures Edge Higher Ahead Of Jobless Claims Report,MRK,0.0009219204575778,-0.3674084297683028,0.0096817407999638,0.0001860158911524,0.0126344250032148,0.0,-0.0128445051174784,-0.0033161356627835,0.3061906538446834,2
2015-11-19,Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial,MRK,0.0009219204575778,-0.3674084297683028,0.0096817407999638,0.0001860158911524,0.0126344250032148,0.0,-0.0128445051174784,-0.0033161356627835,0.3061906538446834,2
2015-11-25,MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan,MRK,0.0044877488015901,-0.4214538993888778,-0.0098130032339304,-0.0016634445533876,-0.0033161356627835,0.0009219204575778,0.0096817407999638,0.0044675109714615,-0.5095164775792627,2
2015-11-30,"Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016",MRK,-0.0176058189105613,3.4818887598460915,0.0044675109714615,0.0044877488015901,-0.0098130032339304,-0.0016634445533876,-0.0033161356627835,0.0294284811343328,-0.0274186387162992,0
2015-12-04,EXCLUSIVE: Relypsa Being Evaluated By 3-4 Potential Acquirers; Sanofi Seen As 'Natural Buyer',MRK,0.0199658008289882,0.0067597743209151,-0.0228537976682715,-0.0137438494544009,0.0294284811343328,-0.0176058189105613,0.0044675109714615,0.0007455545498353,-0.3646525900489515,2
2015-12-07,Must Watch Stocks for Today,MRK,0.0007455545498353,-0.3646525900489515,0.0199658008289882,-0.0228537976682715,-0.0137438494544009,0.0294284811343328,-0.0176058189105613,-0.003911738996994,-0.1291167914352128,2
2015-12-10,Biothera Announces Clinical Study to Evaluate Combination Therapy of Imprime PGG,MRK,0.0164709707037065,0.1056945300988194,-0.0121566335586673,-0.003911738996994,0.0007455545498353,0.0199658008289882,-0.0228537976682715,-0.0202891013381445,-0.0920371307437488,1
2015-12-21,Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average,MRK,0.0044538474419644,-0.4485730884897032,-0.0193692097018053,-0.02517619426683,0.0211723658869227,0.0134100362494042,0.0009584419273243,0.0044339056883813,0.1341342539787791,2
2015-12-21,ALK Sells European Veterinary Business to Fidelio Capital; Terms Not Disclosed,MRK,0.0044538474419644,-0.4485730884897032,-0.0193692097018053,-0.02517619426683,0.0211723658869227,0.0134100362494042,0.0009584419273243,0.0044339056883813,0.1341342539787791,2
2016-01-06,Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer,MRK,-0.0137345143875189,0.1255383331822765,0.012766828635129,-0.0064369718775897,-0.0080750771857501,-0.0016874201076567,0.0094623884431064,-0.0087752459801084,0.0203836220994633,1
2016-01-15,Write A Prescription For This Healthcare ETF,MRK,-0.0127414963705926,0.1416442354836795,0.0225029619688532,-0.0212519479083056,0.0099510459431895,0.003328120052543,-0.0169360576158614,0.0039111480783815,-0.2944339633159888,2
2016-01-25,Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma,MRK,-0.0083736680669558,-0.1417116447551998,0.0084443784894583,0.0073193150819865,-0.0153875260875121,0.0039111480783815,-0.0127414963705926,0.0104085485524245,-0.028338990356123,0
2016-01-27,ACARIZAX Receives Marketing Authorization in France,MRK,-0.0209911294401431,0.4548489260703847,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0073193150819865,-0.0153875260875121,-0.0232283193113508,0.3817182234660625,1
2016-01-28,"Merck Receives FDA Approval of Hep C Drug ZEPATIER; To Cost $54,600/Patient for 12-Week Course",MRK,-0.0232283193113508,0.3817182234660625,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0073193150819865,0.0298780949234629,-0.0664316259348651,0
2016-01-28,Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA',MRK,-0.0232283193113508,0.3817182234660625,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0073193150819865,0.0298780949234629,-0.0664316259348651,0
2016-01-28,Abbott to Sell ALK's House Dust Mite Sublingual Allergy Immunotherapy Tablet in SE Asia,MRK,-0.0232283193113508,0.3817182234660625,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0073193150819865,0.0298780949234629,-0.0664316259348651,0
2016-01-29,Gilead Hits New 52-Week Low; Here Are Two Reasons Why,MRK,0.0298780949234629,-0.0664316259348651,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0015789110343333,-0.3245049475641092,2
2016-01-29,Gilead's Shares Hit A New 52-Week Low: Here Are 2 Reasons Why,MRK,0.0298780949234629,-0.0664316259348651,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0015789110343333,-0.3245049475641092,2
2016-01-29,"Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient",MRK,0.0298780949234629,-0.0664316259348651,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,0.0084443784894583,0.0015789110343333,-0.3245049475641092,2
2016-02-01,"Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data",MRK,0.0015789110343333,-0.3245049475641092,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,-0.0066995223501477,0.3033888936283098,1
2016-02-01,"Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat?",MRK,0.0015789110343333,-0.3245049475641092,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0083736680669558,-0.0066995223501477,0.3033888936283098,1
2016-02-02,"Merck, Sanofi Exploring Potential End To Joint Venture In Europe",MRK,-0.0066995223501477,0.3033888936283098,0.0015789110343333,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0071413978508499,0.3133906084268267,1
2016-02-02,Merck & Sanofi Exploring Potential End To Joint Venture In Europe,MRK,-0.0066995223501477,0.3033888936283098,0.0015789110343333,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,0.0104085485524245,-0.0071413978508499,0.3133906084268267,1
2016-02-03,Shares Of Merck Dip Lower Following Q4 Print,MRK,-0.0071413978508499,0.3133906084268267,-0.0066995223501477,0.0015789110343333,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,-0.0291708993904877,0.0531770377385916,1
2016-02-03,"Earnings Scheduled For February 3, 2016",MRK,-0.0071413978508499,0.3133906084268267,-0.0066995223501477,0.0015789110343333,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,-0.0291708993904877,0.0531770377385916,1
2016-02-03,"Keep an Eye on These 10 Stocks for February 3, 2016",MRK,-0.0071413978508499,0.3133906084268267,-0.0066995223501477,0.0015789110343333,0.0298780949234629,-0.0232283193113508,-0.0209911294401431,-0.0291708993904877,0.0531770377385916,1
2016-02-04,25 Companies That Could Still Buy Back Mountains Of Stock,MRK,-0.0291708993904877,0.0531770377385916,-0.0071413978508499,-0.0066995223501477,0.0015789110343333,0.0298780949234629,-0.0232283193113508,0.0162583992134042,-0.1808027634585864,0
2016-02-05,A Checkup On A Big Healthcare ETF,MRK,0.0162583992134042,-0.1808027634585864,-0.0291708993904877,-0.0071413978508499,-0.0066995223501477,0.0015789110343333,0.0298780949234629,-0.0111380197299167,-0.2095539779162651,1
2016-02-10,ALK's Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet,MRK,0.0075262686473269,0.0363410985965646,0.0067582884727959,-0.0111380197299167,0.0162583992134042,-0.0291708993904877,-0.0071413978508499,-0.0137289836411678,0.0047389582747736,1
2016-02-10,ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet,MRK,0.0075262686473269,0.0363410985965646,0.0067582884727959,-0.0111380197299167,0.0162583992134042,-0.0291708993904877,-0.0071413978508499,-0.0137289836411678,0.0047389582747736,1
2016-02-24,AureoGen Announces Licensing Agreement with Merck,MRK,0.000395272650004,-0.0413696586265726,-0.0045297760128468,0.0129683897745778,-0.0039741861878681,-0.0055337835338638,0.0164726058898303,0.0087026580292675,0.1480317381514304,0
2016-02-25,EXCLUSIVE: Sanofi In Talks To Buy PTC Therapeutics,MRK,0.0087026580292675,0.1480317381514304,0.000395272650004,-0.0045297760128468,0.0129683897745778,-0.0039741861878681,-0.0055337835338638,-0.007058782433132,0.0641383084487561,1
2016-03-07,Gilead Versus Merck: What To Know,MRK,0.0107525734859601,-0.178245181275453,-0.0003838216301353,-0.0032523518062179,0.0100481107126597,0.0306711216483486,-0.0084912669188439,-0.0036089956519602,0.1075098003982781,2
2016-03-07,Gilead Vs. Merck: What To Know,MRK,0.0107525734859601,-0.178245181275453,-0.0003838216301353,-0.0032523518062179,0.0100481107126597,0.0306711216483486,-0.0084912669188439,-0.0036089956519602,0.1075098003982781,2
2016-03-10,"The Stocks That Moved The S&P, Dow And Nasdaq Today",MRK,0.0129866604785375,0.3406224448840538,-0.001716052716193,-0.0036089956519602,0.0107525734859601,-0.0003838216301353,-0.0032523518062179,0.0117918573621247,0.26614223021482,0
2016-03-23,Jury Rules Merck Patents Valid…Bad For Gilead?,MRK,0.0009426886111578,0.0693592346142759,0.0043560840060976,0.0105264647033165,0.0139723898606285,-0.0078935685825941,-0.0091569021624022,-0.0001884162335165,-0.2393867422287621,2
2016-03-24,"Patent Expert: It's Not Over For Gilead, Still Has Strong Defense Against Merck",MRK,-0.0001884162335165,-0.2393867422287621,0.0009426886111578,0.0043560840060976,0.0105264647033165,0.0139723898606285,-0.0078935685825941,-0.0045223743909788,-0.2008142378885203,2
2016-04-04,"The Stocks That Moved The S&P, Dow And Nasdaq Today",MRK,0.013035285240343,0.1804079148657746,0.0149313010509546,-0.0058250709502608,-0.0018753092408756,0.0092751462065183,-0.0045223743909788,-0.0029411445531694,-0.1218389546194363,2
2016-04-04,Make A House Call With A Familiar Healthcare ETF,MRK,0.013035285240343,0.1804079148657746,0.0149313010509546,-0.0058250709502608,-0.0018753092408756,0.0092751462065183,-0.0045223743909788,-0.0029411445531694,-0.1218389546194363,2
2016-04-06,"Home To Hedge Fund Hotels, But This ETF Can Endure",MRK,0.0256267247947989,0.386587896452796,-0.0029411445531694,0.013035285240343,0.0149313010509546,-0.0058250709502608,-0.0018753092408756,-0.0037751015762986,-0.1557322057433721,2
2016-04-06,SocGen Picks New Favorites In Big Pharma,MRK,0.0256267247947989,0.386587896452796,-0.0029411445531694,0.013035285240343,0.0149313010509546,-0.0058250709502608,-0.0018753092408756,-0.0037751015762986,-0.1557322057433721,2
2016-04-12,"Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term",MRK,0.0052679041559913,-0.1597316803040859,-0.0055994506469889,-0.0010827644329428,-0.0037751015762986,0.0256267247947989,-0.0029411445531694,0.0112036631980549,0.4223513559036551,0
2016-04-12,"Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",MRK,0.0052679041559913,-0.1597316803040859,-0.0055994506469889,-0.0010827644329428,-0.0037751015762986,0.0256267247947989,-0.0029411445531694,0.0112036631980549,0.4223513559036551,0
2016-04-12,"Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long-Term",MRK,0.0052679041559913,-0.1597316803040859,-0.0055994506469889,-0.0010827644329428,-0.0037751015762986,0.0256267247947989,-0.0029411445531694,0.0112036631980549,0.4223513559036551,0
2016-04-13,Merck Says FDA Accepts Its sBLA For Keytruda And Grants Priority Review,MRK,0.0112036631980549,0.4223513559036551,0.0052679041559913,-0.0055994506469889,-0.0010827644329428,-0.0037751015762986,0.0256267247947989,0.008756003850975,-0.0103972548191852,0
2016-04-14,"After-Hours Recap: Big Banks, Liquidity Services's DoD Deal, Haemonetics' CFO & More",MRK,0.008756003850975,-0.0103972548191852,0.0112036631980549,0.0052679041559913,-0.0055994506469889,-0.0010827644329428,-0.0037751015762986,-0.0054915928686364,0.0092978596733297,1
2016-04-25,Pharma Names Under Pressure Amid Perrigo Warning,MRK,-0.0091645997792522,0.1672940553576358,0.0024735156079702,0.0003535218695625,-0.0049244970937065,0.0061935931531262,0.0065907948373977,-0.0032016291309336,-0.1272433204842324,2
2016-05-02,"The Market In 5 Minutes: May, She Will Stay",MRK,0.0083882657635041,-0.2683021009101674,-0.0161467074371259,-0.0101221868962985,0.0048177359394177,-0.0032016291309336,-0.0091645997792522,-0.0039783917386382,-0.2146627683359775,2
2016-05-02,"The Market In 5 Minutes: May, She Will Stay Stay",MRK,0.0083882657635041,-0.2683021009101674,-0.0161467074371259,-0.0101221868962985,0.0048177359394177,-0.0032016291309336,-0.0091645997792522,-0.0039783917386382,-0.2146627683359775,2
2016-05-05,Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Zynga Shares Rise Following Earnings Beat,MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-05,"Earnings Scheduled For May 5, 2016",MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-05,Mid-Day Market Update: Fitbit Slides  On Weak Outlook; Atlas Air Worldwide Shares Shares Spike Higher,MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-05,Mid-Morning Market Update: Markets Edge Higher; Merck Profit Beats Views,MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-05,"12 Stocks To Watch For May 5, 2016",MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-05,"Merck's 1Q Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast",MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-05,"Merck's Q1 Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast",MRK,-0.0131363294234011,0.4566831536049038,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,-0.0101221868962985,-0.0090589938393008,-0.0622617627832686,1
2016-05-06,What's M&A Like In The Biotech Sector Right Now?,MRK,-0.0090589938393008,-0.0622617627832686,-0.0131363294234011,-0.0049019757954474,-0.0039783917386382,0.0083882657635041,-0.0161467074371259,0.0093282126440426,-0.2423358541609973,0
2016-05-12,Berenberg Unimpressed With Pfizer; Initiates Coverage At Hold,MRK,-0.0034983750856576,0.2542865185364553,-0.0067664135268391,0.010720728833133,0.0093282126440426,-0.0090589938393008,-0.0131363294234011,-0.0044345426471134,-0.1357421841091681,2
2016-05-12,Merck To Present Final Stage Data On Investigational Medicines Ertugliflozin And MK-1293,MRK,-0.0034983750856576,0.2542865185364553,-0.0067664135268391,0.010720728833133,0.0093282126440426,-0.0090589938393008,-0.0131363294234011,-0.0044345426471134,-0.1357421841091681,2
2016-05-12,Merck To Present Final Stage Data On Investigational Medicines Ertugliflozin and MK-1293,MRK,-0.0034983750856576,0.2542865185364553,-0.0067664135268391,0.010720728833133,0.0093282126440426,-0.0090589938393008,-0.0131363294234011,-0.0044345426471134,-0.1357421841091681,2
2016-05-16,Merck To Present New And Updated Data On KEYTRUDA,MRK,0.0142909795315835,-0.0668192002099847,-0.0044345426471134,-0.0034983750856576,-0.0067664135268391,0.010720728833133,0.0093282126440426,-0.0060382032228744,0.7737738433011296,1
2016-05-19,JPMorgan's Take On Big Pharma's New ASCO Abstracts,MRK,-0.0016463369207683,0.1816618895638484,0.0064431147852543,-0.0060382032228744,0.0142909795315835,-0.0044345426471134,-0.0034983750856576,0.00971080013961,-0.0115411924252771,0
2016-05-19,J.P. Morgan's Take On Big Pharma's New ASCO Abstracts,MRK,-0.0016463369207683,0.1816618895638484,0.0064431147852543,-0.0060382032228744,0.0142909795315835,-0.0044345426471134,-0.0034983750856576,0.00971080013961,-0.0115411924252771,0
2016-05-23,Chardan Initiates Asterias Biotherapeutics At Buy On Potential Cell Therapy Competitiveness,MRK,-0.0034478602283444,-0.3547741257270387,0.00971080013961,-0.0016463369207683,0.0064431147852543,-0.0060382032228744,0.0142909795315835,0.0123815140565335,0.1330091402842981,0
2016-05-23,"Chardan Intiates Asterias Biotherapeutics At Buy, Says It Could Be Significant Competitor In Cell Therapy",MRK,-0.0034478602283444,-0.3547741257270387,0.00971080013961,-0.0016463369207683,0.0064431147852543,-0.0060382032228744,0.0142909795315835,0.0123815140565335,0.1330091402842981,0
2016-05-26,Celgene Rallies Of Possible Interest From Merck,MRK,-0.0031819077099437,-0.403630056464848,0.0174464171379502,0.0123815140565335,-0.0034478602283444,0.00971080013961,-0.0016463369207683,0.0015955924101986,0.3126124671480834,2
2016-05-27,Merck Gets Favorable Opinion From CHMP For Its ZEPATIER,MRK,0.0015955924101986,0.3126124671480834,-0.0031819077099437,0.0174464171379502,0.0123815140565335,-0.0034478602283444,0.00971080013961,-0.0038950995052733,0.2609871725565755,2
2016-06-03,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",MRK,-0.0031676470269815,-0.2547598095866896,0.0086985806318202,0.0012443644495869,-0.0038950995052733,0.0015955924101986,-0.0031819077099437,0.0093572657217348,0.2698413144137521,0
2016-06-06,4 Key Takeaways From ASCO,MRK,0.0093572657217348,0.2698413144137521,-0.0031676470269815,0.0086985806318202,0.0012443644495869,-0.0038950995052733,0.0015955924101986,-0.002973490663012,-0.0943800971668156,2
2016-06-06,Piper Jaffray's Takeaways From ASCO,MRK,0.0093572657217348,0.2698413144137521,-0.0031676470269815,0.0086985806318202,0.0012443644495869,-0.0038950995052733,0.0015955924101986,-0.002973490663012,-0.0943800971668156,2
2016-06-06,"Merck, Pfizer Offers Results from Pivotal Avelumab Study",MRK,0.0093572657217348,0.2698413144137521,-0.0031676470269815,0.0086985806318202,0.0012443644495869,-0.0038950995052733,0.0015955924101986,-0.002973490663012,-0.0943800971668156,2
2016-06-07,"Merck Says Ruling Reversal in Gilead Case 'Doesn't Reflect the Facts,' Co. Will Appeal Ruling Overturn",MRK,-0.002973490663012,-0.0943800971668156,0.0093572657217348,-0.0031676470269815,0.0086985806318202,0.0012443644495869,-0.0038950995052733,0.0108772061442836,0.245937628528893,0
2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",MRK,-0.0042592301512451,-0.3490353903437124,-0.0064707457794137,-0.0076362410036714,0.0108772061442836,-0.002973490663012,0.0093572657217348,0.0024952588503288,0.3850891100985294,2
2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Says Reuters",MRK,-0.0042592301512451,-0.3490353903437124,-0.0064707457794137,-0.0076362410036714,0.0108772061442836,-0.002973490663012,0.0093572657217348,0.0024952588503288,0.3850891100985294,2
2016-06-27,Merck Gets CHMP Positive Opinion for KEYTRUDA for Advanced Non-Small Cell Lung Cancer Treatment,MRK,-0.0102006105096958,-0.2413463737765876,-0.0312065022994597,0.0112203260575129,0.0140440990062529,0.0019596068725518,0.004473012953909,0.0048816547253502,-0.0254480869753176,2
2016-06-27,Merck Gets CHMP Positive Opinion For KEYTRUDA For Advanced Non-Small Cell Lung Cancer Treatment,MRK,-0.0102006105096958,-0.2413463737765876,-0.0312065022994597,0.0112203260575129,0.0140440990062529,0.0019596068725518,0.004473012953909,0.0048816547253502,-0.0254480869753176,2
2016-06-30,Merck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients,MRK,0.0098158895380353,-0.0546270820162682,0.0264484201447403,0.0048816547253502,-0.0102006105096958,-0.0312065022994597,0.0112203260575129,0.0057281306194516,-0.1519127267940138,0
2016-06-30,Merck and Premier Join Hands to Prevent Fractures for Osteoporosis Patients,MRK,0.0098158895380353,-0.0546270820162682,0.0264484201447403,0.0048816547253502,-0.0102006105096958,-0.0312065022994597,0.0112203260575129,0.0057281306194516,-0.1519127267940138,0
2016-07-20,"Benzinga's M&A Chatter for Wednesday July 20, 2016",MRK,0.0022160812606748,-0.2708274376149732,-0.006099696153242,-0.0102295173849312,-0.0003352518195701,0.0016792392010218,-0.0008390802168283,0.0,-0.0662291243298803,2
2016-07-21,The Market In 5 Minutes: Jam-Packed Day Of Earnings And Econmic Data,MRK,0.0,-0.0662291243298803,0.0022160812606748,-0.006099696153242,-0.0102295173849312,-0.0003352518195701,0.0016792392010218,0.0005104013312953,0.0367779269636052,2
2016-07-21,The Market In 5 Minutes: Jam-Packed Day Of Earnings And Economic Data,MRK,0.0,-0.0662291243298803,0.0022160812606748,-0.006099696153242,-0.0102295173849312,-0.0003352518195701,0.0016792392010218,0.0005104013312953,0.0367779269636052,2
2016-07-22,Merck Presents Data On Its Investigational Once-Daily Formulation of ISENTRESS,MRK,0.0005104013312953,0.0367779269636052,0.0,0.0022160812606748,-0.006099696153242,-0.0102295173849312,-0.0003352518195701,-0.0044201898363491,0.2819523696753152,2
2016-07-22,Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS,MRK,0.0005104013312953,0.0367779269636052,0.0,0.0022160812606748,-0.006099696153242,-0.0102295173849312,-0.0003352518195701,-0.0044201898363491,0.2819523696753152,2
2016-07-25,Merck Gets Breakthrough Therapy Status From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine,MRK,-0.0044201898363491,0.2819523696753152,0.0005104013312953,0.0,0.0022160812606748,-0.006099696153242,-0.0102295173849312,-0.0034154230306362,-0.1102872544249746,2
2016-07-25,Merck Gets Breakthrough Therapy Status from FDA and PRIME Status from EMA for Its Investigational Ebola Zaire Vaccine,MRK,-0.0044201898363491,0.2819523696753152,0.0005104013312953,0.0,0.0022160812606748,-0.006099696153242,-0.0102295173849312,-0.0034154230306362,-0.1102872544249746,2
2016-07-27,Can Keytruda Deliver Earnings Growth For Merck?,MRK,0.0041121996182824,0.1032052412864732,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0022160812606748,-0.0029007846015655,-0.0759430161275612,2
2016-07-29,Investors Greet Merck Q2 Results As Key Launches Help Beat,MRK,0.0039363155830127,0.1648215889667608,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0447522120452943,2
2016-07-29,12 Stocks You Should Be Watching Today,MRK,0.0039363155830127,0.1648215889667608,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0447522120452943,2
2016-07-29,Investors Greet Merck 2Q Results As Key Launches Help Beat,MRK,0.0039363155830127,0.1648215889667608,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0447522120452943,2
2016-07-29,A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of GDP Report,MRK,0.0039363155830127,0.1648215889667608,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0447522120452943,2
2016-07-29,"Weak GDP Data, Plunging Oil Renew Questions About Strength Of Economy",MRK,0.0039363155830127,0.1648215889667608,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0447522120452943,2
2016-07-29,"Earnings Scheduled For July 29, 2016",MRK,0.0039363155830127,0.1648215889667608,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0044201898363491,0.0005104013312953,0.0,0.0447522120452943,2
2016-08-02,6 Stocks Moving In Tuesday's After-Hours Session,MRK,-0.0056254305936149,-0.2305100409615211,0.0,0.0039363155830127,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0116579390790368,0.4117897187600381,1
2016-08-02,"Benzinga's M&A Chatter for Tuesday August 2, 2016",MRK,-0.0056254305936149,-0.2305100409615211,0.0,0.0039363155830127,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0116579390790368,0.4117897187600381,1
2016-08-02,6 Stocks Moving In After-Hours: Earnings & Takeovers Shake The Market,MRK,-0.0056254305936149,-0.2305100409615211,0.0,0.0039363155830127,-0.0029007846015655,0.0041121996182824,-0.0034154230306362,-0.0116579390790368,0.4117897187600381,1
2016-08-03,"Benzinga's M&A Chatter for Wednesday August 3, 2016",MRK,-0.0116579390790368,0.4117897187600381,-0.0056254305936149,0.0,0.0039363155830127,-0.0029007846015655,0.0041121996182824,0.0032955526938902,-0.4250049257962215,2
2016-08-03,The Market In 5 Minutes: Downtrend Continues,MRK,-0.0116579390790368,0.4117897187600381,-0.0056254305936149,0.0,0.0039363155830127,-0.0029007846015655,0.0041121996182824,0.0032955526938902,-0.4250049257962215,2
2016-08-03,Why Is Biogen Attractive? Credit Suisse Sees 12-24% Upside Takeout Potential,MRK,-0.0116579390790368,0.4117897187600381,-0.0056254305936149,0.0,0.0039363155830127,-0.0029007846015655,0.0041121996182824,0.0032955526938902,-0.4250049257962215,2
2016-08-05,25 Biggest Mid-Day Gainers For Friday,MRK,0.104080353236265,12.15118968307089,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,0.0039363155830127,-0.0156590473224238,-0.656321699748061,1
2016-08-05,The Market In 5 Minutes: Blowout Jobs Report Pushes Markets Higher,MRK,0.104080353236265,12.15118968307089,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,0.0039363155830127,-0.0156590473224238,-0.656321699748061,1
2016-08-05,Bristol Mayer's Failure Is Merck & Co's Success In Lung Cancer Market,MRK,0.104080353236265,12.15118968307089,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,0.0039363155830127,-0.0156590473224238,-0.656321699748061,1
2016-08-05,Bristol's Opdivo Misses Endpoint In Late-Stage Trial; Merck Rallies Sharply Amid Keytruda Potential,MRK,0.104080353236265,12.15118968307089,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,0.0039363155830127,-0.0156590473224238,-0.656321699748061,1
2016-08-05,Benzinga's Volume Movers,MRK,0.104080353236265,12.15118968307089,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,0.0039363155830127,-0.0156590473224238,-0.656321699748061,1
2016-08-05,Stocks Hitting 52-Week Highs,MRK,0.104080353236265,12.15118968307089,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,0.0039363155830127,-0.0156590473224238,-0.656321699748061,1
2016-08-08,The Market in 5 Minutes: Can The Momentum Continue?,MRK,-0.0156590473224238,-0.656321699748061,0.104080353236265,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,-0.005886220456076,-0.5115208516211629,1
2016-08-08,Watch These 5 Huge Put Purchases In Monday Trade,MRK,-0.0156590473224238,-0.656321699748061,0.104080353236265,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,-0.005886220456076,-0.5115208516211629,1
2016-08-08,"After Roaring To New Highs on Jobs Data, Market Faces Retail Sales, Job Openings",MRK,-0.0156590473224238,-0.656321699748061,0.104080353236265,0.0032955526938902,-0.0116579390790368,-0.0056254305936149,0.0,-0.005886220456076,-0.5115208516211629,1
2016-08-10,"Argus: Bristol-Myers Selloff Is Overdone, Reiterating $90 Target",MRK,0.0024001945920697,-0.2778231914127127,-0.005886220456076,-0.0156590473224238,0.104080353236265,0.0032955526938902,-0.0116579390790368,0.0158047986043532,0.173121785530729,0
2016-08-11,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,MRK,0.0158047986043532,0.173121785530729,0.0024001945920697,-0.005886220456076,-0.0156590473224238,0.104080353236265,0.0032955526938902,-0.0044005669759039,-0.3975591299256525,2
2016-08-24,The 2015 Flash Crash Was One Year Ago Today. Why Did It Happen?,MRK,-0.0133688840072195,0.2905111850581308,0.0004721714256379,0.002998791257164,-0.0042435032979892,0.0053721184904484,0.0039661532442745,-0.0065362368736949,0.0621150335261861,1
2016-09-02,Merck Remains Stable Following Discontinuation Of Odanacatib Development Program,MRK,0.001271952902617,0.1632618665005745,0.0017517540463025,0.0012755709564984,-0.0047611632397932,0.0025460078629591,0.0085045712396116,0.0041282244306473,0.0416512400493618,2
2016-09-15,Seattle Genetics No Longer On Goldman Sachs' Sell List,MRK,0.0167886495412903,-0.1366366704553341,-0.0074420860886407,-0.0146659593843216,0.011201721783894,-0.0118594264057289,0.0058852866112821,-0.0016030551626856,0.3817044328267704,2
2016-09-20,New 5-Year Contraceptive Coming To U.S. Adds To Long-Acting Reversible Contraceptives List,MRK,0.0099462032862971,-0.1839258768959999,-0.0152537507294392,-0.0016030551626856,0.0167886495412903,-0.0074420860886407,-0.0146659593843216,0.0122701118627195,-0.2163142287505268,0
2016-09-21,"The Market In 5 Minutes: We're Waiting For You, Mrs. Yellen",MRK,0.0122701118627195,-0.2163142287505268,0.0099462032862971,-0.0152537507294392,-0.0016030551626856,0.0167886495412903,-0.0074420860886407,0.0051037353353016,0.1702174287741531,0
2016-10-10,The ESMO Conference Proves Its Ability To Move Stocks,MRK,0.0180021822855103,0.8882154473668598,0.001755629063644,-0.0022294695236214,0.0054437667869222,-0.0009600228274004,0.0017627399464297,-0.0308293854151727,-0.3140927685647412,1
2016-10-10,SunTrust Cuts Target On Bristol-Myers As Opdivo Estimates Revised Lower,MRK,0.0180021822855103,0.8882154473668598,0.001755629063644,-0.0022294695236214,0.0054437667869222,-0.0009600228274004,0.0017627399464297,-0.0308293854151727,-0.3140927685647412,1
2016-10-10,Bristol-Myers Opdivo Vs. Merck's Keytruda In Front Line Lung Treatment,MRK,0.0180021822855103,0.8882154473668598,0.001755629063644,-0.0022294695236214,0.0054437667869222,-0.0009600228274004,0.0017627399464297,-0.0308293854151727,-0.3140927685647412,1
2016-10-13,A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Jobless Claims Report,MRK,0.0137854357546232,0.4366374172998593,-0.0043599588322078,-0.0308293854151727,0.0180021822855103,0.001755629063644,-0.0022294695236214,-0.0059189917950893,-0.1607330480569825,1
2016-10-19,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage",MRK,-0.0035430206686171,-0.4410592329115549,0.0092651718628438,-0.0099776257300802,-0.0059189917950893,0.0137854357546232,-0.0043599588322078,0.0008080950676672,0.1326776249557744,2
2016-10-21,Merck Has An Upcoming PDUFA Date For Bezlotoxumab,MRK,-0.0116280409068475,0.1713161598527703,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0099776257300802,-0.0059189917950893,-0.0073528772043166,0.342433133193047,1
2016-10-24,Big News Out Of Merck This Weekend,MRK,-0.0073528772043166,0.342433133193047,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0099776257300802,0.0197530473068818,0.5275570753293775,0
2016-10-25,Epic Earnings: Many US Companies Beating Expectations As Season Continues,MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-10-25,6 Big Pharma Companies Left To Report September Quarterly Figures,MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-10-25,"Earnings Scheduled For October 25, 2016",MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-10-25,12 Stocks You Should Be Watching Today,MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-10-25,"The Market In 5 Minutes: UA, GM, P&G Earnings On The Street's Mind",MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-10-25,"Merck's Q3 Results, Guidance Look Strong",MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-10-25,"A Peek Into The Markets: U.S. Stock Futures Rise; GM, Apple Earnings In Focus",MRK,0.0197530473068818,0.5275570753293775,-0.0073528772043166,-0.0116280409068475,0.0008080950676672,-0.0035430206686171,0.0092651718628438,-0.0174332619143218,-0.3443855799900839,1
2016-11-09,Biotech Is Getting A Big Boost Following Clinton's Loss,MRK,0.0606513444789442,2.506767671221619,0.0076600423346171,0.0209114296947134,0.0066745659801543,-0.0069681887001505,-0.0077569245987223,0.0121530067754429,-0.358650125276,0
2016-11-09,Stocks Hitting 52-Week Highs,MRK,0.0606513444789442,2.506767671221619,0.0076600423346171,0.0209114296947134,0.0066745659801543,-0.0069681887001505,-0.0077569245987223,0.0121530067754429,-0.358650125276,0
2016-11-14,Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price,MRK,-0.0065677512802115,-0.2798921936350212,-0.015547878129505,0.0121530067754429,0.0606513444789442,0.0076600423346171,0.0209114296947134,0.0018889062320988,-0.2799249534139656,2
2016-12-19,Jefferies' 2017 Global Pharma Outlook,MRK,-0.0208199942253162,-0.3202457488711483,0.0011223450108772,0.0092233206574317,0.0001616158192701,0.0088166250886434,0.0080025874040683,-0.0104678093178107,-0.1308233360549715,1
2016-12-19,A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Yellen Speech,MRK,-0.0208199942253162,-0.3202457488711483,0.0011223450108772,0.0092233206574317,0.0001616158192701,0.0088166250886434,0.0080025874040683,-0.0104678093178107,-0.1308233360549715,1
2016-12-20,What Does Biogen's New CEO Mean For The Buyout Argument?,MRK,-0.0104678093178107,-0.1308233360549715,-0.0208199942253162,0.0011223450108772,0.0092233206574317,0.0001616158192701,0.0088166250886434,-0.0176856593597137,0.1614227635884615,1
2016-12-23,6 Worst Biotech Stocks Of 2016,MRK,-0.0003356281347667,-0.2483663366336633,0.0025237677911762,-0.0176856593597137,-0.0104678093178107,-0.0208199942253162,0.0011223450108772,0.0038614670709882,-0.2339326627359949,2
2016-12-23,Where Does Merck's Ebola Vaccine Breakthrough Leave Competitors?,MRK,-0.0003356281347667,-0.2483663366336633,0.0025237677911762,-0.0176856593597137,-0.0104678093178107,-0.0208199942253162,0.0011223450108772,0.0038614670709882,-0.2339326627359949,2
2016-12-23,NewLink CFO: 'Ebola Vaccine Highly Unlikely To Drive Future Profit In Company',MRK,-0.0003356281347667,-0.2483663366336633,0.0025237677911762,-0.0176856593597137,-0.0104678093178107,-0.0208199942253162,0.0011223450108772,0.0038614670709882,-0.2339326627359949,2
2017-01-09,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation",MRK,0.0137709954977689,-0.0492254791285746,0.0026619153758173,-0.0003326388174504,-0.0003326087722158,0.0217428843239917,-0.0028795474701241,-0.0193124592190884,0.5719392765692455,1
2017-01-09,The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know,MRK,0.0137709954977689,-0.0492254791285746,0.0026619153758173,-0.0003326388174504,-0.0003326087722158,0.0217428843239917,-0.0028795474701241,-0.0193124592190884,0.5719392765692455,1
2017-01-11,15 Biggest Mid-Day Gainers For Wednesday,MRK,0.0285381128290445,1.1377121960083325,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,-0.0003326087722158,0.0094110334643278,-0.2392508026547682,0
2017-01-11,All The Markets Trump Moved During His Speech Today,MRK,0.0285381128290445,1.1377121960083325,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,-0.0003326087722158,0.0094110334643278,-0.2392508026547682,0
2017-01-11,Here's What Merck's Keytruda News Means For Bristol-Myers,MRK,0.0285381128290445,1.1377121960083325,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,-0.0003326087722158,0.0094110334643278,-0.2392508026547682,0
2017-01-11,22 Stocks Moving In Wednesday's Pre-Market Session,MRK,0.0285381128290445,1.1377121960083325,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,-0.0003326087722158,0.0094110334643278,-0.2392508026547682,0
2017-01-12,Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck,MRK,0.0094110334643278,-0.2392508026547682,0.0285381128290445,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,0.0020896267207899,-0.5993996372455277,2
2017-01-12,Merck's Leadership Position In Immuno Oncology Is Improving,MRK,0.0094110334643278,-0.2392508026547682,0.0285381128290445,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,0.0020896267207899,-0.5993996372455277,2
2017-01-12,"The Market In 5 Minutes: Jobless Claims Lower, Trump Conference Shakes Sectors",MRK,0.0094110334643278,-0.2392508026547682,0.0285381128290445,-0.0193124592190884,0.0137709954977689,0.0026619153758173,-0.0003326388174504,0.0020896267207899,-0.5993996372455277,2
2017-01-20,Wall Street's M&A Chatter From January 19,MRK,0.0364660790190516,1.2144693356608904,-0.0137321928380969,-0.0050424496196597,-0.0137951574410971,0.0020896267207899,0.0094110334643278,-0.0115142937503934,-0.5958169856955855,1
2017-01-26,Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers,MRK,0.0019643940775633,-0.1270522772549288,-0.0021238444364137,-0.0097072233487226,-0.0115142937503934,0.0364660790190516,-0.0137321928380969,0.0089869235098396,-0.4764351460413623,0
2017-01-27,A CEO Who's Who Of Trump's Manufacturing Council,MRK,0.0089869235098396,-0.4764351460413623,0.0019643940775633,-0.0021238444364137,-0.0097072233487226,-0.0115142937503934,0.0364660790190516,-0.0051820451544238,0.1804244183695098,1
2017-01-30,"The Market In 5 Minutes: Walgreens-Rite Aid, Personal Income And Trump's Executive Order",MRK,-0.0051820451544238,0.1804244183695098,0.0089869235098396,0.0019643940775633,-0.0021238444364137,-0.0097072233487226,-0.0115142937503934,0.0091160740693743,0.2505220474929266,0
2017-02-02,"The Market In 5 Minutes: Facebook Beats, Trump Tweets",MRK,0.0334944988857726,0.7234364031908687,0.0017745411526275,0.0091160740693743,-0.0051820451544238,0.0089869235098396,0.0019643940775633,0.0017136864160818,-0.3864993646281002,2
2017-02-15,Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers,MRK,-0.0076152147775552,0.7556763926977152,0.0137410363190602,0.0096650044966777,-0.0037275792455024,0.0010884693770574,0.001869306086186,0.0015348790495073,-0.3066719894116669,2
2017-02-15,Merck Still Sees Path Forward For Failed Alzheimer's Drug,MRK,-0.0076152147775552,0.7556763926977152,0.0137410363190602,0.0096650044966777,-0.0037275792455024,0.0010884693770574,0.001869306086186,0.0015348790495073,-0.3066719894116669,2
2017-02-16,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?",MRK,0.0015348790495073,-0.3066719894116669,-0.0076152147775552,0.0137410363190602,0.0096650044966777,-0.0037275792455024,0.0010884693770574,0.0019917425842259,-0.2671245718924652,2
2017-02-17,The Market In 5 Minutes,MRK,0.0019917425842259,-0.2671245718924652,0.0015348790495073,-0.0076152147775552,0.0137410363190602,0.0096650044966777,-0.0037275792455024,0.0013766139759123,-0.183702960511538,2
2017-02-21,"Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",MRK,0.0013766139759123,-0.183702960511538,0.0019917425842259,0.0015348790495073,-0.0076152147775552,0.0137410363190602,0.0096650044966777,-0.0029017292144349,0.1751262461351674,2
2017-02-21,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,MRK,0.0013766139759123,-0.183702960511538,0.0019917425842259,0.0015348790495073,-0.0076152147775552,0.0137410363190602,0.0096650044966777,-0.0029017292144349,0.1751262461351674,2
2017-02-23,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market',MRK,0.0085771978995368,-0.2101479284639192,-0.0029017292144349,0.0013766139759123,0.0019917425842259,0.0015348790495073,-0.0076152147775552,0.0047074497923553,0.231737467655086,2
2017-03-02,Why Bermuda Could Be The Next Switzerland,MRK,-0.0019633842312775,-0.1903433227550514,0.0051615718820732,0.0003038180513417,-0.00468539353752,0.0047074497923553,0.0085771978995368,0.0075665196562542,-0.0382530103864262,0
2017-03-08,Here's Your March PDUFA Date Preview,MRK,-0.0024259033087034,0.0106739113050409,-0.0076727264134733,-0.0016521319681456,0.0075665196562542,-0.0019633842312775,0.0051615718820732,0.0013679626506708,-0.0810920185520954,2
2017-03-08,Everything We Know About Merck's Keytruda,MRK,-0.0024259033087034,0.0106739113050409,-0.0076727264134733,-0.0016521319681456,0.0075665196562542,-0.0019633842312775,0.0051615718820732,0.0013679626506708,-0.0810920185520954,2
2017-03-10,"Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump",MRK,-0.0044012531454076,0.1407756702211124,0.0013679626506708,-0.0024259033087034,-0.0076727264134733,-0.0016521319681456,0.0075665196562542,-0.0150468334232914,0.6091071405978321,1
2017-03-20,Leerink Presents: Your 2017 Biopharma Catalyst Tracker,MRK,0.0032863694527922,-0.1022893974031949,-0.0043625599754507,-0.0080370474404576,0.0077879971104255,0.000779451763835,-0.0150468334232914,-0.0031196770580578,-0.1866057056229529,2
2017-04-10,Cardiovascular Players Could Be Eyeing Esperion,MRK,-0.0091873907354402,-0.0613124810531465,-0.0017393320170505,-0.0051910605400886,-0.0015705048663653,0.0031510589003234,-0.0011018901882007,0.000479449129801,-0.0969825912141123,2
2017-04-20,What Would A $5.8 Billion NIH Cut Look Like? Devastation.,MRK,-0.0014365884171495,-0.1340020433608888,0.0059419608231112,-0.0084398436585715,0.0030346772819771,-0.0069782950413617,0.0075103081001377,-0.0105518050901939,0.1713957640625649,1
2017-04-25,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,MRK,0.0025750185404278,0.2086183013944027,0.0040394175860205,-0.0105518050901939,-0.0014365884171495,0.0059419608231112,-0.0084398436585715,0.0064205485984827,-0.1713930362911006,0
2017-05-01,Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here',MRK,0.0008023658789952,0.0798376379179137,-0.0039950329154718,-0.0019139762330423,0.0064205485984827,0.0025750185404278,0.0040394175860205,0.0051299136275251,0.2745788684420978,0
2017-05-02,"12 Stocks To Watch For May 2, 2017",MRK,0.0051299136275251,0.2745788684420978,0.0008023658789952,-0.0039950329154718,-0.0019139762330423,0.0064205485984827,0.0025750185404278,0.0148325865699263,-0.1223037344349694,0
2017-05-02,A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus,MRK,0.0051299136275251,0.2745788684420978,0.0008023658789952,-0.0039950329154718,-0.0019139762330423,0.0064205485984827,0.0025750185404278,0.0148325865699263,-0.1223037344349694,0
2017-05-02,"Earnings Scheduled For May 2, 2017",MRK,0.0051299136275251,0.2745788684420978,0.0008023658789952,-0.0039950329154718,-0.0019139762330423,0.0064205485984827,0.0025750185404278,0.0148325865699263,-0.1223037344349694,0
2017-05-11,"Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers",MRK,0.0076632470877424,0.9223717833520207,0.0102703325458757,-0.0112483074566946,0.0006253761887564,0.009308875686623,-0.0039290320477372,-0.0133478003477311,-0.4414476046298768,1
2017-05-12,"Sympathy Moves, Explained: Unsympathetic Earnings Season Continues As Nvidia, Advanced Micro Devices Diverge",MRK,-0.0133478003477311,-0.4414476046298768,0.0076632470877424,0.0102703325458757,-0.0112483074566946,0.0006253761887564,0.009308875686623,-0.00094381542344,-0.1963528049629649,2
2017-05-19,The Most Notable Abstracts Released Ahead Of ASCO 2017,MRK,-0.0017217871843618,-0.2225772402292535,0.0141270274302749,-0.0123842973335949,0.0044086581726898,-0.00094381542344,-0.0133478003477311,0.0040766019633824,-0.330030047851095,2
2017-05-23,"Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst",MRK,0.0079637028967562,-0.0790010132755649,0.0040766019633824,-0.0017217871843618,0.0141270274302749,-0.0123842973335949,0.0044086581726898,0.0058868713813333,0.2128831265814634,0
2017-05-30,A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Economic Data,MRK,-0.0006162247559695,0.3255554399171132,-0.0018448936605395,0.0016941349278585,0.0058868713813333,0.0079637028967562,0.0040766019633824,0.0035448836978302,0.5941336405142938,2
2017-05-30,Tracking The Busy June PDUFA Calendar,MRK,-0.0006162247559695,0.3255554399171132,-0.0018448936605395,0.0016941349278585,0.0058868713813333,0.0079637028967562,0.0040766019633824,0.0035448836978302,0.5941336405142938,2
2017-06-26,"A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside",MRK,-0.0036274954783587,-0.4624188591080778,0.0021206409730154,0.0085546180668307,0.014411816730155,0.013348208025506,0.0112752044291386,-0.0057644872851209,0.0719603499567447,1
2017-06-27,Ransomware Rears Its Head Again As 150 Countries Hit By New Virus,MRK,-0.0057644872851209,0.0719603499567447,-0.0036274954783587,0.0021206409730154,0.0085546180668307,0.014411816730155,0.013348208025506,-0.0057980550581587,-0.1709392902749559,1
2017-06-28,Russia In The Spotlight As Second Wave Of Ransomware Grips Globe,MRK,-0.0057980550581587,-0.1709392902749559,-0.0057644872851209,-0.0036274954783587,0.0021206409730154,0.0085546180668307,0.014411816730155,-0.0125841802563954,0.2401497173243725,1
2017-07-06,Merck Falls As FDA Puts Hold On 3 Keytruda Myeloma Studies,MRK,-0.0165211114674789,0.7429394030122984,-0.0017115283398703,0.0028085485915285,-0.0038857530531791,-0.0125841802563954,-0.0057980550581587,0.0009508709123453,-0.361404289505895,2
2017-07-10,The Royalty-Amassing Strategy Of Royalty Pharma,MRK,-0.0052247462403356,-0.0731148638474905,0.0009508709123453,-0.0165211114674789,-0.0017115283398703,0.0028085485915285,-0.0038857530531791,-0.0077988917388385,0.0243826731487015,1
2017-07-24,Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers,MRK,-0.0009579306196415,0.127027191700584,-0.0049253990006641,0.0051103390862352,0.0033647672762602,-0.0031946807009586,-0.007136055487652,-0.003356162856367,-0.2348241174366379,2
2017-07-24,What You Need To Know About Dow Components Reporting This Week,MRK,-0.0009579306196415,0.127027191700584,-0.0049253990006641,0.0051103390862352,0.0033647672762602,-0.0031946807009586,-0.007136055487652,-0.003356162856367,-0.2348241174366379,2
2017-07-27,Why Is AstraZeneca Sinking Today?,MRK,0.0305824280457569,1.3323367598103646,-0.0089801099544006,-0.003356162856367,-0.0009579306196415,-0.0049253990006641,0.0051103390862352,0.0065946634155329,-0.3892741368588196,0
2017-07-27,"Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals",MRK,0.0305824280457569,1.3323367598103646,-0.0089801099544006,-0.003356162856367,-0.0009579306196415,-0.0049253990006641,0.0051103390862352,0.0065946634155329,-0.3892741368588196,0
2017-07-28,A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views,MRK,0.0065946634155329,-0.3892741368588196,0.0305824280457569,-0.0089801099544006,-0.003356162856367,-0.0009579306196415,-0.0049253990006641,-0.0035878047429941,-0.1219598382866723,2
2017-07-28,"10 Stocks To Watch For July 28, 2017",MRK,0.0065946634155329,-0.3892741368588196,0.0305824280457569,-0.0089801099544006,-0.003356162856367,-0.0009579306196415,-0.0049253990006641,-0.0035878047429941,-0.1219598382866723,2
2017-07-28,"Earnings Scheduled For July 28, 2017",MRK,0.0065946634155329,-0.3892741368588196,0.0305824280457569,-0.0089801099544006,-0.003356162856367,-0.0009579306196415,-0.0049253990006641,-0.0035878047429941,-0.1219598382866723,2
2017-08-01,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,MRK,0.0006263233361687,-0.4459278427558693,-0.0035878047429941,0.0065946634155329,0.0305824280457569,-0.0089801099544006,-0.003356162856367,-0.0075095311756617,0.0838096436540705,1
2017-08-14,Merck CEO Quits Manufacturing Council To Stand Against Violence; Trump Promptly Calls Him Out About Drug Pricing,MRK,0.004648692600204,-0.089819864485209,0.0032166200179157,-0.0049610189271978,0.0027282383014113,-0.0082751311165549,-0.0041205920568432,-0.0027123915077703,0.1467998184294143,2
2017-08-15,The Market In 5 Minutes,MRK,-0.0027123915077703,0.1467998184294143,0.004648692600204,0.0032166200179157,-0.0049610189271978,0.0027282383014113,-0.0082751311165549,0.0031999211085169,-0.0403419281698244,2
2017-08-16,Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive',MRK,0.0031999211085169,-0.0403419281698244,-0.0027123915077703,0.004648692600204,0.0032166200179157,-0.0049610189271978,0.0027282383014113,-0.0137160990462709,0.509618493804763,1
2017-08-16,"You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum",MRK,0.0031999211085169,-0.0403419281698244,-0.0027123915077703,0.004648692600204,0.0032166200179157,-0.0049610189271978,0.0027282383014113,-0.0137160990462709,0.509618493804763,1
2017-09-07,"Wall Street's M&A Chatter From September 6: Cabelas, Merck-Rigontec, Altice-Charter, Amazon-Kohl's",MRK,0.0049999216137708,-0.0408886310675697,0.0059729599909159,-0.0032899119646145,-0.0004697773222572,0.011723616318672,0.0,-0.0007773626643817,0.0742955229185637,2
2017-10-09,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,MRK,-0.0034082782213226,-0.2720341117935209,-0.0007739424304318,0.0,0.0035730768910495,-0.0027885712303693,0.0081211720985736,0.0020209171971816,-0.0972794847926522,2
2017-10-10,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,MRK,0.0020209171971816,-0.0972794847926522,-0.0034082782213226,-0.0007739424304318,0.0,0.0035730768910495,-0.0027885712303693,-0.0105493598495437,1.0527535441657578,1
2017-10-19,OncoSec Shares Spike 17% After New Data Defended,MRK,0.0037789802922547,0.2769530012264274,0.0045873022411513,-0.0018945616315547,-0.0007890147948504,-0.006893150153122,0.0007840416073077,0.0020390057795021,0.0231352759521945,2
2017-10-23,8 Firms To Debut On The Markets This Week,MRK,-0.0075139624896671,0.1240076445516826,0.0020390057795021,0.0037789802922547,0.0045873022411513,-0.0018945616315547,-0.0007890147948504,-0.0045740533894196,-0.1175012786358405,2
2017-10-23,The Week Ahead: Earnings Season Starts In Earnest,MRK,-0.0075139624896671,0.1240076445516826,0.0020390057795021,0.0037789802922547,0.0045873022411513,-0.0018945616315547,-0.0007890147948504,-0.0045740533894196,-0.1175012786358405,2
2017-10-24,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,MRK,-0.0045740533894196,-0.1175012786358405,-0.0075139624896671,0.0020390057795021,0.0037789802922547,0.0045873022411513,-0.0018945616315547,-0.0104579873594382,0.0778389973667144,1
2017-10-27,"12 Stocks To Watch For October 27, 2017",MRK,-0.0604936656168026,1.751347288185658,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0020390057795021,-0.0606113127531651,0.3189338869593079,1
2017-10-27,"Earnings Scheduled For October 27, 2017",MRK,-0.0604936656168026,1.751347288185658,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0020390057795021,-0.0606113127531651,0.3189338869593079,1
2017-10-27,"A Peek Into The Markets: U.S. Stock Futures Climb After Amazon, Alphabet Results",MRK,-0.0604936656168026,1.751347288185658,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0020390057795021,-0.0606113127531651,0.3189338869593079,1
2017-10-30,The Bull Thesis For Merck Is Evaporating,MRK,-0.0606113127531651,0.3189338869593079,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0069458599905163,-0.5273279283116954,0
2017-10-30,30 Stocks Moving In Monday's Pre-Market Session,MRK,-0.0606113127531651,0.3189338869593079,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0069458599905163,-0.5273279283116954,0
2017-10-30,35 Stocks Moving In Monday's Mid-Day Session,MRK,-0.0606113127531651,0.3189338869593079,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0069458599905163,-0.5273279283116954,0
2017-10-30,"8 Stocks To Watch For October 30, 2017",MRK,-0.0606113127531651,0.3189338869593079,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,-0.0075139624896671,0.0069458599905163,-0.5273279283116954,0
2017-10-31,"The Market In 5 Minutes: A Halloween Scare For Under Armour, Qualcomm And Other Big Tech Names",MRK,0.0069458599905163,-0.5273279283116954,-0.0606113127531651,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,0.0045378992338731,-0.1091094855378552,2
2017-10-31,Attention Biotech Investors: Here Are November PDUFA Catalysts On The Horizon,MRK,0.0069458599905163,-0.5273279283116954,-0.0606113127531651,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,0.0045378992338731,-0.1091094855378552,2
2017-10-31,"A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Mastercard, Kellogg Earnings",MRK,0.0069458599905163,-0.5273279283116954,-0.0606113127531651,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,0.0045378992338731,-0.1091094855378552,2
2017-10-31,40 Biggest Movers From Yesterday,MRK,0.0069458599905163,-0.5273279283116954,-0.0606113127531651,-0.0604936656168026,-0.0073658594609145,-0.0104579873594382,-0.0045740533894196,0.0045378992338731,-0.1091094855378552,2
2017-11-06,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",MRK,-0.0032108017510571,-0.111336451748628,0.0124616522042326,0.0005420673956746,0.0045378992338731,0.0069458599905163,-0.0606113127531651,-0.0051897721328667,0.6426105626930887,1
2017-11-09,Pharma ETFs Down Post Q3 Earnings,MRK,-0.0065393987435293,-0.0656053784033939,0.0178089723067775,-0.0051897721328667,-0.0032108017510571,0.0124616522042326,0.0005420673956746,-0.0129869110623641,0.1841429398079808,1
2017-12-11,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,MRK,0.0138561576435416,-0.0626666384711512,0.0146066920410663,0.007727789249887,-0.0254618954439267,-0.0080040756121222,0.0062645518062769,0.0129570288096749,0.4117111054899958,0
2017-12-13,Merck's Keytruda Gets FDA Priority Review For Rare Lymphoma,MRK,-0.0028033886026228,-0.0326404815026202,0.0129570288096749,0.0138561576435416,0.0146066920410663,0.007727789249887,-0.0254618954439267,-0.0074430131929965,-0.2402248740250619,1
2017-12-20,3 Biotech Pipeline Areas To Keep An Eye On In 2018,MRK,-0.0021339363551453,0.3875315085257593,0.0001777829537019,-0.0003557739375268,0.0041066065038428,-0.0074430131929965,-0.0028033886026228,0.0087326335434894,-0.2416355359703824,0
2017-12-26,7 Stocks Moving In Tuesday's After-Hours Session,MRK,-0.0003546827596387,-0.6117310401621179,-0.004240388925444,0.0087326335434894,-0.0021339363551453,0.0001777829537019,-0.0003557739375268,0.0,0.2848841415418712,2
2017-12-26,Merck's Diabetes Drugs Get FDA Nod As Adjunct Therapies,MRK,-0.0003546827596387,-0.6117310401621179,-0.004240388925444,0.0087326335434894,-0.0021339363551453,0.0001777829537019,-0.0003557739375268,0.0,0.2848841415418712,2
2018-01-02,4 Reasons To Consider Adding Celldex To Your Portfolio,MRK,-0.0008886263847225,0.1939643662309704,-0.0058301919813295,0.0046147659319291,0.0,-0.0003546827596387,-0.004240388925444,-0.0014229329301467,0.0505807604487242,2
2018-01-05,"Lower Jobs Growth in December, But Some Positive Signs For Economy",MRK,-0.0010515085858635,-0.3679990985071405,0.0162093452043181,-0.0014229329301467,-0.0008886263847225,-0.0058301919813295,0.0046147659319291,-0.0057907878571394,0.1695107320832014,1
2018-01-08,Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area,MRK,-0.0057907878571394,0.1695107320832014,-0.0010515085858635,0.0162093452043181,-0.0014229329301467,-0.0008886263847225,-0.0058301919813295,0.0024709616761033,-0.0429909402977665,2
2018-01-11,Key Takeaways From The J.P. Morgan Healthcare Conference,MRK,0.0052356712868868,-0.2158479246151181,0.0088028507245061,0.0024709616761033,-0.0057907878571394,-0.0010515085858635,0.0162093452043181,0.0184025624327595,0.7369236950012903,0
2018-01-19,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,MRK,0.0024537806927447,-0.3890273165431188,-0.0145089969505666,-0.0006444876527759,0.0581318131142787,0.0184025624327595,0.0052356712868868,-0.0004896930361505,0.0070383897403283,2
2018-01-23,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,MRK,0.0073470744936143,-0.0870381710553174,-0.0004896930361505,0.0024537806927447,-0.0145089969505666,-0.0006444876527759,0.0581318131142787,-0.0084278958504299,0.2057505872056249,1
2018-01-29,"PFE, LLY, MRK Write Up 'Scripts For Q4",MRK,-0.0066084156276906,-0.1683580647792035,0.012071907691505,0.0019612819223406,-0.0084278958504299,0.0073470744936143,-0.0004896930361505,-0.0159016437857481,0.4857980226764153,1
2018-01-29,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",MRK,-0.0066084156276906,-0.1683580647792035,0.012071907691505,0.0019612819223406,-0.0084278958504299,0.0073470744936143,-0.0004896930361505,-0.0159016437857481,0.4857980226764153,1
2018-01-29,"Fed, Earnings Are Meaty Filling Between Slices Of Job, Price Data",MRK,-0.0066084156276906,-0.1683580647792035,0.012071907691505,0.0019612819223406,-0.0084278958504299,0.0073470744936143,-0.0004896930361505,-0.0159016437857481,0.4857980226764153,1
2018-01-30,Hang On: Rate Fears In Focus As Futures Point Lower After Monday's Big Losses,MRK,-0.0159016437857481,0.4857980226764153,-0.0066084156276906,0.012071907691505,0.0019612819223406,-0.0084278958504299,0.0073470744936143,-0.0230831045429312,0.1401994957946546,1
2018-02-02,"12 Stocks To Watch For February 2, 2018",MRK,-0.0217172335851955,-0.0825777834500527,0.0102952470028923,-0.0230831045429312,-0.0159016437857481,-0.0066084156276906,0.012071907691505,-0.0368852778319265,0.5986252620737138,1
2018-02-02,"Earnings Scheduled For February 2, 2018",MRK,-0.0217172335851955,-0.0825777834500527,0.0102952470028923,-0.0230831045429312,-0.0159016437857481,-0.0066084156276906,0.012071907691505,-0.0368852778319265,0.5986252620737138,1
2018-02-08,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,MRK,-0.020579957511857,0.5241920759539893,0.007573364932061,-0.0166670183179167,-0.0368852778319265,-0.0217172335851955,0.0102952470028923,0.0025580975440768,-0.1097029228557738,2
2018-02-23,"Pharma Stock Roundup: AstraZeneca, Merck, AbbVie And More",MRK,0.0054972522788787,-0.1619574593924388,0.0003669686167679,-0.0078211030679405,-0.0232724673601633,0.0053580853770438,0.0198544653570234,0.0216874910046558,0.3395924720636325,0
2018-03-05,7 Biotech Stocks With Clinical Trial Outcomes In March,MRK,0.0007358968038198,0.469004797713823,0.0122904365391034,-0.0095904927685489,-0.0091374612703979,-0.0239028261166138,0.0216874910046558,-0.0018383459140682,-0.2929823873362808,2
2018-03-09,'Pharma Bro' Martin Shkreli Gets 7 Years In Prison For Securities Fraud,MRK,0.0069398241079781,0.1992219079530295,0.005323937252579,0.0031309091633555,-0.0018383459140682,0.0007358968038198,0.0122904365391034,0.0039896219161275,0.2195921734249957,2
2018-03-12,"The Market In 5 Minutes: Coincheck, Gun Violence, Oil And More",MRK,0.0039896219161275,0.2195921734249957,0.0069398241079781,0.005323937252579,0.0031309091633555,-0.0018383459140682,0.0007358968038198,0.0001802898350262,0.0890085658590764,2
2018-03-20,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,MRK,0.0001833343447448,-0.3420273888410704,-0.0186813477660662,0.0076014809351123,0.0082116023630531,-0.0016393054095295,0.0001802898350262,0.0009147969863241,0.2865423673933946,2
2018-03-26,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",MRK,0.0117954706782423,-0.1579435738051424,-0.0131190669568498,-0.0104222235048746,0.0009147969863241,0.0001833343447448,-0.0186813477660662,-0.0053662007267792,0.622825940278138,1
2018-04-02,"The Week Ahead: Switch's Lockup Expires, Spotify Debuts, And More",MRK,-0.0220305006357651,0.3740833803394698,-0.0112542959325702,0.0249301435662379,-0.0053662007267792,0.0117954706782423,-0.0131190669568498,0.015393239130979,-0.3100014785162193,0
2018-04-03,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,MRK,0.015393239130979,-0.3100014785162193,-0.0220305006357651,-0.0112542959325702,0.0249301435662379,-0.0053662007267792,0.0117954706782423,0.0083193051878507,-0.0369837312704001,0
2018-04-06,Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial,MRK,-0.0214561036845778,0.0020038795720387,-0.0001831239405399,0.0083193051878507,0.015393239130979,-0.0220305006357651,-0.0112542959325702,0.0524735912354568,0.8588410909286872,0
2018-04-09,31 Stocks Moving In Monday's Mid-Day Session,MRK,0.0524735912354568,0.8588410909286872,-0.0214561036845778,-0.0001831239405399,0.0083193051878507,0.015393239130979,-0.0220305006357651,0.0058761592078397,-0.4463829319980933,0
2018-04-09,20 Stocks Moving In Monday's Pre-Market Session,MRK,0.0524735912354568,0.8588410909286872,-0.0214561036845778,-0.0001831239405399,0.0083193051878507,0.015393239130979,-0.0220305006357651,0.0058761592078397,-0.4463829319980933,0
2018-04-09,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,MRK,0.0524735912354568,0.8588410909286872,-0.0214561036845778,-0.0001831239405399,0.0083193051878507,0.015393239130979,-0.0220305006357651,0.0058761592078397,-0.4463829319980933,0
2018-04-10,40 Biggest Movers From Yesterday,MRK,0.0058761592078397,-0.4463829319980933,0.0524735912354568,-0.0214561036845778,-0.0001831239405399,0.0083193051878507,0.015393239130979,-0.0051338784388909,-0.2993687606582785,1
2018-04-13,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",MRK,0.0075782988432901,-0.1579039490753132,0.009608969843132,-0.0051338784388909,0.0058761592078397,0.0524735912354568,-0.0214561036845778,0.0258875161130229,1.2425374501318207,0
2018-04-17,Stock Market Gets Lift From Earnings As Geopolitical Fears Wane,MRK,0.0105711727825352,-0.3198555798083273,0.0258875161130229,0.0075782988432901,0.009608969843132,-0.0051338784388909,0.0058761592078397,-0.0059050041765587,-0.2669944359371121,1
2018-04-26,Earnings Preview: Oil Giants Chevron And ExxonMobil Report Friday Morning,MRK,-0.0036894488550025,0.0064786782190324,-0.0076551422584353,-0.002655785250157,0.0241374000074026,0.0032402193680196,-0.0047523175382533,0.0010100892771371,-0.4321449409655922,2
2018-04-27,Upcoming Earnings: McDonald's Reports On Monday As It Continues On New Growth Plan,MRK,0.0010100892771371,-0.4321449409655922,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,0.0241374000074026,0.0032402193680196,-0.0100892889764862,0.7090045111613996,1
2018-04-30,"The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More",MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,0.0241374000074026,-0.015118129494625,0.0019311350609569,1
2018-04-30,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,0.0241374000074026,-0.015118129494625,0.0019311350609569,1
2018-04-30,Upcoming Earnings: Tech Giant Apple Reports After Tuesday's Close,MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,0.0241374000074026,-0.015118129494625,0.0019311350609569,1
2018-04-30,"McDonald's Strong Results Start Busy Earnings Week As Fed, Jobs Report Also Loom",MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,0.0241374000074026,-0.015118129494625,0.0019311350609569,1
2018-05-01,"Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed",MRK,-0.015118129494625,0.0019311350609569,-0.0100892889764862,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,-0.0117280108341455,-0.2060761739191622,1
2018-05-01,Benzinga Pro's 5 Stocks To Watch Today,MRK,-0.015118129494625,0.0019311350609569,-0.0100892889764862,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,-0.0117280108341455,-0.2060761739191622,1
2018-05-01,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",MRK,-0.015118129494625,0.0019311350609569,-0.0100892889764862,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,-0.0117280108341455,-0.2060761739191622,1
2018-05-01,"Earnings Scheduled For May 1, 2018",MRK,-0.015118129494625,0.0019311350609569,-0.0100892889764862,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,-0.0117280108341455,-0.2060761739191622,1
2018-05-01,"15 Stocks To Watch For May 1, 2018",MRK,-0.015118129494625,0.0019311350609569,-0.0100892889764862,0.0010100892771371,-0.0036894488550025,-0.0076551422584353,-0.002655785250157,-0.0117280108341455,-0.2060761739191622,1
2018-05-18,"Merck, Bristol Myers Shares Move On Alleged FDA Alert On Keytruda",MRK,0.001184904548128,0.2345841201070539,-0.0113806635942298,0.0092903405079844,-0.0080427490291502,-0.0001676365919902,0.0280744656245783,-0.0096380017506151,-0.1250115995658461,1
2018-05-25,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended",MRK,-0.0006765815567021,-0.0380152152854649,-0.0006761241036036,0.012318315869549,-0.0020489124611167,-0.0096380017506151,0.001184904548128,-0.0116769608779988,0.3210910737474588,1
2018-05-30,Mid-Morning Market Update: Markets Open Higher; Michael Kors Beats Q4 Estimates,MRK,0.0226026875557192,0.2539747161683301,-0.0116769608779988,-0.0006765815567021,-0.0006761241036036,0.012318315869549,-0.0020489124611167,-0.0031813095836775,0.1049085137801399,2
2018-05-30,30 Stocks Moving In Wednesday's Mid-Day Session,MRK,0.0226026875557192,0.2539747161683301,-0.0116769608779988,-0.0006765815567021,-0.0006761241036036,0.012318315869549,-0.0020489124611167,-0.0031813095836775,0.1049085137801399,2
2018-05-30,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",MRK,0.0226026875557192,0.2539747161683301,-0.0116769608779988,-0.0006765815567021,-0.0006761241036036,0.012318315869549,-0.0020489124611167,-0.0031813095836775,0.1049085137801399,2
2018-05-31,41 Biggest Movers From Yesterday,MRK,-0.0031813095836775,0.1049085137801399,0.0226026875557192,-0.0116769608779988,-0.0006765815567021,-0.0006761241036036,0.012318315869549,0.0173019318977625,-0.0961279660228879,0
2018-06-01,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,MRK,0.0173019318977625,-0.0961279660228879,-0.0031813095836775,0.0226026875557192,-0.0116769608779988,-0.0006765815567021,-0.0006761241036036,0.0241084058279881,0.7660869132576356,0
2018-06-05,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",MRK,-0.0101581766345096,-0.3582618661520566,0.0241084058279881,0.0173019318977625,-0.0031813095836775,0.0226026875557192,-0.0116769608779988,0.0087964612120987,-0.3959338590944203,0
2018-06-08,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",MRK,0.0095174984157309,0.2821185566860444,0.0009689875059337,0.0087964612120987,-0.0101581766345096,0.0241084058279881,0.0173019318977625,-0.0039948416354054,-0.2563493110451067,2
2018-06-14,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",MRK,-0.0088553972554898,0.2688425207408911,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0095174984157309,0.0009689875059337,0.007634963653875,0.3766145062531274,0
2018-06-15,Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet,MRK,0.007634963653875,0.3766145062531274,-0.0088553972554898,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0095174984157309,-0.0167660960683602,-0.4207369522785383,1
2018-06-15,Affimed Shares Slide On Updated Hodgkin Lymphoma Drug Combo Data,MRK,0.007634963653875,0.3766145062531274,-0.0088553972554898,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0095174984157309,-0.0167660960683602,-0.4207369522785383,1
2018-06-15,Mid-Afternoon Market Update: Crude Oil Down Over 3%; Canada Goose Shares Gain Following Strong Q4 Results,MRK,0.007634963653875,0.3766145062531274,-0.0088553972554898,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0095174984157309,-0.0167660960683602,-0.4207369522785383,1
2018-06-15,30 Stocks Moving In Friday's Mid-Day Session,MRK,0.007634963653875,0.3766145062531274,-0.0088553972554898,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0095174984157309,-0.0167660960683602,-0.4207369522785383,1
2018-06-15,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",MRK,0.007634963653875,0.3766145062531274,-0.0088553972554898,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0095174984157309,-0.0167660960683602,-0.4207369522785383,1
2018-06-18,40 Biggest Movers From Friday,MRK,-0.0167660960683602,-0.4207369522785383,0.007634963653875,-0.0088553972554898,0.0024022343490164,0.0017647773452589,-0.0039948416354054,0.0006560763342691,0.0511816997938994,2
2018-07-05,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,MRK,0.0153189431897056,0.8636894679228213,0.0041349681269728,-0.0039538924458929,0.0066334573050939,0.0070141040881208,-0.0138339896853167,0.009084830913842,-0.1023323496301078,0
2018-07-09,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,MRK,-0.0028938687652608,0.0212343373804939,0.009084830913842,0.0153189431897056,0.0041349681269728,-0.0039538924458929,0.0066334573050939,0.004514771036292,0.2913513513513512,2
2018-07-25,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",MRK,0.0168714637411997,0.1100124478177451,0.011644717865872,0.0027191258655321,0.0001600307803883,-0.0068320312029049,0.006556943262151,-0.0074430546055029,0.0592943429178023,1
2018-07-26,Merck Q2 Earnings Preview,MRK,-0.0074430546055029,0.0592943429178023,0.0168714637411997,0.011644717865872,0.0027191258655321,0.0001600307803883,-0.0068320312029049,-0.0081237748558162,-0.2450818194546911,1
2018-07-27,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",MRK,-0.0081237748558162,-0.2450818194546911,-0.0074430546055029,0.0168714637411997,0.011644717865872,0.0027191258655321,0.0001600307803883,0.0207907897133161,0.1490323080505984,0
2018-07-27,Benzinga Pro's 5 Stocks To Watch Today,MRK,-0.0081237748558162,-0.2450818194546911,-0.0074430546055029,0.0168714637411997,0.011644717865872,0.0027191258655321,0.0001600307803883,0.0207907897133161,0.1490323080505984,0
2018-07-27,"12 Stocks To Watch For July 27, 2018",MRK,-0.0081237748558162,-0.2450818194546911,-0.0074430546055029,0.0168714637411997,0.011644717865872,0.0027191258655321,0.0001600307803883,0.0207907897133161,0.1490323080505984,0
2018-07-27,"Earnings Scheduled For July 27, 2018",MRK,-0.0081237748558162,-0.2450818194546911,-0.0074430546055029,0.0168714637411997,0.011644717865872,0.0027191258655321,0.0001600307803883,0.0207907897133161,0.1490323080505984,0
2018-07-30,Benzinga Pro's 5 Stocks To Watch Today,MRK,0.0207907897133161,0.1490323080505984,-0.0081237748558162,-0.0074430546055029,0.0168714637411997,0.011644717865872,0.0027191258655321,0.0163555528648347,0.597835450823516,0
2018-07-31,Benzinga Pro's 5 Stocks To Watch Today,MRK,0.0163555528648347,0.597835450823516,0.0207907897133161,-0.0081237748558162,-0.0074430546055029,0.0168714637411997,0.011644717865872,-0.0057689343933069,-0.5088192953794646,1
2018-07-31,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data",MRK,0.0163555528648347,0.597835450823516,0.0207907897133161,-0.0081237748558162,-0.0074430546055029,0.0168714637411997,0.011644717865872,-0.0057689343933069,-0.5088192953794646,1
2018-08-07,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",MRK,0.0054363828475707,-0.0149884851541859,0.0043988217313963,0.0108860227143254,-0.0041227357647345,-0.0057689343933069,0.0163555528648347,0.0016523129392864,-0.1947224616581779,2
2018-08-08,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings Report, Paratek Awaits Adcom Verdict",MRK,0.0016523129392864,-0.1947224616581779,0.0054363828475707,0.0043988217313963,0.0108860227143254,-0.0041227357647345,-0.0057689343933069,-0.0103464147216231,0.0987049356572349,1
2018-08-16,"Benzinga's Daily Biotech Pulse: No Anxiety For Biohaven; Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait",MRK,0.0219683531815324,0.6977898737790407,0.0136922565266226,-0.0038967299299857,0.0098380859232474,0.0010604187721743,-0.0103464147216231,0.0030499737636664,-0.5756213710160583,2
2018-08-17,"The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",MRK,0.0030499737636664,-0.5756213710160583,0.0219683531815324,0.0136922565266226,-0.0038967299299857,0.0098380859232474,0.0010604187721743,0.0160730834560314,0.3277898032299333,0
2018-08-21,"The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows",MRK,-0.0142512458119334,-0.0580364755436778,0.0160730834560314,0.0030499737636664,0.0219683531815324,0.0136922565266226,-0.0038967299299857,-0.0018793540961992,-0.3995374744025711,2
2018-08-22,"The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",MRK,-0.0018793540961992,-0.3995374744025711,-0.0142512458119334,0.0160730834560314,0.0030499737636664,0.0219683531815324,0.0136922565266226,-0.0010139941921522,-0.0598305294957496,2
2018-08-24,30 Stocks Moving In Friday's Pre-Market Session,MRK,0.001015023420005,-0.1054920785705503,-0.0010139941921522,-0.0018793540961992,-0.0142512458119334,0.0160730834560314,0.0030499737636664,-0.0007240039165776,0.0257453748466047,2
2018-08-30,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",MRK,-0.003923751776975,-0.1357269320792615,0.0026226725222449,-0.0052183085522864,-0.0007240039165776,0.001015023420005,-0.0010139941921522,0.0007294205025825,0.2104917985311143,2
2018-08-31,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",MRK,0.0007294205025825,0.2104917985311143,-0.003923751776975,0.0026226725222449,-0.0052183085522864,-0.0007240039165776,0.001015023420005,-0.0093307889794975,0.0043528984488729,1
2018-09-04,Benzinga Pro's 5 Stocks To Watch Today,MRK,-0.0093307889794975,0.0043528984488729,0.0007294205025825,-0.003923751776975,0.0026226725222449,-0.0052183085522864,-0.0007240039165776,0.0098602612148011,0.1024219634227479,0
2018-09-05,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results",MRK,0.0098602612148011,0.1024219634227479,-0.0093307889794975,0.0007294205025825,-0.003923751776975,0.0026226725222449,-0.0052183085522864,0.0110756816783126,0.5155288515571768,0
2018-09-10,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,MRK,-0.0015786976564531,-0.2361800574211813,0.0041796168186627,0.0110756816783126,0.0098602612148011,-0.0093307889794975,0.0007294205025825,-0.0069004868235948,-0.1998376212244604,1
2018-09-11,"A Peek Into The Markets: US Stock Futures Down Ahead Of Job Openings, Wholesale Inventories Data",MRK,-0.0069004868235948,-0.1998376212244604,-0.0015786976564531,0.0041796168186627,0.0110756816783126,0.0098602612148011,-0.0093307889794975,0.0112908793785975,0.0472014444157853,0
2018-09-11,"The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet",MRK,-0.0069004868235948,-0.1998376212244604,-0.0015786976564531,0.0041796168186627,0.0110756816783126,0.0098602612148011,-0.0093307889794975,0.0112908793785975,0.0472014444157853,0
2018-09-14,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",MRK,-0.0052595189434268,-0.2751165191430352,0.0138852378419473,0.0112908793785975,-0.0069004868235948,-0.0015786976564531,0.0041796168186627,0.0062874892275779,-0.099341094900402,0
2018-09-20,Merck Or Pfizer: Which Is The Better Large-Cap Pharma Stock?,MRK,0.0114319179964774,-0.22702096036741,-0.0062482037140341,0.0,0.0062874892275779,-0.0052595189434268,0.0138852378419473,0.0045210176253525,1.773804148083414,2
2018-09-21,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Gets BARDA Funding",MRK,0.0045210176253525,1.773804148083414,0.0114319179964774,-0.0062482037140341,0.0,0.0062874892275779,-0.0052595189434268,-0.0045006700168803,-0.6219831066464717,2
2018-09-26,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,MRK,-0.0045292718585665,0.0724413370417749,-0.0018367547156237,-0.0045006700168803,0.0045210176253525,0.0114319179964774,-0.0062482037140341,0.0055451942281679,-0.1302175758229314,0
2018-10-02,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",MRK,0.0030757185853378,0.3627318858018868,0.008316750814971,0.0031109465444598,0.0055451942281679,-0.0045292718585665,-0.0018367547156237,-0.0052960761216628,-0.0786871354210791,1
2018-10-03,"The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",MRK,-0.0052960761216628,-0.0786871354210791,0.0030757185853378,0.008316750814971,0.0031109465444598,0.0055451942281679,-0.0045292718585665,-0.0021018022853179,0.0796755111546154,2
2018-10-04,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",MRK,-0.0021018022853179,0.0796755111546154,-0.0052960761216628,0.0030757185853378,0.008316750814971,0.0031109465444598,0.0055451942281679,-0.002667744011175,-0.2811415353286972,2
2018-10-04,"A Peek Into The Markets: US Stock Futures Drop Ahead Of Jobless Claims, Factory Orders Data",MRK,-0.0021018022853179,0.0796755111546154,-0.0052960761216628,0.0030757185853378,0.008316750814971,0.0031109465444598,0.0055451942281679,-0.002667744011175,-0.2811415353286972,2
2018-10-10,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",MRK,-0.0261266797932593,0.6073457272179996,0.0123147338015774,0.0060535632036213,-0.002667744011175,-0.0021018022853179,-0.0052960761216628,-0.0295245629887698,0.0175546909309927,1
2018-10-11,"The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares",MRK,-0.0295245629887698,0.0175546909309927,-0.0261266797932593,0.0123147338015774,0.0060535632036213,-0.002667744011175,-0.0021018022853179,0.0210620193065822,-0.2107192495200102,0
2018-10-12,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",MRK,0.0210620193065822,-0.2107192495200102,-0.0295245629887698,-0.0261266797932593,0.0123147338015774,0.0060535632036213,-0.002667744011175,-0.0050138408418392,-0.3523501592365361,1
2018-10-19,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",MRK,0.0019386121634563,0.187093064711296,0.0054304088176539,0.0084244649606217,0.0253385731091839,-0.0050138408418392,0.0210620193065822,0.0030409226863479,-0.1790827941775049,2
2018-10-22,"Benzinga's Week Ahead: Can Tech Earnings Restore The Rally? Amazon, Google To Report",MRK,0.0030409226863479,-0.1790827941775049,0.0019386121634563,0.0054304088176539,0.0084244649606217,0.0253385731091839,-0.0050138408418392,-0.0064766772114103,-0.029577887114608,1
2018-10-22,11 Stocks That Moved From ESMO 2018,MRK,0.0030409226863479,-0.1790827941775049,0.0019386121634563,0.0054304088176539,0.0084244649606217,0.0253385731091839,-0.0050138408418392,-0.0064766772114103,-0.029577887114608,1
2018-10-23,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",MRK,-0.0064766772114103,-0.029577887114608,0.0030409226863479,0.0019386121634563,0.0054304088176539,0.0084244649606217,0.0253385731091839,-0.0216365153132976,0.2666776761096161,1
2018-10-24,Merck's Q3 Earnings Preview,MRK,-0.0216365153132976,0.2666776761096161,-0.0064766772114103,0.0030409226863479,0.0019386121634563,0.0054304088176539,0.0084244649606217,-0.0082222127828351,0.4043167361320601,1
2018-10-25,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",MRK,-0.0082222127828351,0.4043167361320601,-0.0216365153132976,-0.0064766772114103,0.0030409226863479,0.0019386121634563,0.0054304088176539,0.0062892205904281,-0.1758150297406124,0
2018-10-25,"Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market",MRK,-0.0082222127828351,0.4043167361320601,-0.0216365153132976,-0.0064766772114103,0.0030409226863479,0.0019386121634563,0.0054304088176539,0.0062892205904281,-0.1758150297406124,0
2018-10-25,"Earnings Scheduled For October 25, 2018",MRK,-0.0082222127828351,0.4043167361320601,-0.0216365153132976,-0.0064766772114103,0.0030409226863479,0.0019386121634563,0.0054304088176539,0.0062892205904281,-0.1758150297406124,0
2018-10-25,"A Peek Into The Markets: US Stock Futures Rise Ahead Of Earnings, Economic Reports",MRK,-0.0082222127828351,0.4043167361320601,-0.0216365153132976,-0.0064766772114103,0.0030409226863479,0.0019386121634563,0.0054304088176539,0.0062892205904281,-0.1758150297406124,0
2018-10-29,"Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market?",MRK,0.0149148778779095,0.1114414816426876,0.0062892205904281,-0.0082222127828351,-0.0216365153132976,-0.0064766772114103,0.0030409226863479,0.0198741115241558,0.0051699509635911,0
2018-10-30,Earnings Preview: Automaker GM to Report Q3 Results Wednesday Morning,MRK,0.0198741115241558,0.0051699509635911,0.0149148778779095,0.0062892205904281,-0.0082222127828351,-0.0216365153132976,-0.0064766772114103,0.010155077415729,-0.1623224274784974,0
2018-10-30,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",MRK,0.0198741115241558,0.0051699509635911,0.0149148778779095,0.0062892205904281,-0.0082222127828351,-0.0216365153132976,-0.0064766772114103,0.010155077415729,-0.1623224274784974,0
2018-10-31,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",MRK,0.010155077415729,-0.1623224274784974,0.0198741115241558,0.0149148778779095,0.0062892205904281,-0.0082222127828351,-0.0216365153132976,-0.0066569372632032,-0.1273143437627616,1
2018-11-01,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",MRK,-0.0066569372632032,-0.1273143437627616,0.010155077415729,0.0198741115241558,0.0149148778779095,0.0062892205904281,-0.0082222127828351,-0.0116245576353519,-0.0682486089732083,1
2018-11-01,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,MRK,-0.0066569372632032,-0.1273143437627616,0.010155077415729,0.0198741115241558,0.0149148778779095,0.0062892205904281,-0.0082222127828351,-0.0116245576353519,-0.0682486089732083,1
2018-11-08,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",MRK,0.005327626472291,-0.3031680789652452,0.0241440257720826,0.0025986124266921,0.0117612772809698,-0.0116245576353519,-0.0066569372632032,-0.0082139104218112,0.1265237420139364,1
2018-11-09,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",MRK,-0.0082139104218112,0.1265237420139364,0.005327626472291,0.0241440257720826,0.0025986124266921,0.0117612772809698,-0.0116245576353519,-0.0022711667231961,-0.0443221859240112,2
2018-11-14,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",MRK,-0.0069695616095177,-0.400980561786847,-0.0010709168457219,-0.0022711667231961,-0.0082139104218112,0.005327626472291,0.0241440257720826,0.0101226451790061,0.2629757694924002,0
2018-11-20,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",MRK,-0.0205632779561619,-0.1726057229016293,0.003812745226108,0.0163016196001379,0.0101226451790061,-0.0069695616095177,-0.0010709168457219,0.0001338494423614,-0.3336301495209204,2
2018-11-26,"Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",MRK,0.0103119889010871,2.090635859637601,-0.0016046265154054,0.0001338494423614,-0.0205632779561619,0.003812745226108,0.0163016196001379,0.011929912154442,0.3435128469988895,0
2018-11-27,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",MRK,0.011929912154442,0.3435128469988895,0.0103119889010871,-0.0016046265154054,0.0001338494423614,-0.0205632779561619,0.003812745226108,0.0116586345635378,-0.1761673150291086,0
2018-11-29,"The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",MRK,0.0088048103400795,-0.0947672896696611,0.0116586345635378,0.011929912154442,0.0103119889010871,-0.0016046265154054,0.0001338494423614,0.0183545213978,0.9582052911260256,0
2018-11-29,Merck Is Up 40% In 2018: What's Driving The Rally?,MRK,0.0088048103400795,-0.0947672896696611,0.0116586345635378,0.011929912154442,0.0103119889010871,-0.0016046265154054,0.0001338494423614,0.0183545213978,0.9582052911260256,0
2018-11-30,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,MRK,0.0183545213978,0.9582052911260256,0.0088048103400795,0.0116586345635378,0.011929912154442,0.0103119889010871,-0.0016046265154054,-0.0015124884559225,-0.4109601460081465,2
2018-11-30,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",MRK,0.0183545213978,0.9582052911260256,0.0088048103400795,0.0116586345635378,0.011929912154442,0.0103119889010871,-0.0016046265154054,-0.0015124884559225,-0.4109601460081465,2
2018-12-04,"Ahead of Mid-Week Pause, Investors Fret Over Trade Pact Details",MRK,-0.0127492784609394,0.1744532737580961,-0.0015124884559225,0.0183545213978,0.0088048103400795,0.0116586345635378,0.011929912154442,0.002045788382418,0.1192651887477198,2
2018-12-04,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",MRK,-0.0127492784609394,0.1744532737580961,-0.0015124884559225,0.0183545213978,0.0088048103400795,0.0116586345635378,0.011929912154442,0.002045788382418,0.1192651887477198,2
2018-12-06,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",MRK,0.002045788382418,0.1192651887477198,-0.0127492784609394,-0.0015124884559225,0.0183545213978,0.0088048103400795,0.0116586345635378,-0.0210540617786908,-0.2366320286576926,1
2018-12-11,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",MRK,-0.0040042800647779,-0.142044807047531,0.0091240916356651,-0.0210540617786908,0.002045788382418,-0.0127492784609394,-0.0015124884559225,0.0116717213929589,-0.1909465620010874,0
2018-12-14,A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Reports,MRK,-0.0252359523269973,0.2327680164591734,0.0128189599958903,0.0116717213929589,-0.0040042800647779,0.0091240916356651,-0.0210540617786908,-0.016343918712006,0.1392771136357502,1
2018-12-20,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",MRK,-0.0037952299337479,0.0281226053717384,-0.0075338272262264,-0.0119635271206544,-0.016343918712006,-0.0252359523269973,0.0128189599958903,-0.0080284829007708,0.8660079145911508,1
2018-12-21,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",MRK,-0.0080284829007708,0.8660079145911508,-0.0037952299337479,-0.0075338272262264,-0.0119635271206544,-0.016343918712006,-0.0252359523269973,-0.0240056265975048,-0.6949938072247586,1
2018-12-31,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,MRK,0.0137986690088094,-0.2650234858614446,-0.0001326467747763,0.0186485328577949,0.0400561592609831,-0.0240056265975048,-0.0080284829007708,-0.0107315478935363,0.5607867745472466,1
2019-01-03,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",MRK,-0.0205051205748518,-0.0799925265168112,-0.0107315478935363,0.0137986690088094,-0.0001326467747763,0.0186485328577949,0.0400561592609831,0.0301185310687939,0.0605642678389501,0
2019-01-09,How 7 New Laws Affected Stocks In The Last Week,MRK,-0.0076324737766962,0.0016473495223796,0.0074239588279962,-0.0110132652823715,0.0301185310687939,-0.0205051205748518,-0.0107315478935363,-0.012332812680607,0.6057077860849909,1
2019-01-24,Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug,MRK,-0.0300901939972176,0.530117926266489,-0.0051430658553519,-0.000527280574198,0.0035712811072281,0.0132690840873628,0.0014765945521286,-0.0030064324294285,-0.3607885904796376,2
2019-01-29,How To Approach Q4 Earnings: The Technical Perspective,MRK,0.0042510842060887,-0.1054058139423617,-0.000411258344184,-0.0030064324294285,-0.0300901939972176,-0.0051430658553519,-0.000527280574198,0.0019116392061591,0.1650027288240787,2
2019-01-31,Merck's Q4 Earnings Preview,MRK,0.0144476809984479,0.2048906732045881,0.0019116392061591,0.0042510842060887,-0.000411258344184,-0.0030064324294285,-0.0300901939972176,0.0271393350701651,-0.050953591268497,0
2019-02-01,"The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant",MRK,0.0271393350701651,-0.050953591268497,0.0144476809984479,0.0019116392061591,0.0042510842060887,-0.000411258344184,-0.0030064324294285,0.0054937865388857,-0.2582897230211199,0
2019-02-01,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,MRK,0.0271393350701651,-0.050953591268497,0.0144476809984479,0.0019116392061591,0.0042510842060887,-0.000411258344184,-0.0030064324294285,0.0054937865388857,-0.2582897230211199,0
2019-02-01,"12 Stocks To Watch For February 1, 2019",MRK,0.0271393350701651,-0.050953591268497,0.0144476809984479,0.0019116392061591,0.0042510842060887,-0.000411258344184,-0.0030064324294285,0.0054937865388857,-0.2582897230211199,0
2019-02-01,"Earnings Scheduled For February 1, 2019",MRK,0.0271393350701651,-0.050953591268497,0.0144476809984479,0.0019116392061591,0.0042510842060887,-0.000411258344184,-0.0030064324294285,0.0054937865388857,-0.2582897230211199,0
2019-02-05,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",MRK,0.0036423548543675,0.0956959751491965,0.0054937865388857,0.0271393350701651,0.0144476809984479,0.0019116392061591,0.0042510842060887,0.0031110769339974,-0.3535102337274202,2
2019-02-20,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",MRK,0.0023976906792424,-0.068371760141635,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0235951090939896,0.0050359074854671,-0.1393096827414681,0
2019-02-21,Mid-Day Market Update: Immune Design Jumps Following Acquisition News; Carbon Black Shares Slide,MRK,0.0050359074854671,-0.1393096827414681,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0117752272725193,0.0771042884994031,0
2019-02-21,Mid-Afternoon Market Update: Dow Falls 150 Points; Delphi Technologies Shares Spike Higher,MRK,0.0050359074854671,-0.1393096827414681,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0117752272725193,0.0771042884994031,0
2019-02-21,50 Stocks Moving In Thursday's Mid-Day Session,MRK,0.0050359074854671,-0.1393096827414681,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0117752272725193,0.0771042884994031,0
2019-02-21,31 Stocks Moving In Thursday's Pre-Market Session,MRK,0.0050359074854671,-0.1393096827414681,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0117752272725193,0.0771042884994031,0
2019-02-21,Merck To Buy Immune Design For $300M,MRK,0.0050359074854671,-0.1393096827414681,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0117752272725193,0.0771042884994031,0
2019-02-21,Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Misses Q4 Views,MRK,0.0050359074854671,-0.1393096827414681,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,0.0063678097401067,0.0117752272725193,0.0771042884994031,0
2019-02-22,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",MRK,0.0117752272725193,0.0771042884994031,0.0050359074854671,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,-0.0048286206914476,0.1683719603635107,2
2019-02-22,65 Biggest Movers From Yesterday,MRK,0.0117752272725193,0.0771042884994031,0.0050359074854671,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,-0.0048286206914476,0.1683719603635107,2
2019-02-22,"The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data",MRK,0.0117752272725193,0.0771042884994031,0.0050359074854671,0.0023976906792424,-0.0071418148116635,0.0110210448434739,-0.0010124073904237,-0.0048286206914476,0.1683719603635107,2
2019-02-25,"Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",MRK,-0.0048286206914476,0.1683719603635107,0.0117752272725193,0.0050359074854671,0.0023976906792424,-0.0071418148116635,0.0110210448434739,0.0044789196451564,-0.0834956240282961,2
2019-02-26,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",MRK,0.0044789196451564,-0.0834956240282961,-0.0048286206914476,0.0117752272725193,0.0050359074854671,0.0023976906792424,-0.0071418148116635,-0.0014865422146336,-0.1204015003732115,2
2019-02-26,Sellas Reviews Strategic Options To Fund Clinical Development Programs,MRK,0.0044789196451564,-0.0834956240282961,-0.0048286206914476,0.0117752272725193,0.0050359074854671,0.0023976906792424,-0.0071418148116635,-0.0014865422146336,-0.1204015003732115,2
2019-02-26,It Could Be Time For This Pharma ETF,MRK,0.0044789196451564,-0.0834956240282961,-0.0048286206914476,0.0117752272725193,0.0050359074854671,0.0023976906792424,-0.0071418148116635,-0.0014865422146336,-0.1204015003732115,2
2019-02-27,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",MRK,-0.0014865422146336,-0.1204015003732115,0.0044789196451564,-0.0048286206914476,0.0117752272725193,0.0050359074854671,0.0023976906792424,0.0083106510423212,0.4756650279677341,0
2019-02-28,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",MRK,0.0083106510423212,0.4756650279677341,-0.0014865422146336,0.0044789196451564,-0.0048286206914476,0.0117752272725193,0.0050359074854671,0.0044285560461827,-0.0832006931089933,2
2019-03-06,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",MRK,-0.0115054861868922,-0.0610495976749185,0.0040555002869864,-0.0034293452374098,0.0044285560461827,0.0083106510423212,-0.0014865422146336,-0.0038387381868895,0.3377346544439084,2
2019-03-21,FedEx's Struggles May Be Less About Global Demand And More About 'NotPetya',MRK,0.0105996720737497,-0.2035630484110844,0.0020751255434905,0.006883944268714,-0.0026969384091998,0.0009814448844494,0.0054289297438148,-0.0079567572435474,0.1230723304076693,1
2019-03-22,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",MRK,-0.0079567572435474,0.1230723304076693,0.0105996720737497,0.0020751255434905,0.006883944268714,-0.0026969384091998,0.0009814448844494,0.0007290931064456,-0.2594686945652165,2
2019-03-27,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",MRK,-0.0075977505331807,0.0841780421825539,0.0069217785629738,0.0007290931064456,-0.0079567572435474,0.0105996720737497,0.0020751255434905,0.0041318581077731,-0.2853542333989237,2
2019-03-29,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,MRK,0.0065351660836234,0.4170607060340179,0.0041318581077731,-0.0075977505331807,0.0069217785629738,0.0007290931064456,-0.0079567572435474,0.001562987105002,-0.1308349216603793,2
2019-04-01,"Biotech Winners, Losers In Q1",MRK,0.001562987105002,-0.1308349216603793,0.0065351660836234,0.0041318581077731,-0.0075977505331807,0.0069217785629738,0.0007290931064456,-0.0010801617119077,-0.3339115461387743,2
2019-04-01,Advaxis Shares Surge After Positive Clinical Trial Updates,MRK,0.001562987105002,-0.1308349216603793,0.0065351660836234,0.0041318581077731,-0.0075977505331807,0.0069217785629738,0.0007290931064456,-0.0010801617119077,-0.3339115461387743,2
2019-04-01,AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation,MRK,0.001562987105002,-0.1308349216603793,0.0065351660836234,0.0041318581077731,-0.0075977505331807,0.0069217785629738,0.0007290931064456,-0.0010801617119077,-0.3339115461387743,2
2019-04-02,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",MRK,-0.0010801617119077,-0.3339115461387743,0.001562987105002,0.0065351660836234,0.0041318581077731,-0.0075977505331807,0.0069217785629738,-0.0003607337745521,0.1150018518871547,2
2019-04-11,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",MRK,-0.012125903629459,0.5100251397247684,0.0002476248713207,-0.0018532407579024,-0.0024644511853775,-0.0085523638594149,-0.0159892920080351,-0.0051350203894021,-0.0236065102620254,1
2019-04-12,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",MRK,-0.0051350203894021,-0.0236065102620254,-0.012125903629459,0.0002476248713207,-0.0018532407579024,-0.0024644511853775,-0.0085523638594149,-0.0113306332047337,0.3598440376665976,1
2019-04-16,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Mediconova, Proteon To Explore Strategic Alternatives",MRK,-0.0123519385880213,-0.09341594073022,-0.0113306332047337,-0.0051350203894021,-0.012125903629459,0.0002476248713207,-0.0018532407579024,-0.0469315001435369,1.7276977955112218,1
2019-04-26,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",MRK,0.0037988469622465,-0.3648638567218855,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.0036892820500689,-0.0098757318005627,0.0019574805783997,-0.167961699301534,2
2019-04-29,"This Week, Market Eyes China Talks, Fed Meeting As Earnings Continue",MRK,0.0019574805783997,-0.167961699301534,0.0037988469622465,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.0036892820500689,0.0251368244264424,0.5238074311080918,0
2019-04-30,Alphabet Revenue Disappoints Ahead Of Apple Earnings After The Bell,MRK,0.0251368244264424,0.5238074311080918,0.0019574805783997,0.0037988469622465,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.000127042440468,0.3566944794494011,2
2019-04-30,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",MRK,0.0251368244264424,0.5238074311080918,0.0019574805783997,0.0037988469622465,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.000127042440468,0.3566944794494011,2
2019-04-30,"Earnings Scheduled For April 30, 2019",MRK,0.0251368244264424,0.5238074311080918,0.0019574805783997,0.0037988469622465,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.000127042440468,0.3566944794494011,2
2019-04-30,"15 Stocks To Watch For April 30, 2019",MRK,0.0251368244264424,0.5238074311080918,0.0019574805783997,0.0037988469622465,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.000127042440468,0.3566944794494011,2
2019-04-30,"A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Meeting",MRK,0.0251368244264424,0.5238074311080918,0.0019574805783997,0.0037988469622465,0.0215442050684318,0.0017424203711278,0.0155186287904083,0.000127042440468,0.3566944794494011,2
2019-05-15,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",MRK,0.0016790702875755,-0.1022061602011183,0.0032396771342255,-0.0130450878799329,-0.0017872228036759,0.0019186715640373,0.00359429242423,0.0203736557455391,0.3605288622772904,0
2019-05-16,"Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward",MRK,0.0203736557455391,0.3605288622772904,0.0016790702875755,0.0032396771342255,-0.0130450878799329,-0.0017872228036759,0.0019186715640373,-0.0051810948638844,-0.1665979371457348,1
2019-05-16,5 ASCO Abstracts That Moved Stocks,MRK,0.0203736557455391,0.3605288622772904,0.0016790702875755,0.0032396771342255,-0.0130450878799329,-0.0017872228036759,0.0019186715640373,-0.0051810948638844,-0.1665979371457348,1
2019-05-16,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",MRK,0.0203736557455391,0.3605288622772904,0.0016790702875755,0.0032396771342255,-0.0130450878799329,-0.0017872228036759,0.0019186715640373,-0.0051810948638844,-0.1665979371457348,1
2019-05-20,"Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines",MRK,0.002032420843784,0.0026010607882338,-0.0051810948638844,0.0203736557455391,0.0016790702875755,0.0032396771342255,-0.0130450878799329,0.0078598865012529,0.3130640266599334,0
2019-05-21,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",MRK,0.0078598865012529,0.3130640266599334,0.002032420843784,-0.0051810948638844,0.0203736557455391,0.0016790702875755,0.0032396771342255,0.018616586065191,0.2407740524092276,0
2019-05-21,Merck To Buy Clinical-Stage Biopharma Peloton Therapeutics For More Than $1B,MRK,0.0078598865012529,0.3130640266599334,0.002032420843784,-0.0051810948638844,0.0203736557455391,0.0016790702875755,0.0032396771342255,0.018616586065191,0.2407740524092276,0
2019-05-31,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,MRK,-0.0058986464538318,-0.0455678209158808,0.0040325183191138,-0.0112134618471319,-0.0112113823771512,0.0018514158754938,0.000494036908464,0.0132555960422973,0.290553958986939,0
2019-06-04,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-tender Offer",MRK,0.0102169757539414,0.0163485914618224,0.0132555960422973,-0.0058986464538318,0.0040325183191138,-0.0112134618471319,-0.0112113823771512,0.0075235132851445,0.0483684900722674,0
2019-06-07,Sanofi's Leadership Transition: What You Need To Know,MRK,0.0125246138071533,-0.2278860705245524,-0.0030604222821204,0.0075235132851445,0.0102169757539414,0.0132555960422973,-0.0058986464538318,0.0002427498545205,-0.1433557459241533,2
2019-06-10,Merck Strikes $773M Deal For Privately Held Tilos Therapeutics: What You Need to Know,MRK,0.0002427498545205,-0.1433557459241533,0.0125246138071533,-0.0030604222821204,0.0075235132851445,0.0102169757539414,0.0132555960422973,0.0060616679000891,0.0336248434736905,0
2019-06-10,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,MRK,0.0002427498545205,-0.1433557459241533,0.0125246138071533,-0.0030604222821204,0.0075235132851445,0.0102169757539414,0.0132555960422973,0.0060616679000891,0.0336248434736905,0
2019-06-11,"FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer",MRK,0.0060616679000891,0.0336248434736905,0.0002427498545205,0.0125246138071533,-0.0030604222821204,0.0075235132851445,0.0102169757539414,0.0087975274058957,0.4195401376616416,0
2019-06-12,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",MRK,0.0087975274058957,0.4195401376616416,0.0060616679000891,0.0002427498545205,0.0125246138071533,-0.0030604222821204,0.0075235132851445,-0.0096762228215989,-0.0781135459417556,1
2019-06-13,"IBM, Walmart, Merck Included In FDA Program To Test Blockchain Usage In US Drug Supply Chain",MRK,-0.0096762228215989,-0.0781135459417556,0.0087975274058957,0.0060616679000891,0.0002427498545205,0.0125246138071533,-0.0030604222821204,0.0052217125432427,-0.2162103966833042,0
2019-06-19,Report: Merck Searching Internally For Next CEO,MRK,0.0102971152685988,-0.1400135631364175,0.0142855922754729,0.0062817209665682,0.0052217125432427,-0.0096762228215989,0.0087975274058957,-0.0089035723272165,0.2712417658727837,1
2019-06-19,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",MRK,0.0102971152685988,-0.1400135631364175,0.0142855922754729,0.0062817209665682,0.0052217125432427,-0.0096762228215989,0.0087975274058957,-0.0089035723272165,0.2712417658727837,1
2019-06-20,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",MRK,-0.0089035723272165,0.2712417658727837,0.0102971152685988,0.0142855922754729,0.0062817209665682,0.0052217125432427,-0.0096762228215989,-0.0003544754710425,0.2036599385307997,2
2019-06-21,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",MRK,-0.0003544754710425,0.2036599385307997,-0.0089035723272165,0.0102971152685988,0.0142855922754729,0.0062817209665682,0.0052217125432427,0.0111149895983657,-0.4751040521091313,0
2019-06-27,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",MRK,0.00347147623279,-0.0700335541530295,-0.0199435259186071,-0.0031578023911211,0.0111149895983657,-0.0003544754710425,-0.0089035723272165,0.0002385950287151,2.982780354676424,2
2019-07-01,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,MRK,0.0107333559520308,-0.780209942684388,0.0002385950287151,0.00347147623279,-0.0199435259186071,-0.0031578023911211,0.0111149895983657,0.0089676582843276,0.0117660668503223,0
2019-07-05,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",MRK,-0.0149597510103829,0.3419633651460716,0.0162553523033874,0.0089676582843276,0.0107333559520308,0.0002385950287151,0.00347147623279,-0.0182242274863327,0.5618471379861527,1
2019-07-09,Judge Rules Against Trump Proposal Forcing Pharma Companies To Disclose Drug Prices In Commercials,MRK,0.0097572015539255,-0.379929765513329,-0.0182242274863327,-0.0149597510103829,0.0162553523033874,0.0089676582843276,0.0107333559520308,-0.0004713981156597,-0.2938076087375134,2
2019-07-12,Stock Market Eyes Records On Dovish Commentary From Federal Reserve,MRK,-0.0156790700358255,-0.1460973354888345,-0.0450364603367956,-0.0004713981156597,0.0097572015539255,-0.0182242274863327,-0.0149597510103829,0.0154269772686994,-0.4224112822011909,0
2019-07-12,"Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",MRK,-0.0156790700358255,-0.1460973354888345,-0.0450364603367956,-0.0004713981156597,0.0097572015539255,-0.0182242274863327,-0.0149597510103829,0.0154269772686994,-0.4224112822011909,0
2019-07-17,"Merck's Novel Antibiotic For Abdominal, Urinary Tract Infections Receives FDA Nod",MRK,0.0040448458458541,0.1657465998758147,0.0077816739725882,0.0154269772686994,-0.0156790700358255,-0.0450364603367956,-0.0004713981156597,0.0093992560493398,-0.1397439475828965,0
2019-07-23,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",MRK,0.0100973316008941,0.0218643107802487,-0.0022116204789328,-0.0157213970877161,0.0093992560493398,0.0040448458458541,0.0077816739725882,-0.0034134084198286,0.0403920560816304,2
2019-07-23,Eisai's Cancer Drug Combo Gets Breakthrough Therapy Designation For Liver Cancer,MRK,0.0100973316008941,0.0218643107802487,-0.0022116204789328,-0.0157213970877161,0.0093992560493398,0.0040448458458541,0.0077816739725882,-0.0034134084198286,0.0403920560816304,2
2019-07-24,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",MRK,-0.0034134084198286,0.0403920560816304,0.0100973316008941,-0.0022116204789328,-0.0157213970877161,0.0093992560493398,0.0040448458458541,0.0,0.2525724408327923,2
2019-07-29,Merck Q2 Earnings Preview,MRK,0.0130171359536075,0.4561743018731434,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0022116204789328,0.0094556020009473,0.2843737352434203,0
2019-07-29,Merck's Keytruda Gets A Double Dose Of Positive News,MRK,0.0130171359536075,0.4561743018731434,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0022116204789328,0.0094556020009473,0.2843737352434203,0
2019-07-30,"Apple On Today's Menu, With Starring Roles From China Talks, Fed Meeting",MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-07-30,"Earnings Scheduled For July 30, 2019",MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-07-30,"15 Stocks To Watch For July 30, 2019",MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-07-30,"A Peek Into The Markets: US Stock Futures Down Ahead of Fed Meeting, Apple Earnings",MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-07-30,33 Healthcare Stocks Moving In Today's Pre-Market Session,MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-07-30,Merck Reports Q2 Earnings Beat,MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-07-30,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",MRK,0.0094556020009473,0.2843737352434203,0.0130171359536075,-0.0039144311131067,0.0,-0.0034134084198286,0.0100973316008941,-0.0033620386930237,-0.129036292872559,2
2019-08-06,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",MRK,0.014797795103502,-0.0723821761129328,-0.0159818101296349,0.0093200191023159,0.0084345897176743,-0.0033620386930237,0.0094556020009473,-0.0011854071606151,0.0439341462171372,2
2019-08-14,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",MRK,-0.0311336376487366,0.3562647780549197,0.0124678019802986,-0.0058468952506033,0.009324026666678,0.0056969852059245,-0.0011854071606151,0.0007190435759412,-0.163658906185425,2
2019-08-21,"The Daily Biotech Pulse: Ra Medical Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform",MRK,0.0147113452086611,0.0501042807059808,-0.0062653600006435,0.0132846781480029,0.0191711486028918,0.0007190435759412,-0.0311336376487366,-0.0021861692311342,0.015834545160769,2
2019-08-22,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",MRK,-0.0021861692311342,0.015834545160769,0.0147113452086611,-0.0062653600006435,0.0132846781480029,0.0191711486028918,0.0007190435759412,-0.0205260399396733,0.6101160519040258,1
2019-08-28,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,MRK,0.0112253986332813,-0.0562451729717365,-0.0041916698256503,0.0110665743842501,-0.0205260399396733,-0.0021861692311342,0.0147113452086611,0.0027753011010607,0.0261493061451631,2
2019-08-29,Stocks That Hit 52-Week Highs On Thursday,MRK,0.0027753011010607,0.0261493061451631,0.0112253986332813,-0.0041916698256503,0.0110665743842501,-0.0205260399396733,-0.0021861692311342,-0.0028833054175922,0.0750061857183628,2
2019-09-12,Oracle Reports Early In Surprise Move As Trump Surprises With Positive Trade Tweet,MRK,0.0047035001804485,-0.2061364262520305,0.0150569466815726,-0.021325245023944,-0.0358090131869469,0.0054586858780389,0.0005812558894806,-0.0018126847721832,-0.1063602377084219,2
2019-09-18,NewLink Genetics Rallies After Ebola Vaccine Granted Priority Review Status,MRK,0.0061809773961221,-0.0585284469124068,0.0058515789611444,-0.0070206786764347,-0.0018126847721832,0.0047035001804485,0.0150569466815726,0.0114429101263342,-0.0030185488096173,0
2019-09-18,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",MRK,0.0061809773961221,-0.0585284469124068,0.0058515789611444,-0.0070206786764347,-0.0018126847721832,0.0047035001804485,0.0150569466815726,0.0114429101263342,-0.0030185488096173,0
2019-09-20,"The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering",MRK,0.0141716985369542,2.413551706295771,0.0114429101263342,0.0061809773961221,0.0058515789611444,-0.0070206786764347,-0.0018126847721832,-0.0093940765968533,-0.6229749534588673,1
2019-09-25,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",MRK,-0.0059808580439223,-0.2224730819865662,-0.0090090252504675,-0.0093940765968533,0.0141716985369542,0.0114429101263342,0.0061809773961221,0.0093862334739991,0.111643004409859,0
2019-09-30,"Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More",MRK,0.0153177395090855,0.252952277429181,-0.0115639629266334,0.0093862334739991,-0.0059808580439223,-0.0090090252504675,-0.0093940765968533,-0.0067711367675256,-0.2811237186924326,1
2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,MRK,0.0153177395090855,0.252952277429181,-0.0115639629266334,0.0093862334739991,-0.0059808580439223,-0.0090090252504675,-0.0093940765968533,-0.0067711367675256,-0.2811237186924326,1
2019-10-01,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",MRK,-0.0067711367675256,-0.2811237186924326,0.0153177395090855,-0.0115639629266334,0.0093862334739991,-0.0059808580439223,-0.0090090252504675,-0.0238011575517561,0.2428981215747345,1
2019-10-03,What's Behind PDS Biotech's Rally?,MRK,0.0137220545475589,-0.3392137777258895,-0.0238011575517561,-0.0067711367675256,0.0153177395090855,-0.0115639629266334,0.0093862334739991,0.0273144894931505,0.2960958326245078,0
2019-10-15,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",MRK,0.0041327176704075,-0.0558860947534414,0.0041495483653621,0.0069249284607766,-0.0049895607124859,0.0106856369078902,-0.0130348177485285,-0.0069377825584973,0.0924154800424661,1
2019-10-21,Exclusive: Plus Products Hires The Wonderful Company's Mackler As Chief Scientific Officer,MRK,-0.0018895916840216,-0.3210582291943632,0.0105012506445383,-0.0076967520375905,-0.0069377825584973,0.0041327176704075,0.0041495483653621,-0.038097512281095,2.480673510538596,1
2019-10-22,"The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug",MRK,-0.038097512281095,2.480673510538596,-0.0018895916840216,0.0105012506445383,-0.0076967520375905,-0.0069377825584973,0.0041327176704075,0.0193112265024919,-0.5430810222191828,0
2019-10-22,8 Healthcare Stocks Moving In Tuesday's Pre-Market Session,MRK,-0.038097512281095,2.480673510538596,-0.0018895916840216,0.0105012506445383,-0.0076967520375905,-0.0069377825584973,0.0041327176704075,0.0193112265024919,-0.5430810222191828,0
2019-10-28,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,MRK,-0.0007293073450798,0.9772376386307532,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,-0.0018895916840216,0.0352798988280773,0.1165569511877264,0
2019-10-29,"12 Stocks To Watch For October 29, 2019",MRK,0.0352798988280773,0.1165569511877264,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,0.0131609170812709,-0.4227831424282018,0
2019-10-29,"Earnings Scheduled For October 29, 2019",MRK,0.0352798988280773,0.1165569511877264,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,0.0131609170812709,-0.4227831424282018,0
2019-10-29,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,MRK,0.0352798988280773,0.1165569511877264,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,0.0131609170812709,-0.4227831424282018,0
2019-10-29,"Alphabet Misses On Earnings, But Drugmakers, Mastercard Beat Expectations",MRK,0.0352798988280773,0.1165569511877264,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,0.0131609170812709,-0.4227831424282018,0
2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",MRK,0.0352798988280773,0.1165569511877264,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,0.0131609170812709,-0.4227831424282018,0
2019-10-29,"Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats",MRK,0.0352798988280773,0.1165569511877264,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,-0.038097512281095,0.0131609170812709,-0.4227831424282018,0
2019-10-30,"Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close",MRK,0.0131609170812709,-0.4227831424282018,0.0352798988280773,-0.0007293073450798,-0.0038751800088334,-0.0034995413039146,0.0193112265024919,0.0051032012281799,0.2386178304341994,0
2019-11-08,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",MRK,0.0085665098609906,-0.2808464733430076,-0.0044442701186048,0.0039798023520192,-0.0116806298593984,-0.0122440136755643,-0.0198475068130959,-0.0037084896597663,-0.4400793431896569,2
2019-11-11,NextCure Shares Give Back Some Gains After Data Readout,MRK,-0.0037084896597663,-0.4400793431896569,0.0085665098609906,-0.0044442701186048,0.0039798023520192,-0.0116806298593984,-0.0122440136755643,0.0100863192733517,1.3130590104587083,0
2019-11-13,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",MRK,0.0083212280756048,-0.24368769044511,0.0100863192733517,-0.0037084896597663,0.0085665098609906,-0.0044442701186048,0.0039798023520192,-0.0031830416098919,0.2139617973807417,2
2019-11-27,Stocks That Hit 52-Week Highs On Wednesday,MRK,0.0030913037773416,-0.6861027315994763,0.0191364898901327,0.002925685698752,-0.0001168253282336,0.002228194242555,0.0073241026938497,-0.0049081741737074,-0.1916572888822487,2
2019-11-27,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",MRK,0.0030913037773416,-0.6861027315994763,0.0191364898901327,0.002925685698752,-0.0001168253282336,0.002228194242555,0.0073241026938497,-0.0049081741737074,-0.1916572888822487,2
2019-12-02,Stocks That Hit 52-Week Highs On Monday,MRK,-0.0016058516252205,0.1470783501242361,-0.0049081741737074,0.0030913037773416,0.0191364898901327,0.002925685698752,-0.0001168253282336,0.0039063302983883,0.3337202574420814,2
2019-12-03,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",MRK,0.0039063302983883,0.3337202574420814,-0.0016058516252205,-0.0049081741737074,0.0030913037773416,0.0191364898901327,0.002925685698752,0.0147630747443878,-0.0230903106576042,0
2019-12-04,Stocks That Hit 52-Week Highs On Wednesday,MRK,0.0147630747443878,-0.0230903106576042,0.0039063302983883,-0.0016058516252205,-0.0049081741737074,0.0030913037773416,0.0191364898901327,0.0009020799799184,0.1334970164932629,2
2019-12-05,Stocks That Hit 52-Week Highs On Thursday,MRK,0.0009020799799184,0.1334970164932629,0.0147630747443878,0.0039063302983883,-0.0016058516252205,-0.0049081741737074,0.0030913037773416,0.0011267601090632,-0.1235675470900259,2
2019-12-05,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",MRK,0.0009020799799184,0.1334970164932629,0.0147630747443878,0.0039063302983883,-0.0016058516252205,-0.0049081741737074,0.0030913037773416,0.0011267601090632,-0.1235675470900259,2
2019-12-06,Stocks That Hit 52-Week Highs On Friday,MRK,0.0011267601090632,-0.1235675470900259,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,-0.0049081741737074,-0.0014628978830018,0.1116430154990317,2
2019-12-06,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",MRK,0.0011267601090632,-0.1235675470900259,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,-0.0049081741737074,-0.0014628978830018,0.1116430154990317,2
2019-12-09,Mid-Day Market Update: Synthorx Jumps Following Acquisition News; Biocept Shares Plunge,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,48 Stocks Moving In Monday's Mid-Day Session,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,Mid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,ArQule To Be Acquired By Merck For $2.7B,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,20 Stocks Moving In Monday's Pre-Market Session,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls 1%,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,Mid-Morning Market Update: Markets Mixed; Merck To Acquire ArQule For $20/Share,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-09,KalVista Shares Sink On Failed Mid-Stage Study Of Daibetic Macular Edema Drug,MRK,-0.0014628978830018,0.1116430154990317,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0016058516252205,0.0042829940281097,0.0755929708200913,2
2019-12-10,Stocks That Hit 52-Week Highs On Tuesday,MRK,0.0042829940281097,0.0755929708200913,-0.0014628978830018,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0013468408329126,-0.2126069302173168,2
2019-12-10,80 Biggest Movers From Yesterday,MRK,0.0042829940281097,0.0755929708200913,-0.0014628978830018,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0013468408329126,-0.2126069302173168,2
2019-12-10,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",MRK,0.0042829940281097,0.0755929708200913,-0.0014628978830018,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0039063302983883,-0.0013468408329126,-0.2126069302173168,2
2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",MRK,-0.0013468408329126,-0.2126069302173168,0.0042829940281097,-0.0014628978830018,0.0011267601090632,0.0009020799799184,0.0147630747443878,0.0066306803540532,0.0061758382677983,0
2019-12-12,Stocks That Hit 52-Week Highs On Thursday,MRK,0.0066306803540532,0.0061758382677983,-0.0013468408329126,0.0042829940281097,-0.0014628978830018,0.0011267601090632,0.0009020799799184,0.0025856612657895,0.1031376440949691,2
2019-12-13,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",MRK,0.0025856612657895,0.1031376440949691,0.0066306803540532,-0.0013468408329126,0.0042829940281097,-0.0014628978830018,0.0011267601090632,0.0011209374113059,0.3675985895031564,2
2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",MRK,-0.0030237990208054,0.1289559054629938,0.0011209374113059,0.0025856612657895,0.0066306803540532,-0.0013468408329126,0.0042829940281097,0.0067402662889268,-0.0096099882426353,0
2019-12-18,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",MRK,0.0067402662889268,-0.0096099882426353,-0.0030237990208054,0.0011209374113059,0.0025856612657895,0.0066306803540532,-0.0013468408329126,0.0041285205001337,-0.3433593601215525,2
2019-12-19,Stocks That Hit 52-Week Highs On Thursday,MRK,0.0041285205001337,-0.3433593601215525,0.0067402662889268,-0.0030237990208054,0.0011209374113059,0.0025856612657895,0.0066306803540532,0.0176686284762812,1.3477979448397126,0
2019-12-19,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",MRK,0.0041285205001337,-0.3433593601215525,0.0067402662889268,-0.0030237990208054,0.0011209374113059,0.0025856612657895,0.0066306803540532,0.0176686284762812,1.3477979448397126,0
2019-12-20,Stocks That Hit 52-Week Highs On Friday,MRK,0.0176686284762812,1.3477979448397126,0.0041285205001337,0.0067402662889268,-0.0030237990208054,0.0011209374113059,0.0025856612657895,0.0017470628978542,-0.5576411872933467,2
2019-12-20,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",MRK,0.0176686284762812,1.3477979448397126,0.0041285205001337,0.0067402662889268,-0.0030237990208054,0.0011209374113059,0.0025856612657895,0.0017470628978542,-0.5576411872933467,2
2019-12-20,FDA Approves First Ebola Vaccine,MRK,0.0176686284762812,1.3477979448397126,0.0041285205001337,0.0067402662889268,-0.0030237990208054,0.0011209374113059,0.0025856612657895,0.0017470628978542,-0.5576411872933467,2
2019-12-30,Merck-AstraZeneca's Lynparza Snags FDA Nod For Pancreatic Cancer,MRK,-0.0051367205897061,0.0462808123297737,0.0017519455252918,-0.0010936469847457,-0.0032702115831252,0.0017470628978542,0.0176686284762812,-0.0008789557400641,0.1977724518133281,2
2020-01-07,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",MRK,-0.0266257789105898,0.4797726640420803,0.0042739582610142,-0.0085832476652903,0.0119846343927432,-0.0008789557400641,-0.0051367205897061,-0.0067266637660232,0.36544470919017,1
2020-01-09,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV, Applied Genetic Soars On Trial Results, Globus Medical Slips On Guidance",MRK,0.0088038836610533,-0.3608929860624377,-0.0067266637660232,-0.0266257789105898,0.0042739582610142,-0.0085832476652903,0.0119846343927432,0.0016781300614916,-0.3880126611595769,2
2020-01-17,"Cannabis Media Company The Fresh Toast Expands Again, Says It's Cash Positive",MRK,-0.0023033535197934,0.3969337911449251,-0.0039325372101106,0.0179026215082216,0.0046923577829749,-0.0002234949126126,0.0016781300614916,-0.0109924863921037,-0.0107683907159903,1
2020-01-24,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",MRK,-0.0291327827631687,0.133115215963397,-0.0121581261066255,-0.0035569493093492,-0.0109924863921037,-0.0023033535197934,-0.0039325372101106,0.0013956129081327,-0.2746530916832943,2
2020-01-27,A Peek Into The Markets: US Stock Futures Down; Dow Futures Tumble Over 400 Points,MRK,0.0013956129081327,-0.2746530916832943,-0.0291327827631687,-0.0121581261066255,-0.0035569493093492,-0.0109924863921037,-0.0023033535197934,0.0017423686492525,-0.1245616745704599,2
2020-01-28,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,MRK,0.0017423686492525,-0.1245616745704599,0.0013956129081327,-0.0291327827631687,-0.0121581261066255,-0.0035569493093492,-0.0109924863921037,0.0114779418574428,-0.1037367316084806,0
2020-01-29,"February Market Outlook: Coronavirus, D.C. Proceedings, Earnings Season Could Mean Volatility",MRK,0.0114779418574428,-0.1037367316084806,0.0017423686492525,0.0013956129081327,-0.0291327827631687,-0.0121581261066255,-0.0035569493093492,-0.0084821000719148,0.2943458093645017,1
2020-01-31,"Position Scrimmage: Coronavirus, End-Of-Month Profit Taking Influencing Markets",MRK,-0.0122545049308817,-0.1266184062028574,-0.0084821000719148,0.0114779418574428,0.0017423686492525,0.0013956129081327,-0.0291327827631687,0.0222378882809191,0.0111972219124441,0
2020-02-03,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,MRK,0.0222378882809191,0.0111972219124441,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,0.0017423686492525,0.0013956129081327,0.0116785514274684,0.5511164297435853,0
2020-02-03,"Surprise, Surprise: Stocks Wearing Their Rally Hats Despite China Market Tanking",MRK,0.0222378882809191,0.0111972219124441,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,0.0017423686492525,0.0013956129081327,0.0116785514274684,0.5511164297435853,0
2020-02-05,"Merck To Spin Off Slow-Growing Women's Health, Legacy, Biosimilars Businesses: What You Need to Know",MRK,-0.0286328889822057,0.9408615093260656,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,-0.0017476425666184,-0.4499796228306645,2
2020-02-05,Merck Reports Mixed Q4 Earnings,MRK,-0.0286328889822057,0.9408615093260656,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,-0.0017476425666184,-0.4499796228306645,2
2020-02-05,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",MRK,-0.0286328889822057,0.9408615093260656,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,-0.0017476425666184,-0.4499796228306645,2
2020-02-05,"10 Stocks To Watch For February 5, 2020",MRK,-0.0286328889822057,0.9408615093260656,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,-0.0017476425666184,-0.4499796228306645,2
2020-02-05,"Earnings Scheduled For February 5, 2020",MRK,-0.0286328889822057,0.9408615093260656,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,-0.0017476425666184,-0.4499796228306645,2
2020-02-05,"Earnings Bonanza: Results Keep Pouring In, With Investors Looking Over Merck, Disney",MRK,-0.0286328889822057,0.9408615093260656,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,0.0114779418574428,-0.0017476425666184,-0.4499796228306645,2
2020-02-06,"Twitter Up, Tesla Down: Strong User Numbers Help TWTR, But TSLA Selling Continues",MRK,-0.0017476425666184,-0.4499796228306645,-0.0286328889822057,0.0116785514274684,0.0222378882809191,-0.0122545049308817,-0.0084821000719148,-0.0070030160775892,-0.2911665736612339,1
2020-02-07,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",MRK,-0.0070030160775892,-0.2911665736612339,-0.0017476425666184,-0.0286328889822057,0.0116785514274684,0.0222378882809191,-0.0122545049308817,0.006817115170888,-0.0725468974931929,0
2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",MRK,-0.0047860458772075,-0.0319416998403264,0.006817115170888,-0.0070030160775892,-0.0017476425666184,-0.0286328889822057,0.0116785514274684,-0.023460502862341,0.9147099848634832,1
2020-02-19,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",MRK,-0.0055785258434055,0.171993513626615,-0.0022988673799491,0.0082957560831786,-0.0153754202465445,-0.023460502862341,-0.0047860458772075,0.0059754143976864,-0.068047276797198,0
2020-02-20,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",MRK,0.0059754143976864,-0.068047276797198,-0.0055785258434055,-0.0022988673799491,0.0082957560831786,-0.0153754202465445,-0.023460502862341,-0.0018180815475117,-0.150380255416846,2
2020-02-26,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",MRK,-0.0041109749604554,-0.0934884327234416,-0.0130333941121396,-0.012266319401693,-0.0018180815475117,0.0059754143976864,-0.0055785258434055,-0.0232674974722048,0.3177454001718385,1
2020-02-27,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",MRK,-0.0232674974722048,0.3177454001718385,-0.0041109749604554,-0.0130333941121396,-0.012266319401693,-0.0018180815475117,0.0059754143976864,-0.0194672422633896,0.8587547181299298,1
2020-03-02,A Peek Into The Markets: US Stock Futures Down Ahead Of Manufacturing Reports,MRK,0.0628265585709755,-0.3557939674521578,-0.0194672422633896,-0.0232674974722048,-0.0041109749604554,-0.0130333941121396,-0.012266319401693,-0.0275288733938479,-0.0767455259341234,1
2020-03-02,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,MRK,0.0628265585709755,-0.3557939674521578,-0.0194672422633896,-0.0232674974722048,-0.0041109749604554,-0.0130333941121396,-0.012266319401693,-0.0275288733938479,-0.0767455259341234,1
2020-03-12,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",MRK,-0.0605679495719009,0.5878168544754834,-0.0337723652344452,0.038754098412308,-0.0394162955667112,0.0076001370139775,-0.0167532895473082,0.03940983556863,0.1408490052981759,0
2020-03-13,"Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year",MRK,0.03940983556863,0.1408490052981759,-0.0605679495719009,-0.0337723652344452,0.038754098412308,-0.0394162955667112,0.0076001370139775,-0.088990318058601,-0.1952555070573669,1
2020-03-16,Stocks That Hit 52-Week Lows On Monday,MRK,-0.088990318058601,-0.1952555070573669,0.03940983556863,-0.0605679495719009,-0.0337723652344452,0.038754098412308,-0.0394162955667112,0.0652172734884135,0.1892240491487218,0
2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",MRK,0.0652172734884135,0.1892240491487218,-0.088990318058601,0.03940983556863,-0.0605679495719009,-0.0337723652344452,0.038754098412308,-0.0382652560178917,-0.2500338744421022,1
2020-03-24,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",MRK,0.0399096117209865,0.0830985442560199,-0.0695066734332233,0.0089070403239199,-0.0125644860608734,-0.0382652560178917,0.0652172734884135,-0.0120202970095801,-0.0799140726941228,1
2020-03-25,UPS Seeks To Accelerate Growth Of Drone-Delivery,MRK,-0.0120202970095801,-0.0799140726941228,0.0399096117209865,-0.0695066734332233,0.0089070403239199,-0.0125644860608734,-0.0382652560178917,0.0778365874802504,-0.0141247895993631,0
2020-04-15,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",MRK,-0.0092950527409698,-0.1107547608938397,0.0285571825315977,-0.0236389364935669,0.0106588946414658,0.0389512958208226,-0.0217906152570078,0.0113316868892945,-0.1539460556835961,0
2020-04-15,Every Member Of Trump's 'Great American Economic Revival' Industry Groups,MRK,-0.0092950527409698,-0.1107547608938397,0.0285571825315977,-0.0236389364935669,0.0106588946414658,0.0389512958208226,-0.0217906152570078,0.0113316868892945,-0.1539460556835961,0
2020-04-16,Gilead's Encouraging Remdesivir Data: Rapid Reaction On The Stock,MRK,0.0113316868892945,-0.1539460556835961,-0.0092950527409698,0.0285571825315977,-0.0236389364935669,0.0106588946414658,0.0389512958208226,0.0055422649729277,0.6875958577846089,0
2020-04-16,"Next 45 Days Will Be 'Most Critical Period' For US, Says Alan Lancz Who Predicted 1987 and 2008 Crises",MRK,0.0113316868892945,-0.1539460556835961,-0.0092950527409698,0.0285571825315977,-0.0236389364935669,0.0106588946414658,0.0389512958208226,0.0055422649729277,0.6875958577846089,0
2020-04-27,"Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead",MRK,0.0313156189690611,0.6635444628476783,0.0067999838308347,0.0112529615738852,0.0180753198902889,-0.0546330388085531,-0.0043134997379294,-0.0333415147379136,0.5855127568351401,1
2020-04-28,"Earnings Scheduled For April 28, 2020",MRK,-0.0333415147379136,0.5855127568351401,0.0313156189690611,0.0067999838308347,0.0112529615738852,0.0180753198902889,-0.0546330388085531,-0.0050502577886138,-0.3248746643411418,1
2020-04-28,"Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later",MRK,-0.0333415147379136,0.5855127568351401,0.0313156189690611,0.0067999838308347,0.0112529615738852,0.0180753198902889,-0.0546330388085531,-0.0050502577886138,-0.3248746643411418,1
2020-04-28,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",MRK,-0.0333415147379136,0.5855127568351401,0.0313156189690611,0.0067999838308347,0.0112529615738852,0.0180753198902889,-0.0546330388085531,-0.0050502577886138,-0.3248746643411418,1
2020-04-29,"Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut",MRK,-0.0050502577886138,-0.3248746643411418,-0.0333415147379136,0.0313156189690611,0.0067999838308347,0.0112529615738852,0.0180753198902889,-0.0177046880895079,-0.1496520031790299,1
2020-04-29,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",MRK,-0.0050502577886138,-0.3248746643411418,-0.0333415147379136,0.0313156189690611,0.0067999838308347,0.0112529615738852,0.0180753198902889,-0.0177046880895079,-0.1496520031790299,1
2020-04-30,"ServiceNow CEO Bill McDermott Says Company 'Hungry And Humble,' With $10B Ambitions",MRK,-0.0177046880895079,-0.1496520031790299,-0.0050502577886138,-0.0333415147379136,0.0313156189690611,0.0067999838308347,0.0112529615738852,-0.02104871484726,-0.1821750343976456,1
2020-05-05,Why Are Shares Of Gene Therapy Company Genprex AreSurging Higher,MRK,0.0149624119547033,-0.1637082773321221,-0.0104286461174553,-0.02104871484726,-0.0177046880895079,-0.0050502577886138,-0.0333415147379136,-0.0114091407780677,0.6773759541275666,1
2020-05-13,"AbbVie's Potential Is 'Underappreciated,"" Says Morgan Stanley Analyst",MRK,0.0090683697678233,0.1456820882042944,-0.0092413260627632,0.0197643717869011,0.0105821228310507,-0.0197094348708093,-0.0114091407780677,0.0277314378443178,0.0432037212854772,0
2020-05-13,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",MRK,0.0090683697678233,0.1456820882042944,-0.0092413260627632,0.0197643717869011,0.0105821228310507,-0.0197094348708093,-0.0114091407780677,0.0277314378443178,0.0432037212854772,0
2020-05-20,Why Surface Oncology's Stock Is Surging Higher,MRK,-0.0085107103474419,0.0411508992503839,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,0.0090683697678233,-0.0044219079165355,-0.1838423930317196,2
2020-05-20,Mid-Afternoon Market Update: Crude Oil Up 5%; Surface Oncology Shares Spike Higher,MRK,-0.0085107103474419,0.0411508992503839,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,0.0090683697678233,-0.0044219079165355,-0.1838423930317196,2
2020-05-20,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",MRK,-0.0085107103474419,0.0411508992503839,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,0.0090683697678233,-0.0044219079165355,-0.1838423930317196,2
2020-05-21,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",MRK,-0.0044219079165355,-0.1838423930317196,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,-0.0023514348691336,-0.2936389325323552,2
2020-05-21,Mid-Day Market Update: Crude Oil Rises Over 1%; Aurora Cannabis Shares Jump,MRK,-0.0044219079165355,-0.1838423930317196,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,-0.0023514348691336,-0.2936389325323552,2
2020-05-21,51 Stocks Moving In Thursday's Mid-Day Session,MRK,-0.0044219079165355,-0.1838423930317196,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,-0.0023514348691336,-0.2936389325323552,2
2020-05-21,Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher,MRK,-0.0044219079165355,-0.1838423930317196,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,-0.0023514348691336,-0.2936389325323552,2
2020-05-21,Mid-Morning Market Update: Markets Mixed; Best Buy Tops Q1 Expectations,MRK,-0.0044219079165355,-0.1838423930317196,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0277314378443178,-0.0023514348691336,-0.2936389325323552,2
2020-05-22,64 Biggest Movers From Yesterday,MRK,-0.0023514348691336,-0.2936389325323552,-0.0044219079165355,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,-0.0033728257119449,0.0116538015285849,2.011572348926824,0
2020-05-26,"Merck's Coronavirus Plan Of Attack: 2 Partnerships, M&A Deal Aimed At Treatment, Vaccine Development",MRK,0.0116538015285849,2.011572348926824,-0.0023514348691336,-0.0044219079165355,-0.0085107103474419,-0.0272199916673382,-0.0007523356537069,0.0037536589591702,-0.329939642276511,2
2020-06-01,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,MRK,-0.0143705008599527,-0.5361993959652895,0.0212550419961008,0.0192132169587395,0.0037536589591702,0.0116538015285849,-0.0023514348691336,0.0160883013455099,0.8109024680978127,0
2020-06-04,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",MRK,-0.006215187566575,-0.3204665847729988,0.0150918582954258,0.0160883013455099,-0.0143705008599527,0.0212550419961008,0.0192132169587395,0.008706188637293,0.1205666027829759,0
2020-06-05,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",MRK,0.008706188637293,0.1205666027829759,-0.006215187566575,0.0150918582954258,0.0160883013455099,-0.0143705008599527,0.0212550419961008,0.0077802282893064,-0.04383883491062,0
2020-06-10,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",MRK,-0.0059565749169296,0.0265371401492713,-0.0077201636536502,0.0077802282893064,0.008706188637293,-0.006215187566575,0.0150918582954258,-0.0540541356102846,0.5751529580703276,1
2020-06-11,Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July,MRK,-0.0540541356102846,0.5751529580703276,-0.0059565749169296,-0.0077201636536502,0.0077802282893064,0.008706188637293,-0.006215187566575,-0.0057335944131917,0.1885380692930107,1
2020-06-16,"The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO",MRK,0.0398542075666499,0.2122174632872058,-0.0298819820867611,-0.0057335944131917,-0.0540541356102846,-0.0059565749169296,-0.0077201636536502,-0.008834921680657,-0.3477159870411274,1
2020-06-17,"The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked",MRK,-0.008834921680657,-0.3477159870411274,0.0398542075666499,-0.0298819820867611,-0.0057335944131917,-0.0540541356102846,-0.0059565749169296,-0.0009174963786053,-0.4456927657745505,2
2020-06-25,"The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy",MRK,0.0092265611846946,-0.0620382364607804,-0.0162086328366127,0.0048209644115977,-0.0147628436672565,0.0220417407191675,-0.0009174963786053,-0.0180229432739267,0.6257877807738239,1
2020-06-30,"The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test",MRK,0.0158958669505473,0.3747500688010909,0.0123688039121387,-0.0180229432739267,0.0092265611846946,-0.0162086328366127,0.0048209644115977,0.0102159736814793,0.0008012430382895,0
2020-07-02,"The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts",MRK,0.0084485765508297,-0.3137015242790339,0.0102159736814793,0.0158958669505473,0.0123688039121387,-0.0180229432739267,0.0092265611846946,0.0101550119785061,0.1802121466206294,0
2020-07-08,"The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy",MRK,-0.0101626402273424,0.1804061690405429,-0.0108068058509197,0.0101550119785061,0.0084485765508297,0.0102159736814793,0.0158958669505473,-0.0157853847432969,-0.0298775092268134,1
2020-07-16,"The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO",MRK,-0.0005037301564766,-0.2411168918392205,0.0152076445145219,0.0116354813401764,0.0080803322786684,0.000521565270388,-0.0157853847432969,0.0059195275036867,0.4000503181288493,0
2020-07-27,3 ETFs For This Week's Earnings Parade,MRK,0.0237353702170952,0.2083574132436805,-0.0122981000677503,-0.0091393332144379,-0.0013943893063572,-0.0065485428256358,-0.0057591373159959,0.0096287268296957,-0.2248287988281401,0
2020-07-28,"Moderna Looking To Price Its Coronavirus Vaccine At $50-$60, Significantly Above Rivals: FT",MRK,0.0096287268296957,-0.2248287988281401,0.0237353702170952,-0.0122981000677503,-0.0091393332144379,-0.0013943893063572,-0.0065485428256358,-0.004266463978177,-0.2468077231509469,2
2020-07-28,"The Daily Biotech Pulse: Spectrum's Positive Dementia Readout, Pfizer, BioNTech Start Late-Stage Coronavirus Trial, resTORbio Receives COVID-19 Funding",MRK,0.0096287268296957,-0.2248287988281401,0.0237353702170952,-0.0122981000677503,-0.0091393332144379,-0.0013943893063572,-0.0065485428256358,-0.004266463978177,-0.2468077231509469,2
2020-07-29,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More",MRK,-0.004266463978177,-0.2468077231509469,0.0096287268296957,0.0237353702170952,-0.0122981000677503,-0.0091393332144379,-0.0013943893063572,-0.0045368403423564,0.117936117936118,2
2020-07-31,Merck's Debt Overview,MRK,0.0158246874510223,0.7184176383413026,-0.0045368403423564,-0.004266463978177,0.0096287268296957,0.0237353702170952,-0.0122981000677503,0.0286641033564343,-0.1374721201931079,0
2020-07-31,"Four-For-Four: Perfect Day At The Plate For FAANGs As Apple, Amazon, Facebook Up Big Early",MRK,0.0158246874510223,0.7184176383413026,-0.0045368403423564,-0.004266463978177,0.0096287268296957,0.0237353702170952,-0.0122981000677503,0.0286641033564343,-0.1374721201931079,0
2020-07-31,"Earnings Scheduled For July 31, 2020",MRK,0.0158246874510223,0.7184176383413026,-0.0045368403423564,-0.004266463978177,0.0096287268296957,0.0237353702170952,-0.0122981000677503,0.0286641033564343,-0.1374721201931079,0
2020-07-31,"10 Stocks To Watch For July 31, 2020",MRK,0.0158246874510223,0.7184176383413026,-0.0045368403423564,-0.004266463978177,0.0096287268296957,0.0237353702170952,-0.0122981000677503,0.0286641033564343,-0.1374721201931079,0
2020-07-31,A Peek Into The Markets: US Stock Futures Up Following Upbeat Results From Tech Giants,MRK,0.0158246874510223,0.7184176383413026,-0.0045368403423564,-0.004266463978177,0.0096287268296957,0.0237353702170952,-0.0122981000677503,0.0286641033564343,-0.1374721201931079,0
2020-08-24,Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week,MRK,0.0051777452121777,0.1003969961519455,-0.0005881392466964,0.0,0.0055583075341798,-0.0023596385862179,0.0153329896072609,0.0030437468238864,0.3513062034111112,2
2020-08-31,Pharmaceutical Companies Are Doing Much More Than Battling COVID-19,MRK,-0.0044364819643258,0.292665415616993,-0.0019810620411866,0.0032732272395465,-0.0016337866799701,0.0030437468238864,0.0051777452121777,-0.0098510833392545,-0.1427419638597384,1
2020-09-02,A Look Into Merck's Price Over Earnings,MRK,0.0296102469503605,0.7023480775757553,-0.0098510833392545,-0.0044364819643258,-0.0019810620411866,0.0032732272395465,-0.0016337866799701,-0.0165649760743992,0.1220293966338441,1
2020-09-04,The Dow Jones Index: The Story Of COVID-19 Winners,MRK,-0.0029243617589409,-0.279118572927597,-0.0165649760743992,0.0296102469503605,-0.0098510833392545,-0.0044364819643258,-0.0019810620411866,-0.0224072621593875,-0.0282163251595566,1
2020-09-04,Return On Capital Employed Overview: Merck & Co,MRK,-0.0029243617589409,-0.279118572927597,-0.0165649760743992,0.0296102469503605,-0.0098510833392545,-0.0044364819643258,-0.0019810620411866,-0.0224072621593875,-0.0282163251595566,1
2020-09-08,"As Political Pressure Mounts, COVID-19 Vaccine Developers Pledge To Put Safety First",MRK,-0.0224072621593875,-0.0282163251595566,-0.0029243617589409,-0.0165649760743992,0.0296102469503605,-0.0098510833392545,-0.0044364819643258,0.0186007032733213,-0.0256481381310859,0
2020-09-09,"The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment",MRK,0.0186007032733213,-0.0256481381310859,-0.0224072621593875,-0.0029243617589409,-0.0165649760743992,0.0296102469503605,-0.0098510833392545,-0.0154335958096627,-0.2205666086719857,1
2020-09-14,Checkpoint Therapeutics To Release Significant Drug Data At This Week's ESMO Congress,MRK,0.0034578398539535,0.1958848480335517,0.0108891526422032,-0.0154335958096627,0.0186007032733213,-0.0224072621593875,-0.0029243617589409,0.0005939506349568,0.2624400156996378,2
2020-09-18,"The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations",MRK,0.0019848776726902,0.5213539905975622,0.0008182756547219,0.0161500109618257,0.0005939506349568,0.0034578398539535,0.0108891526422032,-0.0312317580074097,-0.1513704492021169,1
2020-09-22,Vaccinex Plummets After Lead Drug Flunks Midstage Huntingon's Disease Study,MRK,-0.0022855832633075,-0.2203994691972312,-0.0312317580074097,0.0019848776726902,0.0008182756547219,0.0161500109618257,0.0005939506349568,-0.0037377293618545,-0.1298423095674044,2
2020-09-23,"The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma",MRK,-0.0037377293618545,-0.1298423095674044,-0.0022855832633075,-0.0312317580074097,0.0019848776726902,0.0008182756547219,0.0161500109618257,0.0062932925818539,0.1070356917357175,0
2020-09-24,"The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO",MRK,0.0062932925818539,0.1070356917357175,-0.0037377293618545,-0.0022855832633075,-0.0312317580074097,0.0019848776726902,0.0008182756547219,-0.0026460038692117,-0.1162858796473353,2
2020-09-29,"The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut",MRK,-0.0103917251314605,0.1010404864791953,-0.0020496356592855,-0.0026460038692117,0.0062932925818539,-0.0037377293618545,-0.0022855832633075,0.012820438090807,0.7195038334198751,0
2020-09-30,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,MRK,0.012820438090807,0.7195038334198751,-0.0103917251314605,-0.0020496356592855,-0.0026460038692117,0.0062932925818539,-0.0037377293618545,-0.0157925054556051,-0.2745737844268456,1
2020-10-08,"The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street",MRK,0.0054971975050279,-0.0637939647093931,0.005149011552848,-0.019817884741108,0.0054455996486835,-0.0102891196150954,-0.0157925054556051,-0.0014912450423948,-0.3538033407253427,2
2020-10-08,Moderna: Coronavirus Vaccine Patents Will Go Unenforced During Pandemic,MRK,0.0054971975050279,-0.0637939647093931,0.005149011552848,-0.019817884741108,0.0054455996486835,-0.0102891196150954,-0.0157925054556051,-0.0014912450423948,-0.3538033407253427,2
2020-10-14,Regeneron's Inmazeb Becomes First Ebola Treatment To Get FDA Approval,MRK,-0.0024783255402389,0.0044213236049894,0.0043556634804415,0.0,-0.0014912450423948,0.0054971975050279,0.005149011552848,-0.0180099944240635,-0.0015435098943696,1
2020-10-20,"The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger",MRK,-0.0050845211724673,0.2937261846512635,-0.0145308952227034,0.0097394538014357,-0.0180099944240635,-0.0024783255402389,0.0043556634804415,-0.0025552528233148,-0.1305492292063004,2
2020-10-26,"FAANGs In Focus: Amazon, Facebook, Apple, Alphabet, All Set To Report Later This Week",MRK,-0.0124013412297679,0.248100215326031,0.0078272581223282,0.0146023202502072,-0.0025552528233148,-0.0050845211724673,-0.0145308952227034,-0.0107813646178488,0.3418380679700619,1
2020-10-27,"Earnings Scheduled For October 27, 2020",MRK,-0.0107813646178488,0.3418380679700619,-0.0124013412297679,0.0078272581223282,0.0146023202502072,-0.0025552528233148,-0.0050845211724673,-0.0232079395951851,-0.2656090729684429,1
2020-10-27,"The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings",MRK,-0.0107813646178488,0.3418380679700619,-0.0124013412297679,0.0078272581223282,0.0146023202502072,-0.0025552528233148,-0.0050845211724673,-0.0232079395951851,-0.2656090729684429,1
2020-10-27,"7 Stocks To Watch For October 27, 2020",MRK,-0.0107813646178488,0.3418380679700619,-0.0124013412297679,0.0078272581223282,0.0146023202502072,-0.0025552528233148,-0.0050845211724673,-0.0232079395951851,-0.2656090729684429,1
2020-10-27,Recap: Merck & Co Q3 Earnings,MRK,-0.0107813646178488,0.3418380679700619,-0.0124013412297679,0.0078272581223282,0.0146023202502072,-0.0025552528233148,-0.0050845211724673,-0.0232079395951851,-0.2656090729684429,1
2020-10-29,"The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal",MRK,-0.0038068913027254,0.036079828662082,-0.0232079395951851,-0.0107813646178488,-0.0124013412297679,0.0078272581223282,0.0146023202502072,-0.0089605724518525,0.1913655439855448,1
2020-11-03,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,MRK,0.0027377937858326,-0.0554782870243908,0.0199441243685196,-0.0089605724518525,-0.0038068913027254,-0.0232079395951851,-0.0107813646178488,0.0481018383160671,0.9147686551042962,0
2020-11-04,"Rich Saperstein And Joe Terranova Share Their Recent Purchases: Visa, Adobe And More",MRK,0.0481018383160671,0.9147686551042962,0.0027377937858326,0.0199441243685196,-0.0089605724518525,-0.0038068913027254,-0.0232079395951851,-0.001984551227433,-0.3702434157408565,2
2020-11-05,"The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping",MRK,-0.001984551227433,-0.3702434157408565,0.0481018383160671,0.0027377937858326,0.0199441243685196,-0.0089605724518525,-0.0038068913027254,-0.0012429592700521,-0.2513358003106537,2
2020-11-10,"The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies",MRK,0.0075777237198957,-0.2315916797910165,0.0017422221876586,-0.0012429592700521,-0.001984551227433,0.0481018383160671,0.0027377937858326,-0.0006164991920554,-0.3318902190550196,2
2020-11-11,"The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap",MRK,-0.0006164991920554,-0.3318902190550196,0.0075777237198957,0.0017422221876586,-0.0012429592700521,-0.001984551227433,0.0481018383160671,-0.0148038230038766,0.3001075643740383,1
2020-11-16,Warren Buffett's Berkshire Bets On These Four Drugmakers Amid Pandemic,MRK,-0.0112219630214696,0.2351468104701122,0.0154017846710794,-0.0148038230038766,-0.0006164991920554,0.0075777237198957,0.0017422221876586,0.0164629078217026,0.0005954664578446,0
2020-11-17,"Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,0.0164629078217026,0.0005954664578446,-0.0112219630214696,0.0154017846710794,-0.0148038230038766,-0.0006164991920554,0.0075777237198957,-0.0153372374271151,-0.0873853588965472,1
2020-11-17,Not Good Enough? Impressive Earnings From Walmart And Home Depot Fail To Lift Market,MRK,0.0164629078217026,0.0005954664578446,-0.0112219630214696,0.0154017846710794,-0.0148038230038766,-0.0006164991920554,0.0075777237198957,-0.0153372374271151,-0.0873853588965472,1
2020-11-19,Has Warren Buffett Invested In Tesla? Here's Why People Are Speculating,MRK,0.0017442854021687,-0.1891024540415991,-0.0153372374271151,0.0164629078217026,-0.0112219630214696,0.0154017846710794,-0.0148038230038766,0.0007465114302949,0.1958659165481284,2
2020-11-20,"The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger",MRK,0.0007465114302949,0.1958659165481284,0.0017442854021687,-0.0153372374271151,0.0164629078217026,-0.0112219630214696,0.0154017846710794,-0.0021131423406249,0.1287048567870485,2
2020-11-23,FDA Approves Eiger Biopharma's Progeria Treatment: What Investors Should Know,MRK,-0.0021131423406249,0.1287048567870485,0.0007465114302949,0.0017442854021687,-0.0153372374271151,0.0164629078217026,-0.0112219630214696,-0.0017438500606817,0.3466100292381531,2
2020-11-23,Merck To Buy Late-Stage COVID-19 Treatment Company OncoImmune For $425M In Cash,MRK,-0.0021131423406249,0.1287048567870485,0.0007465114302949,0.0017442854021687,-0.0153372374271151,0.0164629078217026,-0.0112219630214696,-0.0017438500606817,0.3466100292381531,2
2020-12-02,Merck Cashes Out Direct Investment In Moderna After 600% Year-To-Date Stock Gain,MRK,0.0034335980872326,-0.2951581476614027,0.0144297830636055,0.006636460951231,-0.0024982301086436,-0.0009981646161474,-0.0017438500606817,-0.0046437861728455,-0.0112612609469556,2
2020-12-16,"The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal",MRK,-0.0080766456865132,-0.0594962964314058,0.0019923321694419,-0.0241769136678099,-0.000361666489738,-0.0057505795189898,0.0034866286076349,-0.0001254603494054,0.234240221154893,2
2020-12-23,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",MRK,0.0042812762612161,-0.330998560163068,0.0016394858129356,-0.0030177506847843,-0.003633088487725,-0.0001254603494054,-0.0080766456865132,0.0047642271700123,-0.5116549027274748,2
2020-12-23,"COVID News Flow: Pfizer-BioNTech's US Vaccine Supply Deal, Merck Strikes $356M Contract, Sorrento Files For EUA Of Rapid Test",MRK,0.0042812762612161,-0.330998560163068,0.0016394858129356,-0.0030177506847843,-0.003633088487725,-0.0001254603494054,-0.0080766456865132,0.0047642271700123,-0.5116549027274748,2
2020-12-23,Merck's Debt Overview,MRK,0.0042812762612161,-0.330998560163068,0.0016394858129356,-0.0030177506847843,-0.003633088487725,-0.0001254603494054,-0.0080766456865132,0.0047642271700123,-0.5116549027274748,2
2021-01-07,Moderna Has Big Plans For 2021,MRK,0.019907658054852,-0.0069824384520836,0.0157830247693269,0.0017292701388649,-0.0102689686298542,0.0150141379998296,-0.0101937809442921,-0.0117827236123805,-0.0846891121313875,1
2021-01-07,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",MRK,0.019907658054852,-0.0069824384520836,0.0157830247693269,0.0017292701388649,-0.0102689686298542,0.0150141379998296,-0.0101937809442921,-0.0117827236123805,-0.0846891121313875,1
2021-01-12,Moderna's Coronavirus Vaccine Secures Swiss Regulatory Approval,MRK,-0.0224706670107326,-0.2490753570218782,0.0237262128523045,-0.0117827236123805,0.019907658054852,0.0157830247693269,0.0017292701388649,-0.0090261494872057,-0.0034352209968478,1
2021-01-12,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",MRK,-0.0224706670107326,-0.2490753570218782,0.0237262128523045,-0.0117827236123805,0.019907658054852,0.0157830247693269,0.0017292701388649,-0.0090261494872057,-0.0034352209968478,1
2021-01-15,Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing,MRK,0.0147254407078407,-0.1023068169881082,-0.0020646724307922,-0.0090261494872057,-0.0224706670107326,0.0237262128523045,-0.0117827236123805,-0.0022788477606995,-0.1701588213813679,2
2021-01-20,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",MRK,-0.008774928255857,0.310675189162658,-0.0022788477606995,0.0147254407078407,-0.0020646724307922,-0.0090261494872057,-0.0224706670107326,-0.0155226137034873,-0.1850967133334492,1
2021-01-25,ROCE Insights For Merck & Co,MRK,0.0020992411466578,0.0551822701587361,-0.0024637667168826,-0.0155226137034873,-0.008774928255857,-0.0022788477606995,0.0147254407078407,-0.0110903607694167,-0.2218784561901334,1
2021-01-25,Merck Drops COVID-19 Vaccine Studies After Phase 1 Data Churn Out Inferior Efficacy Results,MRK,0.0020992411466578,0.0551822701587361,-0.0024637667168826,-0.0155226137034873,-0.008774928255857,-0.0022788477606995,0.0147254407078407,-0.0110903607694167,-0.2218784561901334,1
2021-01-26,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",MRK,-0.0110903607694167,-0.2218784561901334,0.0020992411466578,-0.0024637667168826,-0.0155226137034873,-0.008774928255857,-0.0022788477606995,-0.0396260953324479,1.0947061432836152,1
2021-02-01,A Preview Of The Busy Earnings Week Ahead,MRK,0.0037627225421763,-0.2292909036899321,-0.0109085117801891,0.0110288197907986,-0.0396260953324479,-0.0110903607694167,0.0020992411466578,0.0052997619404111,0.1996584879092586,0
2021-02-02,Upcoming Earnings Look To Cut Through The Market's Volatility,MRK,0.0052997619404111,0.1996584879092586,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0396260953324479,-0.0110903607694167,-0.0057862925305622,0.0170370873371163,1
2021-02-02,"FAANGs' Final Fling: Amazon, Alphabet Wrap Up Earnings Season For ""Mega-Caps"" Later Today",MRK,0.0052997619404111,0.1996584879092586,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0396260953324479,-0.0110903607694167,-0.0057862925305622,0.0170370873371163,1
2021-02-03,"Pfizer Is Ready, Even For Covid-19 Variants",MRK,-0.0057862925305622,0.0170370873371163,0.0052997619404111,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0396260953324479,-0.0166839321798908,0.8802112845185908,1
2021-02-04,"The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs",MRK,-0.0166839321798908,0.8802112845185908,-0.0057862925305622,0.0052997619404111,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0030249402963368,-0.2631891569674366,2
2021-02-04,Recap: Merck & Co Q4 Earnings,MRK,-0.0166839321798908,0.8802112845185908,-0.0057862925305622,0.0052997619404111,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0030249402963368,-0.2631891569674366,2
2021-02-04,Citius Pharmaceuticals Says It Is Addressing Several Unmet Needs In The Medical Field,MRK,-0.0166839321798908,0.8802112845185908,-0.0057862925305622,0.0052997619404111,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0030249402963368,-0.2631891569674366,2
2021-02-04,Merck Posts Mixed Q4 Earnings; Kenneth Frazier To Step Down As CEO,MRK,-0.0166839321798908,0.8802112845185908,-0.0057862925305622,0.0052997619404111,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0030249402963368,-0.2631891569674366,2
2021-02-04,"Earnings Scheduled For February 4, 2021",MRK,-0.0166839321798908,0.8802112845185908,-0.0057862925305622,0.0052997619404111,0.0037627225421763,-0.0109085117801891,0.0110288197907986,-0.0030249402963368,-0.2631891569674366,2
2021-02-10,FDA Casts Doubt On Merck's Keytruda Trial Data In Early-Stage Breast Cancer,MRK,-0.0019988188641126,-0.130745287815389,0.0,-0.0100264738355295,-0.0030249402963368,-0.0166839321798908,-0.0057862925305622,-0.0020031671199091,-0.2508695510480425,2
2021-02-11,Merck In Talks To Possibly Produce COVID-19 Shots: WSJ,MRK,-0.0020031671199091,-0.2508695510480425,-0.0019988188641126,0.0,-0.0100264738355295,-0.0030249402963368,-0.0166839321798908,0.0034788183493841,-0.232646644760233,2
2021-02-11,"The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts",MRK,-0.0020031671199091,-0.2508695510480425,-0.0019988188641126,0.0,-0.0100264738355295,-0.0030249402963368,-0.0166839321798908,0.0034788183493841,-0.232646644760233,2
2021-02-16,"Warren Buffett's Berkshire Cuts Apple Stake And Buys These Drugmaker, Telecom Stocks Instead",MRK,-0.010000113675495,0.4446846863425919,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0100264738355295,0.0173737605704535,0.4255000255278853,0
2021-02-16,Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study,MRK,-0.010000113675495,0.4446846863425919,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0100264738355295,0.0173737605704535,0.4255000255278853,0
2021-02-17,AstraZeneca/Merck's PARP Inhibitor In Late-Stage Breast Cancer Study To Enter Early Analysis,MRK,0.0173737605704535,0.4255000255278853,-0.010000113675495,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0017207601030814,-0.2790218227800557,2
2021-02-17,Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer,MRK,0.0173737605704535,0.4255000255278853,-0.010000113675495,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0017207601030814,-0.2790218227800557,2
2021-02-17,Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT,MRK,0.0173737605704535,0.4255000255278853,-0.010000113675495,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0017207601030814,-0.2790218227800557,2
2021-02-17,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",MRK,0.0173737605704535,0.4255000255278853,-0.010000113675495,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0017207601030814,-0.2790218227800557,2
2021-02-17,"Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,0.0173737605704535,0.4255000255278853,-0.010000113675495,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,0.0,-0.0017207601030814,-0.2790218227800557,2
2021-02-18,Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters,MRK,-0.0017207601030814,-0.2790218227800557,0.0173737605704535,-0.010000113675495,0.0034788183493841,-0.0020031671199091,-0.0019988188641126,-0.0145870360119914,0.2382468631764083,1
2021-02-22,Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback,MRK,0.0083434949480105,-0.3047847636920237,-0.0145870360119914,-0.0017207601030814,0.0173737605704535,-0.010000113675495,0.0034788183493841,-0.0052049949470587,0.2656607911510573,1
2021-02-22,Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment,MRK,0.0083434949480105,-0.3047847636920237,-0.0145870360119914,-0.0017207601030814,0.0173737605704535,-0.010000113675495,0.0034788183493841,-0.0052049949470587,0.2656607911510573,1
2021-02-23,Veru Files US Application For TADFIN Combo For Prostate Enlargement,MRK,-0.0052049949470587,0.2656607911510573,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,0.0173737605704535,-0.010000113675495,0.0004023991445984,-0.0973926049712773,2
2021-02-23,FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants,MRK,-0.0052049949470587,0.2656607911510573,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,0.0173737605704535,-0.010000113675495,0.0004023991445984,-0.0973926049712773,2
2021-02-25,Why Pandion Therapeutics Stock Shot Up 133% Today,MRK,0.0006707419320417,0.1085617462394425,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,-0.0268025762861464,0.6177624277353304,1
2021-02-25,Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain,MRK,0.0006707419320417,0.1085617462394425,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,-0.0268025762861464,0.6177624277353304,1
2021-02-25,"The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants",MRK,0.0006707419320417,0.1085617462394425,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,-0.0268025762861464,0.6177624277353304,1
2021-02-25,Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses,MRK,0.0006707419320417,0.1085617462394425,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,-0.0268025762861464,0.6177624277353304,1
2021-02-25,Why Merck Is Buying Autoimmune Disease Drug Company Pandion For $1.85B,MRK,0.0006707419320417,0.1085617462394425,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0017207601030814,-0.0268025762861464,0.6177624277353304,1
2021-02-26,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",MRK,-0.0268025762861464,0.6177624277353304,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0033047795855032,-0.2862021816889245,2
2021-02-26,"FDA Requires Additional Data On Merck COVID-19 Drug, EUA Moved Back",MRK,-0.0268025762861464,0.6177624277353304,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0033047795855032,-0.2862021816889245,2
2021-02-26,Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg,MRK,-0.0268025762861464,0.6177624277353304,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.0083434949480105,-0.0145870360119914,-0.0033047795855032,-0.2862021816889245,2
2021-03-01,Merck's Cough Drug Gefapixant Application Accepted For US Review,MRK,-0.0033047795855032,-0.2862021816889245,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.0083434949480105,0.0064934578198301,0.2741137974971386,0
2021-03-02,"Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report",MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,"People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC",MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC,MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,What's Moving The Market Tuesday? After The Close Update,MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,What's Moving The Market Tuesday?,MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,"AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly",MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May,MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-02,"The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data",MRK,0.0064934578198301,0.2741137974971386,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.0052049949470587,0.006177193666222,-0.1313192445578038,0
2021-03-03,"Medically Necessary: Stimulus Bill Has Billions For Vaccine Distribution, Executive Orders Signal Supply Chain Focus And Merck Helps J&J Produce Vaccine",MRK,0.006177193666222,-0.1313192445578038,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.01541631782892,0.1459985715896703,1
2021-03-03,"The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study",MRK,0.006177193666222,-0.1313192445578038,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.01541631782892,0.1459985715896703,1
2021-03-03,EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters,MRK,0.006177193666222,-0.1313192445578038,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.01541631782892,0.1459985715896703,1
2021-03-03,Direction Hard To Find As Market Keeps Chopping Ahead Of Key Jobs Data,MRK,0.006177193666222,-0.1313192445578038,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0004023991445984,-0.01541631782892,0.1459985715896703,1
2021-03-04,"Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says",MRK,-0.01541631782892,0.1459985715896703,0.006177193666222,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0133020809735309,-0.2337389707088267,0
2021-03-04,Novartis Lends Support To Manufacture CureVac's COVID-19 Shots,MRK,-0.01541631782892,0.1459985715896703,0.006177193666222,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0006707419320417,0.0133020809735309,-0.2337389707088267,0
2021-03-05,"WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg",MRK,0.0133020809735309,-0.2337389707088267,-0.01541631782892,0.006177193666222,0.0064934578198301,-0.0033047795855032,-0.0268025762861464,0.0142210355167309,0.2573434193022821,0
2021-03-08,Merck/Ridgeback Biotherapeutics' COVID-19 Antiviral Shows Promise,MRK,0.0142210355167309,0.2573434193022821,0.0133020809735309,-0.01541631782892,0.006177193666222,0.0064934578198301,-0.0033047795855032,-0.0004042904482027,-0.0780586000692467,2
2021-03-09,"Why AnPac Bio-Medical, Surface Oncology, CorMedix Are Rallying Today",MRK,-0.0004042904482027,-0.0780586000692467,0.0142210355167309,0.0133020809735309,-0.01541631782892,0.006177193666222,0.0064934578198301,0.0083625096960926,-0.0960266160767643,0
2021-03-09,New York Times Credits Report On Emergent BioSolutions For Biden's Canceled Vaccine Plant Visit,MRK,-0.0004042904482027,-0.0780586000692467,0.0142210355167309,0.0133020809735309,-0.01541631782892,0.006177193666222,0.0064934578198301,0.0083625096960926,-0.0960266160767643,0
2021-03-09,Surface Oncology To Test SRF388 Plus Keytruda Combo In Solid Tumor Settings,MRK,-0.0004042904482027,-0.0780586000692467,0.0142210355167309,0.0133020809735309,-0.01541631782892,0.006177193666222,0.0064934578198301,0.0083625096960926,-0.0960266160767643,0
2021-03-10,Johnson And Johnson's Vaccine Could Be A Game Changer,MRK,0.0083625096960926,-0.0960266160767643,-0.0004042904482027,0.0142210355167309,0.0133020809735309,-0.01541631782892,0.006177193666222,-0.001738828530657,0.0294694678775206,2
2021-03-10,Biden Administration Poised To Buy Additional 100M Doses Of J&J's COVID-19 Vaccine: CNBC,MRK,0.0083625096960926,-0.0960266160767643,-0.0004042904482027,0.0142210355167309,0.0133020809735309,-0.01541631782892,0.006177193666222,-0.001738828530657,0.0294694678775206,2
2021-03-10,"Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg",MRK,0.0083625096960926,-0.0960266160767643,-0.0004042904482027,0.0142210355167309,0.0133020809735309,-0.01541631782892,0.006177193666222,-0.001738828530657,0.0294694678775206,2
2021-03-12,Inhibrx's INBRX-105 Shows Dose-Limiting Toxicities In Early-Stage Solid Tumors Study,MRK,0.0083806473478016,-0.1295980318241339,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0142210355167309,0.0133020809735309,0.0218499074915798,0.5659812910107413,0
2021-03-15,"Germany, France Join List Of Countries Suspending AZN's COVID-19 Vaccine; WHO Urges Not To Halt Vaccinations",MRK,0.0218499074915798,0.5659812910107413,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0142210355167309,0.007608400955787,-0.1278610078894756,0
2021-03-15,IDT Biologika To Make J&J's COVID-19 Vaccine Using Takeda's Manufacturing Capacity,MRK,0.0218499074915798,0.5659812910107413,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0142210355167309,0.007608400955787,-0.1278610078894756,0
2021-03-15,"Gilead, Merck Team Up To Develop Long-Acting HIV Infection Treatments",MRK,0.0218499074915798,0.5659812910107413,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0142210355167309,0.007608400955787,-0.1278610078894756,0
2021-03-16,Merck's Belzutifan Wins Priority Review Status In Type Of Kidney Cancer,MRK,0.007608400955787,-0.1278610078894756,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0063792971036649,0.1169578427975688,0
2021-03-16,Immutep's Lead Candidate To Be Tested In Combination With Keytruda In Second Head & Neck Cancer Study,MRK,0.007608400955787,-0.1278610078894756,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0063792971036649,0.1169578427975688,0
2021-03-16,Merck & Co's Debt Overview,MRK,0.007608400955787,-0.1278610078894756,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0004042904482027,0.0063792971036649,0.1169578427975688,0
2021-03-17,"Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters",MRK,0.0063792971036649,0.1169578427975688,0.007608400955787,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0003878545426193,-0.1859086164509642,2
2021-03-17,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",MRK,0.0063792971036649,0.1169578427975688,0.007608400955787,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0003878545426193,-0.1859086164509642,2
2021-03-17,"Amathus Therapeutics, Merck In Agreement For Neurodegenerative Disease-Targeted Therapies",MRK,0.0063792971036649,0.1169578427975688,0.007608400955787,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0083625096960926,-0.0003878545426193,-0.1859086164509642,2
2021-03-18,"The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq",MRK,-0.0003878545426193,-0.1859086164509642,0.0063792971036649,0.007608400955787,0.0218499074915798,0.0083806473478016,-0.001738828530657,0.0031058079337527,3.079057926904237,2
2021-03-19,"The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs",MRK,0.0031058079337527,3.079057926904237,-0.0003878545426193,0.0063792971036649,0.007608400955787,0.0218499074915798,0.0083806473478016,0.0,-0.8050177858546925,2
2021-03-19,Merck' Keytruda Plus Eisai's Lenvima Cuts Risk Of Death By 38% In Endometrial Cancer Trial Compared To Chemo,MRK,0.0031058079337527,3.079057926904237,-0.0003878545426193,0.0063792971036649,0.007608400955787,0.0218499074915798,0.0083806473478016,0.0,-0.8050177858546925,2
2021-03-22,AstraZeneca's COVID-19 Shot Shows 79% Efficacy In US Trials,MRK,0.0,-0.8050177858546925,0.0031058079337527,-0.0003878545426193,0.0063792971036649,0.007608400955787,0.0218499074915798,-0.0159978351328552,0.026281086938388,1
2021-03-22,"Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research",MRK,0.0,-0.8050177858546925,0.0031058079337527,-0.0003878545426193,0.0063792971036649,0.007608400955787,0.0218499074915798,-0.0159978351328552,0.026281086938388,1
2021-03-23,9 Health Care Stocks Showing Unusual Options Activity In Today's Session,MRK,-0.0159978351328552,0.026281086938388,0.0,0.0031058079337527,-0.0003878545426193,0.0063792971036649,0.007608400955787,-0.0003934281052949,-0.2159279115665321,2
2021-03-23,Pfizer Starts Early-Stage Study Of Oral Antiviral COVID-19 Drug,MRK,-0.0159978351328552,0.026281086938388,0.0,0.0031058079337527,-0.0003878545426193,0.0063792971036649,0.007608400955787,-0.0003934281052949,-0.2159279115665321,2
2021-03-23,Merck's Keytruda Wins FDA Approval In Esophageal Cancer Settings,MRK,-0.0159978351328552,0.026281086938388,0.0,0.0031058079337527,-0.0003878545426193,0.0063792971036649,0.007608400955787,-0.0003934281052949,-0.2159279115665321,2
2021-03-23,"The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO",MRK,-0.0159978351328552,0.026281086938388,0.0,0.0031058079337527,-0.0003878545426193,0.0063792971036649,0.007608400955787,-0.0003934281052949,-0.2159279115665321,2
2021-03-29,White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments,MRK,0.0117585545616147,0.1019074826220838,0.0173524216517821,-0.002229706207962,-0.0003934281052949,-0.0159978351328552,0.0,-0.0171137807097668,-0.1157521791819793,1
2021-03-30,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",MRK,-0.0171137807097668,-0.1157521791819793,0.0117585545616147,0.0173524216517821,-0.002229706207962,-0.0003934281052949,-0.0159978351328552,0.0016893853687691,0.3432507527634583,2
2021-03-30,Merck Lines Up $240M Alydia Health Buyout To Beef Up Women's Health Spin-Off,MRK,-0.0171137807097668,-0.1157521791819793,0.0117585545616147,0.0173524216517821,-0.002229706207962,-0.0003934281052949,-0.0159978351328552,0.0016893853687691,0.3432507527634583,2
2021-03-30,FDA Rejects Merck's Keytruda Application In High-Risk Breast Cancer Patients,MRK,-0.0171137807097668,-0.1157521791819793,0.0117585545616147,0.0173524216517821,-0.002229706207962,-0.0003934281052949,-0.0159978351328552,0.0016893853687691,0.3432507527634583,2
2021-03-30,What Does Merck & Co's Debt Look Like?,MRK,-0.0171137807097668,-0.1157521791819793,0.0117585545616147,0.0173524216517821,-0.002229706207962,-0.0003934281052949,-0.0159978351328552,0.0016893853687691,0.3432507527634583,2
2021-03-31,EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report,MRK,0.0016893853687691,0.3432507527634583,-0.0171137807097668,0.0117585545616147,0.0173524216517821,-0.002229706207962,-0.0003934281052949,0.0,-0.3292229666252617,2
2021-03-31,Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents,MRK,0.0016893853687691,0.3432507527634583,-0.0171137807097668,0.0117585545616147,0.0173524216517821,-0.002229706207962,-0.0003934281052949,0.0,-0.3292229666252617,2
2021-04-06,Is Silicon Valley Replacing Big Pharma In Neuroscience?,MRK,-0.0157143156484272,0.3628919152995724,-0.0011673975174586,0.0,0.0016893853687691,-0.0171137807097668,0.0117585545616147,0.0043541038972361,-0.3302897907813972,2
2021-04-07,IMV's Lead Candidate To Be Evaluated With Keytruda In Pretreated B-Cell Lymphoma Patients,MRK,0.0043541038972361,-0.3302897907813972,-0.0157143156484272,-0.0011673975174586,0.0,0.0016893853687691,-0.0171137807097668,-0.0082764766449355,0.3385982556730533,1
2021-04-07,Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots,MRK,0.0043541038972361,-0.3302897907813972,-0.0157143156484272,-0.0011673975174586,0.0,0.0016893853687691,-0.0171137807097668,-0.0082764766449355,0.3385982556730533,1
2021-04-08,"Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC",MRK,-0.0082764766449355,0.3385982556730533,0.0043541038972361,-0.0157143156484272,-0.0011673975174586,0.0,0.0016893853687691,0.0108622515780425,-0.3189998421050527,0
2021-04-08,"The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data",MRK,-0.0082764766449355,0.3385982556730533,0.0043541038972361,-0.0157143156484272,-0.0011673975174586,0.0,0.0016893853687691,0.0108622515780425,-0.3189998421050527,0
2021-04-08,Merck's Keytruda Shows Better Disease-Free Survival As Adjuvant Therapy In Kidney Cancer,MRK,-0.0082764766449355,0.3385982556730533,0.0043541038972361,-0.0157143156484272,-0.0011673975174586,0.0,0.0016893853687691,0.0108622515780425,-0.3189998421050527,0
2021-04-12,"South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Reports",MRK,-0.0011793302406585,0.2192902936970853,0.0108622515780425,-0.0082764766449355,0.0043541038972361,-0.0157143156484272,-0.0011673975174586,0.0027552436430593,-0.1347277294850337,2
2021-04-14,"UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots",MRK,-0.0003922694328065,-0.0245499600920143,0.0027552436430593,-0.0011793302406585,0.0108622515780425,-0.0082764766449355,0.0043541038972361,0.0034028648246755,0.727961053027463,2
2021-04-14,Galectin Therapeutics Stock Is Trading Higher After Belapectin-Pembrolizumab Combo Study Shows Enhanced Tumor Response,MRK,-0.0003922694328065,-0.0245499600920143,0.0027552436430593,-0.0011793302406585,0.0108622515780425,-0.0082764766449355,0.0043541038972361,0.0034028648246755,0.727961053027463,2
2021-04-14,"The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead",MRK,-0.0003922694328065,-0.0245499600920143,0.0027552436430593,-0.0011793302406585,0.0108622515780425,-0.0082764766449355,0.0043541038972361,0.0034028648246755,0.727961053027463,2
2021-04-15,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",MRK,0.0034028648246755,0.727961053027463,-0.0003922694328065,0.0027552436430593,-0.0011793302406585,0.0108622515780425,-0.0082764766449355,0.0105660685801693,-0.1395244886201329,0
2021-04-15,Merck & Co: Debt Overview,MRK,0.0034028648246755,0.727961053027463,-0.0003922694328065,0.0027552436430593,-0.0011793302406585,0.0108622515780425,-0.0082764766449355,0.0105660685801693,-0.1395244886201329,0
2021-04-20,Novel Approach to Cancer From Lixte Biotechnology Could Be a General way to Enhance a Variety of Standard Treatments,MRK,0.0117178933580357,0.2896181437226122,0.002452711365636,0.0105660685801693,0.0034028648246755,-0.0003922694328065,0.0027552436430593,0.0083998717039386,0.0733833847517722,0
2021-04-22,"American, Southwest, Alaska Report Today With Focus On Summer Travel Demand",MRK,-0.0160291614436427,0.1280595956012771,0.0083998717039386,0.0117178933580357,0.002452711365636,0.0105660685801693,0.0034028648246755,-0.0010261430501009,-0.3549528301886793,2
2021-04-23,"The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs",MRK,-0.0010261430501009,-0.3549528301886793,-0.0160291614436427,0.0083998717039386,0.0117178933580357,0.002452711365636,0.0105660685801693,-0.0044940832306976,-0.0889214126556605,2
2021-04-27,"Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, Production",MRK,-0.002192606490833,0.1610349417089309,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0083998717039386,0.0117178933580357,-0.0034902999038178,0.2784357003373645,2
2021-04-28,Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran,MRK,-0.0034902999038178,0.2784357003373645,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0083998717039386,-0.0442342001848656,1.631725625490287,1
2021-04-29,Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales,MRK,-0.0442342001848656,1.631725625490287,-0.0034902999038178,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0111293234662972,-0.4101147043862361,0
2021-04-29,"Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer",MRK,-0.0442342001848656,1.631725625490287,-0.0034902999038178,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0111293234662972,-0.4101147043862361,0
2021-04-29,Merck & Co: Q1 Earnings Insights,MRK,-0.0442342001848656,1.631725625490287,-0.0034902999038178,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0111293234662972,-0.4101147043862361,0
2021-04-29,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",MRK,-0.0442342001848656,1.631725625490287,-0.0034902999038178,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0111293234662972,-0.4101147043862361,0
2021-04-29,Merck Earnings Fall Short of Expectations As Sales Weakened By Widespread Infections,MRK,-0.0442342001848656,1.631725625490287,-0.0034902999038178,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,-0.0160291614436427,0.0111293234662972,-0.4101147043862361,0
2021-04-30,Intel And Apple Lead The Dow Jones Lower To Close The Week,MRK,0.0111293234662972,-0.4101147043862361,-0.0442342001848656,-0.0034902999038178,-0.002192606490833,-0.0044940832306976,-0.0010261430501009,0.0198660494062701,-0.3051616004640786,0
2021-05-04,"Sharing A Ride To The Reopening: Uber, Lyft Earnings Could Offer Hints To Life Beyond The Pandemic",MRK,0.0001313436068977,-0.1693904045362217,0.0198660494062701,0.0111293234662972,-0.0442342001848656,-0.0034902999038178,-0.002192606490833,0.0225028669364042,0.6120365458387016,0
2021-05-05,"Lyft, GM Earnings Impress, Lifting Shares Ahead Of Uber's Report Slated For Later",MRK,0.0225028669364042,0.6120365458387016,0.0001313436068977,0.0198660494062701,0.0111293234662972,-0.0442342001848656,-0.0034902999038178,0.001029796643454,-0.2336093238384454,2
2021-05-06,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom",MRK,0.001029796643454,-0.2336093238384454,0.0225028669364042,0.0001313436068977,0.0198660494062701,0.0111293234662972,-0.0442342001848656,0.0080996183805153,-0.0492668339646825,0
2021-05-06,Fusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer Study,MRK,0.001029796643454,-0.2336093238384454,0.0225028669364042,0.0001313436068977,0.0198660494062701,0.0111293234662972,-0.0442342001848656,0.0080996183805153,-0.0492668339646825,0
2021-05-07,"The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs",MRK,0.0080996183805153,-0.0492668339646825,0.001029796643454,0.0225028669364042,0.0001313436068977,0.0198660494062701,0.0111293234662972,-0.0030606533480196,-0.1060460407913513,2
2021-05-10,FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic,MRK,-0.0030606533480196,-0.1060460407913513,0.0080996183805153,0.001029796643454,0.0225028669364042,0.0001313436068977,0.0198660494062701,-0.0090827036138499,0.1104543628844441,1
2021-05-11,Cannabis Industry Salary Report: Increased Demand For Top Talent As Salaries Continue To Surge,MRK,-0.0090827036138499,0.1104543628844441,-0.0030606533480196,0.0080996183805153,0.001029796643454,0.0225028669364042,0.0001313436068977,0.0069713675346489,0.1013828333018607,0
2021-05-13,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use",MRK,0.008846066878831,-0.1905317685860329,0.0069713675346489,-0.0090827036138499,-0.0030606533480196,0.0080996183805153,0.001029796643454,-0.005083334707491,-0.2361239619661268,1
2021-05-18,"Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,-0.0061348919494587,-0.36619980613617,0.0201813102318841,-0.005083334707491,0.008846066878831,0.0069713675346489,-0.0090827036138499,-0.0002520811210813,0.1497764224725188,2
2021-05-20,Immutep Stock Gains on Encouraging Data from Early-Stage Solid Cancer Studies,MRK,0.0037804491058222,-0.1957312963083813,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.005083334707491,0.008846066878831,-0.0060255734566561,0.4790549557249597,1
2021-05-20,Merck's Next-Gen Pneumococcal Conjugate Vaccine Shows Efficacy In Pediatric Trials,MRK,0.0037804491058222,-0.1957312963083813,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.005083334707491,0.008846066878831,-0.0060255734566561,0.4790549557249597,1
2021-05-20,Iovance Shares Jump After Lifileucel Achieves 86% Response Rate In Melanoma Trial,MRK,0.0037804491058222,-0.1957312963083813,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.005083334707491,0.008846066878831,-0.0060255734566561,0.4790549557249597,1
2021-05-20,Oncolytics Pelareorep/Pembrolizumab Combo Therapy Shows Anti-Cancer Activity In Pancreatic Cancer,MRK,0.0037804491058222,-0.1957312963083813,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.005083334707491,0.008846066878831,-0.0060255734566561,0.4790549557249597,1
2021-05-24,Merck's Keytruda/Chemo Combo Therapy Wins EU Backing For Esophageal Cancer,MRK,-0.001894521144471,-0.1956995162089203,-0.0060255734566561,0.0037804491058222,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.0193598877462235,0.6401764266283356,1
2021-05-24,NGM Biopharma to Release Mid-Stage NASH Data Monday: What to Expect?,MRK,-0.001894521144471,-0.1956995162089203,-0.0060255734566561,0.0037804491058222,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.0193598877462235,0.6401764266283356,1
2021-05-24,NGM Stock Tumbles After Aldafermin Flunks In Mid-Stage NASH Study,MRK,-0.001894521144471,-0.1956995162089203,-0.0060255734566561,0.0037804491058222,-0.0002520811210813,-0.0061348919494587,0.0201813102318841,-0.0193598877462235,0.6401764266283356,1
2021-05-27,EXCLUSIVE: eFFECTOR Therapeutics Announces SPAC Deal To Advance Cancer-Fighting Pipeline,MRK,-0.016962239002726,0.8247285332692438,-0.0034837755548381,-0.0193598877462235,-0.001894521144471,-0.0060255734566561,0.0037804491058222,-0.0003951294060049,-0.2096397603211153,2
2021-06-02,BriaCell Stock Doubles After Reporting Overall Survival Benefit in Pretreated Breast Cancer Patients,MRK,0.0091777705483555,-0.2511856827627519,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.0034837755548381,-0.0193598877462235,0.0209265220654339,0.3502779648420902,0
2021-06-03,Merck Completes Women's Health Organon Spinoff,MRK,0.0209265220654339,0.3502779648420902,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.0034837755548381,0.0027059277473646,-0.203193860176282,2
2021-06-03,"The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout",MRK,0.0209265220654339,0.3502779648420902,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.0034837755548381,0.0027059277473646,-0.203193860176282,2
2021-06-04,"AstraZeneca, Merck Lynparza Earns Win in Early Breast Cancer, Showing Potential in Post-Surgery Setting",MRK,0.0027059277473646,-0.203193860176282,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.017676370485048,0.319432768982991,1
2021-06-04,Merck's Keytruda Shows Clinical Benefit in Post-Surgery Kidney Cancer Setting,MRK,0.0027059277473646,-0.203193860176282,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.017676370485048,0.319432768982991,1
2021-06-04,"The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact",MRK,0.0027059277473646,-0.203193860176282,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.017676370485048,0.319432768982991,1
2021-06-04,Immutep Highlights Encouraging Data from Lead Oncology Candidate at ASCO 2021,MRK,0.0027059277473646,-0.203193860176282,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.016962239002726,-0.017676370485048,0.319432768982991,1
2021-06-07,Iovance's Lifileucel Shows Meaningful Increase in Response Time with Primary Anti-PD-1 Resistance in Melanoma Trial,MRK,-0.017676370485048,0.319432768982991,0.0027059277473646,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.0054943714693705,-0.1867705901967322,1
2021-06-07,Merck/Eisai's Keytruda-Lenvima Combo Results in Better Health-Related Quality of Life Measures Compared to Sunitinib,MRK,-0.017676370485048,0.319432768982991,0.0027059277473646,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.0054943714693705,-0.1867705901967322,1
2021-06-07,"The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck",MRK,-0.017676370485048,0.319432768982991,0.0027059277473646,0.0209265220654339,0.0091777705483555,-0.0093556923544184,-0.0003951294060049,-0.0054943714693705,-0.1867705901967322,1
2021-06-08,"5 Biogen Analysts On FDA Approval Of Alzheimer's Drug Aduhelm, Broad Label, Pricing",MRK,-0.0054943714693705,-0.1867705901967322,-0.017676370485048,0.0027059277473646,0.0209265220654339,0.0091777705483555,-0.0093556923544184,0.0226517831486394,-0.1024330597391947,0
2021-06-08,"Vaccinex Initiates Pepinemab Trials for Alzheimer's, Head & Neck Cancer",MRK,-0.0054943714693705,-0.1867705901967322,-0.017676370485048,0.0027059277473646,0.0209265220654339,0.0091777705483555,-0.0093556923544184,0.0226517831486394,-0.1024330597391947,0
2021-06-09,Merck Inks Molnupiravir Supply Pact With US Government For COVID-19,MRK,0.0226517831486394,-0.1024330597391947,-0.0054943714693705,-0.017676370485048,0.0027059277473646,0.0209265220654339,0.0091777705483555,0.0283630156186807,0.406078948012432,0
2021-06-09,"The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US",MRK,0.0226517831486394,-0.1024330597391947,-0.0054943714693705,-0.017676370485048,0.0027059277473646,0.0209265220654339,0.0091777705483555,0.0283630156186807,0.406078948012432,0
2021-06-15,Fusion Pharma's Stock Moves Higher As Radiopharmaceutical Candidate Shows Early Promising Action In Solid Tumor Study,MRK,0.0033135008541456,0.8090774606575357,-0.0022482856701613,0.0017074679469966,0.0283630156186807,0.0226517831486394,-0.0054943714693705,0.0120211824597318,0.2390576425555313,0
2021-06-17,Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC,MRK,0.0080930131451373,-0.1902326348787328,0.0120211824597318,0.0033135008541456,-0.0022482856701613,0.0017074679469966,0.0283630156186807,-0.0080280420949333,0.3596310035691201,1
2021-06-23,14 Biotech Stocks To Watch Over The Next 6 Months,MRK,-0.008006394090978,-0.1294455852156057,-0.0072963958510995,0.0018274851874602,-0.0080280420949333,0.0080930131451373,0.0120211824597318,0.0103202759510929,-0.0982482624146932,0
2021-06-24,"The Daily Biotech Pulse: Lily Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO",MRK,0.0103202759510929,-0.0982482624146932,-0.008006394090978,-0.0072963958510995,0.0018274851874602,-0.0080280420949333,0.0080930131451373,0.0110004919215815,4.845824759646125,0
2021-06-29,Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested,MRK,0.0045534839973944,-0.1250085264091311,-0.0044040203515809,0.0110004919215815,0.0103202759510929,-0.008006394090978,-0.0072963958510995,0.0072529265942697,0.7945456435309097,0
2021-06-29,Price Over Earnings Overview: Merck & Co,MRK,0.0045534839973944,-0.1250085264091311,-0.0044040203515809,0.0110004919215815,0.0103202759510929,-0.008006394090978,-0.0072963958510995,0.0072529265942697,0.7945456435309097,0
2021-06-29,Merck's Keytruda-Chemo Combo Wins European Approval In Esophagus Cancer,MRK,0.0045534839973944,-0.1250085264091311,-0.0044040203515809,0.0110004919215815,0.0103202759510929,-0.008006394090978,-0.0072963958510995,0.0072529265942697,0.7945456435309097,0
2021-06-30,Sellas Life Sciences Reports Encouraging Immune Response From GPS Combo Trial In Ovarian Cancer,MRK,0.0072529265942697,0.7945456435309097,0.0045534839973944,-0.0044040203515809,0.0110004919215815,0.0103202759510929,-0.008006394090978,0.0028289578694948,-0.3330389012373388,2
2021-06-30,Alpine Immune Sciences Initiates Trial Collaboration With Merck,MRK,0.0072529265942697,0.7945456435309097,0.0045534839973944,-0.0044040203515809,0.0110004919215815,0.0103202759510929,-0.008006394090978,0.0028289578694948,-0.3330389012373388,2
2021-07-01,Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates,MRK,0.0028289578694948,-0.3330389012373388,0.0072529265942697,0.0045534839973944,-0.0044040203515809,0.0110004919215815,0.0103202759510929,0.0078216081010857,-0.1676074685193226,0
2021-07-01,"NGM Biopharma, Merck Amend Development Pact To Focus On Retinal, Cardiovascular & Metabolic Targets",MRK,0.0028289578694948,-0.3330389012373388,0.0072529265942697,0.0045534839973944,-0.0044040203515809,0.0110004919215815,0.0103202759510929,0.0078216081010857,-0.1676074685193226,0
2021-07-02,"The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures",MRK,0.0078216081010857,-0.1676074685193226,0.0028289578694948,0.0072529265942697,0.0045534839973944,-0.0044040203515809,0.0110004919215815,-0.0062341041697835,-0.1235654668753259,1
2021-07-02,Merck To Withdraw Keytruda Accelerated Approval In Third-Line Gastric Cancer Setting,MRK,0.0078216081010857,-0.1676074685193226,0.0028289578694948,0.0072529265942697,0.0045534839973944,-0.0044040203515809,0.0110004919215815,-0.0062341041697835,-0.1235654668753259,1
2021-07-06,Immutep Shares Are Trading Higher On Green Signal To Start Efti Combo Trial In First-Line Head & Neck Cancer,MRK,-0.0062341041697835,-0.1235654668753259,0.0078216081010857,0.0028289578694948,0.0072529265942697,0.0045534839973944,-0.0044040203515809,0.0057609822569355,0.2313220742504278,0
2021-07-07,OncoSec Stock Jumps On Anti-Cancer Gene Therapy Trial Collaboration With Merck In Melanoma,MRK,0.0057609822569355,0.2313220742504278,-0.0062341041697835,0.0078216081010857,0.0028289578694948,0.0072529265942697,0.0045534839973944,-0.005600710916796,0.015141810975094,1
2021-07-07,"The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend",MRK,0.0057609822569355,0.2313220742504278,-0.0062341041697835,0.0078216081010857,0.0028289578694948,0.0072529265942697,0.0045534839973944,-0.005600710916796,0.015141810975094,1
2021-07-09,"Galectin Therapeutics Stock Surges After Robust Data From Belapectin/Keytruda Combo In Melanoma, Head & Neck Cancer",MRK,-0.001664171839053,-0.284974525022618,-0.005600710916796,0.0057609822569355,-0.0062341041697835,0.0078216081010857,0.0028289578694948,-0.0056416442173845,0.8459835178556563,1
2021-07-09,Why Galectin Is Soaring And Sigilon Is Sinking Today,MRK,-0.001664171839053,-0.284974525022618,-0.005600710916796,0.0057609822569355,-0.0062341041697835,0.0078216081010857,0.0028289578694948,-0.0056416442173845,0.8459835178556563,1
2021-07-09,Disney And Goldman Sachs Lead The DIA Higher Friday,MRK,-0.001664171839053,-0.284974525022618,-0.005600710916796,0.0057609822569355,-0.0062341041697835,0.0078216081010857,0.0028289578694948,-0.0056416442173845,0.8459835178556563,1
2021-07-12,"Merck, Ridgeback Highlight Interim Molnupiravir Data In Non-Hospitalized COVID-19 Patients",MRK,-0.0056416442173845,0.8459835178556563,-0.001664171839053,-0.005600710916796,0.0057609822569355,-0.0062341041697835,0.0078216081010857,0.0007735805375135,-0.4168598201643233,2
2021-07-15,Merck Touts Encouraging Event-Free Survival For Keytruda Regime Over Placebo-Chemo Regime In Breast Cancer,MRK,0.0036073072188804,-0.0170175340629885,0.0001289344922243,0.0007735805375135,-0.0056416442173845,-0.001664171839053,-0.005600710916796,0.0015404171857806,0.0847712780310454,2
2021-07-19,"Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival",MRK,-0.0124326405285468,0.2870309758843707,0.0015404171857806,0.0036073072188804,0.0001289344922243,0.0007735805375135,-0.0056416442173845,-0.0114213610331194,0.182796573962932,1
2021-07-20,"The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street",MRK,-0.0114213610331194,0.182796573962932,-0.0124326405285468,0.0015404171857806,0.0036073072188804,0.0001289344922243,0.0007735805375135,0.0028884879515209,-0.3610633320719667,2
2021-07-20,Merck Discloses New Islatravir Data Supporting Safety Profile For PrEP Regime For HIV Infection,MRK,-0.0114213610331194,0.182796573962932,-0.0124326405285468,0.0015404171857806,0.0036073072188804,0.0001289344922243,0.0007735805375135,0.0028884879515209,-0.3610633320719667,2
2021-07-21,"Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod",MRK,0.0028884879515209,-0.3610633320719667,-0.0114213610331194,-0.0124326405285468,0.0015404171857806,0.0036073072188804,0.0001289344922243,0.001832642348015,0.1722369536833887,2
2021-07-22,Adagene To Test Its Anti-CTLA-4 Monoclonal Antibodies In Combination With Keytruda In Solid Tumors,MRK,0.001832642348015,0.1722369536833887,0.0028884879515209,-0.0114213610331194,-0.0124326405285468,0.0015404171857806,0.0036073072188804,0.0131975025243229,-0.2466557200105639,0
2021-07-22,"The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO",MRK,0.001832642348015,0.1722369536833887,0.0028884879515209,-0.0114213610331194,-0.0124326405285468,0.0015404171857806,0.0036073072188804,0.0131975025243229,-0.2466557200105639,0
2021-07-27,Price Over Earnings Overview: Merck & Co,MRK,0.0078975569854273,0.6041642020584408,-0.0038692346991651,0.0131975025243229,0.001832642348015,0.0028884879515209,-0.0114213610331194,0.0061657305804074,0.356674041297935,0
2021-07-27,"Mega-Cap Mania: Apple, Alphabet, Microsoft Earnings All Ahead After Close Today",MRK,0.0078975569854273,0.6041642020584408,-0.0038692346991651,0.0131975025243229,0.001832642348015,0.0028884879515209,-0.0114213610331194,0.0061657305804074,0.356674041297935,0
2021-07-27,"The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts",MRK,0.0078975569854273,0.6041642020584408,-0.0038692346991651,0.0131975025243229,0.001832642348015,0.0028884879515209,-0.0114213610331194,0.0061657305804074,0.356674041297935,0
2021-07-27,Merck's Keytruda Combo Trial Meets Overall Survival Endpoint In PD-L1 Expressing Breast Cancer Patients,MRK,0.0078975569854273,0.6041642020584408,-0.0038692346991651,0.0131975025243229,0.001832642348015,0.0028884879515209,-0.0114213610331194,0.0061657305804074,0.356674041297935,0
2021-07-27,FDA Approves Merck's Keytruda/Chemo Combo For Early Breast Cancer,MRK,0.0078975569854273,0.6041642020584408,-0.0038692346991651,0.0131975025243229,0.001832642348015,0.0028884879515209,-0.0114213610331194,0.0061657305804074,0.356674041297935,0
2021-07-28,The IPO Recap – Party Is Everything But Over,MRK,0.0061657305804074,0.356674041297935,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,0.0028884879515209,-0.0178730507656712,0.0493843937705542,1
2021-07-29,"Earnings Scheduled For July 29, 2021",MRK,-0.0178730507656712,0.0493843937705542,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,-0.0007798150931174,0.1227229560562894,2
2021-07-29,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",MRK,-0.0178730507656712,0.0493843937705542,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,-0.0007798150931174,0.1227229560562894,2
2021-07-29,"Merck Stock Falls As Q2 Earnings Lag Wall Street Estimates, Trimmed FY21 Guidance Below Consensus",MRK,-0.0178730507656712,0.0493843937705542,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,-0.0007798150931174,0.1227229560562894,2
2021-07-29,Merck & Co: Q2 Earnings Insights,MRK,-0.0178730507656712,0.0493843937705542,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,-0.0007798150931174,0.1227229560562894,2
2021-07-29,"7 Stocks To Watch For July 29, 2021",MRK,-0.0178730507656712,0.0493843937705542,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,-0.0007798150931174,0.1227229560562894,2
2021-07-29,"A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of GDP, Jobless Claims Data",MRK,-0.0178730507656712,0.0493843937705542,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0131975025243229,0.001832642348015,-0.0007798150931174,0.1227229560562894,2
2021-08-02,GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine,MRK,-0.0089763432233578,-0.3015187050636317,-0.0007798150931174,-0.0178730507656712,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0030192512651245,0.0956690226126781,2
2021-08-02,Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates,MRK,-0.0089763432233578,-0.3015187050636317,-0.0007798150931174,-0.0178730507656712,0.0061657305804074,0.0078975569854273,-0.0038692346991651,0.0030192512651245,0.0956690226126781,2
2021-08-05,Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients,MRK,0.0014571252816373,-0.2012043989938862,-0.0121711878828235,0.0030192512651245,-0.0089763432233578,-0.0007798150931174,-0.0178730507656712,-0.0019843116296667,-0.0035510710673899,2
2021-08-05,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",MRK,0.0014571252816373,-0.2012043989938862,-0.0121711878828235,0.0030192512651245,-0.0089763432233578,-0.0007798150931174,-0.0178730507656712,-0.0019843116296667,-0.0035510710673899,2
2021-08-09,Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck,MRK,-0.0015905413268285,-0.0926914781966854,-0.0019843116296667,0.0014571252816373,-0.0121711878828235,0.0030192512651245,-0.0089763432233578,-0.0017258225080281,0.4291470700394051,2
2021-08-10,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",MRK,-0.0017258225080281,0.4291470700394051,-0.0015905413268285,-0.0019843116296667,0.0014571252816373,-0.0121711878828235,0.0030192512651245,0.0002658462347526,-0.3816474104117192,2
2021-08-12,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",MRK,0.0110356463576182,-0.1258738241132303,0.0002658462347526,-0.0017258225080281,-0.0015905413268285,-0.0019843116296667,0.0014571252816373,0.008942727964843,0.1206661071892842,0
2021-08-12,Apple And Salesforce Lead The DIA In A Mixed Day Of Trading,MRK,0.0110356463576182,-0.1258738241132303,0.0002658462347526,-0.0017258225080281,-0.0015905413268285,-0.0019843116296667,0.0014571252816373,0.008942727964843,0.1206661071892842,0
2021-08-16,Merck's Belzutifan Wins FDA Approval As First Drug For Rare VHL Tumors,MRK,0.0157717389210378,0.375602020439328,0.008942727964843,0.0110356463576182,0.0002658462347526,-0.0017258225080281,-0.0015905413268285,0.0115487844841113,0.1006788779300627,0
2021-08-17,"Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2",MRK,0.0115487844841113,0.1006788779300627,0.0157717389210378,0.008942727964843,0.0110356463576182,0.0002658462347526,-0.0017258225080281,-0.013193054928032,-0.2766302028783118,1
2021-08-17,"Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,0.0115487844841113,0.1006788779300627,0.0157717389210378,0.008942727964843,0.0110356463576182,0.0002658462347526,-0.0017258225080281,-0.013193054928032,-0.2766302028783118,1
2021-08-18,Werewolf Therapeutics Inks Solid Tumor Trial Collaboration With Merck,MRK,-0.013193054928032,-0.2766302028783118,0.0115487844841113,0.0157717389210378,0.008942727964843,0.0110356463576182,0.0002658462347526,0.00861301573597,0.188534809829604,0
2021-08-19,Adagene Inks Third Cancer Trial Collaboration With Merck,MRK,0.00861301573597,0.188534809829604,-0.013193054928032,0.0115487844841113,0.0157717389210378,0.008942727964843,0.0110356463576182,0.0028039758401041,-0.2911543754370925,2
2021-08-19,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",MRK,0.00861301573597,0.188534809829604,-0.013193054928032,0.0115487844841113,0.0157717389210378,0.008942727964843,0.0110356463576182,0.0028039758401041,-0.2911543754370925,2
2021-08-24,Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial,MRK,-0.0084203085667299,0.3396944213412192,-0.0038130707429477,0.0028039758401041,0.00861301573597,-0.013193054928032,0.0115487844841113,-0.0083634759172462,-0.1899610259711891,1
2021-08-25,"The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug",MRK,-0.0083634759172462,-0.1899610259711891,-0.0084203085667299,-0.0038130707429477,0.0028039758401041,0.00861301573597,-0.013193054928032,-0.0064877027590498,-0.0575378239518578,1
2021-08-26,"The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO",MRK,-0.0064877027590498,-0.0575378239518578,-0.0083634759172462,-0.0084203085667299,-0.0038130707429477,0.0028039758401041,0.00861301573597,-0.0035258780441523,-0.0949340401180651,2
2021-09-01,Pfizer Commences Dosing In Pivotal Oral COVID-19 Drug Trial,MRK,-0.0014419719816406,-0.1609479884926252,-0.0027451163385836,0.0026211635857789,-0.0035258780441523,-0.0064877027590498,-0.0083634759172462,0.0123392905210097,-0.2860283873214907,0
2021-09-01,Merck To Test Oral Antiviral Candidate For Post-Exposure Prophylaxis Of COVID-19 Infection,MRK,-0.0014419719816406,-0.1609479884926252,-0.0027451163385836,0.0026211635857789,-0.0035258780441523,-0.0064877027590498,-0.0083634759172462,0.0123392905210097,-0.2860283873214907,0
2021-09-01,"The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering",MRK,-0.0014419719816406,-0.1609479884926252,-0.0027451163385836,0.0026211635857789,-0.0035258780441523,-0.0064877027590498,-0.0083634759172462,0.0123392905210097,-0.2860283873214907,0
2021-09-01,FDA Extends Full Approval For Merck's Keytruda In 1st-Line Bladder Cancer,MRK,-0.0014419719816406,-0.1609479884926252,-0.0027451163385836,0.0026211635857789,-0.0035258780441523,-0.0064877027590498,-0.0083634759172462,0.0123392905210097,-0.2860283873214907,0
2021-09-07,"Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay",MRK,-0.0165672993878234,1.1085854776916348,0.0018151903143213,0.0123392905210097,-0.0014419719816406,-0.0027451163385836,0.0026211635857789,-0.0081600109187062,-0.4103508709181301,1
2021-09-08,Downgrades On Economy And Pandemic Pharmaceuticals,MRK,-0.0081600109187062,-0.4103508709181301,-0.0165672993878234,0.0018151903143213,0.0123392905210097,-0.0014419719816406,-0.0027451163385836,-0.0204353451597217,0.7746815479801044,1
2021-09-09,Coca-Cola And Merck Lead The Dow Jones Lower,MRK,-0.0204353451597217,0.7746815479801044,-0.0081600109187062,-0.0165672993878234,0.0018151903143213,0.0123392905210097,-0.0014419719816406,-0.0050121112528527,-0.2422771674858326,1
2021-09-09,Moderna Shares Gain Amid R&D Day Presentations: What You Need To Know,MRK,-0.0204353451597217,0.7746815479801044,-0.0081600109187062,-0.0165672993878234,0.0018151903143213,0.0123392905210097,-0.0014419719816406,-0.0050121112528527,-0.2422771674858326,1
2021-09-10,"Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin",MRK,-0.0050121112528527,-0.2422771674858326,-0.0204353451597217,-0.0081600109187062,-0.0165672993878234,0.0018151903143213,0.0123392905210097,-0.003675979014889,0.0144977220442961,2
2021-09-13,Why Are Silverback Therapeutics Shares Falling On Monday?,MRK,-0.003675979014889,0.0144977220442961,-0.0050121112528527,-0.0204353451597217,-0.0081600109187062,-0.0165672993878234,0.0018151903143213,-0.005790740708245,0.351936826379255,1
2021-09-15,"The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs",MRK,0.0097073368213542,-0.1741060857210513,-0.005790740708245,-0.003675979014889,-0.0050121112528527,-0.0204353451597217,-0.0081600109187062,-0.0115369443873986,0.1802339935807071,1
2021-09-15,"Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial",MRK,0.0097073368213542,-0.1741060857210513,-0.005790740708245,-0.003675979014889,-0.0050121112528527,-0.0204353451597217,-0.0081600109187062,-0.0115369443873986,0.1802339935807071,1
2021-09-16,Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial,MRK,-0.0115369443873986,0.1802339935807071,0.0097073368213542,-0.005790740708245,-0.003675979014889,-0.0050121112528527,-0.0204353451597217,-0.0040293375994988,1.9291377902543372,2
2021-09-16,Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial,MRK,-0.0115369443873986,0.1802339935807071,0.0097073368213542,-0.005790740708245,-0.003675979014889,-0.0050121112528527,-0.0204353451597217,-0.0040293375994988,1.9291377902543372,2
2021-09-16,"The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study",MRK,-0.0115369443873986,0.1802339935807071,0.0097073368213542,-0.005790740708245,-0.003675979014889,-0.0050121112528527,-0.0204353451597217,-0.0040293375994988,1.9291377902543372,2
2021-09-20,Apple And Disney Lead The Dow Jones Lower,MRK,0.0034877275141409,-0.6316366635488613,-0.0040293375994988,-0.0115369443873986,0.0097073368213542,-0.005790740708245,-0.003675979014889,0.0005559722503523,-0.2497592154802557,2
2021-09-20,"Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer",MRK,0.0034877275141409,-0.6316366635488613,-0.0040293375994988,-0.0115369443873986,0.0097073368213542,-0.005790740708245,-0.003675979014889,0.0005559722503523,-0.2497592154802557,2
2021-09-20,Merck Backs Up Keytruda Approval In TNBC With Encouraging Overall Survival Data,MRK,0.0034877275141409,-0.6316366635488613,-0.0040293375994988,-0.0115369443873986,0.0097073368213542,-0.005790740708245,-0.003675979014889,0.0005559722503523,-0.2497592154802557,2
2021-09-24,Why AstraZeneca Stock Is Trading Higher Today,MRK,0.0076660268449006,0.1483747609942638,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0034877275141409,-0.0040293375994988,-0.003396390515422,-0.413470882858638,2
2021-09-24,AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients,MRK,0.0076660268449006,0.1483747609942638,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0034877275141409,-0.0040293375994988,-0.003396390515422,-0.413470882858638,2
2021-09-27,Acceleron In Advanced $11B Buyout Talks: Bloomberg,MRK,-0.003396390515422,-0.413470882858638,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0034877275141409,-0.0005451347811921,0.3714226125645956,2
2021-09-27,Merck's Keytruda Tops Placebo On Overall Survival Endpoint In Liver Cancer Patients,MRK,-0.003396390515422,-0.413470882858638,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0034877275141409,-0.0005451347811921,0.3714226125645956,2
2021-09-28,Why Are I-Mab Shares Trading Higher On Tuesday?,MRK,-0.0005451347811921,0.3714226125645956,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0241408297860958,0.3563897196735439,0
2021-09-28,"A Peek Into The Markets: US Stock Futures Down Ahead Of Economic Data, Fed Speakers",MRK,-0.0005451347811921,0.3714226125645956,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0241408297860958,0.3563897196735439,0
2021-09-28,Merck Reportedly Lead Bidder In $11B Acceleron Buyout: WSJ,MRK,-0.0005451347811921,0.3714226125645956,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0241408297860958,0.3563897196735439,0
2021-09-28,Pfizer Begins Late-Stage Study To Test Effectiveness Of Oral Drug Against COVID-19 In Those Exposed To The Virus,MRK,-0.0005451347811921,0.3714226125645956,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0241408297860958,0.3563897196735439,0
2021-09-28,"5 Stocks To Watch For September 28, 2021",MRK,-0.0005451347811921,0.3714226125645956,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0241408297860958,0.3563897196735439,0
2021-09-28,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",MRK,-0.0005451347811921,0.3714226125645956,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0005559722503523,0.0241408297860958,0.3563897196735439,0
2021-09-29,"Merck's COVID-19 Antiviral Pill Effective Against Variants, Lab Studies Show",MRK,0.0241408297860958,0.3563897196735439,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.000972744469615,0.0002663942530476,0.0120900682051761,2
2021-09-30,Merck Seals Acceleron Pharma Deal For $180/Share: Highlights,MRK,0.0002663942530476,0.0120900682051761,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.0837437063934218,5.308069618305577,0
2021-09-30,"A Peek Into The Markets: US Stock Futures Climb Ahead Of GDP, Jobless Claims Data",MRK,0.0002663942530476,0.0120900682051761,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.0837437063934218,5.308069618305577,0
2021-09-30,"GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact",MRK,0.0002663942530476,0.0120900682051761,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.0837437063934218,5.308069618305577,0
2021-09-30,"The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug",MRK,0.0002663942530476,0.0120900682051761,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.0837437063934218,5.308069618305577,0
2021-09-30,"Merck, Sutro Biopharma Extends Cytokine Derivative Research Program",MRK,0.0002663942530476,0.0120900682051761,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0140199751061189,0.0837437063934218,5.308069618305577,0
2021-10-01,35 Stocks Moving In Friday's Mid-Day Session,MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,"Why Moderna, Novavax And Other COVID-19 Vaccine Stocks Are Plummeting",MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,Merck & Co: Debt Overview,MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,Activist Investor Thinks Merck Undervalues Acceleron Buy,MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,Merck Announcement Helps Prompt Positive Pre-Market Price Moves,MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,Why Merck Shares Are Surging Higher Today,MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,"Merck COVID-19 Oral Antiviral Cuts Risk of Hospitalization, Death By 50%",MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-01,"The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO",MRK,0.0837437063934218,5.308069618305577,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,0.0076660268449006,0.0208844869377675,-0.4775150174687528,0
2021-10-04,Tesla and Merck Give Investors Some Hope,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-04,Why Moderna Shares Continue To Fall Today,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-04,Why BioNTech Shares Are Trading Lower Again Today,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-04,Why Merck Shares Are Rising,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-04,A Glimpse of This Week's Earnings Calendar,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-04,Why This Investor Keeps Buying Moderna Shares As The Stock Falls,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-04,54 Biggest Movers From Friday,MRK,0.0208844869377675,-0.4775150174687528,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.003396390515422,-0.0180505637718774,-0.4588979577355644,1
2021-10-05,Rising Oil Prices and Yields Makes Market Navigation More Complex,MRK,-0.0180505637718774,-0.4588979577355644,0.0208844869377675,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.0115195909167958,-0.3923624291699162,1
2021-10-05,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",MRK,-0.0180505637718774,-0.4588979577355644,0.0208844869377675,0.0837437063934218,0.0002663942530476,0.0241408297860958,-0.0005451347811921,-0.0115195909167958,-0.3923624291699162,1
2021-10-06,"Merck Keeps M&A Mode On With Mirati, Biogen, mRNA Companies On Radar: FT",MRK,-0.0115195909167958,-0.3923624291699162,-0.0180505637718774,0.0208844869377675,0.0837437063934218,0.0002663942530476,0.0241408297860958,0.0158690163823798,-0.1940879145842798,0
2021-10-06,Merck Inks Supply Pact With Singapore For Its Oral COVID-19 Antiviral: Reuters,MRK,-0.0115195909167958,-0.3923624291699162,-0.0180505637718774,0.0208844869377675,0.0837437063934218,0.0002663942530476,0.0241408297860958,0.0158690163823798,-0.1940879145842798,0
2021-10-08,A Look Into Merck & Co's Debt,MRK,-0.0159872621607182,-0.1458299566611465,0.0158690163823798,-0.0115195909167958,-0.0180505637718774,0.0208844869377675,0.0837437063934218,-0.0086816827513578,-0.0694161420993144,1
2021-10-08,Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters,MRK,-0.0159872621607182,-0.1458299566611465,0.0158690163823798,-0.0115195909167958,-0.0180505637718774,0.0208844869377675,0.0837437063934218,-0.0086816827513578,-0.0694161420993144,1
2021-10-11,"Merck, Ridgeback File For Emergency Use Nod For COVID-19 Antiviral",MRK,-0.0086816827513578,-0.0694161420993144,-0.0159872621607182,0.0158690163823798,-0.0115195909167958,-0.0180505637718774,0.0208844869377675,-0.0042536754860706,-0.0296727749851503,2
2021-10-12,Winners and Losers of Rising Energy Prices,MRK,-0.0042536754860706,-0.0296727749851503,-0.0086816827513578,-0.0159872621607182,0.0158690163823798,-0.0115195909167958,-0.0180505637718774,-0.0080413299517942,-0.1354408405664686,1
2021-10-15,Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings,MRK,0.0,-0.1191889320162378,-0.0078529445043988,-0.0080413299517942,-0.0042536754860706,-0.0086816827513578,-0.0159872621607182,-0.0150643833928186,0.0162200391705784,1
2021-10-19,"WHO-Led Program Intends To Purchase Oral COVID-19 Antivirals For $10, Including Merck's: Reuters",MRK,0.0303304024907595,0.1913196436082749,-0.0150643833928186,0.0,-0.0078529445043988,-0.0080413299517942,-0.0042536754860706,0.019876816043963,-0.2639515699327859,0
2021-10-20,"The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review",MRK,0.019876816043963,-0.2639515699327859,0.0303304024907595,-0.0150643833928186,0.0,-0.0078529445043988,-0.0080413299517942,0.001233424378852,-0.1370982512755658,2
2021-10-20,Merck Recalls One Lot Of Cubicin Antibiotic Over Glass Particles Presence In Vials,MRK,0.019876816043963,-0.2639515699327859,0.0303304024907595,-0.0150643833928186,0.0,-0.0078529445043988,-0.0080413299517942,0.001233424378852,-0.1370982512755658,2
2021-10-21,PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial,MRK,0.001233424378852,-0.1370982512755658,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,-0.0078529445043988,-0.0002465387682706,-0.2375272903695318,2
2021-10-21,Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg,MRK,0.001233424378852,-0.1370982512755658,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,-0.0078529445043988,-0.0002465387682706,-0.2375272903695318,2
2021-10-21,"CDC's Advisory Committee Backs Pneumococcal Vaccine From Pfizer, Merck",MRK,0.001233424378852,-0.1370982512755658,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,-0.0078529445043988,-0.0002465387682706,-0.2375272903695318,2
2021-10-21,"The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO",MRK,0.001233424378852,-0.1370982512755658,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,-0.0078529445043988,-0.0002465387682706,-0.2375272903695318,2
2021-10-22,"The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs",MRK,-0.0002465387682706,-0.2375272903695318,0.001233424378852,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,0.0062849351438212,0.2415690121427436,0
2021-10-22,"Salarius Pharmaceuticals (SLRX) is Developing a Novel LSD1 Inhibitor, Positioning it as a Significant Mover in Epigenetics-Based Cancer Therapies",MRK,-0.0002465387682706,-0.2375272903695318,0.001233424378852,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,0.0062849351438212,0.2415690121427436,0
2021-10-22,"A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO",MRK,-0.0002465387682706,-0.2375272903695318,0.001233424378852,0.019876816043963,0.0303304024907595,-0.0150643833928186,0.0,0.0062849351438212,0.2415690121427436,0
2021-10-26,"The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children",MRK,0.0072249387327039,-0.0014307220875729,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.019876816043963,0.0303304024907595,-0.0086322414446661,-0.094851643945469,1
2021-10-27,Merck Inks Licensing Pact To Broaden Generic Manufacturing Of COVID-19 Antiviral,MRK,-0.0086322414446661,-0.094851643945469,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.019876816043963,0.0614423867553268,2.4085453729298085,0
2021-10-28,"A Peek Into The Markets: US Stock Futures Edge Higher; Apple, Amazon Earnings In Focus",MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,Recap: Merck & Co Q3 Earnings,MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,"Merck's Q3 Earnings Beat Street View, Revises FY21 Outlook Below Consensus",MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,"7 Stocks To Watch For October 28, 2021",MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,Cheap Antidepressant Fluvoxamine Shows Potential In Reducing COVID-19 Hospitalization,MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,Market Breadth Could Be a Liability as Stocks Struggle to Maintain Highs,MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,Why Merck Shares Are Making New 52-Week Highs Today,MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,Merck & Company Inc. Looks to Continue to Trade Above its Annual-High Share Price Today,MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-28,"Earnings Scheduled For October 28, 2021",MRK,0.0614423867553268,2.4085453729298085,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,0.001233424378852,0.0173309499203977,-0.352666983195112,0
2021-10-29,"The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs",MRK,0.0173309499203977,-0.352666983195112,0.0614423867553268,-0.0086322414446661,0.0072249387327039,0.0062849351438212,-0.0002465387682706,-0.0023849314225397,-0.4140942040624029,2
2021-11-01,Merck Dives Further Into Cytokine Research With Synthekine Deal,MRK,-0.0023849314225397,-0.4140942040624029,0.0173309499203977,0.0614423867553268,-0.0086322414446661,0.0072249387327039,0.0062849351438212,0.0134333449095347,0.3406006999332962,0
2021-11-01,ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates,MRK,-0.0023849314225397,-0.4140942040624029,0.0173309499203977,0.0614423867553268,-0.0086322414446661,0.0072249387327039,0.0062849351438212,0.0134333449095347,0.3406006999332962,0
2021-11-01,Merck Pushes Acceleron Buyout By Refiling For Antitrust Review,MRK,-0.0023849314225397,-0.4140942040624029,0.0173309499203977,0.0614423867553268,-0.0086322414446661,0.0072249387327039,0.0062849351438212,0.0134333449095347,0.3406006999332962,0
2021-11-01,New Data Reaffirms Merck's Keytruda In Extending Survival In Melanoma Patients,MRK,-0.0023849314225397,-0.4140942040624029,0.0173309499203977,0.0614423867553268,-0.0086322414446661,0.0072249387327039,0.0062849351438212,0.0134333449095347,0.3406006999332962,0
2021-11-03,"This Company Wants to Revolutionize What Matters for Hospitals, Big Pharma and Health Insurers",MRK,-0.0038191448381433,-0.2581553226004335,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.0614423867553268,-0.0086322414446661,0.0209742148897293,0.7934563897132463,0
2021-11-03,Evpandpresident And Merck Animal Heallth Of Merck & Co Trades $11M In Company Stock,MRK,-0.0038191448381433,-0.2581553226004335,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.0614423867553268,-0.0086322414446661,0.0209742148897293,0.7934563897132463,0
2021-11-04,Britain Approves First Oral COVID-19 Antiviral From Merck,MRK,0.0209742148897293,0.7934563897132463,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.0614423867553268,-0.0986304620435669,0.9274736421479728,1
2021-11-04,"The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO",MRK,0.0209742148897293,0.7934563897132463,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.0614423867553268,-0.0986304620435669,0.9274736421479728,1
2021-11-05,Will Pfizer Outgun Merck With Oral COVID-19 Pill?,MRK,-0.0986304620435669,0.9274736421479728,0.0209742148897293,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.013111157799007,-0.5041529453352789,0
2021-11-05,Pfizer COVID-19 Pill Adds Momentum to the Reopening Trade,MRK,-0.0986304620435669,0.9274736421479728,0.0209742148897293,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.013111157799007,-0.5041529453352789,0
2021-11-05,"Pfizer Touts Encouraging Data For Its COVID-19 Oral Antiviral, With 89% Reduction In Hospitalization, Death",MRK,-0.0986304620435669,0.9274736421479728,0.0209742148897293,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0173309499203977,0.013111157799007,-0.5041529453352789,0
2021-11-08,Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters,MRK,0.013111157799007,-0.5041529453352789,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0004837818828187,-0.4365261019420338,2
2021-11-08,"Caterpillar, Fluor, and ChargePoint Among Companies That Could Benefit from Infrastructure Bill",MRK,0.013111157799007,-0.5041529453352789,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0004837818828187,-0.4365261019420338,2
2021-11-08,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",MRK,0.013111157799007,-0.5041529453352789,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,-0.0023849314225397,0.0004837818828187,-0.4365261019420338,2
2021-11-09,US Government To Purchase Additional 1.4M Doses Of Merck's COVID-19 Pill,MRK,0.0004837818828187,-0.4365261019420338,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,0.0155947843010355,-0.0624143835616438,0
2021-11-09,ALX Oncology Falls After Updated Data For Solid Tumors Candidate,MRK,0.0004837818828187,-0.4365261019420338,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,0.0155947843010355,-0.0624143835616438,0
2021-11-09,Mirati Posts More Responses For Adagrasib-Keytruda Combo In Lung Cancer Setting,MRK,0.0004837818828187,-0.4365261019420338,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,0.0155947843010355,-0.0624143835616438,0
2021-11-09,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",MRK,0.0004837818828187,-0.4365261019420338,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0134333449095347,0.0155947843010355,-0.0624143835616438,0
2021-11-10,"The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance",MRK,0.0155947843010355,-0.0624143835616438,0.0004837818828187,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0038191448381433,0.0001189116270321,-0.4154262928804066,2
2021-11-11,"Oncorus, Gaeta Therapeutics Ink Cancer Candidate Licensing Agreement",MRK,0.0001189116270321,-0.4154262928804066,0.0155947843010355,0.0004837818828187,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0002379855183239,0.4244033671786862,2
2021-11-11,"The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts",MRK,0.0001189116270321,-0.4154262928804066,0.0155947843010355,0.0004837818828187,0.013111157799007,-0.0986304620435669,0.0209742148897293,-0.0002379855183239,0.4244033671786862,2
2021-11-15,Iovance's Lifileucel Combo Shows Encouraging Response Rates In Advanced Cancers,MRK,-0.0036904159629668,-0.1338540460842969,-0.0002379855183239,0.0001189116270321,0.0155947843010355,0.0004837818828187,0.013111157799007,0.0050184539538749,0.4863397203230073,0
2021-11-16,Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters,MRK,0.0050184539538749,0.4863397203230073,-0.0036904159629668,-0.0002379855183239,0.0001189116270321,0.0155947843010355,0.0004837818828187,-0.0179526767133489,-0.0263979858403059,1
2021-11-17,FDA Plans Quick Review of Pfizer/BioNTech COVID-19 Booster For All Adults: NYT,MRK,-0.0179526767133489,-0.0263979858403059,0.0050184539538749,-0.0036904159629668,-0.0002379855183239,0.0001189116270321,0.0155947843010355,0.0054480843179209,-0.0440099938753487,0
2021-11-18,Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting,MRK,0.0054480843179209,-0.0440099938753487,-0.0179526767133489,0.0050184539538749,-0.0036904159629668,-0.0002379855183239,0.0001189116270321,-0.0282964502380133,0.7878599902375529,1
2021-11-18,"Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3",MRK,0.0054480843179209,-0.0440099938753487,-0.0179526767133489,0.0050184539538749,-0.0036904159629668,-0.0002379855183239,0.0001189116270321,-0.0282964502380133,0.7878599902375529,1
2021-11-19,EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness,MRK,-0.0282964502380133,0.7878599902375529,0.0054480843179209,-0.0179526767133489,0.0050184539538749,-0.0036904159629668,-0.0002379855183239,0.0116482616580815,-0.3811422493473104,0
2021-11-19,"The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial",MRK,-0.0282964502380133,0.7878599902375529,0.0054480843179209,-0.0179526767133489,0.0050184539538749,-0.0036904159629668,-0.0002379855183239,0.0116482616580815,-0.3811422493473104,0
2021-11-19,Merck Pauses Development Of MK-8507 In HIV Infection,MRK,-0.0282964502380133,0.7878599902375529,0.0054480843179209,-0.0179526767133489,0.0050184539538749,-0.0036904159629668,-0.0002379855183239,0.0116482616580815,-0.3811422493473104,0
2021-11-23,Novartis May Have Buyer(s) For Its Sandoz Unit - Report,MRK,0.0142086907583112,0.1149427400231613,0.0116482616580815,-0.0282964502380133,0.0054480843179209,-0.0179526767133489,0.0050184539538749,-0.006280243301786,-0.2962541629571009,1
2021-11-23,Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer,MRK,0.0142086907583112,0.1149427400231613,0.0116482616580815,-0.0282964502380133,0.0054480843179209,-0.0179526767133489,0.0050184539538749,-0.006280243301786,-0.2962541629571009,1
2021-11-24,"Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial",MRK,-0.006280243301786,-0.2962541629571009,0.0142086907583112,0.0116482616580815,-0.0282964502380133,0.0054480843179209,-0.0179526767133489,-0.0379191177250299,1.111046034906876,1
2021-11-26,"Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%",MRK,-0.0379191177250299,1.111046034906876,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0282964502380133,0.0054480843179209,-0.0539414861936499,0.8972589057818223,1
2021-11-29,"FDA's AdComm Meet Tomorrow To Review Safety, Efficacy of Merck's COVID-19 Pill",MRK,-0.0539414861936499,0.8972589057818223,-0.0379191177250299,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0282964502380133,0.00026710569337,-0.1173506393233584,2
2021-11-29,3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries,MRK,-0.0539414861936499,0.8972589057818223,-0.0379191177250299,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0282964502380133,0.00026710569337,-0.1173506393233584,2
2021-11-29,Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma,MRK,-0.0539414861936499,0.8972589057818223,-0.0379191177250299,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0282964502380133,0.00026710569337,-0.1173506393233584,2
2021-11-30,"The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout",MRK,0.00026710569337,-0.1173506393233584,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0062742924871552,-0.2897292568895192,1
2021-11-30,AstraZeneca-Merck's Lynparza Under FDA Priority Review For Breast Cancer Setting,MRK,0.00026710569337,-0.1173506393233584,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0062742924871552,-0.2897292568895192,1
2021-11-30,Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors,MRK,0.00026710569337,-0.1173506393233584,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,0.0116482616580815,-0.0062742924871552,-0.2897292568895192,1
2021-12-01,"AdComm Narrowly Backs Merck's COVID-19 Pill, Despite Efficacy Questions",MRK,-0.0062742924871552,-0.2897292568895192,0.00026710569337,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,-0.0073885743183949,-0.284130827257078,1
2021-12-01,2 Biotech Stocks A Congressman Is Betting On With Omicron Variant Emerging,MRK,-0.0062742924871552,-0.2897292568895192,0.00026710569337,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,-0.0073885743183949,-0.284130827257078,1
2021-12-01,Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In Kids,MRK,-0.0062742924871552,-0.2897292568895192,0.00026710569337,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,-0.0073885743183949,-0.284130827257078,1
2021-12-01,"The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case",MRK,-0.0062742924871552,-0.2897292568895192,0.00026710569337,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,0.0142086907583112,-0.0073885743183949,-0.284130827257078,1
2021-12-02,Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates,MRK,-0.0073885743183949,-0.284130827257078,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,-0.0074435717011027,-0.054505288264159,1
2021-12-02,Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant,MRK,-0.0073885743183949,-0.284130827257078,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0379191177250299,-0.006280243301786,-0.0074435717011027,-0.054505288264159,1
2021-12-03,"The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering",MRK,-0.0074435717011027,-0.054505288264159,-0.0073885743183949,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0379191177250299,0.0010911126544073,-0.0690679513953504,2
2021-12-03,Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review,MRK,-0.0074435717011027,-0.054505288264159,-0.0073885743183949,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0379191177250299,0.0010911126544073,-0.0690679513953504,2
2021-12-06,"Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings",MRK,0.0010911126544073,-0.0690679513953504,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0155271295753998,0.3056460449551337,1
2021-12-06,"Canada, Merck Ink Supply Pact For 1M Doses Of Molnupiravir For COVID-19",MRK,0.0010911126544073,-0.0690679513953504,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0155271295753998,0.3056460449551337,1
2021-12-06,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",MRK,0.0010911126544073,-0.0690679513953504,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,0.00026710569337,-0.0539414861936499,-0.0155271295753998,0.3056460449551337,1
2021-12-07,"Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ",MRK,-0.0155271295753998,0.3056460449551337,0.0010911126544073,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,0.00026710569337,0.0128664178752408,-0.1873366184484352,0
2021-12-07,"The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré",MRK,-0.0155271295753998,0.3056460449551337,0.0010911126544073,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,0.00026710569337,0.0128664178752408,-0.1873366184484352,0
2021-12-07,Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection,MRK,-0.0155271295753998,0.3056460449551337,0.0010911126544073,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,0.00026710569337,0.0128664178752408,-0.1873366184484352,0
2021-12-08,"The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom",MRK,0.0128664178752408,-0.1873366184484352,-0.0155271295753998,0.0010911126544073,-0.0074435717011027,-0.0073885743183949,-0.0062742924871552,-0.0047805770565321,-0.1670039214591735,2
2021-12-13,Famed Robot-Run ETF Buys Back Into Tesla Heavily After Booking Profits Earlier — Here Are Its Other Bets,MRK,0.0110163276828125,0.5340298978839877,-0.0032940228805116,-0.0047805770565321,0.0128664178752408,-0.0155271295753998,0.0010911126544073,0.0136117774964446,0.0837007680386134,0
2021-12-13,Merck Raises $1 Billion Via Inaugural Sustainability Bond,MRK,0.0110163276828125,0.5340298978839877,-0.0032940228805116,-0.0047805770565321,0.0128664178752408,-0.0155271295753998,0.0010911126544073,0.0136117774964446,0.0837007680386134,0
2021-12-14,"CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021",MRK,0.0136117774964446,0.0837007680386134,0.0110163276828125,-0.0032940228805116,-0.0047805770565321,0.0128664178752408,-0.0155271295753998,0.0212969613815301,-0.2473020681066191,0
2021-12-15,"The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO",MRK,0.0212969613815301,-0.2473020681066191,0.0136117774964446,0.0110163276828125,-0.0032940228805116,-0.0047805770565321,0.0128664178752408,0.0082348144870807,0.1639370697028759,0
2021-12-15,Famed Robot-Run ETF Says This Is Why It Now Has Tesla As Its Top Holding,MRK,0.0212969613815301,-0.2473020681066191,0.0136117774964446,0.0110163276828125,-0.0032940228805116,-0.0047805770565321,0.0128664178752408,0.0082348144870807,0.1639370697028759,0
2021-12-17,EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer,MRK,-0.0028982864009614,0.6890197991771927,0.0082348144870807,0.0212969613815301,0.0136117774964446,0.0110163276828125,-0.0032940228805116,0.0095124434065612,-0.5785111588197114,0
2021-12-17,EMA Might Not Decide On Merck's COVID-91 Oral Antiviral Before Christmas: Reuters,MRK,-0.0028982864009614,0.6890197991771927,0.0082348144870807,0.0212969613815301,0.0136117774964446,0.0110163276828125,-0.0032940228805116,0.0095124434065612,-0.5785111588197114,0
2021-12-17,"The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx",MRK,-0.0028982864009614,0.6890197991771927,0.0082348144870807,0.0212969613815301,0.0136117774964446,0.0110163276828125,-0.0032940228805116,0.0095124434065612,-0.5785111588197114,0
2021-12-21,IMV's Basket Clinical Study Shows Promising Top Line Data In Bladder Cancer,MRK,-0.0113858039674572,0.2647476901208245,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0212969613815301,0.0136117774964446,0.0082075615585486,-0.380778442312581,0
2021-12-22,"FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg",MRK,0.0082075615585486,-0.380778442312581,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0212969613815301,-0.0056459440834143,0.0690254969749351,1
2021-12-22,"UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer",MRK,0.0082075615585486,-0.380778442312581,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0212969613815301,-0.0056459440834143,0.0690254969749351,1
2021-12-22,A Look Into Merck & Co's Debt,MRK,0.0082075615585486,-0.380778442312581,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0212969613815301,-0.0056459440834143,0.0690254969749351,1
2021-12-22,Investors Appear Uninterested in Bonds Despite Elevated Uncertainty,MRK,0.0082075615585486,-0.380778442312581,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0212969613815301,-0.0056459440834143,0.0690254969749351,1
2021-12-22,"The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda",MRK,0.0082075615585486,-0.380778442312581,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0212969613815301,-0.0056459440834143,0.0690254969749351,1
2021-12-23,"FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck",MRK,-0.0056459440834143,0.0690254969749351,0.0082075615585486,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0110919347727138,-0.3598015139112067,0
2021-12-23,How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?,MRK,-0.0056459440834143,0.0690254969749351,0.0082075615585486,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0082348144870807,0.0110919347727138,-0.3598015139112067,0
2021-12-27,Holiday Shopping Saw Growth in Apparel and Jewelry,MRK,0.0110919347727138,-0.3598015139112067,-0.0056459440834143,0.0082075615585486,-0.0113858039674572,0.0095124434065612,-0.0028982864009614,0.0031342693613829,-0.0959161444109428,2
2021-12-30,These 8 Dow Jones Stocks Are Negative For 2021,MRK,0.0024692925342413,-0.0113059178886619,0.0018226972678019,0.0031342693613829,0.0110919347727138,-0.0056459440834143,0.0082075615585486,-0.006481872282302,0.027376218190507,1
2022-01-03,Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting,MRK,0.0030011471961979,0.5684359166043691,-0.006481872282302,0.0024692925342413,0.0018226972678019,0.0031342693613829,0.0110919347727138,0.0018212743535874,0.269086556793628,2
2022-01-03,Why Genprex Shares Are Soaring Today,MRK,0.0030011471961979,0.5684359166043691,-0.006481872282302,0.0024692925342413,0.0018226972678019,0.0031342693613829,0.0110919347727138,0.0018212743535874,0.269086556793628,2
2022-01-04,Financial Stocks Could be Positioned to Kick Off the Q4 Earnings Season,MRK,0.0018212743535874,0.269086556793628,0.0030011471961979,-0.006481872282302,0.0024692925342413,0.0018226972678019,0.0031342693613829,0.0242824136449393,0.4562123905622741,0
2022-01-04,Reddy's To Launch Generic Version Of Merck's COVID-19 Drug At $0.50/Pill: Reuters,MRK,0.0018212743535874,0.269086556793628,0.0030011471961979,-0.006481872282302,0.0024692925342413,0.0018226972678019,0.0031342693613829,0.0242824136449393,0.4562123905622741,0
2022-01-07,Why Absci Shares Are Soaring Today,MRK,0.0186478045750073,0.3391788154095358,-0.0006338086714073,0.0242824136449393,0.0018212743535874,0.0030011471961979,-0.006481872282302,0.0257783271627911,0.2908756245069681,0
2022-01-10,Merck's Keytruda As Adjuvant Treatment Improves Disease-Free Survival In Lung Cancer Setting,MRK,0.0257783271627911,0.2908756245069681,0.0186478045750073,-0.0006338086714073,0.0242824136449393,0.0018212743535874,0.0030011471961979,-0.0084984183090129,-0.4100311659740895,1
2022-01-12,"The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award",MRK,-0.0057547575393809,0.1270511260153128,-0.0084984183090129,0.0257783271627911,0.0186478045750073,-0.0006338086714073,0.0242824136449393,0.0014778748444881,-0.2587807306425672,2
2022-01-18,"This Robot-Run ETF Retains Tesla As It Largest Holding In January, It Has Bowed Out Of Netflix And Initiated Position In This Chipmaker",MRK,0.0019660762689099,0.5291306182738975,0.000737846976758,0.0014778748444881,-0.0057547575393809,-0.0084984183090129,0.0257783271627911,-0.0030659540910134,-0.2100930787754172,2
2022-01-18,"Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed",MRK,0.0019660762689099,0.5291306182738975,0.000737846976758,0.0014778748444881,-0.0057547575393809,-0.0084984183090129,0.0257783271627911,-0.0030659540910134,-0.2100930787754172,2
2022-01-19,Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer,MRK,-0.0030659540910134,-0.2100930787754172,0.0019660762689099,0.000737846976758,0.0014778748444881,-0.0057547575393809,-0.0084984183090129,-0.0066429757081999,0.0542792753445957,1
2022-01-19,Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial,MRK,-0.0030659540910134,-0.2100930787754172,0.0019660762689099,0.000737846976758,0.0014778748444881,-0.0057547575393809,-0.0084984183090129,-0.0066429757081999,0.0542792753445957,1
2022-01-20,Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag,MRK,-0.0066429757081999,0.0542792753445957,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0014778748444881,-0.0057547575393809,-0.0095354023600034,0.5296033008550407,1
2022-01-20,"The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug",MRK,-0.0066429757081999,0.0542792753445957,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0014778748444881,-0.0057547575393809,-0.0095354023600034,0.5296033008550407,1
2022-01-21,Merck Scores Win In Insurance Battle Over Cyberattack - Bloomberg Report,MRK,-0.0095354023600034,0.5296033008550407,-0.0066429757081999,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0014778748444881,-0.0143787889663475,-0.0635206941939258,1
2022-01-24,Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients,MRK,-0.0143787889663475,-0.0635206941939258,-0.0095354023600034,-0.0066429757081999,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0079918587672755,-0.2097634333969575,0
2022-01-24,"FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why",MRK,-0.0143787889663475,-0.0635206941939258,-0.0095354023600034,-0.0066429757081999,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0079918587672755,-0.2097634333969575,0
2022-01-24,Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?,MRK,-0.0143787889663475,-0.0635206941939258,-0.0095354023600034,-0.0066429757081999,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0079918587672755,-0.2097634333969575,0
2022-01-24,Merck's Gefapixant For Chronic Cough Slapped With FDA Complete Response Letter,MRK,-0.0143787889663475,-0.0635206941939258,-0.0095354023600034,-0.0066429757081999,-0.0030659540910134,0.0019660762689099,0.000737846976758,0.0079918587672755,-0.2097634333969575,0
2022-01-25,eFFECTOR Secures $50M Funding From Lincoln Park Capital,MRK,0.0079918587672755,-0.2097634333969575,-0.0143787889663475,-0.0095354023600034,-0.0066429757081999,-0.0030659540910134,0.0019660762689099,-0.0040271659064421,-0.0450726080337275,2
2022-01-26,Vaccinex Posts Two Complete Responses In Pepinemab Combo Trial In Head & Neck Cancer,MRK,-0.0040271659064421,-0.0450726080337275,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,-0.0066429757081999,-0.0030659540910134,0.0181957233577543,0.547315009274447,0
2022-01-27,Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock,MRK,0.0181957233577543,0.547315009274447,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,-0.0066429757081999,0.0039711908583492,-0.3106869699611635,2
2022-01-27,"The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study",MRK,0.0181957233577543,0.547315009274447,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,-0.0066429757081999,0.0039711908583492,-0.3106869699611635,2
2022-01-27,Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer,MRK,0.0181957233577543,0.547315009274447,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,-0.0066429757081999,0.0039711908583492,-0.3106869699611635,2
2022-01-27,Cue Pharma Posts Two Responses From CUE-101 Combo In Head & Neck Cancer,MRK,0.0181957233577543,0.547315009274447,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,-0.0066429757081999,0.0039711908583492,-0.3106869699611635,2
2022-01-28,"Merck's COVID-19 Pill works Against Omicron, Lab Studies Show",MRK,0.0039711908583492,-0.3106869699611635,0.0181957233577543,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,0.0071693862326731,-0.063261302307532,0
2022-01-28,"The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron",MRK,0.0039711908583492,-0.3106869699611635,0.0181957233577543,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,-0.0095354023600034,0.0071693862326731,-0.063261302307532,0
2022-01-31,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",MRK,0.0071693862326731,-0.063261302307532,0.0039711908583492,0.0181957233577543,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,0.0053999277712948,-0.1712082853855006,0
2022-01-31,Veru's Cancer Candidate Sabizabulin Gets FDA Fast Track Tag For COVID-19,MRK,0.0071693862326731,-0.063261302307532,0.0039711908583492,0.0181957233577543,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,0.0053999277712948,-0.1712082853855006,0
2022-01-31,Price To Earnings Ratio Insights For Merck & Co,MRK,0.0071693862326731,-0.063261302307532,0.0039711908583492,0.0181957233577543,-0.0040271659064421,0.0079918587672755,-0.0143787889663475,0.0053999277712948,-0.1712082853855006,0
2022-02-03,Mid-Morning Market Update: US Stocks Open Lower After Disappointing Earnings From Meta Platforms,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,"The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,Mid-Day Market Update: Nasdaq Down 2%; Biophytis Shares Spike Higher,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,"Earnings Scheduled For February 3, 2022",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,"7 Stocks To Watch For February 3, 2022",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,"Merck Clocked $950M Sales In Q4 From COVID-19 Treatment, Issues FY22 Sales",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,Recap: Merck & Co Q4 Earnings,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-03,A Peek Into The Markets: Nasdaq Futures Tumble Following Downbeat Earnings From Meta,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498,0.0053999277712948,0.0071693862326731,0.0039711908583492,0.0181957233577543,-0.0056955942142028,-0.4413233653435099,1
2022-02-07,NGM Bio Shares Rise After Vision Disorder Candidate Receives FDA Fast Track Tag,MRK,-0.0124743614420717,1.203700938765607,-0.0056955942142028,-0.0365809806939944,0.0010988095165498,0.0053999277712948,0.0071693862326731,-0.0086362712763847,-0.2595266627991175,1
2022-02-10,"The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly",MRK,0.0003921698243503,-0.1808260500161363,-0.0049410496944333,-0.0086362712763847,-0.0124743614420717,-0.0056955942142028,-0.0365809806939944,0.001044823854795,-0.2488663407731395,2
2022-02-10,Why Are Seagen Shares Sinking Today?,MRK,0.0003921698243503,-0.1808260500161363,-0.0049410496944333,-0.0086362712763847,-0.0124743614420717,-0.0056955942142028,-0.0365809806939944,0.001044823854795,-0.2488663407731395,2
2022-02-15,ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting,MRK,0.0175232647906207,0.1563085081620467,-0.002218140267497,0.001044823854795,0.0003921698243503,-0.0049410496944333,-0.0086362712763847,-0.0075826031093696,-0.1264091163702563,1
2022-02-15,Why Are AstraZeneca Shares Trading Higher Today,MRK,0.0175232647906207,0.1563085081620467,-0.002218140267497,0.001044823854795,0.0003921698243503,-0.0049410496944333,-0.0086362712763847,-0.0075826031093696,-0.1264091163702563,1
2022-02-15,BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer,MRK,0.0175232647906207,0.1563085081620467,-0.002218140267497,0.001044823854795,0.0003921698243503,-0.0049410496944333,-0.0086362712763847,-0.0075826031093696,-0.1264091163702563,1
2022-02-16,"Merck Inks Oncology, Neurology Drug Discovery Pact With British Biotech, Curve Therapeutics",MRK,-0.0075826031093696,-0.1264091163702563,0.0175232647906207,-0.002218140267497,0.001044823854795,0.0003921698243503,-0.0049410496944333,-0.0111368852332763,-0.1094045865768987,1
2022-02-17,"South Africa Authorizes Merck's COVID-19 Antiviral Pill, But Government Not Buying: Reuters",MRK,-0.0111368852332763,-0.1094045865768987,-0.0075826031093696,0.0175232647906207,-0.002218140267497,0.001044823854795,0.0003921698243503,0.0001308412030163,-0.0122394339261808,2
2022-02-18,See Why Did FDA Update Merck's COVID-19 Pill Emergency Use Authorization,MRK,0.0001308412030163,-0.0122394339261808,-0.0111368852332763,-0.0075826031093696,0.0175232647906207,-0.002218140267497,0.001044823854795,-0.0054995953797916,0.0309777347531461,1
2022-02-25,Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting,MRK,0.0382260123755038,-0.3534179299381139,-0.0307224258590228,-0.0014482758188677,-0.0054995953797916,0.0001308412030163,-0.0111368852332763,0.0034065635049078,0.0336750598204289,2
2022-02-28,Celyad Stops Early-Stage Colorectal Cancer Trial Amid Reported Fatalities,MRK,0.0034065635049078,0.0336750598204289,0.0382260123755038,-0.0307224258590228,-0.0014482758188677,-0.0054995953797916,0.0001308412030163,-0.0031339639917715,-0.3057319429991293,2
2022-03-02,Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates,MRK,0.004322734841033,-0.0111957419473249,-0.0031339639917715,0.0034065635049078,0.0382260123755038,-0.0307224258590228,-0.0014482758188677,0.0062607772584939,-0.1553390048981696,0
2022-03-03,WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients,MRK,0.0062607772584939,-0.1553390048981696,0.004322734841033,-0.0031339639917715,0.0034065635049078,0.0382260123755038,-0.0307224258590228,0.008813907794783,0.4914114099449402,0
2022-03-04,"The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan",MRK,0.008813907794783,0.4914114099449402,0.0062607772584939,0.004322734841033,-0.0031339639917715,0.0034065635049078,0.0382260123755038,-0.0012848204842624,0.1466974452166367,2
2022-03-07,Merck's Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients,MRK,-0.0012848204842624,0.1466974452166367,0.008813907794783,0.0062607772584939,0.004322734841033,-0.0031339639917715,0.0034065635049078,-0.0100348187369118,-0.2730004854230319,1
2022-03-07,Why Alpine Immune's Shares Are Falling Today,MRK,-0.0012848204842624,0.1466974452166367,0.008813907794783,0.0062607772584939,0.004322734841033,-0.0031339639917715,0.0034065635049078,-0.0100348187369118,-0.2730004854230319,1
2022-03-14,AstraZeneca-Merck's Lynparza Wins FDA Approval For Early-Stage Breast Cancer,MRK,0.0027073013140239,0.0701257361133216,0.0047503065526681,0.0012853791435256,0.0109162865211951,-0.0100348187369118,-0.0012848204842624,0.011056829468145,0.130644297697662,0
2022-03-15,Merck-AstraZeneca Stop Keytruda/Lynparza Combo Trial In Prostate Cancer Patients,MRK,0.011056829468145,0.130644297697662,0.0027073013140239,0.0047503065526681,0.0012853791435256,0.0109162865211951,-0.0100348187369118,-0.0066123985320839,-0.0402525651144435,1
2022-03-15,"The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial",MRK,0.011056829468145,0.130644297697662,0.0027073013140239,0.0047503065526681,0.0012853791435256,0.0109162865211951,-0.0100348187369118,-0.0066123985320839,-0.0402525651144435,1
2022-03-16,Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors,MRK,-0.0066123985320839,-0.0402525651144435,0.011056829468145,0.0027073013140239,0.0047503065526681,0.0012853791435256,0.0109162865211951,0.0104967137970621,-0.0607273391812865,0
2022-03-16,Todos Medical Acquires Lucrative NLC Assets For Pennies On The Dollar,MRK,-0.0066123985320839,-0.0402525651144435,0.011056829468145,0.0027073013140239,0.0047503065526681,0.0012853791435256,0.0109162865211951,0.0104967137970621,-0.0607273391812865,0
2022-03-16,"The Daily Biotech Pulse:  Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study",MRK,-0.0066123985320839,-0.0402525651144435,0.011056829468145,0.0027073013140239,0.0047503065526681,0.0012853791435256,0.0109162865211951,0.0104967137970621,-0.0607273391812865,0
2022-03-18,"The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill",MRK,0.0021535416450948,1.049224662918069,0.0104967137970621,-0.0066123985320839,0.011056829468145,0.0027073013140239,0.0047503065526681,-0.000632156216004,-0.5025682655425164,2
2022-03-18,Merck Lays Out Keytruda Data In Post Surgery Early-Stage Lung Cancer Setting,MRK,0.0021535416450948,1.049224662918069,0.0104967137970621,-0.0066123985320839,0.011056829468145,0.0027073013140239,0.0047503065526681,-0.000632156216004,-0.5025682655425164,2
2022-03-22,FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer,MRK,0.0030358318221939,-0.044062491052938,-0.000632156216004,0.0021535416450948,0.0104967137970621,-0.0066123985320839,0.011056829468145,0.005422447093454,-0.1543637561647665,0
2022-03-22,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout",MRK,0.0030358318221939,-0.044062491052938,-0.000632156216004,0.0021535416450948,0.0104967137970621,-0.0066123985320839,0.011056829468145,0.005422447093454,-0.1543637561647665,0
2022-03-23,AstraZeneca's COVID-19 Vaccine Expected To Win European Approval This Week: Reuters,MRK,0.005422447093454,-0.1543637561647665,0.0030358318221939,-0.000632156216004,0.0021535416450948,0.0104967137970621,-0.0066123985320839,0.0085286160807755,-0.1021675481677371,0
2022-03-23,Merck Continues to See Executive Exodus; Here's A Look At All Recent Departures,MRK,0.005422447093454,-0.1543637561647665,0.0030358318221939,-0.000632156216004,0.0021535416450948,0.0104967137970621,-0.0066123985320839,0.0085286160807755,-0.1021675481677371,0
2022-03-23,4D Pharma Shares Soar On MRx0518/Keytruda Combo Trial Data In Renal Cell Carcinoma,MRK,0.005422447093454,-0.1543637561647665,0.0030358318221939,-0.000632156216004,0.0021535416450948,0.0104967137970621,-0.0066123985320839,0.0085286160807755,-0.1021675481677371,0
2022-03-23,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",MRK,0.005422447093454,-0.1543637561647665,0.0030358318221939,-0.000632156216004,0.0021535416450948,0.0104967137970621,-0.0066123985320839,0.0085286160807755,-0.1021675481677371,0
2022-03-24,"The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL",MRK,0.0085286160807755,-0.1021675481677371,0.005422447093454,0.0030358318221939,-0.000632156216004,0.0021535416450948,0.0104967137970621,0.011565783601412,-0.0630374753451676,0
2022-03-25,EMA's Advisory Group Backs Approval For Merck's Keytruda In Various Cancer Settings,MRK,0.011565783601412,-0.0630374753451676,0.0085286160807755,0.005422447093454,0.0030358318221939,-0.000632156216004,0.0021535416450948,-0.0015982749722854,-0.007536207477265,2
2022-03-25,"The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO",MRK,0.011565783601412,-0.0630374753451676,0.0085286160807755,0.005422447093454,0.0030358318221939,-0.000632156216004,0.0021535416450948,-0.0015982749722854,-0.007536207477265,2
2022-03-28,FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant,MRK,-0.0015982749722854,-0.007536207477265,0.011565783601412,0.0085286160807755,0.005422447093454,0.0030358318221939,-0.000632156216004,0.004432995617233,0.0462110606767629,2
2022-03-31,Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients,MRK,-0.0042475534265857,0.3366928998777689,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.011565783601412,0.0085286160807755,0.0179156887017257,-0.1909150704270542,0
2022-04-01,Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates,MRK,0.0179156887017257,-0.1909150704270542,-0.0042475534265857,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.011565783601412,-0.0003590970403289,-0.103809967581072,2
2022-04-01,Mitt Romney Says Senators Reached Tentative $10B Deal In Additional COVID-19 Relief Funding: CNBC,MRK,0.0179156887017257,-0.1909150704270542,-0.0042475534265857,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.011565783601412,-0.0003590970403289,-0.103809967581072,2
2022-04-01,"The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study",MRK,0.0179156887017257,-0.1909150704270542,-0.0042475534265857,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.011565783601412,-0.0003590970403289,-0.103809967581072,2
2022-04-01,FDA Pushes Merck's Pneumococcal Vaccine Decision Date Into July For Expanded Use In Kids,MRK,0.0179156887017257,-0.1909150704270542,-0.0042475534265857,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.011565783601412,-0.0003590970403289,-0.103809967581072,2
2022-04-01,Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo,MRK,0.0179156887017257,-0.1909150704270542,-0.0042475534265857,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.011565783601412,-0.0003590970403289,-0.103809967581072,2
2022-04-04,Merck Expands Elkton Manufacturing Facility To Boost HPV Vaccine Supply,MRK,-0.0003590970403289,-0.103809967581072,0.0179156887017257,-0.0042475534265857,0.0101754128010405,0.004432995617233,-0.0015982749722854,0.002754819380659,0.3320169034028055,2
2022-04-05,MindMed Appoints Francois Lilienthal As New CCO,MRK,0.002754819380659,0.3320169034028055,-0.0003590970403289,0.0179156887017257,-0.0042475534265857,0.0101754128010405,0.004432995617233,0.0149307620223688,0.1564168791369415,0
2022-04-06,"The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy",MRK,0.0149307620223688,0.1564168791369415,0.002754819380659,-0.0003590970403289,0.0179156887017257,-0.0042475534265857,0.0101754128010405,0.0215370322443153,-0.0588898544271525,0
2022-04-06,Iovance Outlines Frontline Melanoma Strategy For Lifileucel / Pembrolizumab Combo Therapy,MRK,0.0149307620223688,0.1564168791369415,0.002754819380659,-0.0003590970403289,0.0179156887017257,-0.0042475534265857,0.0101754128010405,0.0215370322443153,-0.0588898544271525,0
2022-04-11,IMV's MVP-S Doublet Combo Therapy Shows Encouraging Anti Tumor Activity,MRK,-0.0119753114749866,0.2604629556589799,0.0101381874261701,0.0215370322443153,0.0149307620223688,0.002754819380659,-0.0003590970403289,-0.0115433578810192,-0.1278075238161463,1
2022-04-11,Syros' CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies,MRK,-0.0119753114749866,0.2604629556589799,0.0101381874261701,0.0215370322443153,0.0149307620223688,0.002754819380659,-0.0003590970403289,-0.0115433578810192,-0.1278075238161463,1
2022-04-13,Japan-Based Shinogi's COVID-19 Drug Associated With Birth Defects: Bloomberg,MRK,0.0058389438722157,0.0160089292832654,-0.0115433578810192,-0.0119753114749866,0.0101381874261701,0.0215370322443153,0.0149307620223688,0.0090562443464059,0.73387058805066,0
2022-04-13,"Morning Brief: Top Stories Dominating Financial Media on Wednesday, April 13",MRK,0.0058389438722157,0.0160089292832654,-0.0115433578810192,-0.0119753114749866,0.0101381874261701,0.0215370322443153,0.0149307620223688,0.0090562443464059,0.73387058805066,0
2022-04-18,Merck's Keytruda Regime Approved In Canada For Early Breast Cancer Setting,MRK,-0.0096652354832915,-0.6381669163336516,0.0090562443464059,0.0058389438722157,-0.0115433578810192,-0.0119753114749866,0.0101381874261701,-0.0032530966740887,0.0624882740678665,2
2022-04-21,Transportation: Strong Earnings Form Railroad And Airline Stocks Boost the Sector,MRK,-0.0026600971608601,-0.018005826088951,0.0078097351476742,-0.0032530966740887,-0.0096652354832915,0.0090562443464059,0.0058389438722157,-0.0190189767763879,-0.0757264318415397,1
2022-04-22,Will X Mark The Spot For Musk As Streaming Wars Heat Up?,MRK,-0.0190189767763879,-0.0757264318415397,-0.0026600971608601,0.0078097351476742,-0.0032530966740887,-0.0096652354832915,0.0090562443464059,0.0100485031911314,0.3360374020722769,0
2022-04-26,"Morning Brief: Top Financial Stories Dominating on Tuesday, April 26",MRK,-0.0112359116459679,-0.1478994457790303,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0078097351476742,-0.0032530966740887,-0.0008286504858867,0.1966458000355175,2
2022-04-26,Biden Administration Working On Wider Availability Of COVID-19 Pills: WSJ,MRK,-0.0112359116459679,-0.1478994457790303,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0078097351476742,-0.0032530966740887,-0.0008286504858867,0.1966458000355175,2
2022-04-27,The S&P 500 And Nasdaq Testing Major Support Levels,MRK,-0.0008286504858867,0.1966458000355175,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0078097351476742,0.0494016934057548,0.9563781733186164,0
2022-04-27,"Nasdaq Loses Nearly 4%, Techs Reel As Global, Fed, And Earnings Fears Mount",MRK,-0.0008286504858867,0.1966458000355175,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0078097351476742,0.0494016934057548,0.9563781733186164,0
2022-04-28,Markets Surge Despite Drop In US GDP,MRK,0.0494016934057548,0.9563781733186164,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0012417412450809,-0.2454971719537462,2
2022-04-28,"Earnings Scheduled For April 28, 2022",MRK,0.0494016934057548,0.9563781733186164,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0012417412450809,-0.2454971719537462,2
2022-04-28,Are These Global Companies On The Right Side Of History?,MRK,0.0494016934057548,0.9563781733186164,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0012417412450809,-0.2454971719537462,2
2022-04-28,Surprise Negative GDP Report Could Hurt Premarket Rally,MRK,0.0494016934057548,0.9563781733186164,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0012417412450809,-0.2454971719537462,2
2022-04-28,"The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates",MRK,0.0494016934057548,0.9563781733186164,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0012417412450809,-0.2454971719537462,2
2022-04-28,"Merck Clocks 50% Q1 Sales Growth Boosted By COVID-19 Treatment, Tightens FY22 EPS Outlook",MRK,0.0494016934057548,0.9563781733186164,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0026600971608601,0.0012417412450809,-0.2454971719537462,2
2022-04-29,"The Nasdaq, S&P 500 And Dow Took A Big Dive In April",MRK,0.0012417412450809,-0.2454971719537462,0.0494016934057548,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0117262156741408,-0.2381081047115155,1
2022-04-29,From Big Tech To Big Energy: A Wild Week Of Earnings Ends With Mixed Results,MRK,0.0012417412450809,-0.2454971719537462,0.0494016934057548,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0117262156741408,-0.2381081047115155,1
2022-04-29,"The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid",MRK,0.0012417412450809,-0.2454971719537462,0.0494016934057548,-0.0008286504858867,-0.0112359116459679,0.0100485031911314,-0.0190189767763879,-0.0117262156741408,-0.2381081047115155,1
2022-05-16,"Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer",MRK,0.0211259304283359,0.358058226055238,-0.0046239675507162,0.0183876968758671,0.015715740435013,0.0019397601782031,-0.0084851100660848,0.007365624746197,0.2560040002857346,0
2022-05-20,CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting,MRK,0.0158540650733316,0.0571410588404546,-0.0001085478903564,-0.0096773885493771,0.007365624746197,0.0211259304283359,-0.0046239675507162,0.0029930719784829,-0.2288064233526975,2
2022-05-23,Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer,MRK,0.0029930719784829,-0.2288064233526975,0.0158540650733316,-0.0001085478903564,-0.0096773885493771,0.007365624746197,0.0211259304283359,0.0086326136054379,-0.0050733428918054,0
2022-05-24,"The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures",MRK,0.0086326136054379,-0.0050733428918054,0.0029930719784829,0.0158540650733316,-0.0001085478903564,-0.0096773885493771,0.007365624746197,-0.0094040554890679,0.239075490522115,1
2022-05-24,FDA Lifts Partial Hold On Alpine Immune's Davoceticept Combo Trial In Advanced Cancer,MRK,0.0086326136054379,-0.0050733428918054,0.0029930719784829,0.0158540650733316,-0.0001085478903564,-0.0096773885493771,0.007365624746197,-0.0094040554890679,0.239075490522115,1
2022-05-26,"The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review",MRK,-0.0153600673626715,0.5432065630675362,-0.0094040554890679,0.0086326136054379,0.0029930719784829,0.0158540650733316,-0.0001085478903564,0.0083415573660017,-0.4317516449752167,0
2022-05-26,Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients,MRK,-0.0153600673626715,0.5432065630675362,-0.0094040554890679,0.0086326136054379,0.0029930719784829,0.0158540650733316,-0.0001085478903564,0.0083415573660017,-0.4317516449752167,0
2022-05-31,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,MRK,-0.0112806521241497,1.3322587227096512,0.0083415573660017,-0.0153600673626715,-0.0094040554890679,0.0086326136054379,0.0029930719784829,-0.0096707575026747,-0.54102656075028,1
2022-06-06,Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients,MRK,-0.0007785178719066,0.182270690339781,-0.0010000752763611,-0.0125081654009486,-0.0096707575026747,-0.0112806521241497,0.0083415573660017,0.0071237483356341,0.2286701291847088,0
2022-06-06,Yumanity Therapeutics Shares Trading Higher Today - Read Here Why,MRK,-0.0007785178719066,0.182270690339781,-0.0010000752763611,-0.0125081654009486,-0.0096707575026747,-0.0112806521241497,0.0083415573660017,0.0071237483356341,0.2286701291847088,0
2022-06-07,Rising Yields And A Stronger Dollar Pose Risk For Stocks,MRK,0.0071237483356341,0.2286701291847088,-0.0007785178719066,-0.0010000752763611,-0.0125081654009486,-0.0096707575026747,-0.0112806521241497,-0.0110520916487798,0.0022160827077211,1
2022-06-07,"Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study",MRK,0.0071237483356341,0.2286701291847088,-0.0007785178719066,-0.0010000752763611,-0.0125081654009486,-0.0096707575026747,-0.0112806521241497,-0.0110520916487798,0.0022160827077211,1
2022-06-13,HC Wainwright Says This Lymphoma Candidate Has Better Response Rates Than Approved Medications,MRK,-0.0250057359428831,0.3559740904577051,-0.0093181301185433,-0.0165401314855648,-0.0110520916487798,0.0071237483356341,-0.0007785178719066,0.0022536369287624,-0.0656785479481695,2
2022-06-15,Chardan Sees Over 200% Upside On This Small-Cap Cancer-Focused Stock,MRK,0.0015383783656119,0.0115971461400743,0.0022536369287624,-0.0250057359428831,-0.0093181301185433,-0.0165401314855648,-0.0110520916487798,0.0030722150152573,0.1380722191404495,2
2022-06-17,Merck Shows Takeover Interest In Seagen: WSJ,MRK,-0.0031804431535619,1.5523086683378209,0.0030722150152573,0.0015383783656119,0.0022536369287624,-0.0250057359428831,-0.0093181301185433,0.0402977319564834,-0.6429547941592829,0
2022-06-21,SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know,MRK,0.0402977319564834,-0.6429547941592829,-0.0031804431535619,0.0030722150152573,0.0015383783656119,0.0022536369287624,-0.0250057359428831,0.0128365268937689,0.0133122781994463,0
2022-06-21,Recap of Tuesday's Biotech Catalysts - End of the Day Summary,MRK,0.0402977319564834,-0.6429547941592829,-0.0031804431535619,0.0030722150152573,0.0015383783656119,0.0022536369287624,-0.0250057359428831,0.0128365268937689,0.0133122781994463,0
2022-06-21,Merck To Start Pivotal Trial For Next-Gen Pneumococcal Vaccine Next Month,MRK,0.0402977319564834,-0.6429547941592829,-0.0031804431535619,0.0030722150152573,0.0015383783656119,0.0022536369287624,-0.0250057359428831,0.0128365268937689,0.0133122781994463,0
2022-06-23,"The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise",MRK,0.0318528214706119,0.2331719087755752,0.0128365268937689,0.0402977319564834,-0.0031804431535619,0.0030722150152573,0.0015383783656119,0.0122825185166479,0.7154310251114251,0
2022-06-24,Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ,MRK,0.0122825185166479,0.7154310251114251,0.0318528214706119,0.0128365268937689,0.0402977319564834,-0.0031804431535619,0.0030722150152573,0.0137444399372594,-0.5267422886202691,0
2022-06-24,"Benzinga Before The Bell: Gun Safety Bill. Bill Gates North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24",MRK,0.0122825185166479,0.7154310251114251,0.0318528214706119,0.0128365268937689,0.0402977319564834,-0.0031804431535619,0.0030722150152573,0.0137444399372594,-0.5267422886202691,0
2022-06-27,"The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies",MRK,0.0137444399372594,-0.5267422886202691,0.0122825185166479,0.0318528214706119,0.0128365268937689,0.0402977319564834,-0.0031804431535619,-0.0266921727940769,0.131751611013474,1
2022-06-27,EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies,MRK,0.0137444399372594,-0.5267422886202691,0.0122825185166479,0.0318528214706119,0.0128365268937689,0.0402977319564834,-0.0031804431535619,-0.0266921727940769,0.131751611013474,1
2022-06-29,This Analyst Believes Seagen Is Evaluating Strategic Alternatives,MRK,0.0067470939266229,-0.3598382051718145,-0.0266921727940769,0.0137444399372594,0.0122825185166479,0.0318528214706119,0.0128365268937689,-0.0144849166504239,1.1429115985722702,1
2022-07-01,"Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?",MRK,0.0137106339264589,-0.3847472427956919,-0.0144849166504239,0.0067470939266229,-0.0266921727940769,0.0137444399372594,0.0122825185166479,0.00238054227643,-0.1611557938635687,2
2022-07-07,"The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill",MRK,-0.0012884261462782,-0.2214379310015016,0.0052891806995647,0.00238054227643,0.0137106339264589,-0.0144849166504239,0.0067470939266229,-0.0024728928068356,-0.1202196533212123,2
2022-07-07,"Benzinga Before The Bell: Elon Musk's Kids, Apple's Potential Security Measure, Covid-19 Vaccine Wastage And Other Top Financial Stories Thursday, July 7",MRK,-0.0012884261462782,-0.2214379310015016,0.0052891806995647,0.00238054227643,0.0137106339264589,-0.0144849166504239,0.0067470939266229,-0.0024728928068356,-0.1202196533212123,2
2022-07-07,Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills,MRK,-0.0012884261462782,-0.2214379310015016,0.0052891806995647,0.00238054227643,0.0137106339264589,-0.0144849166504239,0.0067470939266229,-0.0024728928068356,-0.1202196533212123,2
2022-07-07,Merck's Potential Buyout Of Seagen Expected Within Next Few Weeks: Report,MRK,-0.0012884261462782,-0.2214379310015016,0.0052891806995647,0.00238054227643,0.0137106339264589,-0.0144849166504239,0.0067470939266229,-0.0024728928068356,-0.1202196533212123,2
2022-07-13,Merck Makes $290M Bet On Prostate Cancer Candidate,MRK,0.0018161603624791,-0.1802721523030729,-0.0074230918479996,0.0163828611980612,-0.0024728928068356,-0.0012884261462782,0.0052891806995647,0.0011732180068013,-0.0225388116466114,2
2022-07-18,"PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors",MRK,-0.0275906026251807,-0.1107902876108467,0.011503942639472,0.0011732180068013,0.0018161603624791,-0.0074230918479996,0.0163828611980612,0.0002166311243037,-0.0485457087719704,2
2022-07-19,Merck & AstraZeneca Partnered Lynparza Fails In Late-Stage Colorectal Cancer Study,MRK,0.0002166311243037,-0.0485457087719704,-0.0275906026251807,0.011503942639472,0.0011732180068013,0.0018161603624791,-0.0074230918479996,-0.0293415890798345,0.4384959191605131,1
2022-07-20,"The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study",MRK,-0.0293415890798345,0.4384959191605131,0.0002166311243037,-0.0275906026251807,0.011503942639472,0.0011732180068013,0.0018161603624791,0.0054655847033888,-0.307919621749409,0
2022-07-20,"Pfizer (PFE), BioNTech Seek EU Nod For Omicron-Based COVID Jab",MRK,-0.0293415890798345,0.4384959191605131,0.0002166311243037,-0.0275906026251807,0.011503942639472,0.0011732180068013,0.0018161603624791,0.0054655847033888,-0.307919621749409,0
2022-07-20,What's In The Offing For Infosys (INFY) This Earnings Season?,MRK,-0.0293415890798345,0.4384959191605131,0.0002166311243037,-0.0275906026251807,0.011503942639472,0.0011732180068013,0.0018161603624791,0.0054655847033888,-0.307919621749409,0
2022-07-26,"Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate",MRK,0.0083950172055227,0.0077932280619059,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0293415890798345,0.0002166311243037,-0.0006571974780217,0.0860915794889385,2
2022-07-26,Seagen Shares Jump On Positive Data From Urothelial Cancer Trial,MRK,0.0083950172055227,0.0077932280619059,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0293415890798345,0.0002166311243037,-0.0006571974780217,0.0860915794889385,2
2022-07-27,"Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy",MRK,-0.0006571974780217,0.0860915794889385,0.0083950172055227,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0293415890798345,-0.0141401487784588,0.9967271004694028,1
2022-07-28,"Earnings Scheduled For July 28, 2022",MRK,-0.0141401487784588,0.9967271004694028,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0066711403276266,0.0739622424477706,1
2022-07-28,Meta and Qualcomm Miss— Will Tech Investors Shrug Off These Reports Too?,MRK,-0.0141401487784588,0.9967271004694028,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0066711403276266,0.0739622424477706,1
2022-07-28,"Keytruda, Gardasil Boost Merck's Q2 Revenues, Tightens Annual Guidance",MRK,-0.0141401487784588,0.9967271004694028,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0066711403276266,0.0739622424477706,1
2022-07-28,Merck & Co: Q2 Earnings Insights,MRK,-0.0141401487784588,0.9967271004694028,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0003327909912579,0.0054655847033888,-0.0066711403276266,0.0739622424477706,1
2022-07-29,"Seagen Q2 Earnings - Better Than Expected, Mum On M&A, Lifts Outlook",MRK,-0.0066711403276266,0.0739622424477706,-0.0141401487784588,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0003327909912579,-0.0090665147669428,-0.5084345253236582,1
2022-08-01,"Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial",MRK,-0.0090665147669428,-0.5084345253236582,-0.0066711403276266,-0.0141401487784588,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0103918639611816,0.013577002165239,1
2022-08-01,FDA Removes Clinical Hold On Celyad's Colorectal Cancer Trial,MRK,-0.0090665147669428,-0.5084345253236582,-0.0066711403276266,-0.0141401487784588,-0.0006571974780217,0.0083950172055227,0.0046609709433327,-0.0103918639611816,0.013577002165239,1
2022-08-03,"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",MRK,0.0001141634281061,0.1000403063280934,-0.0103918639611816,-0.0090665147669428,-0.0066711403276266,-0.0141401487784588,-0.0006571974780217,-0.0091303412465152,-0.0236699399091309,1
2022-08-03,Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary,MRK,0.0001141634281061,0.1000403063280934,-0.0103918639611816,-0.0090665147669428,-0.0066711403276266,-0.0141401487784588,-0.0006571974780217,-0.0091303412465152,-0.0236699399091309,1
2022-08-03,Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal,MRK,0.0001141634281061,0.1000403063280934,-0.0103918639611816,-0.0090665147669428,-0.0066711403276266,-0.0141401487784588,-0.0006571974780217,-0.0091303412465152,-0.0236699399091309,1
2022-08-04,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,MRK,-0.0091303412465152,-0.0236699399091309,0.0001141634281061,-0.0103918639611816,-0.0090665147669428,-0.0066711403276266,-0.0141401487784588,0.0067956746096344,0.1010032775400935,0
2022-08-04,"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",MRK,-0.0091303412465152,-0.0236699399091309,0.0001141634281061,-0.0103918639611816,-0.0090665147669428,-0.0066711403276266,-0.0141401487784588,0.0067956746096344,0.1010032775400935,0
2022-08-08,Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern,MRK,0.0123554530520075,-0.0740580829886833,0.0067956746096344,-0.0091303412465152,0.0001141634281061,-0.0103918639611816,-0.0090665147669428,0.0116396945262937,0.6216531278376323,0
2022-08-09,Merck Re-enters Alzheimer's R&D With Research Pact With Cerevance,MRK,0.0116396945262937,0.6216531278376323,0.0123554530520075,0.0067956746096344,-0.0091303412465152,0.0001141634281061,-0.0103918639611816,-0.0036861416175394,-0.3840414664598388,2
2022-08-10,"Benzinga Before The Bell: Elon Musk Sells $6.8B Tesla Shares, Nio Begins ES7 Test Drives, Coinbase Accused Of Misleading Investors And Other Top Financial Stories Wednesday, August 10",MRK,-0.0036861416175394,-0.3840414664598388,0.0116396945262937,0.0123554530520075,0.0067956746096344,-0.0091303412465152,0.0001141634281061,-0.0029151420266425,-0.0913245374806516,2
2022-08-10,"To Avoid Supply Crunch, FDA Temporarily Allows Higher Impurity Levels In Merck's Diabetes Drug: Report",MRK,-0.0036861416175394,-0.3840414664598388,0.0116396945262937,0.0123554530520075,0.0067956746096344,-0.0091303412465152,0.0001141634281061,-0.0029151420266425,-0.0913245374806516,2
2022-08-10,"Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial",MRK,-0.0036861416175394,-0.3840414664598388,0.0116396945262937,0.0123554530520075,0.0067956746096344,-0.0091303412465152,0.0001141634281061,-0.0029151420266425,-0.0913245374806516,2
2022-08-11,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,MRK,-0.0029151420266425,-0.0913245374806516,-0.0036861416175394,0.0116396945262937,0.0123554530520075,0.0067956746096344,-0.0091303412465152,0.0235015252989234,0.6652200951762925,0
2022-08-12,Senate Finance Committee Expands Amgen's Tax Probe: Report,MRK,0.0235015252989234,0.6652200951762925,-0.0029151420266425,-0.0036861416175394,0.0116396945262937,0.0123554530520075,0.0067956746096344,-0.0046142859492059,-0.4852930431182158,2
2022-08-15,Seagen Suffers Loss In Arbitration Dispute Over ADC Technology,MRK,-0.0046142859492059,-0.4852930431182158,0.0235015252989234,-0.0029151420266425,-0.0036861416175394,0.0116396945262937,0.0123554530520075,-0.0001104818255245,-0.1070380769109435,2
2022-08-16,"Merck Bets $250M On Next-Gen Approach To mRNA For Infectious Diseases, Cancer",MRK,-0.0001104818255245,-0.1070380769109435,-0.0046142859492059,0.0235015252989234,-0.0029151420266425,-0.0036861416175394,0.0116396945262937,0.0049675845445007,0.14569349254575,2
2022-08-16,Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary,MRK,-0.0001104818255245,-0.1070380769109435,-0.0046142859492059,0.0235015252989234,-0.0029151420266425,-0.0036861416175394,0.0116396945262937,0.0049675845445007,0.14569349254575,2
2022-08-16,AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use,MRK,-0.0001104818255245,-0.1070380769109435,-0.0046142859492059,0.0235015252989234,-0.0029151420266425,-0.0036861416175394,0.0116396945262937,0.0049675845445007,0.14569349254575,2
2022-08-18,What's In The Cards For Medtronic (MDT) In Q1 Earnings?,MRK,0.0039541839398546,-0.0577243293246994,0.0049675845445007,-0.0001104818255245,-0.0046142859492059,0.0235015252989234,-0.0029151420266425,0.0074398429741766,0.4445807971725899,0
2022-08-19,Looking For Ebola Virus Meds? WHO Recommends These Two Antibody Treatments,MRK,0.0074398429741766,0.4445807971725899,0.0039541839398546,0.0049675845445007,-0.0001104818255245,-0.0046142859492059,0.0235015252989234,-0.0099913060550544,-0.2465368627317725,1
2022-08-22,FDA Says Study Needed To Assess Another Round Of Pfizer's COVID-19 Pill As Infection Rebounds,MRK,-0.0099913060550544,-0.2465368627317725,0.0074398429741766,0.0039541839398546,0.0049675845445007,-0.0001104818255245,-0.0046142859492059,-0.0105310101931346,-0.2169690774341937,1
2022-08-22,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22",MRK,-0.0099913060550544,-0.2465368627317725,0.0074398429741766,0.0039541839398546,0.0049675845445007,-0.0001104818255245,-0.0046142859492059,-0.0105310101931346,-0.2169690774341937,1
2022-08-22,Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays,MRK,-0.0099913060550544,-0.2465368627317725,0.0074398429741766,0.0039541839398546,0.0049675845445007,-0.0001104818255245,-0.0046142859492059,-0.0105310101931346,-0.2169690774341937,1
2022-08-23,Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary,MRK,-0.0105310101931346,-0.2169690774341937,-0.0099913060550544,0.0074398429741766,0.0039541839398546,0.0049675845445007,-0.0001104818255245,-0.0021063031885633,0.066138074028567,2
2022-08-23,Merck Gets FDA Fast Track Status For Chronic Kidney Disease Candidate,MRK,-0.0105310101931346,-0.2169690774341937,-0.0099913060550544,0.0074398429741766,0.0039541839398546,0.0049675845445007,-0.0001104818255245,-0.0021063031885633,0.066138074028567,2
2022-08-25,Back-To-Back Three Japanese Approvals For AstraZeneca's Rare Disease Treatments,MRK,0.0028884116922904,0.0596041993049178,-0.0021063031885633,-0.0105310101931346,-0.0099913060550544,0.0074398429741766,0.0039541839398546,-0.0111885775951406,-0.03211936848903,1
2022-08-26,Merck's Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report,MRK,-0.0111885775951406,-0.03211936848903,0.0028884116922904,-0.0021063031885633,-0.0105310101931346,-0.0099913060550544,0.0074398429741766,-0.0187093720223616,0.3783646164381156,1
2022-08-26,"Benzinga Before The Bell: Elon Musk's Demand For Broad Twitter Data Dismissed, Xiaomi Wants To Join EV Race, Bed Bath & Beyond Plans To Share Turnaround Strategy Next Week And Other Top Financial Stories Friday, August 26",MRK,-0.0111885775951406,-0.03211936848903,0.0028884116922904,-0.0021063031885633,-0.0105310101931346,-0.0099913060550544,0.0074398429741766,-0.0187093720223616,0.3783646164381156,1
2022-08-29,"Bristol Myers-JNJ Partnered Secondary Stroke Drug Misses Endpoint, But Companies See Enough Potential For Phase 3 Trials",MRK,-0.0187093720223616,0.3783646164381156,-0.0111885775951406,0.0028884116922904,-0.0021063031885633,-0.0105310101931346,-0.0099913060550544,-0.0081060305139621,-0.1396397544011617,1
2022-08-30,"With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report",MRK,-0.0081060305139621,-0.1396397544011617,-0.0187093720223616,-0.0111885775951406,0.0028884116922904,-0.0021063031885633,-0.0105310101931346,-0.0174953286927733,0.7177968611193366,1
2022-09-01,"Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash…",MRK,0.0209700709237086,-0.3510946388553697,-0.0174953286927733,-0.0081060305139621,-0.0187093720223616,-0.0111885775951406,0.0028884116922904,-0.0105564156794523,-0.0705443243099647,1
2022-09-01,Novartis Appoints Merck Executive As Research Head,MRK,0.0209700709237086,-0.3510946388553697,-0.0174953286927733,-0.0081060305139621,-0.0187093720223616,-0.0111885775951406,0.0028884116922904,-0.0105564156794523,-0.0705443243099647,1
2022-09-09,"Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary",MRK,-0.0009151141146052,-0.0775785527548956,0.0063313097048911,0.0052071033246114,0.0022032762105204,-0.0105564156794523,0.0209700709237086,0.0093886451189078,-0.1508803358243874,0
2022-09-09,AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer,MRK,-0.0009151141146052,-0.0775785527548956,0.0063313097048911,0.0052071033246114,0.0022032762105204,-0.0105564156794523,0.0209700709237086,0.0093886451189078,-0.1508803358243874,0
2022-09-12,"BP To $47? Plus UBS Sees $2,260 For This Stock",MRK,0.0093886451189078,-0.1508803358243874,-0.0009151141146052,0.0063313097048911,0.0052071033246114,0.0022032762105204,-0.0105564156794523,-0.0213249349379913,0.2044398960875384,1
2022-09-12,Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer,MRK,0.0093886451189078,-0.1508803358243874,-0.0009151141146052,0.0063313097048911,0.0052071033246114,0.0022032762105204,-0.0105564156794523,-0.0213249349379913,0.2044398960875384,1
2022-09-12,Five-Year Data For Merck's Keytruda Plus Chemo Shows Sustained Survival Benefit In Lung Cancer Patients,MRK,0.0093886451189078,-0.1508803358243874,-0.0009151141146052,0.0063313097048911,0.0052071033246114,0.0022032762105204,-0.0105564156794523,-0.0213249349379913,0.2044398960875384,1
2022-09-13,"Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary",MRK,-0.0213249349379913,0.2044398960875384,0.0093886451189078,-0.0009151141146052,0.0063313097048911,0.0052071033246114,0.0022032762105204,0.015889708282694,0.231202614379085,0
2022-09-13,"After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff",MRK,-0.0213249349379913,0.2044398960875384,0.0093886451189078,-0.0009151141146052,0.0063313097048911,0.0052071033246114,0.0022032762105204,0.015889708282694,0.231202614379085,0
2022-09-14,Immutep Issues Development Update For Its Lead Cancer Candidate,MRK,0.015889708282694,0.231202614379085,-0.0213249349379913,0.0093886451189078,-0.0009151141146052,0.0063313097048911,0.0052071033246114,-0.0023001675007908,-0.1499039145529638,2
2022-09-14,"Evercore ISI Group Boosts PT On This Stock By Around 400%, Plus This Analyst Predicts $100 For Merck",MRK,0.015889708282694,0.231202614379085,-0.0213249349379913,0.0093886451189078,-0.0009151141146052,0.0063313097048911,0.0052071033246114,-0.0023001675007908,-0.1499039145529638,2
2022-09-20,Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold,MRK,-0.0073868363502184,-0.2960276695144929,-0.0123118922185103,0.0111815585183621,-0.0023001675007908,0.015889708282694,-0.0213249349379913,-0.0170931017288953,0.3182518149153039,1
2022-09-22,Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial,MRK,0.035253789408411,0.714649274072426,-0.0170931017288953,-0.0073868363502184,-0.0123118922185103,0.0111815585183621,-0.0023001675007908,-0.0083418589153374,-0.2669326909819379,1
2022-09-23,Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings,MRK,-0.0083418589153374,-0.2669326909819379,0.035253789408411,-0.0170931017288953,-0.0073868363502184,-0.0123118922185103,0.0111815585183621,-0.0069140199653399,-0.0218509708469325,1
2022-09-27,"Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer",MRK,-0.0039453655661573,-0.2611582400180975,-0.0069140199653399,-0.0083418589153374,0.035253789408411,-0.0170931017288953,-0.0073868363502184,0.0109507266400323,0.0471364492276602,0
2022-09-29,Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China,MRK,-0.0016133247938096,-0.0348976608187134,0.0109507266400323,-0.0039453655661573,-0.0069140199653399,-0.0083418589153374,0.035253789408411,-0.0060018156918368,0.3687606986502658,1
2022-09-29,"Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29",MRK,-0.0016133247938096,-0.0348976608187134,0.0109507266400323,-0.0039453655661573,-0.0069140199653399,-0.0083418589153374,0.035253789408411,-0.0060018156918368,0.3687606986502658,1
2022-09-30,"'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company",MRK,-0.0060018156918368,0.3687606986502658,-0.0016133247938096,0.0109507266400323,-0.0039453655661573,-0.0069140199653399,-0.0083418589153374,0.0166047634552606,0.0167448758245163,0
2022-10-03,The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short,MRK,0.0166047634552606,0.0167448758245163,-0.0060018156918368,-0.0016133247938096,0.0109507266400323,-0.0039453655661573,-0.0069140199653399,0.0095944604754514,-0.1974441868312488,0
2022-10-05,AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial,MRK,0.0,-0.177309100773091,0.0095944604754514,0.0166047634552606,-0.0060018156918368,-0.0016133247938096,0.0109507266400323,-0.0107477548037855,0.3280412813030648,1
2022-10-06,"Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About ""DeeperPocketed"" Competition",MRK,-0.0107477548037855,0.3280412813030648,0.0,0.0095944604754514,0.0166047634552606,-0.0060018156918368,-0.0016133247938096,0.0018297689586139,0.0970641176835702,2
2022-10-07,"Amazon Halts Delivery Bots; Merck's Covid-19 Pill Didn't Reduce Risk; Samsung Profits Slip; Adidas Reviews Relationship With Kanye: Top Stories Friday, Oct. 7",MRK,0.0018297689586139,0.0970641176835702,-0.0107477548037855,0.0,0.0095944604754514,0.0166047634552606,-0.0060018156918368,0.0328767457059013,0.6390567361441148,0
2022-10-07,UK Study Shows Merck's COVID-19 Antiviral Pill Did Not Cut Hospitalization Risk,MRK,0.0018297689586139,0.0970641176835702,-0.0107477548037855,0.0,0.0095944604754514,0.0166047634552606,-0.0060018156918368,0.0328767457059013,0.6390567361441148,0
2022-10-10,New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope,MRK,0.0328767457059013,0.6390567361441148,0.0018297689586139,-0.0107477548037855,0.0,0.0095944604754514,0.0166047634552606,0.0062997462819429,-0.3273386261649983,0
2022-10-10,Centre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial,MRK,0.0328767457059013,0.6390567361441148,0.0018297689586139,-0.0107477548037855,0.0,0.0095944604754514,0.0166047634552606,0.0062997462819429,-0.3273386261649983,0
2022-10-11,PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers,MRK,0.0062997462819429,-0.3273386261649983,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0095944604754514,-0.0069193190043369,-0.1253451018627803,1
2022-10-11,Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing,MRK,0.0062997462819429,-0.3273386261649983,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0095944604754514,-0.0069193190043369,-0.1253451018627803,1
2022-10-11,"With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade",MRK,0.0062997462819429,-0.3273386261649983,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0095944604754514,-0.0069193190043369,-0.1253451018627803,1
2022-10-11,Merck To Rally Over 29%? Here Are 5 Other Price Target Changes For Tuesday,MRK,0.0062997462819429,-0.3273386261649983,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0095944604754514,-0.0069193190043369,-0.1253451018627803,1
2022-10-12,Moderna Shares Are Surging After Merck Exercised Personalized Cancer Vaccine Pact,MRK,-0.0069193190043369,-0.1253451018627803,0.0062997462819429,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0228931403710974,0.1009833141677032,0
2022-10-12,"Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot",MRK,-0.0069193190043369,-0.1253451018627803,0.0062997462819429,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0228931403710974,0.1009833141677032,0
2022-10-12,Why Moderna Stock Is Moving Higher Today,MRK,-0.0069193190043369,-0.1253451018627803,0.0062997462819429,0.0328767457059013,0.0018297689586139,-0.0107477548037855,0.0,0.0228931403710974,0.1009833141677032,0
2022-10-18,Merck Outlicenses Two Preclinical TB Candidates To Bill & Melinda Gates Research Institute,MRK,0.0052061165995271,-0.2149394136593161,0.0210457840729501,-0.0033516980230952,0.0228931403710974,-0.0069193190043369,0.0062997462819429,-0.0142690325015942,-0.1032800302190883,1
2022-10-24,Merck's Antiviral Therapy Shows Efficacy In Prevention of Cytomegalovirus In Kidney Transplant Patients,MRK,0.0177694573205406,0.1085440702326845,0.0293737827732807,-0.0034313259661818,-0.0142690325015942,0.0052061165995271,0.0210457840729501,0.0034917956502542,-0.2336419942356044,2
2022-10-27,"Merck Clocks More Than 50% Drop In COVID-19 Treatment Sales, Revises Annual Guidance",MRK,0.0135147538479261,0.1777111627324163,0.0071641202294467,0.0034917956502542,0.0177694573205406,0.0293737827732807,-0.0034313259661818,0.0103268819848827,-0.0810580763438748,0
2022-10-27,"Elon Musk & Philippine Billionaire Come Together For Satellite Internet Service In Southeast Asia, Disney May Track Your Theme Park Preferences, Struggling Credit Suisse Reveals Business Overhaul: Top Stories Thursday, Oct. 27",MRK,0.0135147538479261,0.1777111627324163,0.0071641202294467,0.0034917956502542,0.0177694573205406,0.0293737827732807,-0.0034313259661818,0.0103268819848827,-0.0810580763438748,0
2022-10-27,"US Stocks On Track For Mixed Start As Nasdaq Futures Sag Yet Again Amid Big Tech Woes; Traders Look Ahead To Q3 GDP Data, Apple, Amazon Earnings",MRK,0.0135147538479261,0.1777111627324163,0.0071641202294467,0.0034917956502542,0.0177694573205406,0.0293737827732807,-0.0034313259661818,0.0103268819848827,-0.0810580763438748,0
2022-10-31,Bristol Myers Touts Positive Reblozyl Data From Late-Stage Blood Disorder Study,MRK,0.0042671107087419,-0.0164054150338439,0.0103268819848827,0.0135147538479261,0.0071641202294467,0.0034917956502542,0.0177694573205406,-0.014229187999572,0.0032144732791248,1
2022-11-02,EVP of Merck & Co Sold $2.49M In Stock,MRK,-0.0036086838490002,-0.1422292022059155,-0.014229187999572,0.0042671107087419,0.0103268819848827,0.0135147538479261,0.0071641202294467,-0.0065392600674589,0.043057820802862,1
2022-11-02,Massive Insider Trade At Merck & Co,MRK,-0.0036086838490002,-0.1422292022059155,-0.014229187999572,0.0042671107087419,0.0103268819848827,0.0135147538479261,0.0071641202294467,-0.0065392600674589,0.043057820802862,1
2022-11-02,EVP At This Health Care Company Sells $16.42M of Stock,MRK,-0.0036086838490002,-0.1422292022059155,-0.014229187999572,0.0042671107087419,0.0103268819848827,0.0135147538479261,0.0071641202294467,-0.0065392600674589,0.043057820802862,1
2022-11-04,Merck & Co Executive Chair Trades Company's Stock,MRK,0.0045569913676377,-0.1044216005730023,-0.0065392600674589,-0.0036086838490002,-0.014229187999572,0.0042671107087419,0.0103268819848827,0.0087701655339511,-0.0262570965125709,0
2022-11-07,Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch,MRK,0.0087701655339511,-0.0262570965125709,0.0045569913676377,-0.0065392600674589,-0.0036086838490002,-0.014229187999572,0.0042671107087419,0.0142900198453177,-0.0162646769622303,0
2022-11-08,Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?,MRK,0.0142900198453177,-0.0162646769622303,0.0087701655339511,0.0045569913676377,-0.0065392600674589,-0.0036086838490002,-0.014229187999572,0.0008866289767446,0.2468279260104187,2
2022-11-09,Executive Chair At This Health Care Company Sells $23.47M of Stock,MRK,0.0008866289767446,0.2468279260104187,0.0142900198453177,0.0087701655339511,0.0045569913676377,-0.0065392600674589,-0.0036086838490002,0.0029531163659846,-0.0987371379528242,2
2022-11-10,SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients,MRK,0.0029531163659846,-0.0987371379528242,0.0008866289767446,0.0142900198453177,0.0087701655339511,0.0045569913676377,-0.0065392600674589,-0.0385710517877032,0.3962745918794474,1
2022-11-11,What Does Merck & Co's Debt Look Like?,MRK,-0.0385710517877032,0.3962745918794474,0.0029531163659846,0.0008866289767446,0.0142900198453177,0.0087701655339511,0.0045569913676377,0.0243976684730329,-0.3286116857031508,0
2022-11-11,"These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk",MRK,-0.0385710517877032,0.3962745918794474,0.0029531163659846,0.0008866289767446,0.0142900198453177,0.0087701655339511,0.0045569913676377,0.0243976684730329,-0.3286116857031508,0
2022-11-14,European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs,MRK,0.0243976684730329,-0.3286116857031508,-0.0385710517877032,0.0029531163659846,0.0008866289767446,0.0142900198453177,0.0087701655339511,-0.0074737871837905,-0.1107700207630997,1
2022-11-16,"FTX Contagion Spreads To Hong Kong Exchange, Microsoft Outlines New Harassment Policies, Netflix Subscribers Can Terminate Freeloading Account Access: Top Stories Wednesday, Nov. 16",MRK,0.0033132225157508,0.0993986869029237,-0.0074737871837905,0.0243976684730329,-0.0385710517877032,0.0029531163659846,0.0008866289767446,0.0238167134809723,-0.0297909268415222,0
2022-11-16,"Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says",MRK,0.0033132225157508,0.0993986869029237,-0.0074737871837905,0.0243976684730329,-0.0385710517877032,0.0029531163659846,0.0008866289767446,0.0238167134809723,-0.0297909268415222,0
2022-11-17,A Look Into Merck & Co's Debt,MRK,0.0238167134809723,-0.0297909268415222,0.0033132225157508,-0.0074737871837905,0.0243976684730329,-0.0385710517877032,0.0029531163659846,0.0187665134637995,0.3683151304020338,0
2022-11-17,Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial,MRK,0.0238167134809723,-0.0297909268415222,0.0033132225157508,-0.0074737871837905,0.0243976684730329,-0.0385710517877032,0.0029531163659846,0.0187665134637995,0.3683151304020338,0
2022-11-18,Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years,MRK,0.0187665134637995,0.3683151304020338,0.0238167134809723,0.0033132225157508,-0.0074737871837905,0.0243976684730329,-0.0385710517877032,0.0132399357739061,-0.234554415420211,0
2022-11-18,Credit Suisse Believes In This Pharma Giant's Low Risk Growth Against Uncertain Backdrop,MRK,0.0187665134637995,0.3683151304020338,0.0238167134809723,0.0033132225157508,-0.0074737871837905,0.0243976684730329,-0.0385710517877032,0.0132399357739061,-0.234554415420211,0
2022-11-21,Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated',MRK,0.0132399357739061,-0.234554415420211,0.0187665134637995,0.0238167134809723,0.0033132225157508,-0.0074737871837905,0.0243976684730329,0.0122148061953688,-0.0678255593136538,0
2022-11-21,Cancer-Focused Imago BioSciences Shares Soar After Merck Deal,MRK,0.0132399357739061,-0.234554415420211,0.0187665134637995,0.0238167134809723,0.0033132225157508,-0.0074737871837905,0.0243976684730329,0.0122148061953688,-0.0678255593136538,0
2022-11-22,"$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today",MRK,0.0122148061953688,-0.0678255593136538,0.0132399357739061,0.0187665134637995,0.0238167134809723,0.0033132225157508,-0.0074737871837905,-0.0007484480878982,-0.306918041877117,2
2022-11-22,Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients,MRK,0.0122148061953688,-0.0678255593136538,0.0132399357739061,0.0187665134637995,0.0238167134809723,0.0033132225157508,-0.0074737871837905,-0.0007484480878982,-0.306918041877117,2
2022-11-22,10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients,MRK,0.0122148061953688,-0.0678255593136538,0.0132399357739061,0.0187665134637995,0.0238167134809723,0.0033132225157508,-0.0074737871837905,-0.0007484480878982,-0.306918041877117,2
2022-11-23,Mirati Therapeutics Garners Interest From Large Pharmas Ahead Of Much Awaited Data Next Month,MRK,-0.0007484480878982,-0.306918041877117,0.0122148061953688,0.0132399357739061,0.0187665134637995,0.0238167134809723,0.0033132225157508,0.0063659222334098,-0.4497530262974816,0
2022-11-29,"Cramer Expects Dow's Outperformance To Last 'Longer' As Traders Chase 'Old-Fashioned, Profitable' Companies Amid Uncertainty",MRK,0.0035961265571853,-0.0180691899837261,0.0088371536256472,0.0063659222334098,-0.0007484480878982,0.0122148061953688,0.0132399357739061,0.0117604419057915,1.1711860057311494,0
2022-12-06,"Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy",MRK,-0.0098172117751991,0.0713598299314841,-0.0002726767240337,0.0021858298360173,-0.0029059705053122,0.0117604419057915,0.0035961265571853,0.0106489741064919,0.1088259348143778,0
2022-12-07,A Look Into Merck & Co's Debt,MRK,0.0106489741064919,0.1088259348143778,-0.0098172117751991,-0.0002726767240337,0.0021858298360173,-0.0029059705053122,0.0117604419057915,0.0069034556545557,-0.1107080673244341,0
2022-12-07,GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial,MRK,0.0106489741064919,0.1088259348143778,-0.0098172117751991,-0.0002726767240337,0.0021858298360173,-0.0029059705053122,0.0117604419057915,0.0069034556545557,-0.1107080673244341,0
2022-12-08,Here's How Much $100 Invested In Merck & Co 5 Years Ago Would Be Worth Today,MRK,0.0069034556545557,-0.1107080673244341,0.0106489741064919,-0.0098172117751991,-0.0002726767240337,0.0021858298360173,-0.0029059705053122,-0.0186738635186368,0.3144884973078805,1
2022-12-09,"Stryker, Freeport-McMoRan, Southwest Gas And This Health Care Major Feature On CNBC's 'Final Trades'",MRK,-0.0186738635186368,0.3144884973078805,0.0069034556545557,0.0106489741064919,-0.0098172117751991,-0.0002726767240337,0.0021858298360173,0.0017466478387855,0.1333085086576055,2
2022-12-13,"Moderna's Data From Personalized Cancer Vaccine Provides Relief To Investors, Analyst Says",MRK,0.0178030680986409,0.445421024770458,0.0017466478387855,-0.0186738635186368,0.0069034556545557,0.0106489741064919,-0.0098172117751991,0.0124342098107044,-0.3187871363713858,0
2022-12-13,"Tesla, Amazon, Coinbase, Moderna, Nuwellis: Why These 5 Stocks Are Drawing Investors' Attention Today",MRK,0.0178030680986409,0.445421024770458,0.0017466478387855,-0.0186738635186368,0.0069034556545557,0.0106489741064919,-0.0098172117751991,0.0124342098107044,-0.3187871363713858,0
2022-12-13,"Moderna-Merck Partnered Cancer Vaccine Meets Primary Efficacy Endpoint, Stock Jumps",MRK,0.0178030680986409,0.445421024770458,0.0017466478387855,-0.0186738635186368,0.0069034556545557,0.0106489741064919,-0.0098172117751991,0.0124342098107044,-0.3187871363713858,0
2022-12-14,Market Volatility Drops Sharply Ahead Of Fed's Rate Decision,MRK,0.0124342098107044,-0.3187871363713858,0.0178030680986409,0.0017466478387855,-0.0186738635186368,0.0069034556545557,0.0106489741064919,-0.0172121012941134,-0.0849902208874429,1
2022-12-15,"BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities",MRK,-0.0172121012941134,-0.0849902208874429,0.0124342098107044,0.0178030680986409,0.0017466478387855,-0.0186738635186368,0.0069034556545557,-0.0039222965939326,1.984976801669469,2
2022-12-15,"Elon Musk Dumps Another $3.6B Tesla Stock, Facebook's Jobs' Feature To Disappear Next Year, Foxconn Relaxes Covid Restrictions In China Factory: Today's Top Stories",MRK,-0.0172121012941134,-0.0849902208874429,0.0124342098107044,0.0178030680986409,0.0017466478387855,-0.0186738635186368,0.0069034556545557,-0.0039222965939326,1.984976801669469,2
2022-12-15,"FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug, Lynparza",MRK,-0.0172121012941134,-0.0849902208874429,0.0124342098107044,0.0178030680986409,0.0017466478387855,-0.0186738635186368,0.0069034556545557,-0.0039222965939326,1.984976801669469,2
2022-12-15,"West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies",MRK,-0.0172121012941134,-0.0849902208874429,0.0124342098107044,0.0178030680986409,0.0017466478387855,-0.0186738635186368,0.0069034556545557,-0.0039222965939326,1.984976801669469,2
2022-12-20,"Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says",MRK,0.0024670983357528,0.1543276494711849,0.0021978665196216,-0.0039222965939326,-0.0172121012941134,0.0124342098107044,0.0178030680986409,0.0127609260799159,-0.1721640488656195,0
2022-12-21,"Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings",MRK,0.0127609260799159,-0.1721640488656195,0.0024670983357528,0.0021978665196216,-0.0039222965939326,-0.0172121012941134,0.0124342098107044,0.0011699623151963,0.2609284886084717,2
2022-12-21,"After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm",MRK,0.0127609260799159,-0.1721640488656195,0.0024670983357528,0.0021978665196216,-0.0039222965939326,-0.0172121012941134,0.0124342098107044,0.0011699623151963,0.2609284886084717,2
2022-12-22,"Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates",MRK,0.0011699623151963,0.2609284886084717,0.0127609260799159,0.0024670983357528,0.0021978665196216,-0.0039222965939326,-0.0172121012941134,0.0055735653442248,-0.4569425701899996,0
2022-12-23,$100 Invested In Merck & Co 5 Years Ago Would Be Worth This Much Today,MRK,0.0055735653442248,-0.4569425701899996,0.0011699623151963,0.0127609260799159,0.0024670983357528,0.0021978665196216,-0.0039222965939326,0.0023243732831959,0.1271935611558252,2
2022-12-23,"Merck COVID Antiviral Does Not Reduce Risk Of Hospitalization, Death Rates In Vaccinated Individuals",MRK,0.0055735653442248,-0.4569425701899996,0.0011699623151963,0.0127609260799159,0.0024670983357528,0.0021978665196216,-0.0039222965939326,0.0023243732831959,0.1271935611558252,2
2022-12-23,"Meta Settles Cambridge Analytica Scandal Case, Microsoft Files Rebuttal To FTC's Lawsuit Against Activision Deal, US Winter Storm Snaps Holiday Plans: Today's Top Stories",MRK,0.0055735653442248,-0.4569425701899996,0.0011699623151963,0.0127609260799159,0.0024670983357528,0.0021978665196216,-0.0039222965939326,0.0023243732831959,0.1271935611558252,2
2022-12-27,"Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors",MRK,0.0023243732831959,0.1271935611558252,0.0055735653442248,0.0011699623151963,0.0127609260799159,0.0024670983357528,0.0021978665196216,-0.0092757953637878,-0.0035116469624253,1
2022-12-28,"AT&T, Merck And This Leading Payments Processor Stock On CNBC's 'Final Trades'",MRK,-0.0092757953637878,-0.0035116469624253,0.0023243732831959,0.0055735653442248,0.0011699623151963,0.0127609260799159,0.0024670983357528,-0.0023406949078058,-0.1254160303849015,2
2023-01-04,"Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another",MRK,0.0084578002378417,0.0788961240310077,0.0017125013986951,0.001173093307434,-0.0023406949078058,-0.0092757953637878,0.0023243732831959,0.0139185904346121,0.1012001931345274,0
2023-01-11,"FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian's Executive Departures: Today's Top Stories",MRK,0.0023463983990912,-0.288406968687102,0.0038955759311578,-0.0388365803627831,0.0105596328222321,0.0139185904346121,0.0084578002378417,0.0063023373366575,0.0334202747348286,0
2023-01-11,"Merck, Pfizer Rebuts China's Request For Further Price Cuts For COVID-19 Drugs",MRK,0.0023463983990912,-0.288406968687102,0.0038955759311578,-0.0388365803627831,0.0105596328222321,0.0139185904346121,0.0084578002378417,0.0063023373366575,0.0334202747348286,0
2023-01-13,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",MRK,0.0042945214127738,-0.3541302104365773,0.0063023373366575,0.0023463983990912,0.0038955759311578,-0.0388365803627831,0.0105596328222321,-0.0160356585532147,0.7786480947584147,1
2023-01-18,Can Cannabinoid CB2 Receptor Antagonist Combined With KEYTRUDA Be Effective In Patients With Advanced Solid Tumors? These Two Companies Aim To Find Out,MRK,-0.015029406797604,-0.1407661286385251,-0.0160356585532147,0.0042945214127738,0.0063023373366575,0.0023463983990912,0.0038955759311578,0.0102031859480959,-0.2303085402579692,0
2023-01-19,"Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects",MRK,0.0102031859480959,-0.2303085402579692,-0.015029406797604,-0.0160356585532147,0.0042945214127738,0.0063023373366575,0.0023463983990912,0.0003639895180524,0.3607907986239278,2
2023-01-20,Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer,MRK,0.0003639895180524,0.3607907986239278,0.0102031859480959,-0.015029406797604,-0.0160356585532147,0.0042945214127738,0.0063023373366575,-0.0005458205560591,-0.0236206803016328,2
2023-01-31,"February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More",MRK,0.012442303876629,0.2257820461353179,0.0067375514516621,-0.0139422531212999,-0.015839305398428,0.0006449933971535,-0.0123771276760494,-0.004003364222103,0.2726196324427816,2
2023-02-02,Central Banks And More Earnings,MRK,-0.0329033500178703,0.6064118299152743,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,-0.015839305398428,-0.0050260334811975,-0.3092502110302589,1
2023-02-02,"US Stocks Higher, NASDAQ Adds Over 230 Points",MRK,-0.0329033500178703,0.6064118299152743,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,-0.015839305398428,-0.0050260334811975,-0.3092502110302589,1
2023-02-02,"Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?",MRK,-0.0329033500178703,0.6064118299152743,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,-0.015839305398428,-0.0050260334811975,-0.3092502110302589,1
2023-02-02,"Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023",MRK,-0.0329033500178703,0.6064118299152743,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,-0.015839305398428,-0.0050260334811975,-0.3092502110302589,1
2023-02-03,Why Personalis Shares Are Trading Higher Today,MRK,-0.0050260334811975,-0.3092502110302589,-0.0329033500178703,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,0.0105886123963059,-0.1923413137331858,0
2023-02-03,Merck's Keytruda Plus Chemo Combo Aces Late-Stage Study In Advanced Endometrial Cancer Patients,MRK,-0.0050260334811975,-0.3092502110302589,-0.0329033500178703,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,0.0105886123963059,-0.1923413137331858,0
2023-02-03,"Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutations, Study Shows",MRK,-0.0050260334811975,-0.3092502110302589,-0.0329033500178703,-0.004003364222103,0.012442303876629,0.0067375514516621,-0.0139422531212999,0.0105886123963059,-0.1923413137331858,0
2023-02-06,"Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down",MRK,0.0105886123963059,-0.1923413137331858,-0.0050260334811975,-0.0329033500178703,-0.004003364222103,0.012442303876629,0.0067375514516621,0.0158608391114691,-0.126986581257938,0
2023-02-08,"If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today",MRK,0.0090840017179347,0.0874922514453426,0.0158608391114691,0.0105886123963059,-0.0050260334811975,-0.0329033500178703,-0.004003364222103,0.0007502334844173,-0.0720658888126286,2
2023-02-08,Analyst Reiterates This Alzheimer's Candidate As Top Idea For 2023,MRK,0.0090840017179347,0.0874922514453426,0.0158608391114691,0.0105886123963059,-0.0050260334811975,-0.0329033500178703,-0.004003364222103,0.0007502334844173,-0.0720658888126286,2
2023-02-09,"Aligos Reprioritizes Pipeline With Focus On NASH, COVID Programs, Cuts Another 10% Of Its Workforce",MRK,0.0007502334844173,-0.0720658888126286,0.0090840017179347,0.0158608391114691,0.0105886123963059,-0.0050260334811975,-0.0329033500178703,0.0173350813660166,-0.046033497141711,0
2023-02-09,"Amazon, Tesla And 2 Other Stocks Insiders Are Selling",MRK,0.0007502334844173,-0.0720658888126286,0.0090840017179347,0.0158608391114691,0.0105886123963059,-0.0050260334811975,-0.0329033500178703,0.0173350813660166,-0.046033497141711,0
2023-02-10,"If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today",MRK,0.0173350813660166,-0.046033497141711,0.0007502334844173,0.0090840017179347,0.0158608391114691,0.0105886123963059,-0.0050260334811975,0.0090264561833284,-0.0297650336417156,0
2023-02-13,"Stellar Opportunity For Merck At Upcoming Data Presentation, Analyst Says While Boosting Price Target",MRK,0.0090264561833284,-0.0297650336417156,0.0173350813660166,0.0007502334844173,0.0090840017179347,0.0158608391114691,0.0105886123963059,-0.0073939331122409,-0.0540694288307079,1
2023-02-13,"Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling",MRK,0.0090264561833284,-0.0297650336417156,0.0173350813660166,0.0007502334844173,0.0090840017179347,0.0158608391114691,0.0105886123963059,-0.0073939331122409,-0.0540694288307079,1
2023-02-13,IMV Stock Falls After Interim Data From Lead Candidate In Blood Cancer Subtype,MRK,0.0090264561833284,-0.0297650336417156,0.0173350813660166,0.0007502334844173,0.0090840017179347,0.0158608391114691,0.0105886123963059,-0.0073939331122409,-0.0540694288307079,1
2023-02-14,Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,MRK,-0.0073939331122409,-0.0540694288307079,0.0090264561833284,0.0173350813660166,0.0007502334844173,0.0090840017179347,0.0158608391114691,-0.0097480190383699,-0.0812296854193216,1
2023-02-14,BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype,MRK,-0.0073939331122409,-0.0540694288307079,0.0090264561833284,0.0173350813660166,0.0007502334844173,0.0090840017179347,0.0158608391114691,-0.0097480190383699,-0.0812296854193216,1
2023-02-15,EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue,MRK,-0.0097480190383699,-0.0812296854193216,-0.0073939331122409,0.0090264561833284,0.0173350813660166,0.0007502334844173,0.0090840017179347,-0.0108654969975855,-0.0712682729171212,1
2023-02-15,"Robinhood, Merck And 2 Other Stocks Insiders Are Selling",MRK,-0.0097480190383699,-0.0812296854193216,-0.0073939331122409,0.0090264561833284,0.0173350813660166,0.0007502334844173,0.0090840017179347,-0.0108654969975855,-0.0712682729171212,1
2023-02-16,Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings,MRK,-0.0108654969975855,-0.0712682729171212,-0.0097480190383699,-0.0073939331122409,0.0090264561833284,0.0173350813660166,0.0007502334844173,0.0282602011195685,0.5898847180037925,0
2023-02-21,Merck's COVID-19 Treatment Fails To Prevent Infection In Household Exposure,MRK,-0.0041088271355571,-0.2884660038418508,0.0282602011195685,-0.0108654969975855,-0.0097480190383699,-0.0073939331122409,0.0090264561833284,0.0008252262856971,0.070073425795446,2
2023-02-22,Jim Cramer Lists 6 Conditions For Market Selloff To End Amid 'Discouraging' Inflation Data,MRK,0.0008252262856971,0.070073425795446,-0.0041088271355571,0.0282602011195685,-0.0108654969975855,-0.0097480190383699,-0.0073939331122409,0.0130999756915213,-0.0403526525180554,0
2023-02-23,"Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge",MRK,0.0130999756915213,-0.0403526525180554,0.0008252262856971,-0.0041088271355571,0.0282602011195685,-0.0108654969975855,-0.0097480190383699,-0.0063296916493946,-0.1639365574622985,1
2023-02-24,European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill,MRK,-0.0063296916493946,-0.1639365574622985,0.0130999756915213,0.0008252262856971,-0.0041088271355571,0.0282602011195685,-0.0108654969975855,-0.0048229680324914,-0.0229962507990808,2
2023-02-24,"US Senators Warren, Sanders Urge 'Close Scrutiny' On Merck's Keytruda-Related Patents",MRK,-0.0063296916493946,-0.1639365574622985,0.0130999756915213,0.0008252262856971,-0.0041088271355571,0.0282602011195685,-0.0108654969975855,-0.0048229680324914,-0.0229962507990808,2
2023-02-27,Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions,MRK,-0.0048229680324914,-0.0229962507990808,-0.0063296916493946,0.0130999756915213,0.0008252262856971,-0.0041088271355571,0.0282602011195685,-0.02852968658314,0.8055280469689468,1
2023-02-27,Here's How Much $1000 Invested In Merck & Co 5 Years Ago Would Be Worth Today,MRK,-0.0048229680324914,-0.0229962507990808,-0.0063296916493946,0.0130999756915213,0.0008252262856971,-0.0041088271355571,0.0282602011195685,-0.02852968658314,0.8055280469689468,1
2023-02-27,Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?,MRK,-0.0048229680324914,-0.0229962507990808,-0.0063296916493946,0.0130999756915213,0.0008252262856971,-0.0041088271355571,0.0282602011195685,-0.02852968658314,0.8055280469689468,1
2023-02-28,Merck Discontinues Two Keytruda Combo Therapy Trials In Prostate & Lung Cancer Settings,MRK,-0.02852968658314,0.8055280469689468,-0.0048229680324914,-0.0063296916493946,0.0130999756915213,0.0008252262856971,-0.0041088271355571,0.0038592242575266,-0.4026386154614638,2
2023-03-01,"After Shelving Two Keytruda Trials, Merck Touts Encouraging Data From Keytruda Regime Study In Lung Cancer Patients",MRK,0.0038592242575266,-0.4026386154614638,-0.02852968658314,-0.0048229680324914,-0.0063296916493946,0.0130999756915213,0.0008252262856971,0.0033755179431902,-0.1642072470896868,2
2023-03-06,Merck Highlights Promising Data From Two Candidates In Heart Diseases,MRK,0.0394835429950521,1.902870766517522,-0.0012148602637888,0.0033755179431902,0.0038592242575266,-0.02852968658314,-0.0048229680324914,0.0015301256980835,-0.2234004252781747,2
2023-03-07,Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason,MRK,0.0015301256980835,-0.2234004252781747,0.0394835429950521,-0.0012148602637888,0.0033755179431902,0.0038592242575266,-0.02852968658314,-0.0268715454665025,-0.3885826457954553,1
2023-03-07,Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success,MRK,0.0015301256980835,-0.2234004252781747,0.0394835429950521,-0.0012148602637888,0.0033755179431902,0.0038592242575266,-0.02852968658314,-0.0268715454665025,-0.3885826457954553,1
2023-03-07,DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday,MRK,0.0015301256980835,-0.2234004252781747,0.0394835429950521,-0.0012148602637888,0.0033755179431902,0.0038592242575266,-0.02852968658314,-0.0268715454665025,-0.3885826457954553,1
2023-03-08,OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck,MRK,-0.0268715454665025,-0.3885826457954553,0.0015301256980835,0.0394835429950521,-0.0012148602637888,0.0033755179431902,0.0038592242575266,,,2
